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Polyarylmethanes are an extremely valuable molecular scaffold used in fields ranging from materials chemistry
to medicinal chemistry. They are found in dyes and semiconductor dopants and in drugs and drug precursors
that address a variety of ailments ranging form depression and allergies to cancer and vascular disease.
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selective ligand to achieve asymmetric cross-coupling. Medicinally valuable diarylmetheylamines are obtained
from tricarbonylchromium-coordinated tertiary benzylamines in good to excellent enantiomeric excess.
Finally, in the third chapter we use the products of the asymmetric cross-coupling with benzylamines to
introduce novel methods to synthesize a new modular chiral P∧N ligand scaffold using a unimetal super-base.
These ligands may be effective in future cross-coupling reactions and asymmetric catalysis.
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possibilities of deprotonated tricarbonylchromium-stabilized benzylic arenes in the context of selective 
bond-forming reactions to form polyarylmethanes. Various η6-arene-tricarbonylchromium complexes 
are deprotonated with the mild silamide base LiN(SiMe3)2 and used directly in selective palladium-
catalyzed syntheses of polyarylmethanes and other potentially valuable molecules from aryl bromides, 
aryl triflates, and vinyl triflates as coupling partners. In the first chapter, we illustrate the unique 
aspects of tricarbonylchromium activation, such as the ability to activate not just one C–H bond, but 
up to six in one flask, leading to highly substituted and sterically hindered products not accessible 
through traditional methods. Additionally, the sterically bulky nature of the tricarbonylchromium group 
is exploited to direct chemistry to the opposite face of polycyclic systems, leading to stereoselective 
reactions difficult to achieve selectively by other methods. Compatibility with α-heteroatom 
substitution and β-hydrogens is also demonstrated. Finally, an unusual mode of isomerization during 
the cross-coupling processes is explored. In the second chapter, the methodology for the synthesis of 
polyarylmethanes is expanded to asymmetric syntheses of di- and tri-arylmethane complexes. Low-
barrier high-throughput experimentation (HTE) methodology is successfully implemented in the search 
for a highly selective ligand to achieve asymmetric cross-coupling. Medicinally valuable 
diarylmetheylamines are obtained from tricarbonylchromium-coordinated tertiary benzylamines in 
good to excellent enantiomeric excess. Finally, in the third chapter we use the products of the 
asymmetric cross-coupling with benzylamines to introduce novel methods to synthesize a new 
modular chiral P∧N ligand scaffold using a unimetal super-base.  These ligands may be effective in 
future cross-coupling reactions and asymmetric catalysis.   
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Introduction 
 
Catalysis and new catalytic reactions 
 
Synthetic Chemistry: the science dealing with the formation of more complex chemical 
compounds from simpler substances.   
Mosby’s Medical Dictionary, 8th Ed.1 
 
The development of bond forming reactions is by definition the central component of modern 
synthetic chemistry.  In particular, the exploration of efficient catalytic bond-forming processes is 
a significant practical goal for many research groups and can be found in nearly every branch of 
chemistry today.   The motivators for catalysis discovery are varied, but aside from basic science, 
one very practical reason for the continued advancement of catalytic reaction methodology is to 
make resource consumption and output more efficient.  Reducing the time and energy spent on 
chemical synthesis, as well as reducing the hazards of the reactions themselves, are advantages 
reaped through development of efficient catalytic bond-forming processes, and they may often 
translate directly to reduced costs for the synthesis of valuable commodities, increased rate of 
output within the context of pharmaceutical drug discovery, and a reduced environmental 
impact.2  The vast potential economic impact of advances in catalysis cannot be undersold here: 
catalysis has been estimated to account for about $3 billion a year of the United States chemical 
industry, and that each U.S. dollar spent on catalysis generates over $150 in products shipped by 
the U.S. chemical industry (data from 2005).3  
Consider the exploration of efficient stereo- and enantioselective metal-catalyzed C–C bond-
forming processes, which is not only seen in modern synthetic organic chemistry, but in nearly 
every other branch of chemistry, from medicine to materials science.  There have been many 
recent advances in transition metal-catalyzed cross-couplings4 such as the Suzuki-Miyaura,5 
Heck,6 and direct arylation reactions.7  Within the broad range of products accessed through 
these catalytic methods are valuable compounds and substructures that are difficult or 
impossible to access selectively with other methods.   
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Within the Walsh Group, research has been focused around stereo- and enantio-selective C–C, 
C–O, and more recently, C–N bond formation reactions and one-pot catalytic synthetic methods.  
As researchers in the field of methodological chemistry and catalysis, we strive to find and 
develop processes that can then be used in the field.  Method scalability and inexpensive 
methods that utilize mild conditions are ideal.  Within this area, both tricarbonylchromium 
activation and palladium cross-coupling to form C–C bonds are new topics of exploration for us, 
and it has been an honor to be the person starting work on this chemistry. 
This dissertation describes some of the exploratory work done to outline the synthetic 
possibilities of lithiated tricarbonylchromium species in the context of catalytic bond-forming 
reactions.  We take a chromium-stabilized organolithium species and directly use it in the 
palladium-catalyzed synthesis of polyarylmethanes and other valuable molecules such as chiral 
ligand scaffolds that may not be possible to synthesize selectively using other methods.   
The polyarylmethane framework is found in compounds that have found application in a broad 
number of chemical fields, from semiconductors to anti-cancer drugs.8,9  In fact, the 
diarylmethane substructure is considered a “privileged scaffold” in medicinal chemistry, that is, it 
is a skeleton that is frequently observed in pharmacophores.10  Most methods to obtain 
polyarylmethanes still rely on Friedel-Crafts-type reactions and other electrophilc aromatic 
substitution (EAS) variants.  However, these come with significant electronic and steric 
limitations.  Thus, broadening access to polyarylmethanes through other methods such as 
transition-metal cross-coupling has become a hot topic in the last several years, but cross-
coupling reactions with at least one sp3-hybridized carbon are generally considered challenging.11 
Within current transition-metal mediated coupling of benzylic substrates to generate di- or 
triarylmethanes,12 the benzylic synthon employed is typically the electrophile (more carbocationic 
in character).  However, using our η6-arene-tricarbonylchromium-based methodology, a stabilized 
nucleophilic (carbanionic) benzylic synthon is created from an sp3-carbon center, resulting in a 
complementary approach to the previous chemistry. 
Our method for benzylic cross-coupling using tricarbonylchromium as activator is efficient in that 
multiple benzylic C–H bonds can be activated with one metal tricarbonyl, and also stereoselective 
in that the tricarbonyl chromium can force reactivity on one side of the arene and even allow 
asymmetric reaction.  Additionally, using the up-and-coming new technology of low-barrier high-
throughput experimentation (HTE) methods in collaboration with Merck & Co., we were able to 
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identify a successful ligand on micromolar scale that helped us take our original non-
enantioselective protocol and develop a highly enantiosemetric version which allowed us to 
synthesize chiral diarylmethylamines in good enantiomeric excess (ee).   It is my hope that the 
fruits from the development of this methodology can become tools in the synthetic chemist’s 
toolbox. 
Finally, the planar chiral metal arene framework also has members in a family of “privileged” 
molecules, but in this case, it is the family of privileged chiral ligand scaffolds in asymmetric 
synthesis.  Chiral tricarbonylchromium arene frameworks are present in a variety of highly 
successful ligands for metal-catalyzed reactions, in particular, asymmetric reactions such as 
hydrogenation and cross-coupling.  The development of a new family of chiral diarylmethylamine-
based chiral ligands is ongoing, but we hope that both the superbase developed for the selective 
synthesis of these catalysts, as well as the catalysts themselves, find specific applications in 
synthetic chemistry and catalysis. 
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Chapter 1  
Arene tricarbonylchromium benzylic anions in cross-coupling 
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Introduction 
History and features of piano stool complexes 
The arene tricarbonylchromium complex, first reported in 1957,1 was initially discovered upon 
attempts derivatize the bis-benzenechromium sandwich complex.  Also called a “piano stool” 
complex, the tricarbonylchromium is a neutral chromium(0) complex with a pseudo-octahedral 
configuration.  Other isoelectronic arene tricarbonyl complexes in groups 6 and 7 are also known.  
There are two main structural features of this and other arene tricarbonylmetal complexes.  The 
first feature is a charge-neutral arene ring which is bound to the metal center in an η6-fashion, 
like the cushion of a stool.  The second is the presence of three electron-poor carbonyl ligands.  
The carbonyl ligands not only provide a large amount of steric bulk, but also accept electron 
density through back-bonding of d-electrons into the antibonding π* orbitals of the CO.  Upon 
coordination to the Cr(CO)3 metal fragment, the the arene ring is activated, and a drastic change 
in arene properties can be observed (Figure 1-1).2  
  
 
Figure 1-1: A photograph of a piano stool dated from the 1820s, compared to a generic 
tricarbonylchromium arene complex.  Enhanced nucleophilicity, acidity of C–H bonds, and rates of 
solvolysis are characterisitic of these complexes.  A sterically blocked face of the arene is also an 
important feature.  All these properties are synthetically useful and conferred to an otherwise inert 
arene. 
 
With these many activating properties of η6-(Arene)tricarbonylchromium complexes, a number of 
research groups have taken advantage of these complexes for synthetic and catalytic use.3,4,5 For 
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example, we can see enhanced nucleophilicity of the ring once it is coordinated to the Cr(CO)3 
group.  This has recently been exploited in the activation of Ar-F bonds toward nucleophilic attack, 
as in the following example by Costa and coworkers (Scheme 1-1).6  The steric bulk can also 
direct chemistry to a single side of the arene ring and enhance stereodifferentiation, allowing 
planar chirality and stereoselective syntheses, as in the total synthesis of (−)-steganone.7  In the 
total synthesis of lasubine(I) by Kündig and coworkers, a Diels-Alder on the top face of the ring 
sets stereochemistry for the subsequent steps (Scheme 1-2).8 
 
Scheme 1-1: Nucleophilic addition to the tricarbonylchromium-activated arene ring 
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Scheme 1-2: Kündig’s stereo- and diastereo- selective total synthesis of (−)-lasubine(I) uses the steric 
directing ability of the tricaronbylchromium for the highly selective (>98% de) Diels-Alder reaction 
 
A third significant activating feature of the tricarbonylchromium group is the ability to stabilize 
charge on the coordinated arene, directly on the arene (anions), on the benzylic position (anions 
and cations),9 and farther from the ring.10  This enhanced thermodynamic — and kinetic11 — 
acidity allows selective or directed deprotonation, often using comparatively mild conditions 
compared to conditions typically used for deprotonating unactivated C–H bonds.  The 
combination of ease of arene lithiation and planar chiral geometry has led to the synthesis of 
various ligands utilizing the arene–Cr(CO)3 scaffold, in particular structural analogues of 
ferrocenyl ligands and other asymmetric ligands with planar chiral and central chiral character 
(Figure 1-2).12   
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Figure 1-2: Chromium arene complexes as ligands for asymmetric catalysis 
 
The enhanced acidity of the benzylic position has also expanded the use of the benzylic fragment 
from the familiar stabilized benzylic cations to stabilized benzylic anions as well.  The chromium-
stabilized benzylic species can thus exhibit reversed-polarity reactions, for example through 
deprotonation of the benzylic C–H with milder bases, followed by an electrophilic quench of the 
anionic carbon.13  The synthetic utility of the tricarbonylchromium benzylic anion has been 
explored by several groups, including Kalinin and coworkers (Scheme 1-3).14  Additionally, Kalinin 
et al have used transmetalation from lithium to zinc to generate a reagent for Negishi-style cross-
coupling with aryl iodides, though yields were low (average <40% yield, Scheme 1-4). 
   
Scheme 1-3: Deprotonation and electrophilic quench of the benzylic position (Kalinin et al)14 
 
 
Scheme 1-4: Generation of a Negishi coupling reagent from a benzylic anion and use in palladium-
catalyzed cross-coupling (Kalinin et al)14 
 
Here we should emphasize the nature of the change in C–H bond acidity of a 
tricarbonylchromium benzylic complex versus the free arene.  The benzylic position of a Cr-
coordinated arene is considered about as acidic as nitrotoluene (using pKa, a thermodynamic 
measure of acidity), but it is important to note that thermodynamic and kinetic acidities are not 
necessarily directly comparable.15  This point in especially salient in arene-Cr(CO)3 complexes.  In 
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fact, coordination of an arene to the Cr(CO)3 fragment increases the kinetic acidity of the benzylic 
C–H bond by a factor of ~105 in comparison to an uncoordinated benzylic arene.11  These 
particular aspects of activation should be studied in greater depth.  Considering the unusually 
stabilized tricarbonylchromium benzylic anion, we could imagine a highly stabilized organolithium 
species, for example, that could potentially be used in metal-catalyzed cross-coupling reactions.  
Specifically, we envisioned palladium-catalyzed cross-coupling reactions of an anionic benzylic 
species with easily-obtained aryl halides.  Such a route could potentially be used for the synthesis 
of polyarylmethanes. 
 
Polyarylmethanes and benzylic cross-coupling reactions 
Polyarylmethanes are a subset of useful chemical scaffold that have found application in a broad 
number of chemical fields, from dyes16 and fluorophores in materials science17,18 to medicinal 
chemistry, such as treatments for vascular disease19 and cancer.20  Of these, the diarylmethane 
substructure is considered a privileged structure — that is, the skeleton is a substructure 
frequently observed in biologically active natural products and pharmaceuticals.  Triarylmethanes 
are currently being explored in several potential cancer drugs (Figure 1-3).21  Developing methods 
to access polyarylmethanes has become an important topic in synthetic chemistry and catalysis 
over the last decade.22   
  
Figure 1-3: some biologically active polyarylmethanes 
 
Most commercial methods to generate polyarylmethanes still rely on Friedel-Crafts-type 
electrophilic aromatic substitution (EAS) processes to generate them (Figure 1-4 A).23   These 
reactions are typically are restricted in reactivity and selectivity.  For example, the nucleophile 
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substrate must be electron-rich and unhindered for adequate reactivity.  Additionally, the 
regioselectivity is highly dependent on sterics and the relative directing ability of the other arene 
substituents.  Electron-poor- or meta- substitution of the arene tends to be problematic for these 
reasons.  Other known alternatives that have been recently developed,24,25 include metal-
catalyzed cross-coupling at the sp3 benzylic center.26  However, cross-coupling reactions with at 
least one sp3-hybridized carbon tend to be more difficult than reactions with sp2– or sp- 
hybridized partners.27  Therefore, current access to polyarylmethanes remains limited (Figure 1-4 
B).28 
     
Figure 1-4: Typical syntheses of polyarylmethanes use carbocationic benzylic synthons, such as in [A] 
Friedel-Crafts reactions, or [B] transition-metal catalyzed cross-coupling with Bn-LGa species. 
 
These existing methods for synthesis also typically make use of an electrophilic (carbocationic) 
benzylic synthon, with a leaving group such as a halide, carbonate, or ester in the benzlic 
position.29  These reactions also often require heating and harsh conditions, or large excess of 
reagent for adequate reactivity.30  While pharmaceutical products must increasingly be 
synthesized in enantiopure form, many processes still rely on chiral auxiliaries and chemical or 
chromatographic resolution of enantiomers.  Finally, while there has been work on asymmetric 
synthesis of diarylmethanes and heteroaromatic triarylmethanes, there are still no existing 
methods to synthesize non-heteroaromatic triarylmethanes in a catalytic enantioselective 
manner.31  
                                                      
 
 
a LG = Leaving Group, e.g. halide, triflate, carbonate. 
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We wondered if it would be possible to create a complementary transition-metal mediated 
method for polyarylmethane synthesis that both circumvented some of these limitations and 
expanded access to this family of compounds by using the tricarbonylchromium-coordinated 
benzyllithium as the benzylic synthon (Scheme 1-5).  Typically, carbanionic reagents for catalysis 
are based on metals such as boron, tin, or zinc to temper reactivity compared with alkali and 
alkali earth organometallics.  They are also predominantly sp2-hybridized at the C–M bond.32  
Direct use of an organolithium species in catalysis is considered by many to be impractical and 
difficult due to its high reactivity and low functional group tolerance.  On the other hand, some 
limited examples of organolithium cross-coupling were explored in the 1970s.33 The use of 
organolithium reagents as raw materials in catalysis has been touted as efficient and desirable 
because their use avoids stoichiometric transmetalation to milder but often more toxic metals.  
Many of carbanionic metal reagents are, in fact, derived from lithiated species, which are in turn 
often prepared from carbon–halogen bonds.  We envisioned in situ deprotonation at the benzylic 
position with a mild base (Figure 1-5 B) would allow us to use the stabilized benzylic anion directly 
in a metal-catalyzed cross-coupling cycle (Figure 1-5 A, C,D, Scheme 1-5).  Ideally, we could then 
install additional functionality by taking advantage of the remaining C–H bond(s) for further 
elaboration (Figure 1-5, E, Scheme 1-5).34 
 
Scheme 1-5: Concept for the use of a stabilized benzylic anion synthon in a benzylic cross-coupling 
reaction.  Ideally, one or more aromatic groups can be installed. 
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Figure 1-5: Envisioned palladium-catalyed cross-coupling cycle starting from [A] oxidative additon of an 
aryl halide to Pd(0), [B] in-situ deprotonation of the sp3-benzylic C–H bond of a stabilized arene 
tricarbonylmetal complex, [C] transmetalation with the LnPd(II)ArX species, and then [D] reductive 
elimination to form the polyarylmethane and regenerate the Pd(0) species.  [E] Further reaction, either 
sequentially or one-pot is considered. 
 
Initial Studies 
Tricarbonylmolybdenum as activating metal fragment 
Initial studies were performed with molybdenum complexes of simple benzylic arenes, in part due 
to the lower stigma associated with using molybdenum as an activating metal relative to 
chromium.  Chromium has received much negative attention due to its toxicity in higher-valent 
states.35,36  Arene–molybdenum complexes also seemed to be an ideal solution to benzylic 
activation.  The weaker arene–Mo bond was considered a favorable property for arene exchange, 
allowing the activating metal carbonyl to be catalytic.  Arene exchange is known for the benzene 
molybdenumtricarbonyl complex at room temperature.37  Thus, η6-mesitylene 
molybdenumtricarbonyl (MoMes, 1) and η6-toluene molybdenumtricarbonyl (MoTol, 2) were 
prepared in low yields consistent with literature procedures (Scheme 1-6).38,39  
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Scheme 1-6: General scheme for the synthesis of η6-arene-tricarbonylmetal complexes from metal 
hexacarbonyl precursor. 
 
Unfortunately, several disadvantages became clear during preliminary studies, mainly regarding 
practical concerns of stability and handling.  The molybdenum complexes were extremely light 
and moisture sensitive and moderately unstable in solution.  They were also easily oxidized by 
trace amounts of air and quickly displaced by strong donor ligands such as THF (Figure 1-6),40 
leading to decomposition products.  Furthermore, after mild heating, metallic molybdenum is 
often deposited on reaction vessels.  In fact, when a small amount of the more stable complex 1 
was dissolved in THF, formation of undesired (and more air-sensitive) (THF)3Mo(CO)3 species40 
occurred within minutes.  Because palladium-catalyzed coupling reactions with reactive 
organometallics tend to employ ethereal or coordinating solvents, this result ruled out a large 
fraction of initial reaction conditions.  Additionally, common arene solvents exchange with the 
parent arene complex, likely limiting us to solvent compositions containing either aliphatic 
hydrocarbon or reagent arene as solvent.  While molybdenum may be a metal to return to for the 
labile property of the arene, for initial cross-coupling reaction development, a more robust and 
easy-to-manage arene activator was desired. 
 
Figure 1-6: Order of stability of ligands in L3-tricarbonylmolybdenum complexes.  The range of energies 
here spans >30 kcal/mol relative to η6-(benzene)tricarbonylmolybdenum. 
 
Tricarbonylchromium as an alternative to molybdenum 
Tricarbonylchromium arene complexes were next explored as an alternative to molybdenum.  
Unlike molybdenum, in η6-(arene)Cr(CO)3 complexes the arene–Cr bond is not easily displaced by 
strongly donating ethereal solvents.41  Moreover, the complexes are considerably more light- and 
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air- stable, and can even be purified via silica gel chromatography.2  The complexes still have the 
ability to undergo arene exchange reactions, and can also be demetallated by simply adding 
iodine or exposing a solution of the complex to bright light and air.42  Test complexes of 
tricarbonylchromium-coordinated toluene (CrTol, 3) and diphenylmethane (CrDPM, 4a) were 
synthesized in good yield from existing literature procedures.  
 
Figure 1-7: Synthesis of η6-(arene)-tricaronylchromium complexes 3 and 4a. 
 
First, we examined conditions for deprotonation of the benzylic hydrogens of (η6-arene)Cr(CO)3 
complexes.  Selected thermodynamic acidities are noted below in Table 1-1.43   It seemed that 
tert-butoxide and amide bases would be appropriate bases to start with due to a similar range of 
pKa values relative to the anticipated range of acidity in coordinated benzylic arenes.  In 
particular, NaOtBu and LiHMDSa have been successfully used for palladium-catalyzed α–arylation 
of ketones, another case where a highly labile and stabilized C–H bond undergoes deprotonation 
and cross-coupling.44,45   
Table 1-1: Thermodynamic acidities of selected conjugate acids and free arenes. 
Proton iPr2N-H HMDS-H tBuO-H PhCH3 Ph2CH2 Ph3C-H 4-NO2-C6H4-CH3 
pKa 36a 30b, 26a  29.4b 43b 32.3b 30.6b 20.4b 
a pKa value in THF. b pKa value in DMSO. 
 
CrTol 3 and CrDPM 4a were reacted with base in NMR tubes to asses the extent of deprotonation 
in THF (Scheme 1-7).  Addition of LiHMDS to CrDPM (4a) led to immediate change in color from 
                                                      
 
 
a LiHMDS = lithium hexamethylsilazane, LiN(SiMe3)2 
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yellow to a deep orange, and deprotonation was found to be approximately 50% overall.a  In the 
case of CrTol (3), color change was not noticeable but this was not surprising: only about 10% of 
3 was deprotonated with 1 equivalent of LiHMDS.  Equilibrium for both LiHMDS deprotonation 
reactions was established quickly (within minutes), and decomposition of the anion did not seem 
to be a problem.  Earlier work by Kalinin et al on benzylic (η6-arene)Cr(CO)3 complexes 
deprotonated using the much stronger lithium amide base LiNEt2 indicated that the lithiated 
species were not thermally stable above 0 °C.b,46  These favorable results paved the way for 
screening additional cross-coupling experiments.c    
  
Scheme 1-7: Deprotonation experiments of 3 and 4a using LiHMDS as base, observed by 1H NMR.  
The monomeric organolithium is depicted for clarity. 
 
                                                      
 
 
a Extent of deprotonation was determined by integration of arene protons of 4a vs 4a-Li in protio-THF by 1H 
NMR. 
b Kalinin and coworkers claim that the practical barrier to using lithiated species of tricarbonylchromium for 
benzylic functionalization (generated using a strong lithium amide base LiNEt2) is the insufficient thermal 
stability of the lithium derivatives, which are only “stable for a few minutes at 20 °C”  
c Experiments with NaOtBu as base were difficult to monitor in situ due to the low solubility of both the base 
and formation of orange insoluble precipitate. 
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Figure 1-8: Inset of a protio-THF 1H NMR and diagram depicting the successful deprotonation (~50%) 
of 4a (blue peaks), indicated by an upfield shift and diasterotopic arene hydrogens in 4a-Li (red peaks) 
(Scheme 1-7).  Monomeric anion is depicted for clarity. 
 
Coupling diarylmethanes with aryl bromidesa 
The tricarbonylchromium complex of diphenylmethane CrDPM (4a) was used as a starting 
material for initial cross-coupling reactions due to the more stabilized nature of the chromium-
coordinated diarylmethyl anion (Scheme 1-8).  Thus, a THF solution of 4a, 4-bromotoluene, a 
slight excess (1.5 equiv.) of base, and catalyst (3–10 mol%) was reacted at room temperature or 
55–60 °C to yield the tricarbonylchromium-coordinated triarylmethane (5a) (Scheme 1-8, Table 
1-2). 
 
Scheme 1-8: Optimization of cross-coupling reaction with 4a to form 5a. 
 
                                                      
 
 
a Initial reaction optimization was done in collaboration with undergraduate researcher J. Temaismithi. 
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Table 1-2: Initial screen of conditions for the coupling reaction of 4a with 4-bromotoluene. 
entry      catalyst mol % Base* time (h) yield (%) rec. SM (%) 
1 PdBr2(PPh3)2 10 LiOtBu 24 0† – 
2 PdBr2(PPh3)2 5 NaOtBu 24 0† 67 
3 PdCl2(PPh3)2 3 LiHMDS 20 70† 5 
4 PdCl2(PPh3)2 3 LiHMDS 0.75 91 0 
5 PdCl2(PPh3)2 3 LDA 12 50 trace 
6 PdCl2(PPh3)2 5 NaHMDS 18 26 38 
7 PdCl2(PPh3)2 5 KHMDS 20 9 48 
8 NiCl2(PPh3)2 5 LiHMDS 20 0 29 
9 Pd(PPh3)4 5 LiHMDS 17 67 <20 
10 PdCl2(dppf) 5 LiHMDS 19 78 <20 
* HMDS = hexamethyldisilazide, N(SiMe3)2; LDA = lithium diisopropylamide. †Conducted at room temperature. 
 
Neither alkoxide bases LiOtBu or NaOtBu resulted in the formation of coupling product 5a when 
run at room temperature in THF (entries 1 and 2).  On the other hand, switching to LiHMDSa led 
to a bright red solution that showed clean and moderate conversion on TLC.b  Unfortunately, 
attempts to isolate the product using a standard aqueous workup and extraction resulted in low 
isolated yields.  A milder workup involving minimal use of water and direct column purification of 
the crude reaction mixture was found to be more suitable.  Encouragingly, running the reaction 
for 20 h at room temperature, followed by the new purification procedure led to 70% isolated 
yield of the coupling product (entry 3).  While organolithium reagents are typically sensitive to 
high temperatures, in our case raising the temperature to 55–60 ºC led to clean and rapid 
formation of product after only 45 minutes.  Thus, compound 5a was obtained in 91% isolated 
yield using only 3 mol% of simple bis-triphenylphosphine palladium(II) precatalyst PdCl2(PPh3)2 
(entry 4).  A stronger lithium base, such as LDA,c led to the formation of multiple products and 
decomposition (entry 5); adding any amount of butyllithium quickly led to decomposition of 
                                                      
 
 
a LiHMDS = Lithium hexamethyldisilazide, LiN(SiMe3)2 
b TLC = Thin-Layer Chromatography, run on glass-backed silica. 
c LDA = Lithium diisopropylamide, iPr2NLi. 
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starting materials above 0 °C.  Other bases such as NaHMDS (entry 6), and KHMDS (entry 7) 
were also explored, but the reactions became cloudy and were slower and less clean than with 
LiHMDS.  A nickel precatalyst (NiCl2(PPh3)2, entry 8) was ineffective, and decomposed the starting 
material over time (20 h).  Other palladium-based precatalysts were also examined, but both 
Pd(PPh3)4 and PdCl2(dppf)a were less active (entries 9 and 10).  The optimal conditions listed in 
entry 4 of Table 1-2 were used as the base conditions for examining substrate scope of the 
coupling reaction.  
 
Diphenylmethane cross-coupling scope 
CrDPM (4a) couples readily with a variety of aryl bromides to generate triarylmethane complexes 
5a–5k in good yield (81–94%) (Scheme 1-9, Table 1-3).  4-Bromotoluene (5a, entry 1, 
bromobenzene (5b, entry 2), and 2-bromonaphthalene (5c, entry 3) all provided ≥90% yield of 
desired coupling product.  The presence of low to moderately electron-withdrawing groups on the 
aryl bromide also provided desired coupling products 5d (4-Cl- substitution, entry 4) and 5e (4-F 
substitution, entry 5), though yields in this case were slightly lower.  The intact C–X (X = Cl, F) 
bonds have the potential to be further functionalized through lithium-halogen exchange or 
additional transition-metal mediated cross-coupling processes,47 allowing additional structural 
complexity to be added.  It should be noted that strongly electron-withdrawing aryl bromides 
showed little to no yield: desired product was not observed for p-NO2-bromobenzene, and only 
27% yield was obtained for p-CF3 substituted product 5f (entry 6).  In the case of the very 
electron-rich p-NMe2- and p-MeO- substituted products 5g (entry 7) and 5h (entry 8), yields were 
very high: 91% and 94%, respectively.  This indicates that oxidative addition is not likely a 
bottleneck in the catalytic cycle.  
  
                                                      
 
 
a dppf = bis-diphenylphosphinoferrocene 
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Scheme 1-9: Single coupling of 4a with aryl bromides to form triarylmethane complexes: reaction 
scope (Table 1-3). 
Table 1-3: Scope of the single-coupling reaction of 4a with ArBr (Scheme 1-9).  
Entry*  Ar =  yield† 
1 5a 
 
91‡ 
 
2 5b 
 
92 
3 5c 
 
90 
4 5d 
  
83 
5 5e 
 
88 
6 5f 
 
27 
 
Entry*  Ar =  yield† 
7 5g 
 
91 
 
8 5h 
 
94 
9 5i 
 
91 
10 5j 
 
81◊ 
11 5k 
 
89 
    
 
*Conducted at 55–60 °C using 1.5 equiv. LiHMDS, 1.5 equiv. ArBr, 3–5 mol % PdCl2(PPh3)2, and THF as solvent. 
†Isolated yields. ‡Averaged over 3 runs.  ◊A small amount (<10%) of unreacted starting material was also isolated. 
 
Steric issues did not seem to be a concern for the substrates explored.  Single ortho-substitution 
on the aromatic ring (2-MeO-, 5i, Table 1-3, entry 9) gave an isolated yield comparable to arenes 
with para-substitution (91%); a single-crystal X-ray crystal structure was obtained, and is included 
below (Figure 1-9).  Even the bulky 2,6-subsituted aryl bromide 2-bromo-1,3-dimethylbenzene 
was a successful reaction partner, though the reaction took longer and had a slightly lower yield 
of product 5j (81%, entry 10).  TIPS-protected 4-bromoindole showed good reactivity as well to 
provide 5k in 89% yield (entry 11), illustrating the complementary synthetic utility of our method 
compared with EAS processes in producing medicinally relevant structures. 48   EAS methods to 
install the indole functionality would favour construction of the C–C bond at the 3-position 
(alternately, at the 2-position if the 3-position is blocked).49 
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In no instances was a second coupling event to form 6 observed, despite the fact that the 
benzylic C–H should be more acidic, and the anion should be more stabilized than the mono- or 
di- arylmethane complexes.  This is likely due to sterics of the tertiary triarylbenzyllithium species, 
which should hamper transmetalation with the active catalyst center despite deprotonation of the 
triarylmethane.a 
 
Scheme 1-10: No formation of tetraarylmethane product 6 was observed under these conditions. 
 
 
Figure 1-9: X-ray crystal structure of single-coupled product 5i; thermal elipsoids are at 50% 
probability.  Full details can be found on page 249. 
 
                                                      
 
 
a The topic of triarylmethane deprotonation is addressed in greater depth on p. 19 (Scheme 1-12). 
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Examining cross-coupling at a less acidic toluene complex. 
Following the success of coupling at the stabilized diphenylmethane complex, we considered the 
possibility of benzylic cross-coupling at the less acidic methyl of CrTol (3).  Despite the low 
percentage of deprotonated species in solution noted in the NMR experiment discussed earlier 
(see Figure 1-8, p. 12), it was possible that the kinetically fast and reversible deprotonation would 
still allow cross-coupling to occur (similar to reactions with ketones, in which the active enolate 
species is a minor component of the solution).  CrTol (3) was reacted with bromobenzene in THF 
with PdBr2(PPh3)2 (Table 1-4).  Disappointingly, coupling did not proceed at room temperature 
with 1 equivalent of base.  However, upon adding larger excess of base to increase the fraction of 
deprotonated primary benzyllithium in solution, moderate amounts of product 5b were observed 
(18% isolated yield) after 24h.  Finally, upon heating the reaction and adding additional base, 
excellent conversion to coupling products was seen, resulting in up to 90% isolated yield of the 
triarylmethane complex (5b).  
  
Table 1-4: Double-coupled triarylmethane 5b, not the diarylmethane, was isolated after reaction of 3 
with bromobenzene at elevated temperature and with excess base. 
 
Interestingly, in all cases (even when only 1 equivalent of base was used), only the triarylmethane 
complex 5b was isolated as the main product.  One might initially expect the more sterically-
hindered secondary organolithium 4a-Li to react slower with the palladium catalyst relatively to 
the primary organolithium 3-Li.  However, it seems that this effect is overridden by the greater 
acidity of the diphenylmethane intermediate 4a relative to 3 (Scheme 1-11), leading to a 
predominance of 4-Li in solution compared to 3-Li.  Thus, preferential reactivity of the 
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diarylmethane to form triarylmethane is observed, and little if any diarylmethane intermediate is 
intercepted.a   
 
Scheme 1-11: Reaction of CrTol (3) with most aryl bromides yields tri-arylmethane due to the greater 
acidity of the diarylmethane 4 and higher proportion of  4-Li in solution. 
 
The scope of the double-coupling reaction was next explored.  Triarylmethanes (Table 1-5, entries 
1–8) were synthesized in good yields from CrTol (3) and aryl bromides using a moderate excess 
of LiHMDS (2.8 equiv.) and 4–8 mol % palladium catalyst loading (Scheme 1-11).  As in the case 
of the single-coupling reaction with CrDPM 4a (see p. 15), more electron-withdrawing aryl 
bromides (entries 2 and 3) performed slightly poorer with respect to the more electron-rich and 
electron-neutral aryl bromides (entries 1, 5–8) and required slightly higher catalyst to achieve 
similar yields.  In the case of entries 4 and 6, some unexpected isomerization and side products 
were observed, which will be discussed in detail later in this chapter (see p. 40). 
                                                      
 
 
a Referring back to the 1H NMR deprotonation study (p. 25), the extent of deprotonation of Cr-
diphenylmethane 4a was several times higher than that of CrTol 3 (50% vs 10%) in THF. 
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Table 1-5: Single and double coupling reactions of CrTol (3) with aryl bromides to yield di- and tri-
arylmethanes 4 and 5. 
Entry#  Ar = Yield (%)* 
1 5b 
 
90 
2 5l 
 
83 
3 5m 
 
78 
4 5n 
 
78+ 
 
5 5o 
 
84 
                  
 
Entry  Ar = Yield (%) 
6 5p,5p′ 
 
93† 
7 5q OMe
 
86‡ 
8 5r 
 
88 
9 4b 
 
86+ 
                 
10 4c 
 
81‡  
                  
 
# Reactions were conducted at 45–60 °C using 2.8 equiv. LiHMDS, 3 equiv. ArBr, 4–8 mol% PdCl2(PPh3)2, and 
THF as solvent.. *Isolated yield. +Isolated yield of desired triarylmethane product; 6% walk/polymerization product 
isolated separately, see p.40.  †Isolated in a mixture of isomers; running the same reaction with higher catalyst 
loading led to 82% yield of the major product 5p after purification ‡Trace starting material 3 recovered. 
 
While overall the isolated yields are slightly lower than the single-coupling case, it should be kept 
in mind that isolated yields are after two consecutive cross-coupling events, in which the single 
Cr(CO)3 moiety activates two separate C–H bonds.  This is a more efficient one-pot route 
compared to sequential installation of two aryl groups through generation and use of 
stoichiometric transmetalation reagents, which can only effect one coupling per equivalent.  The 
crystal structure of the double-coupled triarylmethane 5n was obtained and is included below 
(Figure 1-10). 
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Figure 1-10: X-ray crystal structure of 5n.  Thermal ellipsoids are at 30% probability.  Full details can 
be found on p. 257. 
 
While a single ortho substituent on the aryl group did not seem to drastically affect the outcome 
of the double-coupling reaction to form sterically congested product 5r (Table 1-5, entry 8), 
adding a second ortho substituent to the aryl bromide led to the exclusive isolation of 
diarylmethanes 4b and 4c in 81–86% yield (entries 9, 10).  That is, the steric bulk was increased 
to such a level that the diarylmethane could not easily adopt a planar sp2-hybridized benzylic 
position upon deprotonation (steric inhibition of conjugation, Figure 1-11 below), and the reaction 
stopped at a the single-coupling product.  It should be noted that 1,3,5-triisopropylbromobenzene 
used in entry 10 is an extremely unusual coupling partner, as the massive sterics for this arene 
typically do not allow it to be a successful cross-coupling substrate. 
  
Figure 1-11: A deprotonated diarylmethane with two ortho substituents is not able to stabilize anionic 
charge on tricarbonylchromium thorugh conjugation due to steric limitations at the benzylic carbon, 
which cannot easily adopt an sp2-configuration. 
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To verify that these bulky diarylmethanes do not deprotonate under our reaction conditions, a 
sample of 4c was combined with LiHMDS (8 equiv.) and heated in THF for 15 h at 60 °C.  Upon 
quenching with D2O, no D incorporation was detected by 1H NMR.  The tricarbonylchromium 
complex did, however, partially decompose, likely due to the harsh conditions and lengthy 
reaction time.  
As in the coupling reactions with CrDPM (4a), Tetraarylmethane products were not observed with 
these conditions (see Scheme 1-10, p. 16), despite the added stability of the tertiary benzylic 
anion.  This led us to question whether the anion was forming in solution in the first place.  
Triarylmethane 5l was deprotonated with 2 equivalents of LiHMDS at both room temperature and 
at 65 °C, then shaken with D2O to quench the anion (Scheme 1-12).  While ~95% deuterium 
incorporation was observed for the heated reaction, no detectable deuterium incorporation was 
observed in the reaction at room temperature.  This indicates that the triarylmethane has a 
higher thermodynamic acidity (pKa), but that the kinetic barrier to deprotonation is higher than 
that of either the di- or mono- arylmethane. 
 
Scheme 1-12: Deprotonation experiments with triarylmethane 5l indicates a higher acidity than a di- or 
mono- arylmethane, but the kinetic acidity is lower than expected: no noticeable D-incorporation was 
observed at room temperature (determined by 1H NMR). 
 
A large-scale reaction was run at 5 mmol to generate a triarylmethane that would not be able to 
be produced through traditional Friedel-Crafts processes (Scheme 1-13).  The CrTol complex (3) 
was reacted with 3-bromoanisole to generate a solution of double-coupled product 5q, which was 
directly decomplexed through exposure to sunlight and air.  The decomplexed triarylmethane 
PhCH(3-C6H4-OMe)2 7 was isolated in 93% yield after chromatography. 
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Scheme 1-13: Large-scale (5 mmol) coupling reaction and in-situ decomplexation gave triarylmethane 
7 in 93% isolated yield after column chromatography. 
 
Activation of multiple benzylic positions on a single arene 
If two coupling reactions could occur on a single methyl group of CrTol (3), then it seemed 
possible that multiple methyl groups such in tricarbonylchromium complexes of p-xylene 8 and 
mesitylene 9 could be activated as well.  Referring back to Scheme 1-12, the triarylmethane 
complex’s tertiary benzylic center is thermodynamically more acidic than the di- or mono- 
arylmethane center, so we were concerned that persistent deprotonation of the tertiary center 
and disfavored formation of a di-anion would hamper further reactivity of the other aryl methyl 
group (Scheme 1-14 below). 
  
Scheme 1-14: Reaction at multiple benzylic positions on a single arene: Would the presence of a 
persistent triarylmethane anion prevent the less acidic tolyl proton from reacting? 
 
The p-xylene complex 8 was reacted with the bulky (doubly ortho-substituted) aryl bromide 1,3,5-
triisopropylbenzene, which was expected to only undergo coupling once per benzylic position, 
disfavoring further deprotonation and reaction.  The reaction was sluggish due to the large size of 
the aryl bromide, but an encouraging mixture of single-coupled intermediate 10 and desired 
double-coupled product 11 was observed.  Full conversion was obtained using more forcing 
conditions (≥5 equiv. base and >10 mol% catalyst loading with heating at 55 °C for 24 hours), 
and 11 was isolated in 73% yield (Scheme 1-14). 
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Scheme 1-15: Single coupling on each methyl of (η6-p-xylene)Cr(CO)3 (8)  with the extremely bulky 
arene 1,3,5-triisopropylbromobenzene. 
 
Moving on to a less sterically bulky aryl bromide in which deprotonatable triarylmethane centers 
could be generated and remain deprotonated in solution meant that an even larger excess of 
LiHMDS was expected to be necessary to form the tetraarylated product 12 (Scheme 1-16).  In 
this case, nearly 10 equivalents of LiHMDS was required for full conversion (70% yield), also 
suggesting the possibility of polyanions such as 13-Li2 forming reversibly during the reaction.50,a  
The 70% isolated yield obtained here reflects a per-coupling yield of 91%.   
 
Scheme 1-16: Tetra-arylated complex 12 is formed in good yield from 8, though large excess of base 
and 10 mol % catalyst loading is needed for full conversion. 
 
We also examined arylation of the mesitylene complex CrMes (9) with both bulky 1,3,5-
triisopropylbromobenzene and electron-rich 4-bromoanisole or slightly electron-poor 4-
bromofluorobenzene.  Coupling at 2 of the 3 methyl groups of the mesitylene did not pose much 
difficulty.  Diarylation with 1,3,5-triisopropylbenzene led to product 14 in up to 55% yield, and 
tetraarylation with 4-bromofluorobenzenee provided 15 in up to 64% yield (Scheme 1-17).  
                                                      
 
 
a The tricarbonylchromium group has been known to stabilize di- and tri-anions directly on the arene ring, 
see work by S. Gibson and coworkers. 
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However, achieving full conversion to the C3-symmetric products tri-arylated  16 from 1,3,5-
triisopropylbenzene (up to 33% yield) or hexa-arylated 17 from 4-bromoanisole (43% yield, or 
>86% yield per coupling event) proved to be more difficult.  This is not surprising, considering the 
massive crowding at the central arene due to the multiple aryl groups and the 
tricarbonylchromium group, which forces all benzylic aryl groups upward (see the x-ray crystal 
structure of 17a below, Figure 1-12).  In reactions of CrMes (9) with 1,3,5-triisopropylbenzene or 
4-bromofluorobenzene, LDA was also examined as an alternative base to LiHMDS due to its 
greater basicity, in hopes that the tri- and hexa-arylated products could be isolated.  However, the 
less substituted di- and tetra-coupled products 14 and 15b were generated as the major product 
instead of the fully substituted C3-symmetric products.  Since equilibrium of deprotonation of the 
benzylic position is considered to lie far to the right for the much stronger LDA (pKa of iPr2NH vs 
HMDS-H is 36 and 26, respectively, in THF solvent.  See Table 1-1 on p. 10), this may support the 
idea that the Cr(CO)3 group can stabilize more than one anion on the benzlic position (see 
Scheme 1-16 above).  It is also possible that the lithiated species that is assumed to be 
oligomeric in solution does not transmetallate as readily with the diisopropylamine when there is 
excessive crowding. 
 
Scheme 1-17: Reactions using (η6-mesitylene)Cr(CO)3 9 showed that coupling products 14 or 15 
formed relatively  easily at 2 of 3 methyl groups, though complete coupling to form the C3-symmetric 
products 16 and 17was difficult due to sterics. aLDA was used as base instead. 
                                                      
 
 
a The crystal structure for 17 can also be accessed through the Cambridge Crystallographic Data Centre 
(use the reference ID number: CCDC 775771). 
b For 15, LDA was used instead of LiHMDS 
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Figure 1-12: X-ray crystal structure (side and top views) of the pinwheel-like 17 illustrates the sterically 
crowded nature of the complex.  Thermal ellipsoids are at 50% probability.  CO ligands are unusually 
distorted, see full details on page 264. 
 
Next we examined reaction with ortho-substituted xylene complex CroXyl (18, Scheme 1-18).  
Single arylation of each benzylic methyl could be achieved with a 2,6-di-substituted 
bromobenzene (this time using 2-bromo-1,3-dimethylbenzene) to give 19 in 85% yield.  Using less 
the sterically demainding aryl bromide N,N-dimethy-4-bromoaniline and 3 equiv. of LiHMDS and 
running the reaction for 20 h provided the racemic planar chiral complex 20, in which the two 
couplings happened at a single methyl, in 64% isolated yield; a symmetrical coupling product 
analogous to 19 was not observed.  By simply increasing the amount of LiHMDS to 5 equiv. and 
increasing the run time of the reaction to 24 h, the tri-arylated product 21 was isolated as the 
major product (48% yield).  Despite attempting reaction of CroXyl (18) with large amounts of 
excess base, formation of tetracoupled product 22 was not observed; as can ben seen in Scheme 
1-19, both formation and transmetallation with 21-Li would be extremely unfavorable due to 
sterics. 
 
Scheme 1-18: Coupling of (η6-o-xylene)Cr(CO)3 18 with various aryl bromides leads to symmetrical di-
coupled 19, planar chiral di-coupled 20, and tri-coupled 21 products. 
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Scheme 1-19: In the coupling reaction of 18 with 4-NMe2-C6H4-Br, the reaction stops at 3 coupling 
events due to sterics which prevent deprotonation and further reaction at the second benzylic site. 
 
As seen in the activation and coupling at multiple C–H bonds of toluene, xylene, and mesitylene, 
the reactions presented here have a distinct advantage over other cross-coupling methods.  
Tricarbonylchromium allows us to perform up to 6 coupling reactions per equivalent of 
tricarbonylchromium to form highly symmetric complexes.  We can also synthesize unusual 
planar-chiral complexes that lack central chirality centers.  Further functionalization of Ar–F 
bonds47 or deprotection and then functionalization of Ar–OMe bonds could potentially establish 
these polyarylated methanes as useful dendrimer cores.  
 
Compatibility with benzylic heteroatoms 
Single coupling with aryl bromides α- to benzylic ethers 
So far, we have examined the reactions of carbon-substituted benzylic centers.  We next 
considered the compatibility of the reaction with heteroatom substitution at the benzylic carbon.  
Polyarylated benzyl ethers are known to be particularly promising candidates in cancer drug 
development.51 An alkyl benzyl ether complex (η6-nPrOC6H5)Cr(CO)3 (23) was synthesized to test 
for reactivity in the coupling reaction.  It was expected to be a successful coupling partner due to 
a more stabilized benzyl anion influenced by the alkoxy subistution.  Thus, 23 was reacted with 
bromobenzene in THF using the typical reaction conditions in the hopes of isolating 24a as 
product (Scheme 1-20). However, the benzyl ether turned out to be a considerably more sensitive 
substrate under these conditions, and initially large amounts of highly polar dimerized products 
(25) lacking the propyl ether substitution were observed as baseline side products (Scheme 
1-20).  The proposed mechanism of elimination is given below (Scheme 1-21). 
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Scheme 1-20: Coupling reaction of tricarbonylchromium-coordinated benzyl ether 23 with PhBr under 
standard conditions led to multiple products, including the elimination dimer (25), a bis-
tricarbonylchromium stilbene. 
 
    
Scheme 1-21: Proposed mechanism for the formation of bis-tricarbonylchromium stilbene (25). 
 
Luckily, the solution to the problem was relatively simple.  Employing slow addition of a THF 
solution of LiHMDS added over several hours and high catalyst loadings avoided high 
concentrations of benzylic anion 23-Li and circumvented excessive formation of 25; 24a was 
formed in good yield (Scheme 1-22 and entry 1, Table 1-6).  Slightly electron-withdrawing p-
bromofluorobenzene was a successful coupling partner (75% yield, Table 1-6, entry 2), as was 
electron-rich p-bromoanisole (80% yield, entry 3).  Single and double ortho-substitution also were 
tolerated (entries 4 and 5), though in the case of 2-bromo-1,3-dimethylbenzene yields were lower 
(<60%).  Note that the slow base addition protocol is slightly reminiscient of Murahashi’s solution 
to a palladium-catalyzed coupling reaction of stabilized ortho-lithiated sp3-carbon centers, in 
which a slow and precise rate of addition of their deprotonated sp2-organolithium was required to 
minimize homocoupling product while preserving catalyst stability. 52 
 
Scheme 1-22: Single coupling of Cr(CO)3-benzylmethyl ether 23 with aryl bromides to yield diarylmethyl 
ether complexes 24a–24e (Table 1-6).  To minimize formation of stilbene dimers (25), slow addition of 
LiHMDS was required. 
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Table 1-6: Single coupling of (η6-nPrO-C6H5)Cr(CO)3 23 with ArBr resulting in 24a–24e (Scheme 1-22). 
Entry  Ar = Yield (%)* 
1 24a 
 
81 
2 24b 
 
75 
3 24c 
 
80 
 
Entry  Ar = Yield (%) 
4 24d 
 
77 
5 24e 
 
58 
    
 
*isolated yields. 
 
During a larger scale reaction of Cr-benzylpropylether 23 to form the diarylmethyl ether 24a, a 
trace amount of a less polar side product was noticed on TLC.  We originally hypothesized that 
this was a small fraction of the diarylmethane product that had eliminated propoxide.  However, 
isolation of this material revealed the formation of a symmetrical product that still retained the 
propoxy group: the tri-aryl methyl ether 26a, a fully-substituted benzylic center, was isolated in 3% 
yield (Scheme 1-23)! 
   
 
Scheme 1-23: Comparison of the deprotonated species 5b, in which further arylation is not observed, 
and 24a, in which further arylation to form the fully-substitued complex 26a was observed. 
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Double coupling to furnish fully-substituted triarylmethyl benzyl ethers. 
While the sterics of a lithiated chromium triarylmethane such as 5b-Li (Scheme 1-23, above left) 
seem to be too great for transmetallation and further reaction to form tetraarylmethanes, the 
stabilized anion of tricarbonylchromium diarylmethyl benzyl ether 24a-Li is surprisingly still able to 
undergo further reaction to form the fully substituted triarylmethane center.  The difference in 
reactivity is likely due to the smaller size of the propoxy group vs aryl.  We were interested to see 
whether larger amounts of triarylmethyl ether could be isolated by modifying these reaction 
conditions.  By screening varying amounts of catalyst, base, and reaction time (Table 1-7), we saw 
that combining longer reaction times and higher amounts of LiHMDS with 10 mol % palladium 
catalyst loading could provide 26a in good yields (up to 73% yield, Table 1-7, entry 5). 
Table 1-7: Optimization of reaction conditions for one-pot synthesis of triphenylmethyl ether complex 
26a from simple tricarbonylchromium benzyl propyl ether 23. 
entry           mol % [Pd]* Time (h) Equiv. LiHMDS† Yield 24a (%)# Yield 26a (%) 
1 7 1.5 2.0 73 1.5 
2 10 1.3 2.2 77  – 
3 8 48 2.2 44 20 
4 10 48 2.3 18 43 
5 10 16 4.0 9 73 
6 5 48 4.0 57◊ 14◊ 
Reactions are run in THF at 55 °C. *Unless otherwise stated, Pd catalyst = PdCl2(PPh3)2. # Yields are after 
isolation. †Unless otherwise stated, LiHMDS was added to the reaction mixture slowly over 1.5–3 h. ◊Reaction 
was run with PdCl2[norbornadiene] and racemic BINAP. 
 
The optimized conditions above were used to form symmetrical and unsymmetrical 
tricarbonylchromium triarylmethyl ethers (Scheme 1-24).  In Table 1-8, entries 1–3, yields of 
symmetrical 26a and 26b, and unsymmetrical 26c are one-pot without isolation of the 
diarylmethylether intermediate 24a or 24b. In entries 4–7, the diarylmethyl ether intermediate 
was isolated separately (for yields, see entries in Table 1-6, p.28), and electron-rich (26e, Table 
1-8, entries 4, 5, and 6) and sterically hindered (26f, entry 6) aryl bromides were good substrates.  
In the case of entries 4 and 5 it should be noted that the triarylmethyl propyl ether is chiral even 
after decomplexation from tricarbonylchromium.  Unsymmetrical triarylmethanes mixing both 
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electron rich and electron poor groups are considered difficult compounds to make due to the 
electronic restrictions of typical Friedel-Crafts-type reactons.53 
 
Scheme 1-24: One-pot and stepwise syntheses of symmetric and non-symmetric triarylmethanes. 
 
Table 1-8:  Synthesis of tricarbonylchromium-coordinated triarylmethyl benzyl ethers (Scheme 1-24). 
One-pot reactions 
Entry    Ar =   Ar’ = Yield 
(%) 
1 26a 
  
 81* 
2 26b 
  
 53* 
3 26c 
 
 31*† 
     
 
Stepwise reactions 
Entry  Ar = Ar’ = Yield 
(%) 
4 26d 
  
 80# 
5 26e 
 
 69# 
6 26f 
  
 59# 
7 26g 
  
 61# 
 
*Reactions in entries 1–3 start from benzyl propyl ether complex 23; intermediate diarylmethyl ether complex was 
not isolated. #Isolated yields are starting from the diarylmethyl ether 24b (entries 4 and 5) or from 24a (entries 6 
and 7). †1 equivalent of bromobenzene was added; 4-tert-butylbromobenzene was then added after full 
conversion to diarylmethyl ether intermediate 24a was observed by TLC. 
 
Coupling α- to benzylamines 
We next addressed cross-coupling α- to tertiary benzylic amines.  It is known that, unlike other 
kinds of heteroaromatic substitution, α- amino substitution makes deprotonation at sp3 carbon 
centers surprisingly difficult.54,55  We initially synthesized a complex of N,N-dimethylbenzylamine 
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(η6-Me2NCH2C6H5)Cr(CO)3 (27) to test our reaction strategy on tertiary amines.  Subjecting 27 to 
palladium cross-coupling conditions similar to other standard (non-ether) chromium complexes 
yielded diphenylmethyl N,N-dimethylbenzylamine (28a), though the reaction was markedly slower 
than the aryl ether substrates.  Larger amounts of LiHMDS were required to push the less 
reactive benzylamine to completion, but diarylmethylbenzylamines 28a–28d were isolated in 
moderate to good yields (62–82%).  Electron rich and poor aryl bromides and singly ortho-
substituted 2-bromoanisole all served as good coupling partners (Scheme 1-25, Table 1-9, 
entries 1–4).  The crystal structure of 28c was obtained and is shown in Figure 1-13.  
Unfortunately, doubly ortho-substituted aryl bromide (in our case, 2-bromo-1,3-dimethylbenzene) 
was not effective, and no product 28e was detected, indicating that this system is more sterically 
hindered and less reactive. 
 
Scheme 1-25: Cross-coupling of N,N-dimethylbenzylamine tricarbonylchromium complex 27 with aryl 
bromides to yield diarylmethylamines in 62–82% yield (Table 1-9). 
 
Table 1-9: Synthesis of diarylmethylamines 28a–28d from 27. 
Entry  Ar = Yield (%)* 
1 28a 
 
82 
2 28b 
 
62 
3 28c 
 
77 
 
Entry  Ar = Yield (%) 
4 28d 
 
72 
5 28e 
 
 – # 
    
 
*Isolated yields. # No coupling product was observed for this reaction. 
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Unlike the benzyl ether substrates, we were unable to observe any amount of di-coupling 
triarylmethylamine product 29.  Additionally, attempts to push the formation of these species by 
running the reaction with high catalyst loadings and large amounts of base failed to yield to 
triarylmethylamine products.  It is likely that an entirely different set of deprotonation conditions 
and catalyst would be necessary.  The diarylmethylamines we were able to synthesize are a very 
important class of molecules.  The substructure is present in numerous medicines and drug 
candidates,56 including the “non-drowsy” antihistamine cetirizine hydrochloride, marketed under 
the brand name Zyrtec. 
 
Figure 1-13: X-ray crystal structure of 28c.  Thermal ellipsoids are at 50% probability.  Full details can 
be found on p. 276. 
 
Compatibility with β-hydrogens 
β-hydrogens not constrained to ring systems. 
All the substrates explored thus far have a certain aspect of complexity removed from them which 
tends to be a significant issue that must be addressed in typical sp2–sp3- and sp3–sp3-cross-
coupling reactions: that is, the presence of β-hydrogens.  The simple tricarbonylchromium 
ethylbenzene substrate 30 was synthesized in excellent yield and subjected to the standard 
coupling conditions with PdCl2(PPh3)2, excess LiHMDS, and 4-bromofluorobenzene (Scheme 
1-26).   
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Scheme 1-26: Attempted cross-coupling of (η6-ethylbenzene)Cr(CO)3 30 with 4-bromofluorobenzene 
using standard conditions leads to a large amouts of oligomeric side products. 
 
To our disappointment, we did not see the desired 1,1-diarylethane 31a as our main product.  
Instead, we observed a complex reaction mixture that included large amounts of polar oligomeric 
products such as diastereomers 32a and b.  Fluorobenzene was also observed in the 19F NMR 
spectrum of the reaction mixture (Scheme 1-26 above).  These products arise from β-hydride 
elimination to form η6-styrene tricarbonylchromium 33 (and possibly 34), followed by fast and 
irreversible nucleophilic attack by the benzylic anions in solution, such as 30-Li (Scheme 1-27). 
   
Scheme 1-27: Formation of undesired oligomers 32a,b by nucleophilic attack by stabilized benzylic 
anions such as Li-ethylbenzene tricarbonylchromium 30-Li on β-hydride elimination products such as 
33. 
 
Because the rate of β-hydrogen elimination is influenced by several factors, such as competing 
rates of reductive elimination (Scheme 1-28) and the presence of open coordination sites on the 
metal center, we wondered if it would be possible to disfavor the formation of styrene-type 
products through changing the substrate.  An electron-poor aryl undergoes reductive elimination 
from the metal center slower than an electron-rich aryl group,57 so we decided to try 4-
bromoanisole as a substrate in the same coupling reaction.  Indeed, the more electron-rich aryl 
bromide showed different reactivity, with a reduction in oligomer formation that had been seen in 
the earlier test with 4-bromofluorobenzene.  However, yields of desired 31b were still relatively 
low (<60%).  As in the case of reactions with the benzyl ethers (see p. 26), a slow addition of 
34 
 
LiHMDS helped, and clean formation of 31b was observed in 70% yield (Scheme 1-29).  
Surprisingly, approximately 6% of side product 35, the fully substituted quaternary carbon center, 
was observed, confirming the reactivity of the tertiary benzylic center of diarylethane 31b towards 
further deprotonation and cross-coupling.  Up to 18% yield of 35 was isolated in a later run, but 
higher yields were not obtained.  Sterically congested 2-bromo-1,3-dimethylbenzene was also an 
acceptable partner.  In this case, the sterics in the system would seem to preclude deprotonation 
of the single-coupled diarylethane product (see Figure 1-11, p.20).  As expected, further-coupled 
products and β-hydrogen elimination products were not observed. 
 
Scheme 1-28: Competing β-hydride elimination and reductive elimination processes from the 
palladium center. 
 
 
Scheme 1-29: Cross-coupling of (η6-ethylbenzene)Cr(CO)3 30 with 4-bromoanisole using slow addition 
of LiHMDS minimized amouts of oligomeric side products. 
 
Examining the effect of additional sterics on the the β-position of the ethylbenzene led us to react 
the substituted ethylbenzene (η6-phenethylmorpholine)Cr(CO)3 36 with the aryl bromide 4-tert-
butylbromobenzene using standard conditions (Scheme 1-30).  We successfully obtained the 
expected coupling product 37 in 78% yield after isolation.  However, when we tested the reactivity 
of a differently substituted but approximately electronically equivalent 2-bromotoluene as a 
reactant, no coupling product was observed, and the reaction conversion stalled without going to 
completion.  Approximately 50% of the β-hydride eliminated styrene 38 was isolated instead 
(Scheme 1-30). 
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Scheme 1-30: Reaction with a substituted ethyl benzene (η6-phenethylmorpholine)Cr(CO)3 36 showed 
formation of both standard coupling product 37, or 38, depending on the substitution of the aryl 
bromide used in the reaction. 
 
The interesting steric and electronic effects at play in the palladium-catalyzed cross-coupling 
reaction of tricarbonylchromium complexed ethylbenzene derivatives with aryl bromides is still 
not very well-understood.  Coupling reactions to form fully-substituted all-carbon sp3-centers is 
very unusual, and further exploration of these substrates is ongoing.  Additionally, coupling a 
different aryl bromide with isolated teryiary diarylmethyl products could lead to chiral all-carbon 
quaternary products, of which even racemic or achiral varieties are a “significant synthetic 
challenge.”58 
 
Reactivity of β-hydridogen-containing complexes in polycyclic systems 
It is well known that the Cr(CO)3 group can effectively shield one face of coordinated arenes.59  To 
take advantage of this property for stereoselective coupling reactions, we synthesized 
tricarbonylchromium complexes of indane 39 and tetrahydronaphthalene 40 to use in cross-
coupling.a  Employing excess LiHMDS in THF and unhindered aryl bromides, exclusively cis-
substituted diarylated complexes 41a and 41b (Scheme 1-31) and 42a, 42b, and 42c (Scheme 
1-32) were obtained from indane and tetrahydronaphthalene starting materials 39 and 40, 
respectively, in moderate yields.  β-hydrogen elimination products and stereoisomers which could 
arise from palladium-mediated isomerization through β-hydride elimination and reinsertion were 
                                                      
 
 
a A tricarbonylchromium-coordinated complex of 9,10-dihydroanthracene was also synthesized.  However, 
we were disappointed to find that under the cross-coupling reaction conditions, large amounts of free 
anthracene were isolated as the major product instead. 
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not observed.  On the other hand, when 2-bromo-1,3-dimethylbenzene was used as coupling 
partner with indane complex 39, the mono-arylated product was isolated 43a and was the only 
product.  No desired products (single coupled 44a or double coupled 42) were observed for this 
same aryl bromide when the tetrahydronaphthalene complex 40 was used as starting material.  
1H NMR spectra of the cis complexes revealed that no trans-product was formed.  An X-ray crystal 
structre was obtained for 41b,a which confirms the cis-configuration of the two aryl groups (Figure 
1-14).  Isomers of 1,3-diarylindane are difficult to obtain as a single diastereomer by conventional 
methods, as their syntheses typically provides cis/trans mixtures, which are difficult to 
separate.60  However, the stereoselective synthesis of these compounds are of interest in 
medicinal chemistry,61 as the cis-1,3-diarylindane moiety is present in some potent nonpeptide 
endothelin receptor antagonists.60  
 
Scheme 1-31: Coupling reactions with excess ArBr and LiHMDS led to the isolation of double-coupled 
products 41a–b from (η6-indane)Cr(CO)3 (39).  Sterically hindered 2-bromo-1,3-dimethylbenzene led to 
exclusive isolation of the mono-arylated product 43a. 
 
 
Scheme 1-32: Coupling reactions with excess ArBr and LiHMDS led to the isolation of double coupled 
products 42a–c from the tricarbonylchromium tetrahydronaphthalene complex 40.  Reaction to form 
even monoarylated 44a was not observed when 2-bromo-1,3-dimethylbenzene was used as ArBr. 
                                                      
 
 
a Determined by 1H NMR and X-ray diffraction of 41b, Figure 1-14 (see p. 205 for the full report). The crystal 
structure can also be accessed through the Cambridge Crystallographic Data Centre (use the reference ID 
number: CCDC 765716). 
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Figure 1-14: X-ray crystal structure of 41b, showing the cis-stereochemistry of the aryl rings and the 
downward pucker of the cyclopentene ring.  Thermal ellipsoids are at 50% probability.  Further details 
can be found on p. 276. 
 
By adjusting the conditions by running the reaction with fewer equivalents of base, the mono-
arylated products 43b and 43c could be formed from 39, though yields are lower than in the case 
of the doube-coupled products due to partial conversion to diarylated products (Scheme 1-33).  
For mono-arylation reactions of 40 to form 44b and 44c, adding less base to favor monoarylation 
led to formation of inseparable mixtures of what seemed to be the expected product (aryl group 
pointing up), combined with smaller amounts (<20%) of a similar isomer (likely the complex with 
aryl group pointing down, determined by 1H NMR analysis of coupling constants).  While changing 
the catalyst loading, temperature, or identity of the aryl bromide coupling partner did not seem to 
impact the formation of this isomer, we found that changing the solvent mix to 40:60 toluene:THF 
prevented the formation of this isomer, and gratifyingly, 44b and 44c were isolated in moderate 
yields as well without isomeric impurities.  It is not clear why the mono-coupling reactions (but not 
the double-coupling reactions to form 42a–c) had problems, though it is possible that the 
conditions for monocoupling of tetrahyronaphthalene complex (40) in THF solvent favored a small 
amount of β-hydride elimination and isomerization. Finally, monoarylated indane complex 43c 
could be isolated and re-subjected to coupling conditions to produce differently substituted 
diarylindane 41c (Scheme 1-34). 
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Scheme 1-33: Formation of racemic planar- and central- chiral mono-arylated indanes and 
tetrahydronaphthalenes 43 and 44.  In the case of tetrahydronaphthalene (40) reactions, a 40:60 
mixture of Toluene:THF as solvent was necessary to avoid formation of isomerized products. 
 
 
Scheme 1-34: unsymmetrical cis-substituted diarylindane could be obtained by subjecting 43c to 
coupling conditions to provide racemic 41c in 80% isolated yield. 
 
Finally, to demonstrate the practical advantages to our method, double coupling of indane 
tricarbonylchromium (39) with bromobenzene, followed by exposure to light and air and 
purification by column chromatography provided 79% isolated yield of cis-1,3-diphenylindane (45, 
Scheme 1-35).   
Cr
OC
CO
CO
39
i. PhBr
PdCl2(PPh3)2
LiHMDS
Ph
Ph
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Scheme 1-35: The one-pot coupling of (η6-indane)Cr(CO)3 complex 39 and direct decomplexation of 
product provides cis-substituted 1,3-diphenylindane (45) in 79% yield after isolation. 
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Polycyclic system with β-heteroatom substitution. 
Tricarbonylchormium phthalan 46 was also explored as a substrate in cross-coupling.  Initially, 
the substrate was of interest to Merck & Co. for stereoselective synthesis of a monoarylated 
phthalan.a  While the project itself was ultimately abandoned, the synthesis of some phthalan 
derivatives are still presented here.  As in the case of benzylic ethers, standard reaction 
conditions were low-yielding (initial test reaction exhibited 15 and 4% yield of the mono- and di-
coupled products  47 and 48, respectively) (Scheme 1-36).  The stabilized benzylic anion could 
lead to ring opening to the aldehyde, which could either close back up, or be attacked by the 
strongly nucleophilic carbanions in solution (Scheme 1-37).  In support of this hypothesis, 
aldehyde peaks were observed in the 1H NMR of the crude reaction mixture; additionally, small 
amounts of the other (endo-) stereoisomer of the mono-arylated phthalan were isolated as a side-
product of the reaction.  By either adding base slowly or using toluene as a co-solvent (40:60 
toluene:THF), both mono- or di- coupled products could be observed, but this reaction was not 
fully optimized (Scheme 1-36).  Cylohexenyl triflate was also examined as a coupling partner, and 
mono-coupled product 49 was isolated in 62% yield. 
    
Scheme 1-36: Tricarbonylchromium pthlalan 46 as reactant gives mono- coupled products 47a and 
47b.  Using 1-cyclohexenyl trifluoromthanesulfonate provided 49 in 62% yield. 
 
                                                      
 
 
a The racemic complexes of phthalan derivatives were used as chiral chromatrography references for the 
asymmetric synthesis of monosubstituted phthalan, though no more than approximately 30% ee was 
obtained.  
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Scheme 1-37: Possible routes for decomposition arise from opening of the phthalan ring. 
 
Walking the tricarbonylchromium group 
Here it should be noted that some odd behavior was observed with some of the cross-coupling 
reactions earlier in this chapter.  Attempts to run the CrTol (3) coupling reaction with 4-
bromotoluene at lower catalyst loadings (using higher temperatures to make up for the expected 
slower coupling at lower catalyst loadings) led to an extremely messy reaction in which an 
inseparable mixture of tricarbonylchromium-complexed arene products were isolated.  Returning 
to running the reaction at higher catalyst loadings (8–10 mol% PdCl2(PPh3)2 and 45–50 °C) 
provided the expected triarylmethane 5n in 78% yield, which was lower than expected (see Table 
1-5, entry 4, on p.19). Additionally, approximately 6% of an unexpected polyarylated side product 
50 was isolated. 
 
Scheme 1-38: Anomalous complex 50 is observed as a side product in the reaction of 3 with 4-
bromotoluene. 
 
Repeating the low catalyst-loading cross-coupling reaction with 3 and 4-tert-butylbromobenzene 
and quenching the reaction before completion led to a mixture of products.  After isolation, two 
diarylmethane complexes and two triarylmethane complexes were obtained: the expected 
diarylmethane complex  4d, its chromium-coordinated regioisomer  4d′, the desired double-
coupled triarylmethane complex 5p, and the chromium-coordinated regioisomer 5p′ (Scheme 
1-39).  Indeed, the Cr(CO)3 fragment was migrating to other aryl rings during reaction. 
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Scheme 1-39: The reaction of 3 with 4-tBu-C6H4Br at low catalyst loading also showed an unusual 
mixture of isomers, indicating migration of the tricarbonylchromium group. 
 
Since arene exchange is generally not observed for arene tricaronbylchromium complexes except 
at higher temperatures or by replacing one of the carbonyl groups with a phosphine ligand 
containing a pendant donor group,a,62 it is unlikely that the observed arene exchange is an 
intermolecular process.  Rather, intramolecular arene exchange was more plausible.  In work by 
Traylor and coworkers, the tricarbonylchromium group was seen to reversibly migrate across 
certain conjugated silbene molecular frameworks in which the Cr(CO)3 was able to easily adopt 
bridging intermediates with sp2-hybridized benzylic carbon(s) (Figure 1-15).63  Additionally, the 
Cr(CO)3 group is known to quickly migrate to the Cp-likeb anionic side of deprotonated indene 
(isomerization is irreversible and complete when warmed above −20 °C).64 It has also been 
reported to migrate under light or thermal excitation in substituted naphthalenes.65 
    
Figure 1-15: Internal tricarbonylchromium migration in di-p-tolylethylene isomers examined by Traylor 
et al.  In the case of the E-isomer, the [Cr] group must temporarily adopt an η2-bonding mode, leading 
to slowest exchange (approx. an order of magnitude less than the 1,1-isomer, in which the Cr(CO)3 
group crosses the conjugated system in an η5-configuration). 
                                                      
 
 
a Work on arene exchange of (arene)dicarbonylchromium phosphine complexes has been explored by 
Semmelhack and coworkers. 
b Cp = cyclopentadienyl anion, C5H5− 
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In light of these known cases of tricaronbylchromium migration, we considered the possibility that 
in our case, the tricarbonylchromium group was taking advantage of the sp2-hybridized benzylic 
carbanion in the intermediate 4d-Li to migrate to the other arene, temporarily adopting an η5-
coordinated state before reaching the other aromatic group in 4d′-Li (Scheme 1-40).  Since in the 
4-tBu-C6H4- fragment, the alkyl-subistitution of the aromatic ring makes it slightly more electron-
rich than simple phenyl, migration to the other aryl group is considered a slightly 
thermodynamically favorable process.  However, is likely that the steps of the walking process 
happen reversibly, with the location of the Cr(CO)3 becoming locked only after the second 
transmetallation and coupling process installs the final arene, giving a mixture of 5p and 5p′. 
 
Scheme 1-40: Proposed mechanism for “walking” of the tricarbonylchromium group. 
 
It was also considered possible for migration to occur in the triarylmethane if it were to become 
deprotonated.  However, as noted in Scheme 1-12 (see p. 21), the kinetic barrier to 
deprotonation of that remaining acidic C–H bond is relatively high, leading us to expect lower 
proportions of deprotonated 5p and 5p′ in solution and a lower probability of walking after 
triarylmethane formation.  Indeed, while monitoring the reaction by 1H NMR using low catalyst 
loadings of Pd(PPh3)4, the relative proportion of 4d:4d′ and 5p:5p′ were found to be similar, 
supporting the claim that walking of the triarylmethane is not a significant factor in compared to 
walking in the diarylmethane.  Running the coupling reaction of CrTol (3) with 4-tert-
butylbromobenzene at various catalyst loadings (Table 1-10 and Figure 1-16) led to the 
conclusion that the rate of walking in the diarylmethane species seems to be approximately of 
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the same order of magnitude as the rate of palladium-catalyzed cross-coupling. Theoretically, by 
modulating the identity of the transmetalating ligand and maintaining a large excess of LiHMDS 
base, it should be possible to out-compete coupling processes and favor “walking” processes, 
leading to a stepwise walking/coupling reaction. 
Table 1-10: amount of “walking” product observed at varying catalyst loadings (Scheme 1-40 and 
Figure 1-16). 
entry [Pd] (mol%) temp. (°C) rxn time (h) yield (%)a ratiob 5p:5p′ 
1 10 60 3 70 >99 : 1 
2 5 60 3 92   82 : 18 
3 2 60  25 93    42 : 58 
4 1.4 60 67 84   33 : 67 
aYield is the combined yield of regioisomers.  bRatio of 5p:5p′ was determined by 1H NMR integration of the 
benzylic CH. 
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Figure 1-16: The influence of catalyst loading (and speed of reaction with deprotonated species) on 
the total amount of “walking” product (as % of total isolated yield). 
 
Indeed, “outrunning” the second coupling seems to be critical to the success of an envisioned 
walking and polymerization, as the triarylmethane “walks” very slowly under reaction conditions 
with excess LiHMDS. To verify this, we started from a complex that contained one methyl on a 
free aryl group (5a, see p.12).  The product of a walk and then further reaction at the new 
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benzylic carbon was observed (51), but formation of the walked product was slow (subsequent 
cross-coupling at the newly-activated tolyl position was, however, fast). 
[Cr][Cr]
CH3 [Cr] CH3
5a
LiHMDS
small amounts of "pentaphenyl"
walk/poly product 47 observed.
[Pd]-cat
coupling(slow)
PhBr
LiHMDS
 
Scheme 1-41: Starting from 5a, reaction with a large excess of LiHMDS and PhBr led to the isolation 
of small amounts of the first generation walk/polymerization product 51. 
 
These results seem to indicate that there is a possibility for developing reactions that exploit 
“walking” followed by cross-coupling.  For example, by “walking” to an adjactent aryl group and 
then coupling with aryl bromides containing benzylic protons (illustrated in Scheme 1-38 and 
Scheme 1-41), a method for the synthesis of polymeric branched polyarylmethanes could be 
developed.  Further work on “walking” and possible polymerization reactions is ongoing. 
 
Summary and conclusions 
In summary, we have introduced an efficient method for benzylic cross-coupling reactions. 
Activation of the benzylic C–H’s is accomplished by an (η6-arene)Cr(CO)3 complex and an 
organolithium which is formed reversibly using a base of moderate strength (LiHMDS).66  The in-
situ generated organolithium is directly employed in transmetallation to palladium in the cross-
coupling cycle, and the activated arene can undergo multiple arylations to give polyarylated arene 
complexes that are easily demetallated and are potentially useful in medicinal and materials 
chemistry.  Furthermore, this method enables the synthesis of organic compounds that would be 
very difficult to access through conventional cross-coupling reactions.  In particular, we are able 
to access fully-substituted and quaternary sp3-carbon centers and cis-disubstituted aryl indanes.  
The highly symmetric and potentially dendrimeric complexes, such as the bulky C3-symmetric 
hexa-coupled arene 17 may be of interest in materials science. 
Our method is complementary to existing approaches utilizing electrophilic aromatic substitution 
(Friedel-Crafts chemistry), and enables the selective synthesis of polyarylmethanes that are not 
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accessible through electrophilic aromatic substitution reactions alone. Currently, efforts are 
underway to broaden the application of our method to the generation of quaternary 
polyarylmethanes and their enantioselective syntheses, as well as to explore the migratory and 
potentially catalytic aspects of the activating tricarbonylchromium group itself. 
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Experimental Section 
General Methods.  
All reactions were performed under nitrogen using oven-dried glassware.  Air- and moisture- sensitive 
solutions were handled under nitrogen and transferred via syringe.  THF was freshly distilled from 
Na/benzophenone ketyl.  Glyme and toluene were drawn from a Grubbs column.  Unless otherwise 
stated, reagents were commercially available and used as purchased without further purification.  
Chemicals were obtained from Sigma-Aldrich or Acros, and solvents were purchased from Fisher 
Scientific.  Reactions were monitored by thin-layer chromatography using Whatman Partisil® K6F 250 
µm precoated 60 Å silica gel plates and visualized by short-wave ultra-violet light as well as by 
treatment with ceric ammonium molybdate (CAM) stain.  NMR spectra were recorded in CDCl3 on a 
Bruker 300 MHz Fourier-transform spectrometer.  Chemical shifts are reported in ppm referenced to 
tetramethylsilane (TMS) or the CHCl3 solvent residual peak at 7.26 ppm for 1H and 77.23 ppm for 
13C{1H}; 19F peaks were referenced to an external standard of trifluoroacetic acid in CDCl3 at −76.55 
ppm.  Infrared spectra were obtained on NaCl using a Perkin-Elmer Spectrum 100 Series FTIR 
spectrometer.  Chromium-complexed masses were recorded with Electrospray + (ES+) HRMS 
methods, and [M]+ or [M − (CO)3]+ was confirmed by the presence of the characteristic chromium 
isotope pattern.  Decomplexed masses were recorded with Chemical Ionization + (CI+) HRMS 
methods, and [M]+ or [MH]+ were observed. 
Molybdenum complexes 1 and 2,67 and tricarbonylchromium complexes 3, 4a, 8, 9, 18, 23, 27, 30, 
36, 39, 40, and 4667,68,69,70,71 were prepared according to general literature procedure for the 
synthesis of arene tricarbonylmetal complexes from M(CO)6 and parent arene (where M = Mo, Cr), and 
were crystallized from dichloromethane and hexanes or purified by column chromatography eluting in 
diethyl ether in either pentane or hexanes to afford pale yellow solids (1 and 2), bright yellow 
crystalline solids (3, 4a, 8, 9, 18, 27, 30, 36, 39, 40, and 46), or a viscous orange oil (23). 
 
Caution: Care should be taken to avoid direct light exposure of reactions, as arene 
tricarbonylchromium complexes can decompose in solution under light.  Compound 23 and 27 are 
best stored at or below 0 ºC. 
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Procedure for monitoring deprotonation of arene tricarbonylchromium complexes.   
The following is representative of the procedure used to monitor deprotonation of tricarbonylchromium 
complexes in protio solution by 1H NMR using the characteristic arene shifts as handles. 
A 5 mm NMR tube was charged with 4a (24 mg, 0.08 mmol, 1 equiv), sealed with a septum, and 
purged with dry nitrogen.  A 0.40 M solution of LiHMDS in dry THF (0.20 mL, 0.08 mmol, 1.0 equiv, 
freshly generated in a nitrogen atmosphere glovebox) was added to the NMR tube via syringe at room 
temperature, and an immediate color change to bright orange is observed.  The homogeneous 
solution was diluted with ~0.3 ml of THF, taking care to match the solvent height of a sealed d8-THF 
standard NMR tube, then shaken vigorously.  The 1H NMR was recorded (without lock or sweep) on a 
300 MHz spectrometer which was pre-shimmed using the sealed d8-THF solvent standard as 
reference. 
 
General procedures and characterizations for benzylic coupling reactions.    
The following procedures are representative of arene tricarbonylchromium coupling reactions with aryl 
bromides.  Unless otherwise specified, chromatography was run in 2 – 50 % by volume diethyl ether in 
pentane or hexane. 
General procedure 1-A for benzylic cross-coupling of arene tricarbonylchromium complexes with aryl 
bromides: 
5a – (4-C6H4-CH3)PhCH(η6-C6H5)Cr(CO)3: An oven-dried glass reaction tube 
was charged with a small magnetic stirbar and CrDPM (PhCH2(η6-
C6H5)Cr(CO)3, 4a) (44.5 mg, 0.146 mmol, 1.0 equiv), sealed with a septum, 
and purged with nitrogen.  PdCl2(PPh3)2 (3.2 mg, 0.0045 mmol, 3 mol %) and 
LiHMDS (38 mg, 0.23 mmol, 1.6 equiv) were dissolved in 1.0 mL of dry THF 
under a nitrogen atmosphere, forming an orange solution, to which neat 4-bromotoluene (28 µL, 0.23 
mmol, 1.6 equiv) was added.  The catalyst, base, and aryl bromide solution was taken up by syringe 
and added to 4a, which turned intensely red-orange.  The reaction mixture was heated with stirring for 
45 min at 57 ºC, then allowed to cool.  The orange solution was quenched with two drops of aqueous 
2N HCl and allowed to stir for 5 min.  The golden solution was opened to air and diluted with 3 mL 
diethyl ether, then filtered over a pad of MgSO4 and silica.  The pad was rinsed with an additional 1 mL 
diethyl ether and the solution was concentrated in vacuo, loaded directly onto a silica gel column, and 
Cr
OC
CO
CO
CH3
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eluted with 20% diethyl ether in pentane.  The title compound 5a (52.6 mg, 0.133 mmol, 91% yield ) 
was obtained as a highly crystalline yellow solid.  1H NMR (300 MHz, CDCl3) δ: 7.34 – 7.25 (m, 3H), 
7.19 – 7.12 (m, 4H), 7.06 (d, J = 6.3 Hz, 2H), 5.38 – 5.33 (m, 1H),  5.24 – 5.20 (m, 3H),  5.13 – 5.09 
(m, 2H),  2.33 (s, 3H) ppm; 13C{1H} NMR (75 MHz) δ: 233.1, 141.8, 138.6, 137.0, 129.6, 129.5, 
128.8, 127.3, 115.3, 95.55, 95.50, 93.2, 91.3, 54.6, 21.2 ppm; tricarbonylchromium-coordinated 
protons and carbons exhibit diastereotopic signals; meta- and meta'- proton signals overlap with the 
benzylic proton; meta- and meta'- carbon signals overlap;  IR: 3027, 2923, 1963, 1877, 1512, 1494, 
1453, 701, 661, 630 cm-1.  HRMS (ES+) calc’d for C20H18Cr 310.0814, observed 310.0806 [M -
(CO)3]+. 
5b – Ph2CH(η6-C6H5)Cr(CO)3: Using General procedure 1-A, 4a (30.1 mg, 
0.099 mmol, 1.0 equiv) was reacted with LiHMDS (27 mg, 0.16 mmol, 1.6 
equiv) and PdCl2(PPh3)2 (2.5 mg, 0.0036 mmol, 3.6 mol %) in 0.8 mL THF and 
bromobenzene (17 µL, 0.16 mmol, 1.6 equiv) for 50 min at 56 ºC, yielding 5b 
(34.6 mg, 0.091 mmol, 92% yield) as a bright yellow crystalline solid after 
silica gel chromatography eluting with 20% diethyl ether in pentane.  1H NMR (300 MHz, CDCl3) δ: 
7.36 – 7.26 (m, 6H), 7.18 (m, 4H), 5.36 (t, J = 6.3 Hz, 1H), 5.24-5.20 (m, 3H), 5.11 (d, J = 6.3 Hz, 2H) 
ppm; 13C{1H} NMR (75 MHz) δ: 233.1, 141.6, 129.6, 128.8, 127.4, 114.9, 95.6, 93.3, 91.2, 54.9 
ppm;  tricarbonylchromium-coordinated arene meta- protons overlap with the benzylic proton; IR 
3085, 3053, 3028, 1963 and 1878 (strong CO stretch), 1626, 1568, 1495, 1452, 1415, 1301, 
1268, 1213, 1184, 1081, 923, 826, 758, 741, 702, 662, 630, 619, 534 cm-1;  HRMS (ES+) calc’d 
for C19H16Cr 296.0657, observed 296.0650 [M -(CO)3]+.  Existing literature characterization 
corresponds with the characterization data for this compound.72 
5c – (2-naphthyl)PhCH(η6-C6H5)Cr(CO)3:  Using General procedure 1-A, 4a 
(15.2 mg, 0.050 mmol, 1.0 equiv) was reacted with LiHMDS (12 mg, 
0.070 mmol, 1.4 equiv) and PdCl2(PPh3)2 (1.7 mg, 0.0025 mmol, 5 mol %) 
in 0.6 mL THF and 2-bromonaphthalene (12.3 mg, 0.060 mmol, 1.2 equiv) 
for 1 h at 57 ºC, yielding 5c (19.5 mg, 0.045 mmol, 90% yield) as a pale 
yellow solid after silica gel chromatography eluting with 6% diethyl ether in pentane.  1H NMR (300 
MHz, CDCl3) δ: 7.84 - 7.80 (m, 2H), 7.78 - 7.75 (m, 1H), 7.56 (br s, 1H), 7.50 - 7.45 (m, 2H), 7.37 - 
7.28 (m, 4H), 7.26 - 7.23 (m, 2H), 5.41 - 5.36 (m, 2H), 5.28 - 5.20 (m, 2H), 5.17 - 5.11 (m, 2H) 
ppm; 13C{1H} NMR (75 MHz)  δ: 233.1, 141.3, 139.4, 133.4, 132.6, 129.8, 128.8, 128.5, 128.3, 
128.1, 127.9, 127.8, 127.5, 126.6, 126.4, 114.7, 95.8, 95.5, 93.4, 91.2, 55.0 ppm.  
Tricarbonylchromium-coordinated protons and carbons exhibit diastereotopic signals; meta- and 
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meta'- carbon signals overlap; IR 3059, 3028, 1963 and 1877 (strong CO stretches), 1600, 1494, 
1453, 1414, 816, 748, 702, 630, 660 cm-1. 
5d – (4-C6H4-Cl)PhCH(η6-C6H5)Cr(CO)3: Using General procedure 1-A, 4a (45.8 
mg, 0.151 mmol, 1.0 equiv) was reacted with LiHMDS (40 mg, 0.24 mmol, 1.6 
equiv) and PdCl2(PPh3)2 (5.7 mg, 0.008 mmol, 5 mol %) in 2 mL THF and 1M 4-
bromochlorobenzene THF solution (0.225 mL, 0.225 mmol, 1.5 equiv) for 6 h 
at 57 ºC, yielding 5d (51.8 mg, 0.125 mmol, 83% yield), as a highly crystalline yellow solid after 
purification by silica gel chromatography eluting with 20% diethyl ether in pentane. 1H NMR (300 MHz, 
CDCl3) δ: 7.33 – 7.27 (m, 5H), 7.17 – 7.11 (m, 4H),  5.38 (t, J = 6.2 Hz, 1H),  5.23(m, 3H),  5.10 (d, J 
= 6.3 Hz, 1H),  5.05 (d, J = 6.3 Hz, 1H) ppm; 13C{1H} NMR (75 MHz) δ: 232.9, 141.24, 140.0, 133.4, 
130.9, 129.5, 129.0, 128.9, 127.6, 114.2, 95.4, 95.2, 93.3, 91.2, 91.1, 54.3 ppm; 
tricarbonylchromium-coordinated protons and carbons exhibit diastereotopic signals; meta- and meta'- 
proton signals overlap with the benzylic proton; IR 3080, 3027, 1964 and 1879 (strong CO stretch), 
1625, 1568, 1491, 1454, 1184, 1091, 1015, 923, 813, 755, 661, 629, 619 cm-1;  HRMS (ES+) 
calc’d for C19H15ClCr 330.0267, 330.0258 [M -(CO)3]+. 
5e – (4-C6H4-F)PhCH(η6-C6H5)Cr(CO)3: Using General procedure 1-A, 4a (60.5 
mg, 0.199 mmol, 1.0 equiv) was reacted with LiHMDS (60.5 mg, 0.36 mmol, 
1.8 equiv) and PdCl2(PPh3)2 (7.6 mg, 0.01 mmol, 5 mol %) in 3 mL THF and 4-
bromofluorobenzene (35 µL, 0.3 mmol, 1.5 equiv) for 6 h at 60 ºC, yielding 5e 
(69.7 mg, 0.175 mmol, 88% yield) as a bright yellow crystalline solid after 
purification by silica gel chromatography.  1H NMR (300 MHz, CDCl3) δ: 7.37 – 7.24 (m, 3H), 7.17 – 
7.13 (m, 4H), 7.02 (t, J =  Hz, 2H),  5.37 (t, J = 6.2 Hz, 1H), 5.25 – 5.20 (m, 3H), 5.12 (d, J = 6.8 Hz, 
1H), 5.05 (d, J = 6.6 Hz, 1H) ppm; 13C{1H} NMR (75 MHz) δ:232.9, 162.1 (d, J = 347 Hz), 141.6, 
131.13 (d, J = 8 Hz), 129.5, 128.9, 127.5, 115.7 (d, J = 21 Hz), 114.6, 95.5, 95.3, 93.4, 91.2, 91.1, 
54.2 ppm; 19F NMR (282 MHz) δ: −115.4 (m) ppm; tricarbonylchromium-coordinated arene carbons 
and protons exhibit diastereotopic signals; meta- and meta'- proton signals overlap with the benzylic 
proton;  IR 3079, 3027, 2895, 2746, 1964 and 1877 (strong CO stretch), 1624, 1507, 1495, 1454, 
1303, 1224, 1183, 1098, 922, 819, 741, 702, 661, 629, 619 cm-1;  HRMS (ES+) calc’d for 
C19H15CrF 314.0563, observed 314.0549 [M -(CO)3]+ . 
5g – [4-C6H4-N(CH3)2]PhCH(η6-C6H5)Cr(CO)3:  Using General procedure 1-A, 
4a (30.2 mg, 0.099 mmol, 1.0 equiv)  was reacted with LiHMDS (27 mg, 
0.16 mmol, 1.6 equiv) and PdCl2(PPh3)2 (3.1 mg, 0.004 mmol, 4 mol %) in 1 
mL THF and 4-bromo-N,N-dimethylaniline (29.9 mg, 0.15 mmol, 1.5 equiv) 
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for 1 h at 52 ºC, yielding 5g (38.2 mg, 0.090 mmol, 91% yield) as a shiny pale yellow flakes after silica 
gel chromatography eluting with 6% diethyl ether in pentane.  1H NMR (300 MHz, CDCl3) δ: 7.34 – 
7.01 (m, 5H), 7.03 (d, J = 8.7 Hz, 2H), 6.68 (d, J = 8.8 Hz, 2H), 5.33 (t, J = 6.1 Hz, 1H), 5.25 – 5.20 
(m, 2H), 5.16 – 5.08 (m, 3H), 2.94 (s, 6H) ppm; 13C{1H} NMR (75 MHz) δ: 233.3, 149.7, 142.4, 130.2, 
129.5, 129.2, 128.7, 127.1, 116.3, 112.6, 95.7, 95.4, 93.1, 91.4, 54.0, 40.7 ppm; 
tricarbonylchromium-coordinated protons and carbons exhibit diastereotopic signals; the ortho'- 
proton signal overlaps with the benzylic proton; meta- and meta'- carbon signals overlap; IR 3030, 
2921, 2852, 2804, 1963 and 1878 (strong CO stretch), 611, 1520, 1452, 1352, 947, 702, 662, 
630 cm-1. 
5h – (4-C6H4-OCH3)PhCH(η6-C6H5)Cr(CO)3: Using General procedure 1-A, 4a 
(44.8 mg, 0.147 mmol, 1.0 equiv) was reacted with LiHMDS (39 mg, 0.23 
mmol, 1.6 equiv) and PdCl2(PPh3)2 (4.2 mg, 0.006 mmol, 4 mol %) in 1 mL 
THF and 4-bromoanisole (32 µL, 0.25 mmol, 1.7 equiv) for 45 min at 56 ºC, 
yielding 5h (56.7 mg, 0.138 mmol, 94% yield) as a yellow solid after silica 
gel chromatography eluting with 20% diethyl ether in pentane.   1H NMR (300 MHz, CDCl3) δ: 7.35 – 
7.26 (m, 3H), 7.17 (d, J = 6.9 Hz, 2H), 7.09 (d, J  = 8.7 Hz, 2H), 6.86 (d, J = 8.7Hz, 2H), 5.35 (t, J = 6.6 
Hz, 1H),  5.25 – 5.19 (m, 3H),  5.12 – 5.09 (m, 2H),  3.80 (s, 3H) ppm; 13C{1H} NMR (75 MHz) δ: 
233.1, 158.9, 142.1, 133.6, 130.6, 129.5, 128.8, 127.3, 115.5, 114.2, 95.51, 95.48, 93.2, 91.3, 
55.5, 54.1 ppm; tricarbonylchromium-coordinated protons and carbons exhibit diastereotopic signals; 
meta- and meta'- proton signals overlap with the benzylic proton; meta- and meta'- carbon signals 
overlap; IR 3085, 3064, 3030, 3003, 2956, 2934, 2907, 2838, 1962 and 1875 (strong CO stretch), 
1609, 1510, 1496, 1454, 1302, 1255, 1180, 1112, 1077, 1033, 922, 818, 741, 703, 662, 629, 
619 cm-1;  HRMS (ES+) calc’d for C20H18CrO 326.0763, observed 326.0933 [M -(CO)3]+. 
5i – (2-C6H4-OCH3)PhCH(η6-C6H5)Cr(CO)3:  Using General procedure 1-A, 4a 
(44.0 mg, 0.145 mmol, 1.0 equiv) was reacted with LiHMDS (38 mg, 0.23 
mmol, 1.6 equiv) and PdCl2(PPh3)2 (4 mg, 0.006 mmol, 4 mol %) in 1 mL THF 
and 2-bromoanisole (31 µL, 0.25 mmol, 1.7 equiv) for 1 h at 54 ºC, yielding 5i 
(54.0 mg, 0.132 mmol, 91% yield) as a highly crystalline yellow solid after 
silica gel chromatography eluting with 6% diethyl ether in pentane.  1H NMR (300 MHz, CDCl3) δ: 7.30 
– 7.19 (m, 6H), 6.94 – 6.86 (m, 3H), 5.63 (s, 1H), 5.37 (t, J = 6.1 Hz, 1H), 5.28 (d, J = 7.0 Hz), 5.16 (t, 
J = 6.5 Hz, 2H), 5.08 (d, J = 6.5 Hz), 3.77 (s, 3H) ppm; 13C{1H} NMR (75 MHz) δ: 233.2, 141.2, 130.8, 
130.2, 129.6, 128.6, 128.5, 127.1, 120.4, 114.4, 111.1, 96.2, 96.1, 93.8, 90.42, 90.39, 55.6, 47.9 
ppm; tricarbonylchromium-coordinated protons and carbons exhibit diastereotopic signals; IR 3064, 
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3028, 2936 and 2838 (strong CO stretch), 1962, 1878, 1598, 1491, 1454, 1248, 1029, 755, 702, 
662, 630 cm-1. 
5j – [2,6-C6H3-(CH3)2]PhCH(η6-C6H5)Cr(CO)3: Using General procedure 1-A, 4a 
(60.5 mg, 0.199 mmol, 1.0 equiv) was reacted with LiHMDS (50.3 mg, 0.30 
mmol, 1.5 equiv) and PdCl2(PPh3)2 (6.8 mg, 0.01 mmol, 5 mol %) in 3.5 mL 
THF with 1-bromo-2,6-dimethylbenzene (55 µL, 0.4 mmol, 2 equiv) for 24 h 
at 58 ºC, yielding 5j (65.3 mg, 0.16 mmol, 81% yield) as a yellow solid after 
silica gel chromatography eluting with 10% diethyl ether in pentane (5.7 mg, 10% of starting material 
4a also isolated).  1H NMR (300 MHz, CDCl3) δ: 7.36 – 7.25 (m, 3H), 7.14 (t, J = 7.4 Hz, 1H), 7.05 
(broad d, J  = 7.2 Hz, 2H), 5.84 (s, 1H), 5.30 – 5.25 (m, 4H),  5.09 (d, J = 6.3 Hz, 1H), 2.16 (very broad 
s, 6H) ppm; 13C{1H} NMR (75 MHz) δ: 133.4, 138.5, 137.2, 129.6, 128.9, 127.7, 127.5, 116.6, 
95.16, 92.7, 92.2, 91.6, 49.5 ppm; tricarbonylchromium-coordinated protons and carbons exhibit 
diastereotopic signals; meta- and meta'- carbon signals overlap; signals from the non-axial carbons of 
the xylyl group were not observed in the 13C{1H} NMR due to the hindered rotation.  IR 3064, 3022, 
2962, 2914, 2743, 1961 and 1873 (strong CO stretch), 1625, 1495, 1467, 1455, 1301, 1214, 
1183, 1097, 1078, 924, 821, 772, 738, 662, 629, 619 cm-1; HRMS (ES+) calc’d for C21H20Cr 
324.097, observed 324.0985 [M -(CO)3]+. 
5k – [1-(triisopropylsilyl)-1H-indol-4-yl]PhCH(η6-C6H5)Cr(CO)3:  Using  
General procedure 1-A, 4a (30.4 mg, 0.100 mmol, 1.0 equiv) was 
reacted with LiHMDS (25 mg, 0.15 mmol, 1.5 equiv) and PdCl2(PPh3)2 (5 
mg, 0.005 mmol, 7 mol %) in 1 mL THF and 4-bromo-1-TIPS-indole (45 
mg, 0.13 mmol, 1.3 equiv) for 40 min at 58 ºC, yielding 5k (51.4 mg, 
0.089 mmol, 89% yield)  as a shiny pale yellow solid after silica gel chromatography eluting with 6% 
diethyl ether in pentane. 1H NMR (300 MHz, CDCl3) δ: 7.42 (d, J = 8.3 Hz, 1H), 7.31 - 7.24 (m, 5H), 
7.17 (d, J = 3.3 Hz, 1H), 7.08 (t, J = 7.8 Hz, 1H), 6.72 (d, J = 7.3 Hz, 1H), 6.51 (d, J = 2.6 Hz, 1H), 5.62 
(s, 1H), 5.45 (d, J = 6.9 Hz, 1H), 5.38 (t, J = 6.2 Hz, 1H), 5.23 - 5.18 (m, 2H), 5.01 (d, J = 6.6 Hz, 1H), 
1.67 (septet, J = 7.5 Hz, 3H), 1.12 (d, J = 7.5 Hz, 18H) ppm; 13C{1H} NMR (75 MHz) δ: 233.3, 141.2, 
140.6, 134.9, 131.5, 131.2, 129.7, 128.6, 127.3, 121.1, 120.1, 115.3, 113.1, 103.5, 96.9, 95.7, 
93.7, 91.0, 90.8, 52.8, 18.4, 13.1 ppm; tricarbonylchromium-coordinated protons and carbons exhibit 
diastereotopic signals;  IR 3062, 3027, 2949, 2869, 1966 and 1883 (strong CO stretch), 1600, 
1426, 1283, 1148, 1016, 883, 751, 631, 661 cm-1. 
5b from CrTol (3): Using General procedure 1-A, (η6-toluene)Cr(CO)3 (3) (45.8 
mg, 0.201 mmol, 1.0 equiv) was reacted with LiHMDS (93.5 mg, 0.57 mmol, 
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2.8 equiv) and 5.4 mg of PdCl2(PPh3) in 2 mL THF with 64 µL of bromobenzene (0.6 mmol, 3 equiv) for 
5 h at 57 ºC, yielding 68.9 mg (0.181 mmol, 90% yield) of 5b.  All appearances and characterization 
data are consistent with that of 5b obtained from cross-coupling of 4a with bromobenzene (p. 48). 
5l – (4-C6H4-F)2CH(η6-C6H5)Cr(CO)3: Using General procedure 1-A, 3 (45.5 mg, 
0.199 mmol, 1.0 equiv) was reacted with LiHMDS (97 mg, 0.58 mmol, 2.9 
equiv)  and PdCl2(PPh3)2 (5.1 mg, 0.007 mmol, 4 mol %) of in 2.5mL THF with 4-
bromofluorobenzene (66 µL, 0.6 mmol, 3 equiv) for 5.5 h to yield 5l (68.7 mg, 
0.165 mmol, 83% yield) as a deep yellow solid after silica gel chromatography 
eluting with 13% diethyl ether in pentane.  1H NMR (300 MHz, CDCl3) δ: 7.15 – 7.11 (m, 4H), 7.06 – 
7.00 (t, J = 8.5 Hz, 4H), 5.39 (t, J = 6.1 Hz, 1H), 5.25 – 5.20 (m, 3H), 5.06 (d, J = 6.2 Hz, 2H) ppm; 
13C{1H} NMR (75 MHz)  δ: 232.8, 62.1 (d, J = 246.5 Hz), 137.2, 131.0 (d, J = 8.0 Hz), 115.8 (d, J 
= 21.4 Hz), 114.2, 95.2, 93.4, 91.1, 53.4 ppm;  19F NMR (282 MHz) δ: −118.1 (m) ppm; 
tricarbonylchromium-coordinated arene meta- proton signals overlap with the benzylic proton; IR 
3074, 3044, 1966 and 1880 (strong CO stretch), 1631, 1605, 1506, 1457, 1321, 1302, 1268, 
1225, 1185, 1159, 1100, 924, 824, 661, 629 cm-1;  HRMS (ES+) calc’d for C19H14CrF2 332.0469, 
observed 332.0460 [M -(CO)3]+.  
5m – (4-C6H4-Cl)2CH(η6-C6H5)Cr(CO)3: Using General procedure 1-A, 3 (11.4 mg, 
0.050 mmol, 1.0 equiv) was reacted with LiHMDS (34 mg, 0.20 mmol, 4 equiv) 
and PdCl2(PPh3)2 (3.9 mg, 0.005 mmol, 10 mol %) in 0.6 mL THF and 1M 4-
bromochlorobenzene THF solution (0.125 mL, 0.125 mmol, 2.5 equiv) for 2 h at 
53 ºC to yield 5m (17.5 mg, 0.039 mmol, 78%)  as a highly crystalline yellow 
solid after silica gel chromatography eluting with 20% diethyl ether in pentane.  
1H NMR (300 MHz, CDCl3) δ: 7.31 (d, J = 8.4 Hz, 4H), 7.09 (d, J = 8.4 Hz, 4H), 5.38 (t, J = 6.2 Hz, 1H), 
5.23 (t, J = 6.3Hz, 2H), 5.18 (s, 1H), 5.04 (d, J = 6.3 Hz, 2H) ppm; 13C{1H} NMR (75 MHz) δ: 232.7, 
139.6, 133.6, 130.8, 129.1, 113.5, 95.0, 93.3, 91.1, 53.6 ppm;  IR 3090, 3027, 1965 and 1881 
(strong CO stretch), 1490, 1405, 1092, 1014, 810, 659, 629 cm-1.   
5n – (4-C6H4-CH3)2CH(η6-C6H5)Cr(CO)3: Using General procedure 1-A, 3 (34 
mg, 0.149 mmol, 1.0 equiv) was reacted with LiN(SiMe3)2 (64 mg 0.38 mmol, 
2.6 equiv) and PdCl2(PPh3)2 (8 mg, 0.01 mmol, 8 mol%) in 2 mL THF with 4-
bromotoluene (50 µL, 0.4 mmol, 2.7 equiv) for 2 h at 62 ºC to yield 5n (47.6 
mg, 0.117 mmol, 78% yield) as a fluffy bright yellow solid after silica gel 
chromatography.  1H NMR (300 MHz, CDCl3) δ: 7.12 (d, J = 8.1 Hz, 4H), 7.05 (d, J = 8.1 Hz, 4H), 5.34 
(t, J = 6.2 Hz, 1H), 5.22 (t, J = 6.3 Hz, 2H), 5.17 (s, 1H), 5.10 (d, J = 6.3 Hz, 2H), 2.33 (s, 6H); 13C{1H} 
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NMR (75 MHz) δ: 233.3, 138.8, 136.9, 129.43, 129.42, 115.7, 95.5, 93.1, 91.4, 54.2, 21.3 ppm; IR 
3022, 2921, 1963, 1878, 1626, 1567, 1510, 1456, 1300, 1214, 1188, 1113, 923, 810, 768, 736, 
661, 631, 619, 534 cm-1;  HRMS (ES+) calc’d for C21H20Cr 324.0970, found 324.0972 [M -(CO)3]+.  X-
ray crystal structure was determined for this compound; see p.257. 
5o – (4-C6H4-OCH3)2CH(η6-C6H5)Cr(CO)3: UsingGeneral procedure 1-A, 3 
(22.1 mg, 0.097 mmol, 1.0 equiv) was reacted with LiN(SiMe3)2 (62 mg, 
0.37 mmol, 3.8 equiv) and PdCl2(PPh3)2 (5.4 mg, 0.008 mmol, 8 mol%) in 
1.3 mL THF and 4-bromoanisole (38 µL, 0.3 mmol, 3 equiv) for 2 h at 56 ºC 
to yield 5o (35.8 mg, 0.081 mmol, 84% yield) as a bright yellow solid after 
column chromatography.  1H NMR (300 MHz, CDCl3) δ: 7.08 (d, J = 8.6 Hz, 4H), 6.85 (d, J = 8.8 Hz, 
4H), 5.34 (t, J = 6.2 Hz, 1H), 5.23 (t, J = 6.3 Hz, 2H), 5.15 (s, 1H), 5.09 (d, J = 6.3 Hz, 2H), 3.79 (s, 
6H); 13C{1H} NMR (75 MHz) δ: 233.2, 158.8, 134.1, 130.5, 116.0, 114.1, 95.4, 93.1, 91.4, 55.5, 
53.3 ppm; IR 3077, 3038, 3000, 2934, 2904, 2837, 1961, 1875, 1766, 1616, 1567, 1509, 1464, 
1301, 1245, 1180, 1112, 1034, 924, 820, 735, 678, 663, 630, 619, 535 cm-1;  HRMS (ES+) calc’d 
for C21H20CrO2 356.0868, observed 356.0862 [M -(CO)3]+. 
5p – [4-C6H4-tBu]2CH(η6-C6H5)Cr(CO)3: Using General procedure 1-A, 3 (34 
mg, 0.149 mmol, 1.0 equiv) of  was reacted with LiHMDS (70 mg , 0.42 
mmol, 2.8 equiv) and PdCl2(PPh3)2 (10.9 mg, 0.015 mmol, 10 mol %) in 4 
mL THF with 4-tert-butyl-bromobenzene (65 µL, 0.45 mmol, 3 equiv) for 5 h 
at 46 ºC to yield 5d (60.0 mg, 0.122 mmol, 82% yield) as a pale yellow solid 
after silica gel chromatography eluting with 3% diethyl ether in pentane.  1H 
NMR (300 MHz, CDCl3) δ: 7.33 (d, J = 8.4 Hz, 4H), 7.10 (d, J = 8.4 Hz, 4H), 5.34 (t, J = 6.2 Hz, 1H), 
5.22 (t, J = 6.3 Hz, 2H), 5.16 – 5.13 (m, 3H), 1.30 (S, 18H) ppm; 13C{1H} NMR (75 MHz) δ: 233.3, 
150.1, 138.7, 129.2, 125.6, 115.9, 95.6, 93.1, 91.3, 54.1, 34.7, 31.6 ppm; tricarbonylchromium-
coordinated arene ortho- proton signals overlap with the benzylic proton; IR 3028, 2965, 2905, 2870, 
1960 and 1880 (strong CO stretch), 1476, 1461, 1365, 1265, 704, 667, 623 cm-1.  HRMS (ES+) 
calc’d for C27H32Cr 408.1909, found 408.1901 [M -(CO)3]+.  
5p′ – (4-C6H4-tBu)CHPh(η6-4-C6H4-tBu)Cr(CO)3: The “walking” isomer is the more 
thermodynamically stable isomer due to the slightly more electron-rich 
coordinating arene.  It can be synthesized from 5p by heating with base in THF 
and then quenching with 2 drops water, diluting with ether, and filtering over a 
small plug of MgSO4 and silica gel.  1H NMR (300 MHz, CDCl3) δ: 7.32 (m, 4H), 
7.26 (m, 1H), 7.20 (m, 2H), 7.11 (d, J  = 8.2 Hz, 2H), 5.40 (m, 2H),  5.23 (s, 1H),  CrOC
COCO
t -Bu
t -Bu
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5.06 (m, 1H), 5.01 (m, 1H), 1.30 (s, 9H), 1.29 (s, 9H) ppm; 13C{1H} NMR (75 MHz) δ: 233.9, 150.2, 
142.0, 138.7, 129.6, 128.7, 127.3, 125.7, 123.2, 115.7, 94.2, 94.0, 91.1, 54.1, 34.7, 34.1, 31.6, 
31.3 ppm; HRMS (ES+): 408.1917 [M -(CO)3]+ 
5q  – (3-C6H4-OCH3)2CH(η6-C6H5)Cr(CO)3: Using General procedure 1-A, 3 
(34.8 mg, 0.153 mmol, 1.0 equiv) was reacted with LiHMDS (96 mg, 0.57 
mmol, 3.7 equiv) and PdCl2(PPh3)2 (8.3 mg, 0.012 mmol, 8 mol %) in 3 mL 
THF and 3-bromoanisole (57 µL, 0.45 mmol, 3 equiv) for 1.5 h at 57 ºC to 
yield 5q (57.7mg, 0.131 mmol, 86% yield) as a yellow solid after silica gel 
chromatography eluting with 15% diethyl ether in pentane.  1H NMR (300 MHz, CDCl3) δ: 7.24 (t, J = 
7.5 Hz, 2H), 6.82 – 6.73 (m, 6H), 5.36 (t, J = 6.1 Hz, 1H),  5.23 (t, J = 6.4 Hz, 2H),  5.17 – 5.13 (m, 
3H),  3.79 (s, 6H) ppm; 13C{1H} NMR (75 MHz) δ: 233.1, 159.9, 143.0, 129.7, 122.0, 115.6, 114.9, 
112.7, 95.5, 93.3, 91.3, 55.4, 54.9 ppm;  tricarbonylchromium-coordinated arene ortho- proton 
signals overlap with the benzylic proton; IR 3079, 3005, 2940, 2837, 1961 and 1874 (strong CO 
stretch), 1598, 1584, 1488, 1455, 1266, 1049, 759, 662, 631 cm-1;  HRMS (ES+) calc’d for 
C21H20CrO2 356.0868, observed 356.0866 [M -(CO)3]+. 
5f – (2-C6H4-CH3)2CH(η6-C6H5)Cr(CO)3: Using General procedure 1-A, 3 (45 mg, 
0.197 mmol, 1.0 equiv) was reacted with LiHMDS (94 mg, 0.56 mmol, 2.8 
equiv) and PdCl2(PPh3)2 (13 mg, 0.018 mmol, 9 mol %) in 4.2 mL THF and 2-
bromotoluene (75 µL, 0.6 mmol, 3 equiv) for 12 h at 58 ºC to yield 70.7 mg 
(0.173 mmol, 88% yield) of 5r as a yellow solid after silica gel chromatography 
eluting with 10% diethyl ether in pentane.  1H NMR (300 MHz, CDCl3) δ: 7.21 – 
7.09 (m, 6H), 6.93 (d, J = 7.4 Hz, 2H), 5.52 (t, J = 6.1 Hz, 1H), 5.45 (s, 1H), 5.29 (d, J = 6.3 Hz, 2H), 
5.11 (t, J = 6.3 Hz, 2H), 2.41 (s, 6H) ppm; 13C{1H} NMR (75 MHz)  ppm 233.0, 140.0, 137.2, 131.2, 
129.4, 127.2, 126.1, 111.9, 97.5, 95.8, 88.8, 47.5, 19.9 ppm; IR 3073, 3020, 2945, 2913, 1963 
and 1877 (strong CO stretch), 1628, 1492, 1461, 1297, 1213, 1183, 1101, 1056, 923, 823, 742, 
729, 663, 629 cm-1.   
4b – [2,6-C6H3-(CH3)2]CH(η6-C6H5)Cr(CO)3: Using general procedure A, 3 (91.4 
mg, 0.401 mmol, 1.0 equiv) was reacted with LiHMDS (98.5 mg, 0.59 mmol, 1.5 
equiv) and PdCl2(PPh3)2 (15.5 mg, 0.022 mmol, 5 mol %) in 4 mL THF and 1-
bromo-2,6-dimethybenzene (0.11 mL, 0.8 mmol, 2 equiv) for 8 h at 63 ºC to yield 
4b (114 mg. 0.343 mmol, 86% yield) as a fluffy yellow solid after silica gel 
chromatography eluting with 20% diethyl ether in pentane . 1H NMR (300 MHz, CDCl3) δ: 7.07 (m, 3H), 
5.32 (t, J = 6.3 Hz, 2H), 5.21 (m, 3H), 3.91 (s, 2H), 2.33 (s, 6H) ppm; 13C{1H} NMR (75 MHz)  δ: 233.4, 
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137.3, 134.6, 128.8, 127.4, 111.4, 93.9, 92.8, 91.8, 33.7, 20.7 ppm; tricarbonylchromium-
coordinated arene ortho- and para- proton signals overlap; IR 3074, 3041, 2944, 1971 and 1858 
(strong CO stretch), 1625, 1502, 1462, 1300, 1213, 1184, 1097, 923, 820, 775, 736, 672, 632, 
616 cm-1; HRMS (ES+) calc’d for C15H16Cr 248.0657, observed 248.0653 [M -(CO)3]+. 
4c – (2,4,6-C6H2-iPr3)CH(η6-C6H5)Cr(CO)3: Using General procedure 1-A, 3 (45.5 
mg 0.199 mmol, 1.0 equiv) was reacted with LiHMDS (50 mg, 0.30 mmol, 1.5 
equiv) and PdCl2(PPh3)2 (8.5 mg, 0.012 mmol, 6 mol %) in 1.5 mL THF and 
2,4,6-triisopropylbromobenzene (74 µL, 0.4 mmol, 2 equiv) for 12 h at 63 ºC to 
yield 4c (69.4 mg, 0.162 mmol, 87% yield) as a fluffy pale yellow solid after 
column chromatography eluting with 6% diethyl ether in pentane.  1H NMR (300 MHz, CDCl3) δ: 7.02 
(s, 2H), 5.33 (t, J = 6.4 Hz, 2H), 5.19 (m, 3H), 3.95 (s, 2H), 3.09 (m, J = 6.8 Hz, 2H), 2.89 (m, J = 6.9 
Hz, 1H), 1.26 (d, J = 6.9 Hz, 6H), 1.20 (d, J = 6.8 Hz, 12H) ppm; 13C{1H} NMR (75 MHz) δ: 233.4, 
148.2, 147.7, 128.5, 121.6, 113.7, 94.1, 92.8, 91.7, 34.4, 31.5, 30.2, 24.5, 24.2 ppm; 
tricarbonylchromium-coordinated arene ortho- and para- proton signals overlap; IR (CH2Cl2 film) 2962, 
2928, 2869, 1965 and 1882 (strong CO stretch), 1607, 1574, 1526, 1457, 1384, 1363, 1153, 879, 
664, 630 cm-1; HRMS (ES+) calc’d for C22H30Cr 346.1753, observed 346.1765 [M -(CO)3]+. 
11 – 1,4-[2,4,6-C6H2-iPr3CH2]2(η6-C6H4)Cr(CO)3: Using General 
procedure 1-A, (η6-p-xylene)Cr(CO)3 (8) (23.9 mg, 0.099 mmol, 1.0 
equiv) was reacted with LiHMDS (82 mg, 0.49 mmol, 4.9 equiv) and 
PdCl2(PPh3)2 (8.4 mg, 0.012 mmol, 12 mol %) in 2.4 mL THF and 
2,4,6-triisopropylbromobenzene (56 µL, 0.3 mmol, 3 equiv) for 24 h 
at 55 ºC to yield 11 (46.4 mg, 0.072 mmol, 73% yield) as a fluffy pale yellow solid after silica gel 
chromatography eluting with 3% diethyl ether in pentane.  1H NMR (300 MHz, CDCl3) δ: 6.97 (s, 4H), 
5.20 (s, 4H), 3.88 (s, 4H), 3.04 (m, J = 6.8Hz, 4H), 2.87 – 2.82 (m, J = 6.9Hz, 2H), 1.23 (d, J = 6.8 Hz, 
12H), 1.15 (d, J = 6.9 Hz, 24 H) ppm; 13C{1H} NMR (75 MHz) δ: 233.8, 148.1, 147.6, 128.6, 121.5, 
112.2, 94.0, 34.4, 31.0, 30.1, 24.2, 24.2 ppm;  IR 3058, 2962, 2928, 2869, 1962 and 1882 (strong 
CO stretch), 1608, 1462, 1384, 1363, 1101, 878, 667, 625 cm-1;  HRMS (ES+) calc’d for C38H54Cr 
562.3631, found 562.3657 [M -(CO)3]+. 
12 – 1,4-[(4-C6H4-F)2CH]2(η6-C6H4)Cr(CO)3: Using General 
procedure 1-A, 8 (12.1 mg, 0.050 mmol, 1.0 equiv) was reacted 
with LiHMDS (75.6 mg, 0.45 mmol, 9.0 equiv) and PdCl2(PPh3)2 
(3.6 mg, 0.005 mmol, 10 mol %) in 1.0 mL THF and 4-
bromofluorobenzene (33 µL, 0.3 mmol, 6 equiv) for 20 h at 58 – 
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60 ºC to yield 12 (21.5 mg, 0.035 mmol, 70% yield) as a highly crystalline pale yellow solid after silica 
gel chromatography eluting with 20% diethyl ether in pentane.  1H NMR (300 MHz, CDCl3) δ: 7.12 (m, 
4H), 7.02 (t, J =  Hz, 4H), 1.32 (s, 9H) ppm; 13C{1H} NMR (75 MHz) δ: 232.8, 162.1 (d, J = 247 Hz), 
137.1, 130.9 (d, J = 8 Hz), 115.9 (d, J = 22 Hz), 114.6, 93.7, 35.0 ppm; 19F NMR (282 MHz) δ: 
−117.9 (m) ppm; IR 3112, 3077, 3044, 2884, 2747, 1963 and 1876 (strong CO stretch), 1766, 
1630, 1567, 1505, 1468, 1300, 1223, 1183, 1159, 1100, 924, 826, 737, 665, 622 cm-1.  HRMS 
(ES+) calc’d for C32H22CrF4 618.0910, found 618.0919 [M]+.  
17 – 1,3,5-[(4-C6H4-OCH3)2CH]3(η6-C6H3)Cr(CO)3:  Using General 
procedure 1-A, (η6-mesitylene)Cr(CO)3 (9) (25.5 mg (0.099 mmol, 
1.0 equiv) was reacted with LiHMDS (188 mg, 1.1 mmol, 11 
equiv) and PdCl2(PPh3)2 (14.1 mg, 0.02 mmol, 20 mol %) in 2.6 
mL of THF and 4-bromoanisole (0.125 mL, 1.0 mmol, 10 equiv) 
for 5 h at 55 ºC to yield 17 (38.6 mg, 0.043 mmol, 43% yield) as 
a yellow crystalline solid after silica gel chromatography eluting 
with 40% diethyl ether in pentane.  1H NMR (300 MHz, CDCl3) δ: 6.96 (d, J = 8.6 Hz, 12H), 6.81 (d, J = 
8.6 Hz, 2H), 4.94 (s, 3H), 4.93 (s, 3H), 3.81 (s, 18H) ppm; 13C{1H} NMR (75 MHz) δ: 233.4, 158.6, 
134.4, 130.3, 113.9, 113.6, 97.6, 55.5, 53.0 ppm; the tricarbonylchromium-coordinated arene 
proton signal overlaps with the benzylic proton sigmal; IR 3071, 3000, 2953, 2932, 2903, 2835, 
1956 and 1874 (strong CO stretch), 1766, 1611, 1509, 1464, 1302, 1250, 1179, 1112, 1035, 925, 
830, 736, 667, 625 cm-1;  HRMS (ES+) calc’d for C54H48CrO9 892.2703, found 892.2746 [M]+.  X-ray 
crystal structure was determined for this compound; see p. 264. 
19 – 1,2-[(2,6-C6H3-Me2)CH2]2(η6-C6H4)Cr(CO)3: Using General procedure 
1-A, (η6-o-xylene)Cr(CO)3 (18) (12.2 mg, .0504 mmol, 1.0 equiv) was reacted 
with LiHMDS (50 mg, 0.30 mmol, 6 equiv) and PdCl2(PPh3)2 (4.9 mg, 7 
µmol, 14 mol %) in 0.75 mL THF and 2-bromo-1,3-dimethylbenzene (20 µL, 
0.15 mmol, 3 equiv) for 5 h at 62 ºC to yield 19 (19.3 mg, 0.0428 mmol, 
85% yield) as a pale yellow solid after silica gel chromatography eluting with 6% diethyl ether in 
pentane.  1H NMR (300 MHz, CDCl3) δ: 7.13 (m, 6H), 5.10 (dd, J = 4.7, 2.9 Hz, 2H), 4.87 (dd, J = 4.6, 
3.0 Hz, 2H), 4.11 (s, 1H), 2.37 (s, 12H) ppm; 13C{1H} NMR (75 MHz) δ: 233.7, 137.6, 133.9, 128.8, 
127.5, 109.9, 92.9, 92.1, 31.1, 20.3 ppm; IR 2923, 2853, 1952 and 1869 (strong CO stretch), 1470, 
1434, 1381, 1027, 769, 666 cm-1;  HRMS (ES+) calc’d for 450.1287 C27H26CrO3, found 450.1274 
[M]+.  
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20 – 1-[(4-C6H4-NMe2)2CH]-2-Me-(η6-C6H4)Cr(CO)3: Using General procedure 
1-A, (η6-o-xylene)Cr(CO)3 (18) (12.1 mg, 0.050 mmol, 1 equiv) was reacted 
with LiHMDS (26 mg, 0.15 mmol, 3 equiv) and PdCl2(PPh3)2 (4.2 mg, 6 
µmol, 12 mol %) in 0.7 mL THF and 4-bromo-N,N-dimethylaniline (30 mg, 
0.15 mmol, 3 equiv) for 10 h at 48 ºC to yield 20 (15.4 mg, 0.032 mmol, 
64% yield) as a yellow solid after silica gel chromatography eluting with 
40% diethyl ether in pentane.  1H NMR (300 MHz, CDCl3) δ: 7.06 (d, J = 8.8 
Hz, 2H), 6.93 (d, J = 8.6 Hz, 2H), 6.67 (m, 4H), 5.39 (dt, J = 1.1, 6.3 Hz, 1H), 5.19 (s, 1H), 5.11 - 5.06 
(m, 2H), 4.92 (dd, J = 0.7, 6.2 Hz, 1H), 2.93 (s, 6 H), 2.92 (s, 6H), 2.01 (s, 3H) ppm; 13C{1H} NMR (75 
MHz) δ: 233.9, 149.7, 149.4, 130.7, 130.4, 129.7, 128.7, 116.4, 112.7, 112.5, 110.3, 96.2, 94.6, 
93.1, 89.8, 50.8, 40.8, 19.5 ppm; diastereotopic carbon signals on dimethylamino group overlap 
(40.8 ppm);  IR 3074, 2922, 2854, 2804, 1958 and 1873 (strong CO stretche), 1611, 1520, 1352, 
1227, 1203, 1166, 947, 816, 667, 630 cm-1;  HRMS (ES+) calc’d for C24H29N2 345.2331, found 
345.2324 [MH - Cr(CO)3]+.  
21 –1-[(4-C6H4-NMe2)2CH]-2-[(4-C6H4-NMe2)CH2](η6-C6H4)Cr(CO)3: Using 
General procedure 1-A, (η6-o-xylene)Cr(CO)3 (18) (12.3 mg, 0.0508 mmol, 1 
equiv) was reacted with LiHMDS (39 mg, 0.25 mmol, 5 equiv) and 
PdCl2(PPh3)2 (5 mg, 7 µmol, 14 mol %) in 0.75 mL THF and 4-bromo-N,N-
dimethylaniline (42 mg, 0.2 mmol, 4 equiv) for 24 h at 48 ºC to yield 21 
(14.6 mg, 0.024 mmol, 48% yield) as a pale yellow solid after silica gel 
chromatography eluting with 40% diethyl ether in pentane.  1H NMR (300 
MHz, CDCl3) δ: 7.12 (d, J = 8.7 Hz, 2H), 6.97 (d, J = 8.7 Hz, 2H), 6.93 (d, J = 
8.7 Hz, 2H), 6.71 - 6.63 (m, 6H), 5.38 (s, 1H), 5.27 (dt, J = 1.1, 6.3 Hz, 1H), 5.11 (dt, J = 1.1, 6.3 Hz, 
1H), 4.90 (dd, J = 0.9, 6.4 Hz, 1H), 4.66 (dd, J = 1.0, 6.2 Hz, 1H), 3.88 (d, J = 16.6, Hz, 1H), 3.42 (d, J 
= 16.7 Hz, 1H), 2.94 (s, 6H), 2.93 (s, 6H), 2.92 (s, 6H) ppm; 13C{1H} NMR (75 MHz) δ: 234.0, 149.73, 
149.69, 149.5, 130.9, 130.8, 130.3, 129.8, 129.0, 124.3, 116.5, 115.1, 112.9, 112.5, 95.6, 94.0, 
92.8, 90.6, 50.4, 50.83, 40.79, 35.9 ppm; diastereotopic carbons on dimethylamino groups overlap 
(112.9, 40.8 ppm);  IR 2917, 2850, 2800, 1957 and 1870 (strong CO stretches), 1613, 1520, 1444, 
1351, 1202, 1164, 947, 811, 667, 630 cm-1;  HRMS (ES+) calc’d for C32H38N3 464.3066, found 
464.3051 [MH - Cr(CO)3]+.  
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General Procedure 1-B (for sensitive liquid substrates): 
24a – nPrOPhCH(η6-C6H5)Cr(CO)3:  An oven-dried reaction tube was charged 
with a small magnetic stirbar, PdCl2(PPh3)2 (8.5 mg, 0.012 mmol, 6 mol %) and 
LiHMDS (13 mg, 0.08 mmol, 0.4 equiv) under nitrogen and sealed with a 
septum.  1.4 mL of dry THF was added via syringe with stirring, forming a red-
orange solution to which neat bromobenzene (27 µL, 0.26 mmol, 1.3 equiv) 
was added.  The catalyst, base, and aryl bromide solution was allowed to stir for 5 min, and neat 
nPrOCH2(η6-C6H5)Cr(CO) (23) (44 µL, 0.20 mmol, 1.0 equiv) was added.  The reaction mixture was 
heated with stirring at 57 ºC.  A separate portion of  LiHMDS (54 mg, 0.32 mmol, 1.6 equiv) was 
dissolved in 0.35 mL dry THF and added via syringe over 1.5 h.  The reaction mixture was heated for 
an additional 30 min before cooling to room temperature and quenching with 2 drops H2O.  The 
orange solution was then opened to air, diluted with 3 mL diethyl ether, and filtered over a pad of 
MgSO4 and silica.  The pad was rinsed with additional diethyl ether and the resulting solution was 
concentrated in vacuo, loaded onto a silica gel column and eluted with 6% diethyl ether in pentane.  
The result was 24a (58.9 mg, 0.162 mmol, 81% yield) as an orange oil.  Upon storage at 0 ºC, product 
crystallized as a pale yellow solid.  1H NMR (300 MHz, CDCl3) δ: 7.39-7.32 (m, 5H), 5.70 (broad d, J = 
6.3 Hz, 1H), 5.34 (dt, J = 1.4 Hz, 6.2 Hz, 1H), 5.26 - 5.17 (m, 2H), 5.12 - 5.09 (m, 1H), 5.00 (s, 1H), 
3.49 - 3.36 (m, 2H), 1.65 (sextet, J = 7.0 Hz, 2H), 0.96 (t, J = 7.3 Hz, 3H) ppm; 13C{1H} NMR (75 MHz) 
δ: 233.2, 140.5, 129.0, 128.7, 127.4, 113.9, 92.3, 92.2, 91.9, 91.7, 91.6, 81.5, 71.6, 55.6, 23.2, 
10.9 ppm; tricarbonylchromium-coordinated protons and carbons exhibit diastereotopic signals; IR 
3031, 2965, 2936, 2876, 1965 and 1881 (strong CO stretches), 1455, 1100, 1075, 753, 703, 661, 
630 cm-1; HRMS (ES+) calc’d for C16H18CrO 278.0763, found 278.0753 [M -(CO)3]+. 
24b – nPrO(4-C6H4-F)CH(η6-C6H5)Cr(CO)3:  Using General Procedure 1-B, 23 (88 
µl, 0.40 mmol, 1.0 equiv) was combined with LiHMDS (28 mg, 0.16 mmol, 
0.25 equiv) and PdCl2(PPh3)2 (16 mg, 0.022 mmol, 5.5 mol %) in 2.5 mL THF 
and 4-bromofluorobenzene (70 µL, 0.64 mmol, 1.6 equiv) and heated at 57 ºC. 
More LiHMDS (108 mg, 0.64 mmol, 1.6 equiv) dissolved in 0.7 mL THF was 
added over 1h.  The reaction was allowed to proceed for an additional 1.8 h, 
and yielded 24bb (115 mg, 0.30 mmol, 75% yield) as a viscous orange oil after silica gel 
chromatography eluting with 6% diethyl ether in pentane.  Upon storage at 0 ºC, 24b became a 
crystalline yellow-orange solid.  1H NMR (300 MHz, CDCl3) δ: 7.37 - 7.33 (m, 2H), 7.07 (apparent t, J = 
8.4 Hz, 2H), 5.65 (d, J = 6.2 Hz, 1H), 5.33 (t, J = 5.9 Hz, 1H), 5.27 - 5.18 (m, 2H), 5.09 (d, J = 6.2 Hz, 
1H), 5.00 (s, 1H), 33.48 - 3.34 (m, 2H), 1.65 (sextet, J = 6.9 Hz, 2H), 0.95 (t, J = 7.3 Hz, 3H) ppm; 
13C{1H} NMR (75 MHz) δ: 233.0, 162.9 (d, J = 247 Hz), 136.2 (d, J = 3 Hz), 129.1 (d, J = 8.3 Hz), 
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115.9 (d, J = 21.9), 113.5, 92.4, 92.0, 91.9, 91.8, 91.7, 80.8, 71.7, 23.2, 10.9 ppm; 19F NMR (282 
MHz) δ: −113.3 (m) ppm; tricarbonylchromium-coordinated protons and carbons exhibit diastereotopic 
signals; IR 3088, 2966, 2937, 2877, 1967 and 1885 (strong CO stretch), 1604, 1508, 1456, 1224, 
1157, 1090, 823, 810, 660, 630 cm-1.   
24c – nPrO(4-C6H4-OMe)CH(η6-C6H5)Cr(CO)3:  Using General Procedure 1-B, 23 
(22 µl, 0.10 mmol, 1.0 equiv) was combined with LiHMDS (8 mg, 0.05 mmol, 
0.5 equiv) and PdCl2(PPh3)2 (3.5 mg, 0.005 mmol, 5 mol %) in 0.7 mL THF and 
4-bromoanisole (18 µL, 0.15 mmol, 1.5 equiv) and heated at 58 ºC. More 
LiHMDS (24 mg, 0.15 mmol, 1.5 equiv) dissolved in 0.3 mL THF was added 
over 30 min.  The reaction was allowed to proceed for an additional 1 h, and 
yielded 24c (31.4 mg, 0.080 mmol, 80% yield) as an orange oil after silica gel chromatography eluting 
with 20% diethyl ether in pentane.  Upon storage at 0 ºC, 24c became a yellow-orange solid.  1H NMR 
(300 MHz, CDCl3) δ: 7.28 (d, J = 8.6 Hz, 2H), 6.91 (d, J = 8.6 Hz, 2H), 5.69 (d, J = 6.5 Hz, 1H), 5.36 - 
5.32 (m, 1H), 5.23 - 5.20 (m, 2H), 5.09 (br d, J = 5.7 Hz, 1H), 4.97 (s, 1H), 3.81 (s, 3H), 3.43 - 3.38 
(m, 2H), 1.64 (sextet, J = 7.0 Hz, 2H), 0.95 (t, J = 7.4 Hz, 3H) ppm; 13C{1H} NMR (75 MHz) δ: 233.2, 
159.9, 132.5, 128.7, 114.4, 114.3, 92.3, 92.2, 92.1, 91.1, 91.7, 81.0, 71.4, 55.5, 23.2, 10.9 ppm; 
tricarbonylchromium-coordinated protons and carbons exhibit diastereotopic signals; IR 3087, 2964, 
2936, 2876, 1965 and 1882 (strong CO stretches), 1610, 1510, 1457, 1248, 1172, 1095, 1033, 
661, 631 cm-1.   
24d – nPrO(2-C6H4-OMe)CH(η6-C6H5)Cr(CO)3:  Using General Procedure 1-B, 23 
(22 µl, 0.10 mmol, 1.0 equiv) was combined with LiHMDS (7 mg, 0.042 mmol, 
0.4 equiv) and PdCl2(PPh3)2 (4.9 mg, 0.007 mmol, 7 mol %) in 0.8 mL THF and 
2-bromoanisole (20 µL, 0.16 mmol, 1.6 equiv) and heated at 58 ºC. More 
LiHMDS (24 mg, 0.15 mmol, 1.5 equiv) dissolved in 0.2 mL THF was added 
over ~50 min.  The reaction was allowed to proceed for an additional 1.7 h, and yielded 24d (30.3 mg, 
0.077 mmol, 77% yield) as an orange oil after silica gel chromatography eluting with 20% diethyl ether 
in pentane.  1H NMR (300 MHz, CDCl3) δ: 7.40 (dd, J = 1.7, 7.6 Hz, 1H), 7.30 - 7.27 (m, 1H), 6.98 
(t, J = 7.5 Hz, 1H), 6.91 (d, J = 8.3 Hz, 1H), 5.70 (d, J = 6.4 Hz, 1H), 5.52 (s, 1H), 5.41 (d, J = 6.3 Hz, 
1H), 5.29 (dt, J = 1.4, 6.3 Hz, 1H), 5.24 - 5.15 (m, 2H), 3.88 (s, 3H), 3.47 - 3.38 (m, 2H), 1.65 
(sextet, J = 7.0 Hz, 2H), 0.96 (t, J = 7.4 Hz, 3H) ppm; 13C{1H} NMR (75 MHz) δ: 233.4, 157.1, 129.43, 
129.36, 127.2, 121.2, 114.5, 110.8, 92.5, 92.2, 91.9, 91.8, 91.6, 74.1, 71.6, 55.6, 23.2, 10.9 ppm; 
tricarbonylchromium-coordinated protons and carbons exhibit diastereotopic signals; IR 3080, 2964, 
2937, 2877, 1964 and 1882 (strong CO stretch), 1600, 1489, 1463, 1242, 1112, 1090, 1027, 757, 
662, 631 cm-1.   
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24e – nPrO(2,6-C6H3Me2)CH(η6-C6H5)Cr(CO)3:  Using General Procedure 1-B, 
23 (22 µl, 0.10 mmol, 1.0 equiv) was combined with LiHMDS (8 mg, 0.05 
mmol, 0.5 equiv) and PdCl2(PPh3)2 (5.6 mg, 0.008 mmol, 8 mol %) in 1.0 mL 
THF and 2-bromo-1,3-dimethylbenzene (20 µL, 0.15 mmol, 1.5 equiv) and 
heated at 58 ºC. More LiHMDS (26 mg, 0.15 mmol, 1.5 equiv) dissolved in 0.2 
mL THF was added over ~40 min.  The reaction was allowed to proceed for an 
additional 4.8 h, and yielded 24e (22.5 mg, 0.058 mmol, 58% yield) as a yellow solid after silica gel 
chromatography eluting with 6% diethyl ether in pentane.  1H NMR (300 MHz, CDCl3) δ: 7.13 (t, J = 7.5 
Hz, 1H), 7.02 (br. d, J = 7.3 Hz, 2H), 6.12 (d, J = 6.3 Hz, 1H), 5.82 (s, 1H), 5.49 - 5.44 (m, 1H), 5.24 - 
5.20 (m, 2H), 4.87 (broad d, J = 5.7 Hz, 1H), 3.44 - 3.38 (m, 1H), 3.36 - 3.30 (m, 1H), 2.6 - 2.1 (very 
br. s, 6H), 1.64 (sextet, 7.3 Hz, 2H), 0.96 (t, J = 7.4 Hz, 3H) ppm; 13C{1H} NMR (75 MHz) ppm 233.4, 
137.9, 136.1, 130.4, 128.6, 113.9, 92.8, 92.5, 92.4, 92.1, 91.1, 76.6, 71.0, 23.3, 20.9, 11.0 ppm; 
tricarbonylchromium-coordinated protons and carbons exhibit diastereotopic signals; non-axial 
carbons on the xylyl group exhibit diminished signals due to the hindered rotation; IR 3071, 2965, 
2934, 2877, 1965 and 1881 (strong CO stretches), 1471, 1456, 1104, 1088, 774, 663, 629 cm-1.   
26a – nPrOPh2C(η6-C6H5)Cr(CO)3:  Using General Procedure 1-B, 23 (19 µl, 
0.085 mmol, 1.0 equiv) was combined with LiHMDS (58 mg, 0.35 mmol, 4.1 
equiv) and PdCl2(PPh3)2 (6 mg, 0.009 mmol, 10 mol %) in 0.8 mL THF and 
bromobenzene (32 µL, 0.30 mmol, 3.5 equiv) and heated at 55 ºC for 16 h, 
and yielded 26a (27.1 mg, 0.062 mmol, 73% yield) as a pale yellow solid 
after silica gel chromatography eluting with 6% diethyl ether in pentane.   1H 
NMR (300 MHz, CDCl3) δ: 7.43 - 7.35 (m, 10H), 5.71 (d, J = 6.0 Hz, 2H), 5.46 (t, J = 6.2 Hz, 1H), 5.04 
(t, J = 6.5 Hz, 2H), 3.09 (t, J = 6.7 Hz, 2H), 1.69 (sextet, J = 7.0 Hz, 2H), 0.95 (t, J = 7.4 Hz, 3H) ppm; 
13C{1H} NMR (75 MHz) ppm 232.9, 141.2, 129.8, 128.2, 128.0, 118.7, 95.8, 95.4, 87.9, 84.4, 66.3, 
23.2, 11.0 ppm; IR 3060, 3028, 2964, 2935, 2875, 1965 and 1887 (strong CO stretches), 1492, 
1447, 1074, 1029, 753, 706, 660, 651, 633 cm-1.   HRMS (ES+) calc'd for C25H22CrO 438.0923 
found 438.091 [M]+. 
26b – nPrO(4-C6H4-F)2C(η6-C6H5)Cr(CO)3:  Using General Procedure 1-B, 23 
(22 µl, 0.10 mmol, 1.0 equiv) was combined with LiHMDS (7 mg, 0.04 mmol, 
0.4 equiv) and PdCl2(PPh3)2 (7 mg, 0.01 mmol, 10 mol %) in 0.6 mL THF and 
4-bromofluorobenzene (43 µL, 0.04 mmol, 4 equiv) and heated at 56 ºC. 
More LiHMDS (70 mg, 0.42 mmol, 44.2 equiv) dissolved in 0.2 mL THF was 
added over 30 min.  The reaction was allowed to proceed for an additional for 40 h, and yielded 26b 
(27.4 mg, 0.058 mmol, 58% yield) as a pale yellow solid after silica gel chromatography eluting with 
Cr
OC
CO
CO
F
O
F
61 
 
4% diethyl ether in pentane.   1H NMR (300 MHz, CDCl3) δ 7.38 (m, 4H), 7.06 (t, J = 8.6 Hz, 4H), 5.65 
(d, J = 6.4 Hz, 2H), 5.49 (t, J = 6.1 Hz, 1H), 5.04 (t, J = 6.4 Hz, 2H), 3.04 (t, J = 6.6 Hz, 2H), 1.68 
(sextet, J = 7.0 Hz, 2H), 0.95 (t, J = 7.4 Hz, 3H); 13C{1H} NMR (75 MHz) ppm 232.6, 162.6 (d, J = 
248.3 Hz), 137.02 (d, J = 3 Hz), 131.82 (d, J = 8.3 Hz), 118.07, 115.03 (d, J = 21.1 Hz), 95.53, 
95.49, 87.8, 83.7, 66.3, 23.2, 11.0; 19F NMR (282 MHz) ppm −113.8 (m); IR 3070, 2965, 2936, 
2876, 1968 and 1889 (strong CO stretches), 1604, 1507, 1228, 1159, 1078, 831, 816, 657, 628 
cm-1. 
 
General Procedure 1-C (for sensitive solid substrates): 
26d – nPrO(4-C6H4-F)(4-C6H4-tBu)C(η6-C6H5)Cr(CO)3:  An oven-dried 
reaction tube was charged with small magnetic stirbar and nPrO(4-C6H4-
F)CH(η6-C6H5)Cr(CO)3  (24b) (19 mg, 0.050 mmol, 1.0 equiv), sealed with 
a septum, and purged with nitrogen.  PdCl2(PPh3)2 (3.2 mg, 0.0046 mmol, 
9 mol %) and LiHMDS (8 mg, 0.04 mmol, 0.8 equiv) was dissolved in 0.6 
mL of dry THF in a nitrogen atmosphere, forming an orange solution, to 
which neat 4-tert-butylbromobenzene (20 µL, 0.15 mmol, 3 equiv) was added.  The catalyst, base, and 
aryl bromide solution was taken up by syringe and added to 24b, which turned deep red.  The reaction 
mixture was heated with stirring at 58 ºC.  A separate portion of  LiHMDS (43 mg, 0.26 mmol, 5.2 
equiv) was dissolved in 0.2 mL dry THF and added to the reaction mixture via syringe over 20 min, and 
then allowed to stir for an additional 24 before cooling to room temperature and quenching with 2 
drops H2O.  The golden solution was then opened to air, diluted with 3 mL diethyl ether, and filtered 
over a pad of MgSO4 and silica.  The pad was rinsed with additional diethyl ether and the solution was 
concentrated in vacuo, loaded directly onto a silica gel column, and eluted with 3% diethyl ether in 
pentane.  The result was 26d (20.5 mg, 0.040 mmol, 80% yield) as a pale yellow solid.  1H NMR (300 
MHz, CDCl3) δ 7.45 - 7.41 (m, 2H), 7.36 (d, J = 8.6 Hz, 2H), 7.27 (d overlapping with solvent pk, J = 
7.3 Hz, 2H), 7.06 (apparent t, J = 8.7 Hz, 2H), 5.79 (d, J = 6.8 Hz, 1H), 5.60 (d, J = 6.7 Hz, 1H), 5.47 
(t, J = 6.2 Hz, 1H), 5.06 - 5.01 (m, 2H), 3.06 (apparent dt, J = 2.4, 6.6 Hz, 2H), 1.68 (sextet, J = 7.1 Hz, 
2H), 0.96 (t, J = 7.4 Hz, 3H); 13C{1H} NMR (75 MHz) ppm 232.9, 162.5 (d, J = 247 Hz), 151.3, 138.0, 
137.4 (d, J = 3.8 Hz), 131.6 (d, J = 8.3 Hz), 129.5, 125.0, 118.8, 114.8 (d, J = 21 Hz), 95.9, 95.8, 
95.5, 87.8, 87.7, 83.8, 66.2, 34.8, 31.5, 23.2, 11.1 ; 19F NMR (282 MHz) ppm −114.3 (m); 
tricarbonylchromium-coordinated protons and carbons exhibit diastereotopic signals; IR 3089, 2964, 
2873, 1969 and 1893 (strong CO stretch), 1604, 1507, 1229, 1159, 1079, 830, 657, 626 cm-1; 
HRMS (ES+) calc’d for C29H29CrOF d512.1455, found 512.1478 [M]+.  
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26e – nPrO(4-C6H4-F)(4-C6H4-OMe)C(η6-C6H5)Cr(CO)3:  Using General 
Procedure 1-C, 24b (19 mg, 0.050 mmol, 1.0 equiv) was combined with 
LiHMDS (13 mg, 0.08 mmol, 1.6 equiv) and PdCl2(PPh3)2 (3.5 mg, 0.005 
mmol, 10 mol %) in 0.55 mL THF and 4-bromoanisole (19 µL, 0.15 mmol, 3.0 
equiv) and heated at 55 ºC. More LiHMDS (20 mg, 0.12 mmol, 2.4 equiv) 
dissolved in 0.15 mL THF was added over 40 min.  The reaction was allowed 
to proceed for an additional 16 h, and yielded 26e (16.7 mg, 0.0343 mmol, 69 % yield) as a pale 
yellow solid after silica gel chromatography eluting with 6% diethyl ether in pentane.   1H NMR (300 
MHz, CDCl3) δ 7.41 (dd, J = 5.5, 8.5 Hz, 2H), 7.28 (d, J = 8.8 Hz, 2H), 7.06 (apparent t, J = 8.6 Hz, 2H), 
6.88 (d, J = 8.7 Hz, 2H), 5.77 (d, J = 6.6 Hz, 1H), 5.55 (d, J = 6.6 Hz, 1H), 5.48 (t, J = 6.1 Hz, 1H), 5.08 
- 5.00 (m, 2H), 3.82 (s, 3H), 3.11 - 2.99 (m, 2H), 1.67 (sextet, J = 7.0 Hz, 2H), 0.95 (t, J = 7.3 Hz, 3H); 
13C{1H} NMR (75 MHz) ppm .9, 162.4 (d, J = 248.0 Hz), 159.5, 137.6 (d, J = 3.4 Hz), 132.9, 131.4 (d, 
J = 8.1 Hz), 131.2, 118.9, 114.9 (d, J = 21.3 Hz), 113.4, 95.7, 95.6, 95.4, 88.0, 87.8, 83.7, 66.2, 
55.6, 23.2, 11.1; 19F NMR (282 MHz) ppm −114.3 (m); tricarbonylchromium-coordinated protons and 
carbons exhibit diastereotopic signals; IR 2963, 2934, 2875, 1967 and 1889 (strong CO stretches), 
1605, 1508, 1254, 1227, 1184, 1160, 1077, 1033, 830, 658, 628 cm-1.  
26g – nPrOPh(3-C6H4-OMe)C(η6-C6H5)Cr(CO)3:  Using General Procedure 
1-C, 24a (18 mg, 0.050 mmol, 1.0 equiv) was combined with LiHMDS (40 
mg, 0.25 mmol, 5.0 equiv) and PdCl2(PPh3)2 (3.5 mg, 0.005 mmol, 10 
mol %) in 0.65 mL THF and 3-bromoanisole (18 µL, 0.15 mmol, 3.0 equiv) 
and heated at 58 ºC for 24 h, and yielded 26g (14.4 mg, 0.0307 mmol, 
61% yield) as a pale yellow solid after silica gel chromatography eluting 
with 10% diethyl ether in pentane.  1H NMR (300 MHz, CDCl3) δ 7.40 - 7.33 (m, 5H), 7.27 (t, J = 8.0 
Hz, 1H), 7.09 (br s, 1H), 6.94 - 6.88 (m, 2H), 5.79 (d, J = 6.8 Hz, 1H), 5.66 (d, J = 6.7 Hz, 1H), 5.46 (t, 
J = 6.2 Hz, 1H), 5.08 - 5.01 (m, 2H), 3.82 (s, 3H), 3.18 - 3.02 (m, 2H), 1.69 (sextet, J = 7.0 Hz, 2H), 
0.96 (t, J = 7.4 Hz, 3H); 13C{1H} NMR (75 MHz) ppm 232.9, 159.5, 142.9, 141.0, 129.9, 128.7, 
128.2, 127.9, 122.5, 118.7, 115.5, 113.7, 95.8, 95.7, 95.4, 88.0, 87.9, 84.4, 66.4, 55.5, 23.2, 
11.1; tricarbonylchromium-coordinated protons and carbons exhibit diastereotopic signals; IR 2963, 
2926, 2873, 1964 and 1883 (strong CO stretches), 1598, 1488, 1448, 1254, 1075, 1029, 706, 
657, 632 cm-1. 
26f – nPrOPh(2-C6H4-Me)C(η6-C6H5)Cr(CO)3:  Using General Procedure 1-C, 
24a (18 mg, 0.050 mmol, 1.0 equiv) was combined with LiHMDS (17 mg, 
0.10 mmol, 2.0 equiv) and PdCl2(PPh3)2 (3.5 mg, 0.005 mmol, 10 mol %) in 
0.6 mL THF and 2-bromotoluene (18 µL, 0.15 mmol, 3.0 equiv) and heated 
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at 58 ºC.  More LiHMDS (33 mg, 0.20 mmol, 4.0 equiv) dissolved in 0.2 mL THF was added over 2h.  
The reaction was allowed to proceed for an additional 40 h, and yielded 26f (13.3 mg, 0.0293 mmol, 
59% yield) as a pale yellow solid after silica gel chromatography eluting with 6% diethyl ether in 
pentane.   1H NMR (300 MHz, CDCl3) δ 7.46 - 7.39 (m, 3H), 7.36 - 7.18 (m, 5H), 7.15 - 7.12 (m, 1H), 
5.78 (d, J = 6.4 Hz, 1H), 5.63 (d, J = 6.4 Hz, 1H), 5.47 (t, J = 6.2 Hz, 1H), 5.08 - 5.03 (m, 2H), 3.26 (dt, 
J = 8.9, 6.5 Hz, 1H), 2.90 (dt, J = 8.9, 7.0 Hz, 1H), 1.80 (s, 3H), 1.79 - 1.72 (m, 2H), 0.98 (t, J = 7.4 Hz, 
3H); 13C{1H} NMR (75 MHz) ppm, 144.3, 140.2, 138.5, 132.7, 129.8, 128.5, 128.02, 128.03, 127.8, 
125.6, 118.2, 97.5, 95.7, 95.6, 87.4, 87.3, 84.7, 67.6, 23.3, 22.5, 11.0; tricarbonylchromium-
coordinated protons and carbons exhibit diastereotopic signals; propoxy methylene protons exhibit 
diastereotopic signals in the 1H NMR; IR 3022, 2963, 2930, 2873, 1966 and 1887 (strong CO 
stretches), 1448, 1074, 750, 706, 659, 632 cm-1. 
 
General Procedure 1-D (for liquid substrates): 
28a – Me2NPhCH(η6-C6H5)Cr(CO)3:  An oven-dried reaction tube was charged with 
small magnetic stirbar, PdCl2(PPh3)2 (4.2 mg, 0.006 mmol, 6 mol %) and LiHMDS 
(38 mg, 0.23 mmol, 2.3 equiv) under nitrogen and sealed with a septum.  0.7 mL 
of dry THF was added via syringe with stirring, forming a red solution to which 
neat bromobenzene (17 µL, 0.16 mmol, 1.6 equiv) was added.  The catalyst, 
base, and aryl bromide solution was allowed to stir for 5 min, and neat Me2NCH2(η6-C6H5)Cr(CO) (27) 
(21 µL, 0.10 mmol, 1.0 equiv) was added dropwise and then heated at 56 ºC with stirring for 6 h.  The 
dark reaction mixture was cooled to room temperature and quenched with 2 drops H2O.  The brownish 
orange solution was then opened to air and diluted with 3 mL diethyl ether, then filtered over a pad of 
MgSO4 and silica.  The pad was rinsed with additional diethyl ether and the solution was concentrated 
in vacuo, loaded directly onto a silica gel column and eluted with 50% diethyl ether in pentane.  The 
result was 28a (28.6 mg, 0.082 mmol, 82% yield) as an orange oil which solidified on standing.  
 1H NMR (300 MHz, CDCl3) δ 7.39-7.28 (m, 5H), 5.91 - 5.88 (m, 1H), 5.33 - 5.26 (m, 3H), 5.17 - 5.12 
(m, 1H), 4.14 (s, 1H), 2.24 (s, 6H) ; 13C{1H} NMR (75 MHz) ppm 233.0, 140.0, 129.0, 128.6, 128.1, 
114.0, 95.1, 94.5, 93.6, 91.0, 90.5, 73.4, 44.3; tricarbonylchromium-coordinated protons and 
carbons exhibit diastereotopic signals; IR 2946, 2864, 2823, 2781, 1962 and 1876 (strong CO 
stretches), 1611, 1521, 1454, 1353, 1016, 812, 663, 632 cm-1; HRMS (ES+) calc’d for C15H17Cr 
263.0766, found 263.0757 [M -(CO)3]+.  
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28b – Me2N(4-C6H4-F)CH(η6-C6H5)Cr(CO)3:  Using General Procedure 1-D, 27 
(21 µl, 0.10 mmol, 1.0 equiv) was combined with LiHMDS (37 mg, 0.23 
mmol, 2.3 equiv) and PdCl2(PPh3)2 (4.9 mg, 0.007 mmol, 5 mol %) in 0.85 
mL THF and 4-bromofluorobenzene (18 µL, 0.16 mmol, 1.6 equiv) and 
heated at 58 ºC for 5 h, yielding 28b (22.7 mg, 0.062 mmol, 62% yield) as a yellow solid after silica 
gel chromatography eluting with 40% diethyl ether in pentane.   1H NMR (300 MHz, CDCl3) δ 7.31 - 
7.27 (m, 2H), 7.08 - 7.02 (m, 2H), 5.85 (d, J = 6.4 Hz, 1H), 5.34 (tt, J = 6.1, 1.1 Hz, 1H), 5.30 - 5.24 
(m, 2H), 5.17 - 5.12 (m, 1H), 4.10 (s, 1H), 2.22 (s, 6H); 13C{1H} NMR (75 MHz) ppm 232.8, 162.5 
(d, J = 246.8 Hz), 136.0 (d, J = 3.0 Hz), 130.5 (d, J = 7.5 Hz), 115.6 (d, J = 24.2 Hz), 113.6, 95.5, 
94.4, 93.9, 90.7, 90.2, 72.9, 44.3; 19F{1H} NMR (282 MHz) ppm −114.2 (s); tricarbonylchromium-
coordinated protons and carbons exhibit diastereotopic signals; ; IR 2925, 2851, 2825, 2780, 1965, 
1881, 1605, 1506, 1455, 1223, 1157, 1014, 820, 660, 631 cm-1. 
28c – Me2N(4-C6H4-NMe2)CH(η6-C6H5)Cr(CO)3:  Using General Procedure 
1-D, 27 (21 µl, 0.10 mmol, 1.0 equiv) was combined with LiHMDS (38 mg, 
0.23 mmol, 2.3 equiv) and PdCl2(PPh3)2 (3.5 mg, 0.005 mmol, 5 mol %) in 
0.7 mL THF and 4-bromo-N,N-dimethylaniline (28 mg, 0.16 mmol, 1.6 equiv) 
and heated at 55 ºC for 4 h, yielding 28c (30.1 mg, 0.077 mmol, 77% yield) as a yellow solid after 
silica gel chromatography eluting with 40% diethyl ether in pentane.   1H NMR (300 MHz, CDCl3) δ 
7.08 (d, J = 8.8 Hz, 2H), 6.68 (d, J = 8.8 Hz, 2H), 5.92 (br. d, J = 6.5 Hz, 1H), 5.36 (dt, J = 1.1, 6.4 Hz, 
1H) 5.28 - 5.17 (m, 3H), 4.15 (s, 1H), 2.95 (s, 6H), 2.23 (s, 6H); 13C{1H} NMR (75 MHz) ppm 233.3, 
150.3, 130.1, 127.4, 115.6, 112.3, 94.26, 9.24, 92.9, 91.8, 91.5, 72.4, 44.1, 40.7; IR cm-1; 
tricarbonylchromium-coordinated protons and carbons exhibit diastereotopic signals; IR 2950, 2867, 
2824, 2780, 1963 and 1875 (strong CO stretches), 1454, 1015, 755, 705, 661, 630 cm-1. 
28d – Me2NCH(2-C6H4-OMe)(η6-C6H5)Cr(CO)3:  Using General Procedure 1-D, 
27 (21 µl, 0.10 mmol, 1.0 equiv) was combined with LiHMDS (34 mg, 0.20 
mmol, 2 equiv) and PdCl2(PPh3)2 (4.2 mg, 0.006 mmol, 6 mol %) in 0.7 mL 
THF and 2-bromoaniline (22 µL, 0.17 mmol, 1.7 equiv) and heated at 58 ºC 
for 5 h, yielding 28d (27.2 mg, 0.072 mmol, 72% yield) as a yellow solid after silica gel 
chromatography eluting with 30 – 40% diethyl ether in pentane.   1H NMR (300 MHz, CDCl3) δ: 7.27 - 
7.22 (m, 2H), 6.96 - 6.91 (m, 2H), 5.91 (d, J = 6.7 Hz, 1H), 5.39 (d, J = 6.6 Hz, 1H), 5.32 (tt J = 1.1, 
6.2 Hz, 1H), 5.25 (dt, J = 1.4, 6.3 Hz, 1H), 5.11 (dt, J = 1.4, 6.3 Hz, 1H), 4.68 (s, 1H), 3.85 (s, 3H), 
2.23 (s, 6H); 13C{1H} NMR (75 MHz) δ: 33.0, 157.4, 129.3, 129.0, 128.9, 120.5, 114.9, 111.1, 95.9, 
94.7, 93.9, 90.6, 89.9, 64.9, 55.6, 44.5; tricarbonylchromium-coordinated protons and carbons 
Cr
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exhibit diastereotopic signals;  IR 2924, 2822, 2771, 1962 and 1881 (strong CO stretch), 1489, 
1456, 1243, 1027, 755, 700, 662 cm-1. 
31b – CH3CH(4-C6H4-OCH3)(η6-C6H5)Cr(CO)3:  Using General Procedure 1-C, 
CH3CH2(η6-C6H5)Cr(CO)3 (30) (24.4 mg, 0.10 mmol, 1.0 equiv) was 
combined with LiHMDS (13 mg, 0.08 mmol, 0.8 equiv) and PdCl2(PPh3)2 
(5.8 mg, 0.008 mmol, 8 mol %) in 0.85 mL of dry THF and 4-bromoanisole 
(19 µL, 0.15 mmol, 1.5 equiv) and heated at 58 ºC.  More LiHMDS (20 mg, 
0.12 mmol, 1.2 equiv) dissolved in 0.15 mL THF was added over 30 min.  The reaction was allowed to 
proceed for an additional 3.5 h and yielded 31b (24.5 mg, 0.070 mmol, 70% yield)  as a yellow-orange 
oil after silica gel chromatography eluting with 6% diethyl ether in pentane.   1H NMR (300 MHz, CDCl3) 
δ 7.15 (d, J = 8.6 Hz, 2H), 6.86 (d, J = 8.6 Hz, 2H), 5.43 (d, J = 6.3 Hz, 1H), 5.38 - 5.34 (m, 1H), 5.29 - 
5.21 (m, 2H), 5.10 (d, J = 6.1 Hz, 1H), 3.86 - 3.77 (m, 4H), 1.56 (d, J = 7.2 Hz, 3H); 13C{1H} NMR (75 
MHz) δ: 233.4, 158.8, 136.6, 128.6, 117.9, 114.3, 94.4, 92.8, 92.5, 92.1, 91.4, 55.5, 43.1, 21.3; 
tricarbonylchromium-coordinated protons and carbons exhibit diastereotopic signals; methoxy signal 
overlaps with the benzylic proton signal; IR 3089, 2971, 2936, 2838, 1962 and 1877 (strong CO 
stretch), 1611, 1511, 1457, 1247, 1180,1031, 835, 662, 630 cm-1.  HRMS (ES+) calc’d for 
C15H16CrO 264.0606, found 264.0608 [M -(CO)3]+.  
41a – 1,3-cis-Ph2(η6-indane)Cr(CO)3: Using General procedure 1-A, 39(25.5 mg, 
0.100 mmol, 1.0 equiv) was reacted with LiHMDS (83 mg, 0.50 mmol, 5 equiv) 
and PdCl2(PPh3)2 (4.3 mg, 0.006 mmol, 6 mol %) in 1 mL THF and bromobenzene 
(52 µL, 0.5 mmol, 5 equiv) for 5 h at 52 ºC to yield 41a (30.8 mg, 0.076 mmol, or 
76%) as a yellow solid after silica gel chromatography eluting with 20% diethyl 
ether in pentane.  1H NMR (300 MHz, CDCl3) δ 7.35 (m, 6H), 7.25 (m, 4H), 5.39 (dd, J = 4.5, 2.7 Hz, 
2H), 5.22 (dd, J = 4.6, 3.0 Hz, 2H), 4.48 (t, J = 8.4 Hz, 2H), 3.11 (dt, J = 13.5, 8.4 Hz, 1H), 2.20 (dt, J = 
13.5, 8.4 Hz, 1H); 13C{1H} NMR (75 MHz) ppm 233.8, 143.5, 129.3, 128.4, 127.6, 119.0, 92.2, 91.8, 
50.1, 45.8.  IR: 3081, 3027, 2970, 2935, 2856, 1956 and 1877 and 1867 (strong CO stretch), 
1602, 1494, 1450, 1427, 1263, 1152, 1078, 803, 760, 747, 696, 667, 632 cm-1. HRMS (ES+) 
calc’d for C21H18Cr 322.0814, found 322.0819 [M -(CO)3]+. 
41b – 1,3-cis-(4-C6H4-F)2(η6-Indane)Cr(CO)3: Using General procedure 1-A, 39 
(12.6 mg, 0.049 mmol, 1.0 equiv) was reacted with LiHMDS (43 mg, 0.26 mmol, 
5.1 equiv) and PdCl2(PPh3)2 (3.6 mg, 0.005 mmol, 10 mol %) in 1.2 mL of THF and 
4-bromofluorobenzene (27.5 µL, 0.25 mmol, 5 equiv) for 16 h at 53 ºC to yield 
41b (12.1 mg, 0.030 mmol, or 61% yield) as a yellow solid after silica gel 
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chromatography eluting with 20% diethyl ether in pentane.  1H NMR (300 MHz, CDCl3) δ 7.16 (m, 4H), 
7.03 (t, J = 8.7 Hz, 4H), 5.36 (dd, J = 4.7, 2.7 Hz, 2H), 5.23 (dd, J = 4.8, 3.0 Hz, 2H), 4.45 (t, J =  8.3 
Hz, 2H), 3.09 (dt, J = 13.5, 8.3 Hz, 1H), 2.10 (dt, 13.5, 8.3 Hz) ;13C{1H} NMR (75 MHz) ppm 233.3, 
162.1 (d, J = 246 Hz), 138.9 (d, J = 2.9 Hz), 129.6 (d, J = 8.0 Hz), 118.0, 116.0 (d, J = 21.4 Hz), 91.9, 
91.3, 49.0, 45.8; 19F NMR (282 MHz) ppm −118.3 (m); IR 3079, 3041, 2934, 1962 and 1875 
(strong CO stretch), 1605, 1509, 1225, 1159, 1098, 834, 667, 630 cm-1; HRMS (ES+) calc’d for 
C21H16CrF2 358.0625, found 358.0617 [M -(CO)3]+.  X-ray crystal structure was determined for this 
compound; see p. 283. 
41c – 1,3-cis-Ph(3-C6H4-OMe)(η6-indane)Cr(CO)3: Using General procedure 1-A, 
43c (35.9 mg, 0.0996 mmol, 1.0 equiv) was reacted with LiHMDS (33 mg, 
0.20 mmol, 2.0 equiv) and PdCl2(PPh3)2 (7 mg, 0.01 mmol, 10 mol %) in 1.0 
mL THF and 4-bromo-tert-butylbenzene (22 µL, 0.15 mmol, 1.5 equiv) for 5 h 
at 57 ºC to yield 41c (40.1 mg, 0.0815 mmol, or 82%) as a yellow solid after 
silica gel chromatography eluting with 10% diethyl ether in pentane.  1H NMR 
(300 MHz, CDCl3) δ 7.36 (d, J = 8.3 Hz, 2H), 7.26 (t, 7.9 Hz, 1H), 7.16 (d, J = 8.3 Hz, 2H), 6.84 - 6.79 
(m, 2H), 6.72 - 6.71 (m, 1H), 5.44 - 5.40 (m, 2H), 5.24 - 5.21 (m, 2H), 4.49 - 4.41 (m, 2H), 3.75 (s, 
3H), 3.09 (dt 13.5, 8.5 Hz, 1H), 2.20 (dt, 13.5, 8.2 Hz, 1H), 1.32 (s, 9H); 13C{1H} NMR (75 MHz) ppm 
233.6, 160.2, 150.3, 145.1, 140.3, 130.1, 127.8, 125.0, 120.5, 118.71, 118.66, 114.0, 112.5, 
92.0, 91.9, 91.7, 91.5, 55.4, 49.9, 49.3, 45.1, 34.7, 31.5; IR 3027, 2963, 1962 and 1878 (strong 
CO stretch), 1600, 1455, 1268, 1050, 667, 630 cm-1; HRMS (ES+) calc’d for C26H28CrO 408.1545, 
found 408.1526 [M -(CO)3]+. 
42a – 1,4-cis-Ph2(η6-tetrahydronaphthalene)Cr(CO)3: Using General procedure 1-A, 
(η6-tetrahydronaphthalene)Cr(CO)3 (40) (13.3 mg, 0.050 mmol, 1.0 equiv) was 
reacted with LiHMDS (42 mg, 0.25 mmol, 5 equiv) and PdCl2(PPh3)2 (3.5 mg, 
0.005 mmol, 10 mol %) of in 1 mL THF and bromobenzene (26 µL, 0.25 mmol, 5 
equiv)  for 12 h at 52 ºC to yield 42a (18.4 mg, 0.044 mmol, 88% yield) as a yellow 
solid after silica gel chromatography eluting with 20% diethyl ether in pentane.  1H NMR (300 MHz, 
CDCl3) δ 7.36 (m, 4H), 7.28 (m, 2H), 7.21 (m, 4H), 5.23 (m, 2H), 5.17 (m, 2H), 4.10 (t, J = 6.3 Hz, 
2H), 2.11 (m, 2H), 1.86 (m, 2H); 13C{1H} NMR (75 MHz) ppm 233.6, 145.3, 128.9, 128.7, 127.1, 
112.3, 94.8, 92.2, 44.5, 28.9.;  IR 3085, 3029, 2937, 2855, 1951 and 1875 and 1856 (strong CO 
stretch), 1600, 1492, 1416, 1443, 1077, 1054, 1029, 831, 755, 700, 667, 635 cm-1;  HRMS (ES+) 
calc’d for C22H20Cr 336.0970, found 336.0968 [M -(CO)3]+. 
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42b – 1,4-cis-(4-C6H4-F)2(η6-tetrahydronaphthalene)Cr(CO)3: Using General 
procedure 1-A, 40 (13.4 mg, 0.050 mmol, 1.0 equiv) was reacted with LiHMDS 
(42 mg, 0.25 mmol, 5 equiv) and PdCl2(PPh3)2 (2.6 mg, 0.0037 mmol, 7 mol %) 
in 1 mL THF and 4-bromofluorobenzene (28 µL, 0.25 mmol, 5 equiv) for 5 h at 
55 – 57 ºC to yield 42b (14.6 mg, 0.033 mmol, 64% yield) as a yellow solid 
after silica gel chromatography eluting with 20% diethyl ether in pentane.  1H 
NMR (300 MHz, CDCl3) δ 7.14 (m, 4H), 7.05 (t, J = 8.7 Hz, 4H), 5.25 (dd, J = 4.9, 2.9 Hz, 2H), 5.12 
(dd, J = 4.8, 2.9 Hz, 2H), 4.08 (t, J = 6.2 Hz, 2H), 2.10 (m, 2H), 1.80 (m, 2H); 13C{1H} NMR (75 MHz) 
ppm 233.3, 161.9 (d, J = 246 Hz), 140.9, 130.0 (d, J = 8.0 Hz), 115.9 (d, J = 21.3 Hz), 111.8, 94.6, 
92.3, 43.7, 28.9; 19F NMR (282 MHz) ppm −118.7 (m); IR 3077, 3041, 2940, 2863, 1960 and 1871 
(strong CO stretch), 1626, 1567, 1508, 1457, 1301, 1224, 1184, 1159, 1097, 924, 828, 736, 667, 
628 cm-1; HRMS (ES+) calc’d for C22H18Cr 372.0782, found 372.0773 [M -(CO)3]+.  
42c – 1,4-cis-(3-C6H4-OCH3)2(η6-tetrahydronaphthalene)Cr(CO)3: Using General 
procedure 1-A, 40 (13.6 mg, 0.051 mmol, 1.0 equiv) was reacted with LiHMDS 
(42 mg, 0.25 mmol, 4.9 equiv) and PdCl2(PPh3)2 (2.7 mg, 0.0037 mmol, 7 mol 
%) in 1 mL THF and 3-bromoanisole (32 µL, 0.25 mmol, 5 equiv) for 5 h at 55 
ºC to yield 42c (17.6 mg, 0.037 mmol, 73% yield) as a yellow solid after silica 
gel chromatography eluting with 20% diethyl ether in pentane.  1H NMR (300 MHz, CDCl3) δ 7.27 (t, J = 
8.0 Hz, 2H), 6.78 (m, 6H), 5.24 (m, 2H), 5.18 (m, 2H), 4.06 (t, J = 6.2 Hz), 3.80 (s, 6H), 2.09 (m, 2H), 
1.87 (m, 2H); 13C{1H} NMR (75 MHz) ppm 233.5, 160.0, 146.9, 129.9, 121.1, 114.8, 112.2, 112.1, 
94.8, 92.3, 55.4, 44.4, 28.8;  IR 3000, 2939, 2835, 1959 and 1874 (strong CO stretch), 1599, 
1584, 1487, 1455, 1266, 1149, 1046m 783, 700, 667, 630 cm-1; HRMS (ES+) calc’d for C24H24CrO2 
396.1181, found 396.1149 [M -(CO)3]+.  
43a – 1-(2,6-C6H3Me2)(η6-indane)Cr(CO)3: Using General procedure 1-A, 39 (25.3 
mg, 0.099 mmol, 1.0 equiv) was reacted with LiHMDS (67 mg, 0.40 mmol, 4.2 
equiv) and PdCl2(PPh3)2 (4.8 mg, 0.007 mmol, 7 mol %) in 1 mL THF and 1-bromo-
2,6-dimethylbenzene (41 µL, 0.3 mmol, 3 equiv) for 10 h at 55 ºC to yield 43a 
(0.047 mmol, 17 mg, or 47% yield) as a yellow solid after silica gel 
chromatography eluting with 3% diethyl ether in pentane.  1H NMR (300 MHz, CDCl3) δ 7.07 (d, J = 4.5 
Hz, 2H), 6.98 – 6.96 (m, 1H), 5.61 (d, J = 6.1 Hz, 1H), 5.24 (m, 3H), 5.04 (t, J =  9.0 Hz, 1H), 3.15 (t, J 
= 7.9 Hz, 2H), 2.66 (m, 1H), 2.48 (s, 3H), 2.16 (m, 1H), 1.96 (s, 3H); 13C{1H} NMR (75 MHz) ppm 
233.9, 139.5, 137.5, 136.0, 130.7, 128.7, 127.2, 119.4, 115.7, 92.2, 91.7, 91.2, 90.4, 45.6, 31.8, 
30.1, 21.6, 21.5; methyl carbons and protons on the xylyl moiety exhibit diastereotopic signals;  IR 
2962, 1957 and 1867 (strong CO stretch), 1469, 1449, 1084, 773, 667, 631 cm-1. 
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43b – 1-(4-C6H4-tBu)(η6-indane)Cr(CO)3: Using General Procedure 1-C, 39 (22.5 
mg, 0.0885 mmol, 1.0 equiv) was reacted with LiHMDS (13 mg, .078 mmol, 0.88 
equiv) and PdCl2(PPh3)2 (4.8 mg, 0.0068 mmol, 7.6 mol %) in 0.8 mL THF and 4-
bromo-tert-butylbenzene (16 µL, 0.12 mmol, 1.3 equiv) and heated at 58 ºC. More 
LiHMDS (21 mg, 0.13 mmol, 1.5 equiv) dissolved in 0.2 mL THF was added over 3 
h.  The reaction was allowed to proceed for an additional 2 h, and yielded 43b 
(0.0497 mmol, 19.2 mg, or 56% yield) as a fluffy yellow solid after silica gel chromatography eluting 
with 3% diethyl ether in pentane.  1H NMR (300 MHz, CDCl3) δ: 7.31 (d, J = 8.4 Hz, 2H), 7.01 (d, J = 
8.3 Hz, 2H), 5.53 (d, J = 6.4 Hz, 1H), 5.39 (d, J = 6.4 Hz, 1H), 5.31 (dt, J = 6.2, 1.0 Hz, 1H), 5.21 
(dt, J = 6.2, 1.0 Hz, 1H), 4.18 (dd, J = 8.5, 1.6 Hz, 1H), 3.08 - 3.00 (m, 1H), 2.79 - 2.70 (m, 1H), 2.66 - 
2.54 (m, 1H) 2.10 - 2.02 (m, 1H), 1.30 (s, 9H); 13C{1H} NMR (75 MHz) δ: 233.6, 150.0, 141.4, 126.8, 
125.9, 116.6, 114.9, 92.5, 91.9, 91.5, 90.3, 49.3, 34.7, 33.3, 31.6, 30.8 ppm;  IR 3087, 3028, 
2964, 2868, 1963 and 1877 (strong CO stretches), 1510, 1452, 1434, 1365, 1270, 1017, 830, 
670, 631 cm-1.  HRMS (ES+) calc’d for C22H22CrO3 386.0974, found 386.0981 [M]+. 
43c – 1-(3-C6H3OMe)(η6-indane)Cr(CO)3: Using General Procedure 1-C, 39 (61.3 
mg, 0.241 mmol, 1.0 equiv) was reacted with LiHMDS (25 mg, .15 mmol, 0.62 
equiv) and PdCl2(PPh3)2 (17.5 mg, 0.025 mmol, 10 mol %) in 2 mL THF and 3-
bromoanisole (48 µL, 0.38 mmol, 1.6 equiv) and heated at 55 ºC. More LiHMDS 
(50 mg, 0.30 mmol, 1.2 equiv) dissolved in 0.5 mL THF was added over 3h.  The 
reaction was allowed to proceed for an additional 1 h, and yielded 43c (0.128 mmol, 46.0 mg, or 53% 
yield) as a fluffy yellow solid after silica gel chromatography eluting with 6% diethyl ether in pentane.  
1H NMR (300 MHz, CDCl3) δ: 7.22 (t, J = 7.9 Hz, 1H), 6.77 (ddd, J = 8.3, 2.5, 1.8 Hz, 1H), 6.68 (d, J = 
7.7 Hz, 1H), 6.62 (t, J = 1.9 Hz, 1H), 5.52 (d, J = 6.3 Hz, 1H), 5.39 (d, J = 6.3 Hz, 1H), 5.31 (dt, J = 0.9, 
6.2 Hz, 1H), 5.22 (dt, J = 0.9, 6.2 Hz, 1H), 4.18 (dd, J = 8.6, 1.5 Hz, 1H), 3.75 (s, 3H), 3.09 - 2.97 (m, 
1H), 2.80 - 2.69 (m, 1H), 2.66 - 2.56 (m, 1H), 2.09 - 2.02 (m, 1H); 13C{1H} NMR (75 MHz) δ: 233.6, 
160.1, 146.1, 130.1, 119.6, 116.2, 114.9, 113.6, 111.8, 92.5, 91.9, 91.4, 90.3, 55.4, 49.8, 33.2, 
30.8 ppm; IR 3081, 2924, 2851, 1958 and 1866 (strong CO stretches), 1599, 1488, 1451, 1265, 
1050, 777, 701, 670, 629 cm-1. 
 
General Procedure 1-E: 
44b – 1-(3-C6H4-Me)(η6-tetrahydronaphthalene)Cr(CO)3: An oven-dried glass 
reaction tube was charged with a small magnetic stirbar and (η6-
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tetrahydronaphthalene)Cr(CO)3 (40) (19.9 mg, 0.0742 mmol, 1.0 equiv), sealed with a septum, purged 
with nitrogen, and dissolved in 0.3 ml toluene.  PdCl2(PPh3)2 (3.6 mg, 5 µ mmol, 7 mol %) and LiHMDS 
(38 mg, 0.23 mmol, 3 equiv) were dissolved in 0.45 mL of dry THF under a nitrogen atmosphere, 
forming an orange solution, to which 3-bromotoluene (15 µL, 0.12 mmol, 1.6 equiv)  was added.  The 
catalyst, base, and aryl bromide THF solution was taken up by syringe and added to the toluene 
solution of 24, which turned red-orange.  The reaction mixture was heated with stirring for 4.5 h at 58 
ºC, then allowed to cool and quenched with one drop of aqueous 2N HCl and allowed to stir for 5 min.  
The pale orange solution was opened to air and diluted with 2 mL diethyl ether and filtered over a pad 
of MgSO4 and silica which was rinsed with an additional 1 mL diethyl ether.  After concentration in 
vacuo and purification by silica gel flash chromatography eluting with 6% diethyl ether in pentane, 44b 
(14.7 mg, 0.041 mmol, 55% yield) was obtained as an orange oil.  1H NMR (300 MHz, CDCl3) δ 7.20 (t, 
J = 7.6 Hz, 1H), 7.06 (d, J = 7.9 Hz, 1H), 6.94 - 6.89 (m, 2H), 5.31 - 5.27 (m, 2H), 5.18 - 5.14 (ddd, J = 
2.1, 5.3, 6.6 Hz, 1H), 5.06 (d, J = 6.7 Hz, 1H), 3.95 (dd, J = 5.8, 8.1 Hz, 1H), 2.82 - 2.67 (m, 2H), 2.33 
(s, 3H), 2.20 - 2.12 (m, 1H), 1.87 - 1.69 (m, 3H); 13C{1H} NMR (75 MHz) ppm 233.8, 145.5, 138.6, 
129.4, 128.8, 127.8, 125.7, 112.1, 110.5, 95.3, 93.4, 92.6, 91.6, 44.5, 32.5, 29.1, 21.7, 20.5;  IR 
3019, 2939, 2862, 1957 and 1868 (strong CO stretch), 1606, 1456, 788, 704, 667, 632, 536 cm-1;  
HRMS (ES+) calc’d for C20H18CrO3 358.0661, found 358.0660 [M]+.  
44c – 1-(4-C6H4-NMe2)(η6-tetrahydronaphthalene)Cr(CO)3: Using  General 
Procedure 1-E, a solution of (η6-tetrahydronaphthalene)Cr(CO)3 (40) (20.1 mg, 
0.075 mmol, 1 equiv) in 0.3 ml Toluene was reacted with LiHMDS (32 mg, 
0.19 mmol, 2.5 equiv) and PdCl2(PPh3)2 (3.2 mg, 4.5 µmol, 6 mol %) of in 
0.45 mL THF and 4-bromo-N,N-dimethylaniline (25 mg, 0.12 mmol, 1.6 equiv)  
for 6 h at 60 ºC to yield 44c (12.9 mg, 0.033 mmol, 44% yield) as a yellow-
orange oil after silica gel chromatography eluting with 20% diethyl ether in pentane.  1H NMR (300 
MHz, CDCl3) δ 6.99 (d, J = 8.7 Hz, 2H), 6.68 (d, J = 8.8 Hz, 2H), 5.30 - 5.24 (m, 2H), 5.17 - 5.13 (m, 
1H), 5.11 (d, J = 6.3 Hz, 1H), 3.89 (dd, J = 5.7, 8.0 Hz, 1H), 2.94 (s, 6H), 2.81 - 2.67 (m, 2H), 2.17 - 
2.08 (m, 1H), 1.88 - 1.65 (m, 3H); 13C{1H} NMR (75 MHz) ppm 233.9, 149.7, 133.3, 129.3, 113.0, 
112.9, 110.5, 95.5, 93.5, 92.6, 91.6, 43.5, 40.8, 32.4, 29.1, 20.5;  IR  2921, 2850, 1954 and 1865 
(strong CO stretch), 1610, 1520, 1446, 1348, 814, 666, 631, 534 cm-1;  HRMS (ES+) calc’d for 
C18H22N 252.1752, found  252.1736 [MH - Cr(CO)3]+.  
47a Using General Procedure 1-C, 46 (51 mg, 0.20 mmol, 1.0 equiv) was 
combined with LiHMDS (13 mg, 0.08 mmol, 0.4 equiv) and PdCl2(PPh3)2 (14 mg, 
0.02 mmol, 10 mol %) in 1.4 mL THF and 4-bromotoluene (44 µL, 0.36 mmol, 1.8 
equiv) and heated at 57 ºC.  More LiHMDS (56 mg, 0.32 mmol, 1.6 equiv) CrOC
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dissolved in 0.4 mL THF was added over 4h.  The reaction was allowed to proceed for an additional 20 
h, and yielded 47a (37.3 mg, 0.11 mmol, 54% yield) as a yellow solid after silica gel chromatography 
eluting with 20% diethyl ether in pentane.  1H NMR (300 MHz, CDCl3) δ: 7.18 (apparent s, 4H), 5.96 
(d, J = 1.8 Hz, 1H), 5.56 (d, J = 6.2 Hz, 1H), 5.39 (d, J = 6.2 Hz, 1H), 5.29 (dt, J = 0.8, 6.2 Hz, 1H), 
5.22 - 5.15 (m, 2H), 5.01 (d, J = 12.3 Hz, 1H), 2.35 (s, 3H) ppm; 13C{1H} NMR (75 MHz) δ: 232.5, 
138.9, 138.1, 112.3, 109.6, 91.4, 91.1, 87.2, 85.9, 84.9, 72.0, 21.4 ppm;  IR 3087, 2923, 2863, 
1964, 1881, 1514, 1043, 1019, 805, 663, 629 cm-1. 
47b Using General Procedure 1-C, 46 (38 mg, 0.15 mmol, 1.0 equiv) was 
combined with LiHMDS (10 mg, 0.07 mmol, 0.5 equiv) and PdCl2(PPh3)2 (9.5 mg, 
0.013 mmol, 9 mol %) in 1 mL THF and 2-bromotoluene (25 µL, 0.21 mmol, 1.6 
equiv) and heated at 57 ºC.  More LiHMDS (41 mg, 0.24 mmol, 1.6 equiv) 
dissolved in 0.4 mL THF was added over 2h.  The reaction was allowed to proceed 
for an additional 6 h, and yielded 47b (23.6 mg, 0.068 mmol, 45% yield) as a yellow solid after silica 
gel chromatography eluting with 10% diethyl ether in pentane.  1H NMR (300 MHz, CDCl3) δ: 7.25 - 
7.23 (m, 2H), 7.22-7.13 (m, 1H), 7.06 (d, J = 7.6 Hz, 1H), 6.28 (br s, 1H), 5.58 (d, J = 6.2 Hz, 1H), 
5.37 (d, J = 6.2 Hz, 1H), 5.32 (dt, J = 6.2, 0.9 Hz, 1H), 5.21 (dt, J = 6.2, 0.8 Hz, 1H), 5.11 (dd, J = 
12.3, 2.0 Hz, 1H), 5.01 (d, J = 12.2 Hz, 1H), 2.48 (s, 3H) ppm; 13C{1H} NMR (75 MHz) δ: 232.5, 138.4, 
136.6, 131.3, 129.0, 126.9 126.5, 111.7, 110.5, 91.6, 90.9, 87.6, 85., 82.5, 71.7, 19.6 ppm; IR 
2919, 2854, 1961 and 1873 (strong CO stretches), 1027, 754, 662, 626 cm-1. 
49 – 1-(1-cyclohexenyl)(η6-phthalan)Cr(CO)3: Using  General Procedure 1-E, a 
solution of (η6-phthalan)Cr(CO)3 (46) (19.3 mg, 0.075 mmol, 1 equiv) in 0.6 ml 
Toluene was reacted with LiHMDS (20 mg, 0.12 mmol, 1.6 equiv) and 
PdCl2(PPh3)2 (2.2 mg, 3 µmol, 4 mol %) of in 0.4 mL THF and 1-cyclohexenyl 
trifluoromethanesulfonate (16 µL, 0.085 mmol, 1.2 equiv)  for 8 h at 50 ºC to 
yield 49 (15.8 mg, 0.047 mmol, 62% yield) as a yellow-orange oil after silica gel chromatography 
eluting with 20% diethyl ether in pentane.  1H NMR (300 MHz, CDCl3) δ: 5.83 - 5.80 (br s, 1H), 5.49 
(d, J = 6.1 Hz, 1H), 5.42 (d, J = 6.0 Hz, 1H), 5.33 (br s, 1H), 5.37 (dt, J = 1.1, 6.1 Hz, 1H), 5.22 (dt, J = 
1.1, 6.1 Hz, 1H), 5.00 (dd, J = 2.0, 12.2 Hz, 1H), 4.90 (d, J = 12.2 Hz, 1H), 2.07 - 1.96 (m, 3H), 1.76 - 
1.51 (m, 5H) ppm; 13C NMR (75 MHz) δ: 232.6, 137.4, 127.3, 111.1, 110.2, 91.5, 91.0, 88.1, 87.0, 
85.8, 72.2, 25.3, 23.5, 22.5, 22.4 ppm. 
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Procedure and characterization for decomplexation:  
Triphenylmethane: Ph2CH(η6-C6H5)Cr(CO)3  (64.5 mg, 0.170 mmol) was dissolved in 
1.5 mL CHCl3 and 10 mL diethyl ether and placed in bright sunlight for 3 h, until the 
clear yellow solution became a muddy purple-brown color.  This suspension was 
filtered and concentrated under reduced pressure. The dark residue was diluted with 1:10 CHCl3 in 
hexanes and filtered again over a pad of MgSO4 and silica gel, and solvent was evaporated from the 
colorless solution in vacuo, yielding triphenylmethane (40.5 mg, 0.166 mmol, 98% yield) as a white 
crystalline solid, with no further purification necessary.  All characterization data is consistent with 
triphenylmethane, a well-known compound. 
45 – cis-1,3-diphenylindane: Using General procedure 1-A, (η6-indane)Cr(CO)3 (3) 
(0.127 g, 0.499 mmol, 1.0 equiv) was reacted with LiHMDS (0.42 g, 2.51 mmol, 5.0 
equiv) and PdCl2(PPh3)2 (24 mg, 0.034 mmol, 7 mol %) of in 5 mL THF and 
bromobenzene (0.26 mL, 2.50 mmol, 5.0 equiv) for 5 h at 53 ºC resulted in a deep 
red solution, which was quenched with 7 drops of aqueous 2N HCl solution, diluted 
with 6 mL diethyl ether and 1 mL CHCl3 then filtered over a pad of MgSO4 and silica 
gel.  The red solution was placed in sun light for 5 h, and monitored for complete decomplexation by 
TLC.  The cloudy solution was filtered, concentrated in vacuo, and chromatographed on silica gel with 
6% diethyl ether in pentane to yield cis-1,3-diphenylindane (0.106 g, 0.392 mmol, 79% yield) as a 
highly crystalline white solid.  1H NMR (300 MHz, CDCl3) δ:  7.38 – 7.23 (m, 10H), 7.16 (dd, J = 5.6, 
3.2 Hz, 2H), 6.95 (ddd, J = 5.0, 3.1, 0.5 Hz, 2H), 4.35 (dd, J = 11.1, 7.2 Hz, 2H), 2.96 (dt, J = 12.5, 7.2 
Hz, 1H), 2.14 (dt, J = 12.5, 11.1 Hz, 1H) ppm; 13C{1H} NMR (75 MHz) δ: 147.4, 144.6, 128.8, 128.7, 
127.0, 126.8, 124.9, 51.0, 48.2 ppm.  IR 3082, 3061, 3022, 2934, 2865, 1599, 1492, 1454, 1476, 
1344, 1073, 1029, 906, 768, 749, 735, 701 cm-1. HRMS (CI+) calc’d for C21H18 270.1409, found 
270.1409 [M]+.  Characterization data of this product is consistent with existing literature data.73 
7 – 3,3’-(phenylmethylene)bis(methoxybenzene): For the large-scale reaction, 
a 50 mL Shlenk flask was charged with a stirbar and LiHMDS (2.51 g, 15 
mmol, 3 equiv) and PdCl2(PPh3)2 (139 mg, 0.20 mmol, 4 mol %) under 
nitrogen.  Base and catalyst were dissolved in 28 mL of dry THF, and 3-
bromoanisole (1.9 mL, 15 mmol, 3 equiv) was added.  (η6-toluene)Cr(CO)3 (3) 
(1.14 g, 5.0 mmol, 1.0 equiv) was added to the stirring brownish-orange solution in one portion, then 
heated at 55 ºC for 5 h.  The reaction was quenched with 0.2 mL of 2N HCl added dropwise, and 
solids formed in the stirred solution.  The flask was opened to air and diluted with 20 mL Et2O and 3 
mL CHCl3, filtered over a pad of MgSO4 and silica gel, rinsed with diethyl ether, and the yellowish-
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orange clear solution was exposed to 12 h of sunlight.  Precipitating solids were filtered from the 
brownish green suspension twice during the decomplexation process, and progress was monitored by 
TLC.  The suspension was again filtered, concentrated in vacuo, and loaded onto a short silica gel 
column and eluted with hexanes, slowly increasing polarity to 3.5% diethyl ether in hexanes to yield 
3,3’-(phenylmethylene)bis(methoxybenzene) (1.42 g, 4.66 mmol, 93%) as a colorless solid.  1H NMR 
(300 MHz, CDCl3) δ: 7.33 – 7.15 (m, 7H), 6.80 – 6.71 (m, 6H), 5.51 (s, 1H), 3.76 (s, 6H); 13C{1H} NMR 
(75 MHz) δ: 159.8, 145.6, 143.8, 129.6, 129.4, 128.5, 126.6, 122.2, 115.8, 111.6, 57.0, 55.3.  IR 
3058, 3025, 3000, 2955, 2937, 2834, 1597, 1583, 1486, 1464, 1452, 1434, 1314, 1263, 1151, 
1050, 878, 776, 758, 732, 697 cm-1. HRMS (CI+) calc’d for C21H21O2 305.1542, found 305.1546 
[MH]+. 
 
Computational analysis of the deprotonated lithium species.   
Computational analysis of the lithiated diphenylmethane tricarbonylchromium (4a-Li) is in agreement 
with similar computational studies (gas-phase model) presented by Merlic and co-workers, and 
confirms the sp2-hybridized geometry of the benzylic center.74,75  Tim Kowalczyk is gratefully 
acknowledged for his work on the quantum calculations presented here. 
The geometry of complex 4a-Li was optimized at the level of density functional theory with the B3LYP76 
functional and the SV(P)77 basis set.  The effect of the THF environment was modeled under the 
conductor-like screening model (COSMO)78 with dielectric constant ε = 7.58 and with cavitation 
surface defined by Bondii atomic radii.  The stability of the optimized geometry was confirmed via 
frequency calculations which presented no negative eigenvalues of the Hessian.  All quantum 
chemistry calculations used the Turbomole79 program package. 
73 
 
 
Figure 1-17: Optimized geometry of 4a-Li with HOMO is pictured.  The THF solvent environment was 
modeled using COSMO.  Note that most of the charge is localized on benzylic carbon, with some 
charge density spread on the other phenyl rings and on the Cr(CO)3 center. 
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Introduction 
The development of enantio- and diastereo- selective metal-catalyzed carbon-carbon bond 
forming reactions has enabled efficient access to valuable chemical scaffolds often difficult or im-
possible to access through conventional methods.  As noted in Chapter 1, the privileged diaryl- 
and triarylmethane frameworks are found in a large number of pharmacological compounds. 
Examples of biologically active chiral polyarylmethanes are given below (Figure 2-1). 
 
Figure 2-1: Some biologically active chiral polyarylmethanes. 
 
Considering the importance of the privileged diaryl and triarylmethane frameworks, it is no 
surprise that medicinally relevant chiral diarylmethane derivatives have been heavily pursued.1,2 
On the other hand, the selective syntheses of unsymmetrical triarylmethanes is still considered 
very challenging, particularly when one or more of the aryl groups to be installed is electron-poor 
or sterically hindered.3  For example, to the best of my knowledge, there have been only two 
published examples of nonracemic chiral triarylmethane syntheses (Scheme 2-1).  The strategies 
employed were: a palladium-catalyzed directed desymmetrization of a tri(hetero/aryl)methane at 
the ortho position by Yu and coworkers,4 and a chiral phosphoric acid-catalyzed Friedel-Crafts 
synthesis of substituted indolyl triarylmethanes by You and coworkers (most %ee were in the 50 – 
60 range).5  To date, there does not seem to be existing asymmetric syntheses of chiral non-
heteroaromatic triarylmethanes.  The asymmetric synthesis of polyarylmethanes is clearly an 
important area of exploration. 
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Scheme 2-1: Previous strategies for nonracemic tri-hetero/arylmethane syntheses.  Yu uses 
desymmetrization of a 2-pyridyl substituted triarylmethane.  You uses a chiral phosphoric acid to 
catalyze an asymmetric Friedel-Crafts alkylation of an electron-rich indole. 
 
Asymmetric cross-coupling at the benzylic position of tertiary benzylamines to 
form enantioenriched diarylmethyl benzylamines 
Optically active benzyl amines possessing chirality α to the nitrogen are found in a variety of 
pharmaceuticals marketed today,6 from Amoxicillin to Zyrtec. Their functions range from 
anaesthetics and antihistamines, to antibiotics and potential cancer drugs or cancer drug 
precursors (Figure 2-2).7 
 
Figure 2-2: Some examples of biologically active tertiary benzylamines that posess chirality in the α-
position. 
 
Despite the diarylmethyl amine family’s prominence in medicinal chemistry, most syntheses of α-
alkyl or α-aryl benzylamines are typically accomplished through Mannich-tpe reactions and 
generate racemic products.8  To access enantioenriched diarylmethylamines, racemic mixtures 
are typically resolved through chromatography,9 or chemical methods, such as crystallization with 
tartaric acid.10  In the case of the popular antihistamine drug Zyrtec, the current industrial 
synthetic method involves diastereoselective synthesis using a chiral auxiliary.11  Recently, 
asymmetric reduction of benzophenone imines has been reported, but ortho-substitution of 
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substrates is required for high enantioselectivity.12,13  Catalytic asymmetric methods to prepare 
highly enantioenriched diarylmethyl amines has remained challenging. 
Currently, asymmetric methods to prepare enantioenriched diarylmethanes involve asymmetric 
additions14 to activated imine15 or iminium species using metalated arene nucleophiles, such as 
tetraarylborates,16 organostannanes17, phenylzinc18, or aryl rhodium (catalytic) reagents.14,19   
However, asymmetric cross-coupling of electrophiles to an sp3 C–H bond α- to a tertiary amine 
has not yet been realized.  Part of the reason for this lies in the fact that α–amino-substituted 
secondary organometallic partners for cross-coupling are difficult to access.  A popular method 
for preparing some varieties of organometallic cross-coupling reagents (such as zinc and tin 
derivatives) is metathesis with an organolithium precursor, but lithiation α- to an unactivated 
amine is considered difficult, making this method for preparing cross-coupling reagents 
ineffective.20   
As described in Chapter 1, we initially developed a non-enantioselective palladium-catalyzed 
cross-coupling reaction between tricarbonylchromium-coordinated benzylic arenes and aryl 
bromides using LiHMDS as a base (Scheme 2-2).  We wondered if an enantioselective variant of 
this reaction would be feasible, made possible by some unique aspects of the activating metal 
fragment, the tricarbonylchromium group. 
[Cr]Cr
OC
CO
CO
Z Z
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R'
[Cr]
Z
R
Ar'BrArBr
PdCl2(PPh3)2
LiN(SiMe3)2
Z = H, Ar, OR, NMe2,CH3
" "
Z = H, OR,CH3
1 2 3
 
Scheme 2-2: Tricarbonylchromium-assisted synthesis of achiral and racemic polyarylmethanes using 
our methods (see Chapter 1). 
 
We first considered whether we could synthesize enantioenriched relevant diarylmethylamines 
(Scheme 2-3).  We decided to pursue the family of diarylmethylamines due to the medicinal 
relevance of their structures.  Additionally, the system contained fewer complicating variables 
that could hamper enantioselectivity in the reaction.  For example, diarylmethylamine products 
formed from achiral catalysts failed to undergo further arylation to form substituted 
triarylmethanes (Chapter 1, Scheme 1-25, p.31), minimizing competing coupling reactions which 
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may consume one (or both) enantiomers of product.  Also, tricarbonylchromium “walking” 
(Chapter 1, p. 40) was not observed in the reaction with amines; this minimizes a potential 
source of product isomerization to side-products which could be difficult to separate from the 
desired product regioisomer. 
 
Scheme 2-3: Envisioned eantioselective synthesis of diarylmethylamine derivatives from benzylamine 
and aryl bromides.  L* denotes a chiral ligand. 
 
Due to the tricarbonylcrhomium group’s ability to delocalize charge,21 the lithiated intermediates 
1-Li and 1-Li′ were expected to be planar chiral and configurationally stable due to a partial 
double bond charactera between ipso and benzylic carbons (Scheme 2-4).22 However, we also 
hypothesized that due to the rapid and reversible nature deprotonation of 1 by LiHMDS, both 
enantiomers 1-Li and 1-Li’ would be readily available for reaction.  Providing that the 
diasteromeric transmetallation of 1-Li to an enantioenriched L*Pd(II) center was faster than with 
1-Li’ and irreversible, dynamic kinetic resolution (DKR) conditions would be achieved.23  We 
anticipated that the aryl-alkyl Pd(II) intermediate 4 does not have a method for interconverting to 
4’, and that there is a lack of racemization pathways between product enantiomers. 
                                                      
 
 
a The bond is intermediate in length and strength between a single and double bond, determined by gas-
phase calculations by Merlic and coworkers. 
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Scheme 2-4: Proposed asymmetric arylation of tricarbonylchromium-stabilized benzyllithium. 
 
Considering the many chiral mono- and bi-dentate ligands available for reaction and the unusal 
nature of our proposed asymmetric organolithium cross-coupling, it was possible that an 
extremely specific ligand would be required for highly enantioselective reactions.  However, many 
chiral ligands are expensive, and some can be rather difficult to obtain.  We needed a rapid and 
cost-efficient method to identify promising chiral ligands, which would circumvent the 
conventional time-consuming and expensive screening of ligands at laboratory scale.  Thankfully, 
an industrial collaboration with Merck & Co. under the GOALIa grant provided an opportunity to 
investigate a large range of chiral ligands using low-barrier high-throughput experimentation (HTE) 
procedures. 
 
                                                      
 
 
a GOALI (Grant Opportunities for Academic Liason with Industry) is an NSF-funded program to foster 
collaborative efforts and cross-pollination of techniques and ideas between industry and academia.  See 
http://www.nsf.gov/pubs/2010/nsf10580/nsf10580.htm for more information.  The PI in this program is 
G. Molander (UPenn) with Co-PIs: S. Dreher (Merck), M. Kozlowski (UPenn), and P. Walsh (UPenn). 
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Initial High-throughput Screen of Ligandsa 
Considerations in HTE design. 
Low-barrier high-throughput experimentation (HTE) is a new set of technologies in chemistry and 
catalysis which enables the rapid identification and optimization of reaction conditions (ligands, 
reagents, additives, etc) and even reaction discovery.24  It is allows microscale experimentation of 
dozens to hundreds of reactions in parallel, saving time and reagent, which can (in the case of 
multi-hundred-dollar custom chiral ligands, for example), be extremely expensive if run on typicaly 
synthetic-lab scale.  Through the GOALI grant, HTE reactions have been conducted both at Merck 
& Co. in Rahway, NJ, and at the new high-throughput screening center at the University of 
Pennsylvania.  Opened in the fall of 2010, it is currently only one of three such academic facilities 
in the country. 
Generally, reactions are run in multiples of 24- or 96- well plates (4×6 and 8×12 wells, 
respectively).  The plates are loaded with glass vials in either 1 mL or 250 µL capacity, and 
numbering is as in a typical grid (i.e. A1, A2, B1, B2, etc. See Figure 2-3 B).  Glass vials may be 
pre-dosed with reagent solutions, such as ligand, low-solubility reagents such as palladium 
precatalyst, or additives.  Unnecessary solvent is removed by either a GeneVac, which is a 
vacuum centrifuge that can accommodate HTE reaction plates, or a blow-down tool, which runs a 
constant stream of nitrogen into each vial in order to evaporate solvent quickly.  Reagents are 
then added via pipette or multi-channel pipette from standardized solutions.b  Total reaction 
volume is approximately 10% of the vessel size with 25 µL or 100 µL volume reactions typically 
conducted (Figure 2-3 A).  In practical terms, this translates to using the material of two 0.1 
mmol-scale reactions to furnish one entire 96-well plate run in 250 µL vials.  Finally, the reaction 
is sealed with screws by a metal plate lined with rubber mats and a PTFE liner film.  This allows 
the reaction to maintain inert atmosphere outside of the glovebox and effectively contains vapors 
from reactions that are need to be heated (Figure 2-3, A). 
                                                      
 
 
a Initial ligand screens were run in collaboration with Dr. C. Stanciu at Merck & Co (Rahway). 
b  Homogeneous solutions are preferred in HTE screens.  While non-homogeneous suspensions and slurries 
can also be added, they are more difficult to handle and require pipetting while the mixture is stirring 
vigorously, as well as a cut pipet tip to prevent clogging. 
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  A           
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B
1 2
   B 
Figure 2-3: Schematic view of the high-throughput setup of a theoretical 2×2 plate.  In the cut-away 
side view (A, Left), the reaction vial filling, seals, and screw fastening of the top are illustrated.  In the 
unsealed top-view (B, Right), arrangement of reactions in a grid are shown.  Both 1 mL and 250 µL 
reaction vessels are pictured, but typically only one size of vial is used at a time.   
 
Once the reactions have been run for the specified time, they are quenched simultaneously, 
worked up in solubilizing organic solvents such as DMSO and acetonitrile with water.  Analysis of 
the reactions is accomplished using HPLC (with internal standard, such as biphenyl, for 
conversion data) and SFC (for enantioselectivity).  Provided that chromatographic methods are 
developed that successfully separate reaction components — such as starting materials, side-
products, and product enantiomers — the large amount of intercomparable data that results from 
the screening can then be analyzed at once.  All steps from reaction design, execution, and 
instrumental analysis can be accomplished within a few days.  Thus, HTE ideally allows 
meaningful conclusions to be obtained in a fraction of the time of conventional lab-scale 
experimentation.24 
 
Reaction screening 
Initially, we decided to focus on the α-arylation of dimethylbenzylamine (Chapter 1, p.31) because 
of the medicinal importance of chiral diarylbenzylamines.  The N,N’-dimethylbenzyl amine 
complex (η6-Me2NCH2Ph)Cr(CO)3 (compound 27)25 was employed in a low-barrier high-throughput 
experimentation (HTE) screen with a large library of enantioenriched mono- and bidentate 
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phosphine ligands, palladium precursor PdCl2[COD], 4-bromotoluene, and 1.3 equivalents of 
LiHMDS (Scheme 2-5) in hopes of forming enantioenriched tertiary diarylmethylamine 28f 
(Scheme 2-5).  The parallel reactions were run on extremely small (2 µmol, or ~0.5 mg 27) scale 
to allow efficient use of our valuable (and expensive) catalysts and starting materials.24  All in all, 
less than 0.5 mmol of tricarbonylchomium reagent was used in the screen of 192 reactions!a  
Reactions were then analyzed for conversion to product (determined by HPLC relative to an 
internal standard), and those that showed product formation were then analyzed on chiral SFC. 
 
Scheme 2-5: Initial High-Throughput screen of ligands is conducted on microscale for the asymmetric 
cross-coupling of benzylamine 27 with 4-bromotoluene (2 µmol ~ 0.5 mg substrate) to form 28f. 
 
Table 2-1: Promising hits in the HTE screen of ligands (Scheme 2-5). Ligands given below showed 
conversion to product via HPLC, and were analyzed on chiral stationary-phase SFC for enantiomeric 
ratio (er). 
 
                                                      
 
 
a For a full list of ligands screened, see Appendix V, Table V-1 and Table V-2 (p.330). 
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Although several of the ligands screened showed high conversion by HPLC, only a small handful 
of ligands exhibited enantioselectivity under these conditions (>2:1 er, Table 1-1).  Dicyclohexyl 
phosphine derivatives of the Taniaphos26 and Mandyphosa,27 ligand family showed the greatest 
selectivity (>9:1 er for both ligands), although conversion to product in the case of Mandyphos 
was low relative to other ligands screened.  Taniaphos and Mandyphos are modular “privileged 
scaffold”b,28 ferrocene-amine phosphine ligands that have been known for producing extremely 
high selectivity in reactions, but their main popularity has been in rhodium-catalyzed asymmetric 
hydrogenation reactions and ring-opening reactions, not in cross-coupling.29  It is possible that 
the tertiary amine functionality present in both ligands is one contributing factor in the success of 
Mandyphos and Taniaphos ligands by coordinating to 27-Li.  In fact, a similar hypothesis was 
made by Kumada et al in the case of an asymmetric cross-coupling reaction of secondary alkyl 
Grignards with aryl bromide.  In their case, however, the organometallic magnesium species was 
hypothesized to be configurationally labile, rapidly undergoing inversion during their reaction.30  
In contrast, our system is expected to be configurationally stable as an organolithium, racemizing 
only upon protonation and subsequent deprotonation of the other benzylic C–H. 
 
Further examination of “hits” 
The most promising ligands, cylcohexyl Mandyphos and cyclohexyl Taniaphos, were used in test 
reactions on laboratory scale to verify the ligands as “hits.”  Indeed, upon running the reactions 
using the same conditions but at larger scale, we found that the performance of both ligands was 
comparable to the results obtained by microscale HTE.  Taniaphos had a higher conversion and a 
lower ee than Mandyphos, which exhibited very high enantioselectivity (>9:1 er) but very low 
conversion.  Cyclohexl Mandyphos was chosen as the ligand with which to optimize the reaction.  
                                                      
 
 
a Ferriphos is the original moniker for Mandyphos (Phenyl) before it was expanded into the Mandyphos 
family of ligands. 
b “Privileged” ligand substructures are “certain classes of synthetic catalysts [which] are enantioselective 
over a wide range of different reactions.” For an overview of these successful ligands, see: Yoon, T. P.; 
Jacobsen, Science 2003, 299, 1691-1693. 
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Unfortunately, attempts to increase conversion on laboratory scale reactions while maintaining 
enantioselectivity encountered numerous setbacks.  Increasing reaction concentration or 
equivalents of base led to higher rates of product decomposition over time (Figure 2-4 A), while 
lowering the temperature to increase the enantioselectivity resulted in very low conversions.  A 
more troublesome trend was observed upon monitoring the reaction by chiral stationary phase 
SFC: the product ee decreased as the reaction progressed (Figure 2-4 B).   
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Figure 2-4: Erosion of product (28f) yield vs. internal standard (I.S.) over the course of reaction of 27 
with 4-bromotoluene [A].  Erosion of enantiomeric excess of product 28f over the course of reaction 
[B].  Reactions were run at 25 ºC  in pure THF with 10 mol% catalyst loading. 
 
There were several possible reasons for the erosion in ee.  It was unlikely, but possible, that slow 
racemization of chiral lithium intermediate (27-Li) through deprotonation and reprotonation was 
leading to the buildup of the slow-reacting enantiomer of 27-Li, thus favoring reaction with the 
wrong enantiomer of organolithium.  In such a scenario, the cross-coupling reaction would start to 
resemble a kinetic resolution in which further conversion would lead to successively lower 
product ee in the reaction mixture.23  Another possibility for the loss of ee during the course of 
reaction was that the catalyst was becoming less selective over time.  For example, salt or amine 
byproducts in the reaction could be changing the nature of either the transmetalating species or 
the catalyst, thereby lowering the selectivity for the desired enantiomer of 27-Li.31  Finally, there 
was also the possibility that the enantiomerically enriched product was somehow racemizing 
through an unanticipated pathway.  Since any of these possibilities, or a combination thereof, 
could be leading to the drop in ee, we decided to turn our attention to a different substrate that 
might be more resistant to the erosion of ee during the course of reaction. 
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Asymmetric cross-coupling of a benzylmorpholine complex. 
We examined several other benzylamine derivatives as potential alternatives for optimizing the 
cross-coupling reaction.  First we switched to a phthalamide-protected benzylamine complex, but 
this substrate underwent partial decomposition under our cross-coupling.  Going back to the 
simpler and more stable alkyl-substituted benzylic amines, we also attempted to use 
tricarbonylchromium-coordinated benzylpyrrolidine 52, benzylpiperidine 53, and 
benzylmorpholine 54 as substrates for cross-coupling.  The complex of the five-membered ring 
amine benzylpyrrolidine (52) was inert to coupling conditions.  However, both six-membered ring 
amine complexes 53 and 54 were successful substrates.  Test reactions with Mandyphos were 
undertaken which monitored %ee of product over time. 
We ultimately decided upon tricarbonylchromium benzylmorpholine 54, which was not only a 
viable substrate for the enantioselective coupling, but seemed to exhibit far less erosion of ee 
during the course of the reaction.  Additionally, the highly crystalline product 55a could be easily 
recrystallized to higher enantiomeric purity.  To determine whether racemization of the 
diarylmethylamine 55a was possible under basic conditions, a sample of 55a recrystallized to 
94.6% ee was heated at 40 °C in THF with 4 equivalents of LiHMDS for 16 h.  The reaction was 
then quenched with D2O (Scheme 2-6).  No detectable deuterium incorporation (by 1H NMR) and 
negligible (<1%) erosion of ee were observed.  This result prompted us to begin an in-depth 
examination of the effect of various solvents and additives on the enantioselective cross-coupling 
reaction (Scheme 2-7). 
 
Scheme 2-6: Resistance of tricarbonylchromium diarylmethyl morpholine 55a to deprotonation and 
racemization. 
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Optimization of Reaction Conditions 
While it seemed that THF as a solvent was a key component of maintaining high reactivity during 
the course of the cross-coupling reaction, the addition of co-solvents had a noticeable impact on 
the ee of product 55a (Table 2-2, entries 1–4).  Several co-solvents such as dioxane and 
cyclopentylmethylether displayed an effect on the rate of reaction and enantioselectivity (Table 
2-2, entries 2–4), but the reaction was cleanest and the enantioselectivity increase was most 
pronounced in the case of toluene co-solvent.  Specifically, by varying the fraction of toluene 
relative to THF, a smooth increase in enantioselectivity (up to 81% ee) was observed at 35–40% 
by volume (Figure 2-5 A). The decomposition of product over time was also noticeably reduced, 
although yields remained low (<50% after isolation).   Further increasing the percentage toluene 
negatively affected both enantioselectivity and conversion (Figure 2-5 A).  When pure toluene was 
used as the reaction solvent, no conversion to product was observed.  Similar results were 
observed with other reaction solvents without THF, such as pure glyme or dioxane. 
 
Scheme 2-7: Optimization of reaction conditions for the asymmetric cross-coupling of (η6-
benzylmorpholine)Cr(CO)3  
 
Table 2-2: Effect of solvent composition and amine in the asymmetric coupling reaction of 4-
bromotoluene with η6-tricarbonylchromium benzylmorpholine (54). 
Entry X = Additives (equiv.)* % co-solvent# temp (ºC) time (h) % conv† % ee 
1 -Br (none) 0 50 9 95 55 
2 -Br (none) 40 (Diox) 40 9 66 74 
3 -Br (none) 40 (CPME) 40 9 66 80 
4 -Br (none) 40 (Tol) 40 9 62 81 
5 -Br H-B (2) 40 (Tol) 40 9 56 82 
6 -Br TMEDA (1) 40 (Tol) 18 40 38 86 
* H-B = Hüenig’s Base (diisopropylethylamine), TMEDA = N,N,N′,N′-tetra-methylethylenediamine. # Unless 
otherwise stated, reactions are run at 0.08–0.1 M [54]; co-solvent abbreviations: Tol = Toluene, Diox = 1,4-
Dioxane, CPME = cyclopentylmethylether.  † % conversion to product determined by chiral HPLC or SFC. 
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Figure 2-5: Enantiomeric excess dependence on solvent [A], and ee dependence on halide additives 
[B].  %ee were measured after reactions had reached 30–50% conversion. 
 
Tertiary amines are known to decrease aggregation of organolithiums and enhance reactivity, 
leading us to examine amine additives in the cross-coupling reaction. Tertiary amines such as 
Hüenig’s Base (iPr2NEt) were hoped to accelerate the reaction, perhaps due to reduced 
aggregation and/or stabilization of the benzyllithium (Table 2-2, entry 5).  The popular bidentate 
tertiary amine TMEDA (N,N,N′,N′-tetramethylethylenediamine) significantly accelerated the 
reaction (Table 2-2, entry 6), allowing the reaction to be run at lower temperatures, providing an 
encouraging 86 %ee.  Lithium halide additives additives were also examined, as they are known 
to affect reactions with organolithium species.32  Unfortunately, as can be seen in Figure 2-5 B 
(above), addition of halide had a detrimental effect on the enantioselectivity (Cl < Br < I).  Other 
metal salts and palladium precatalysts were also examined, but aside from some notable 
exceptionsa the reaction was surprisingly robust to the presence of other salts in the reaction 
mixture, and improvements in ee were not observed. 
At this point, we considered it prudent to re-screen chiral ligands, as well as screen additional 
members of the Mandyphos and Taniaphos ligand family.  Since we had changed the coupling 
                                                      
 
 
a Tetrabutylammonium iodide (Bu4NI), 15-Crown-5, silver(I) tetrafluoroborate, silver(I) 
trifluoromethanesulfonate, and Zinc(II) chloride were salt additives with a significant negative (>20% ee) 
impact on the enantioselectivity of the reaction.  Pd(ACN)2Cl2, PdCl2, and PdSO4 were not viable precatalysts 
for the reaction. 
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partner from dimethyl-substituted benzylamine (27) to morpholino-substituted benzylamine (54), 
and the two systems did exhibit slightly different behavior (in particular, the apparent lower extent 
of racemization), we wanted to confirm that there was not a more effective ligand to use.  Thus, a 
smaller-scale HTE screening was employed for the cross-coupling reaction, using 54 and 4-
bromotoluene as reaction partners.  Again, cyclohexyl Mandyphos was determined to be the most 
effective ligand in both conversion and selectivity (Figure 2-6, below). 
 
Figure 2-6: HTE of the benzylmorpholine reaction verifies that cyclohexyl-Mandyphos is still the most 
effective chiral ligand for the cross-coupling process under our conditions. 
 
Additionally, a selection of six different Mandyphos ligands and six different Taniaphos ligands 
were examined (Figure 2-7).  We noted that while the Mandyphos ligands all exhibited high 
conversion under these conditions, the cyclohexyl Mandyphos ligand (Figure 2-7, entry 2) was the 
most enantioselective.  It seems that electronics (and to a lesser extent, sterics) at the phosphine 
centers plays a significant role in the high enantioselectivity of the catalyst.  Cyclohexyl 
Mandyphos, while sterically bulky, is considered a more electron-rich and donating phosphorus 
center than aryl-substituted phosphines (entries 1, 3–6), and performs the best in this coupling 
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reaction.  On the other hand, the electron-donating Mandyphos with methyl and methoxy aryl 
substitution (entry 4), as well as the electron-neutral phenyl substitutution (entry 1) showed 
moderate ee (25 and 38%, respectively).  Electron-withdrawing Mandyphos with trifluoromethyl 
substitution (entry 3) performed poorly (<20% ee), as did the more sterically hindered aryl 
Mandyphos variants with xylyl and o-tolyl substitution (entries 5 and 6). 
 
Figure 2-7: HTE screen of additional Mandyphos and Taniaphos ligands.  Cyclohexyl Mandyphos and 
chelating tertiary amine are the most effective combination. 
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At this point we returned to the optimization of the system.  Considering that the lithium halide 
additves specifically led to decreasing ee, we wondered if the stoichiometric equivalent of LiBr 
byproduct formed over the course of the cross-coupling reaction was at least partially responsible 
for the decreasing enantioselectivity observed with increasing conversion in the absence of 
amine.  This may be due to the formation of nLiX•54-Li intermediates that are less 
diastereoselective in our proposed enantiodetermining transmetallation (Scheme 2-4, p.84).  We 
have previously demonstrated that the negative impacts of LiCl on enantioselective reactions can 
be counteracted by sequestering the salt with polydentate amines.33  Thus, amine additives were 
re-examined for the additional potential role of LiBr binding (Table 2-3). 
Table 2-3: Effect of chelating amine additives and solvent composition in the asymmetric coupling 
reaction of 4-bromotoluene with η6-tricarbonylchromium benzylmorpholine (54). 
Entry X = Additives (equiv.)# % co-solvent† temp (ºC) time (h) % conv‡ % ee 
1* -Br TMEDA (1) 40 (Tol) 18 40 38 86 
2 -Br TMEDA (2) 40 (Tol) 18 40 41 91 
3 -Br TEEDA (2) 40 (Tol) 18 12 58 75 
4 -Br PMDTA (1) 40 (Tol) 18 48 60 77 
5 -Br PMDTA (2) 40 (Tol) 18 42 35◊ 90 
* Entry 1 is re-listed from Table 2-3, entry 5. # TEEDA = N,N,N′,N′-tetraethylethylenediamine, TMEDA = N,N,N′,N′-
tetra-methylethylenediamine, PMDTA = N,N,N′,N″,N″-pentamethyl-diethylenetriamine. † Unless otherwise stated, 
reactions are run at 0.08–0.1 M [54].  ‡ % conversion to product determined by chiral HPLC or SFC. ◊ isolated 
yields (%). 
 
By varying equivalents of TMEDA, we found that decreasing the amount of amine or using large 
excess did not improve our reaction.  However, using two equivalents of TMEDA further increased 
the ee of the reaction to 91% (Table 2-3, entry 2).  We also examined an amine used previously in 
our group to sequester LiCl, N,N,N′,N′-tetraethylenediamine (TEEDA, entry 3).  While the reaction 
was much faster (reaching >50% conversion in only 12 hours at room temperature), the ee was 
lower.  Finally, we examined a tridentate ligand that is known for successfully binding LiBr: 
N,N,N′,N″,N″-pentamethyldiethylenetriamine (PMDTA, entries 4 and 5).  In this case we were 
disappointed to see the low enantioselectivity using one equivalent of additive (entry 4).  
However, by increasing the amount of chelating ligand, we found that the optimal amount of this 
additive (2 equivalents, entry 5) led to 90% ee, though after isolation of the product we observed 
only 35% yield of 55a. 
96 
 
 
Introduction of aryl triflates in the asymmetric coupling of benzylamines 
In an effort to circumvent the detrimental formation of LiBr altogether, other aryl halide 
electrophiles were next examined as alternatives to bromotoluene (Table 2-4, entries 1–3).  
Chloride and tosylate leaving groups (entries 1 and 2) were unsuccessful even after heating.  
However, we found that the triflate leaving group provided clean reactivity and extremely high 
conversion at room temperature, with only slightly lower ee than many reactions with aryl 
bromide.  Thus, we were pleased to obtain 55a (entry 3) in 80% yield and 81% ee after isolation, 
using 2 equivalents of the triamine PMDTA as additive. 
In order to further improve the enantioselectivity of this reaction, the temperature was lowered to 
0 °C, but while the ee increased to 87%, the reaction was significantly slower (50% conversion 
after 24 h, Table 2-4 entry 4).  On the other hand, since there was no longer any LiBr formation in 
this reaction, the amount of PMDTA was decreased to 1 equivalent (entry 5), and we were happy 
to see a restored reactivity (80% isolated yield), and slightly higher enantioselectivities as well 
(87% ee, entry 5).  Most importantly, the enantioselectivity remained nearly constant over the 
course of the reaction.  Finally, we verified that the amine additive was a necessary component of 
the reaction, as the extremely low conversions were observed in its absence (entries 7 and 8). 
In the final phase of optimization, we found that addition of a small amount (2% by volume) of 
chlorobenzene resulted in a slight increase of the product ee to 92% (76% isolated yield, entry 9).  
The optimized conditions for the aryl triflate do not lead to the same improvements in aryl 
bromide, unfortunately: using the conditions from entry 9 (including chlorobenzene additive) with 
4-bromotoluene did not show any significant effect in either yield or enantioselectivity (entry 10).  
The role of the chlorobenzene is not clear, but the impact of the addition of chlorbenzene or other 
aryl halide additives to the aryl triflate reaction is currently under investigation. 
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Table 2-4: Effect of electrophile leaving group in the asymmetric coupling reaction of Tol-X with 54 to 
yield 55a. 
Entry X = Additives (equiv.)* % co-solvent# temp (ºC) time (h) % conv† % ee 
1 -Cl TMEDA (2) 40 (Tol) 35 24 (trace) - 
2 -OTs PMDTA (1) 40 (Tol) 50 24 0 - 
3 -OTf PMDTA (2) 40 (Tol) 18 7 80‡ 81 
4 -OTf PMDTA (2) 40 (Tol) 0 24 50 87 
5 -OTf PMDTA (1) 40 (Tol) 18 12 80‡ 87 
6 -OTf PMDTA (1) 40 (Tol) 5-10 48 73‡ 89 
7 -OTf (none) 40 (Tol) 18 12 18 79 
8 -OTF (none) 0 18 12 23 63 
9 -OTf PMDTA (1) 40 (Tol), 
2 (PhCl) 
18 8 76‡ 92 
10 -Br PMDTA (1) 40 (Tol), 
2 (PhCl) 
18 48 32‡ 88 
* TMEDA = N,N,N′,N′-tetra-methylethylenediamine, PMDTA = N,N,N′,N″,N″-pentamethyl-diethylenetriamine. # 
Unless otherwise stated, reactions are run at 0.08–0.1 M [1b]; co-solvent abbreviations: Tol = Toluene, PhCl = 
chlorobenzene.  † % conversion to product determined by chiral HPLC or SFC. ‡ isolated yields (%). 
 
Substrate Scope 
Using conditions similar to the optimized conditions described above (Table 2-4, entry 9 for aryl 
triflates, and Table 2-3, entry 5 for aryl bromides), the scope of the cross-coupling was examined.  
Electron rich aromatics were good substrates (Table 2-5, entries 1–6), although increased steric 
congestion at the 2-position (entry 7) was less compatible with these conditions.a  The cross-
coupling was relatively insensitive to the nature of the benzylic amino group: benzylpiperazine 
complex 56, benzyl piperazine complex 53, and even the N,N-dimethybenzylamine complex 27 
(Table 2-5, entries 8–10) which had proved to be problematic during the initial optimization 
studies underwent cross-coupling with similar enantioselectivities to the morpholino derivative 
                                                      
 
 
a 2-tolyl triflate did not furnish any coupling product. 
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55c.  Vinyl triflate (entry 11) exhibited very high reactivity, but low enantioselectivity (53%).  
Lowering the temperature did not improve the ee by a significant amount (57% maxiumum ee 
obtained).  This result indicates that the catalyst would need to be reoptimized for vinyl triflate 
cross-coupling. 
    
Scheme 2-8: Scope of the asymmetric cross-coupling of tertiary benzylamines to form enantioenriched 
α- substituted tertiary benzylamines. 
 
Table 2-5: Scope of asymmetric cross-coupling of tertiary benzylamines with aryl triflates, aryl 
bromides, and vinyl triflate (Scheme 2-8). 
Entry* –NR2 Ar–X product Temp (ºC) Time 
(h) 
Yield 
(%) 
ee (%) 
1 
  
55a 18 8 76 92 
2# 
  
55b 0→18 24 74 90 
3# 
  
55c 0→18 18 72 87 
4# 
 
 
55d 0→18 20 72 90 
5 
  
55e 0→19 16 80 89 
6† 
   
55f 19 60 59 84 
7† 
 
  
55g 18 48 36 62 
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8  
 
28a 0→19 24 66 87 
9† 
N
  
57 8-10 60 72 85 
10 
  
58 0→19  24 69 88 
11 
  
59 0→18 18 88 53 
* Reaction conditions: 1 equiv. [Cr] SM (0.08 M [Cr]), 4 equiv. LiHMDS, 1.5–2 equiv. R-X, 4–5 mol % Pd2Cl2(allyl)2, 
12 mol % cyclohexyl Mandyphos, 40:60 toluene:THF, 2%/vol PhCl, 1 equiv. PMDTA. # isolated yields and %ee were 
averaged over two runs. † PhCl was not used. 
 
Certain aryl triflates, such as 3-pyridyl triflate and electron-poor triflates such as 3-
trifluoromethylphenyl triflate were not compatible with these conditions.  In fact, in the case of 
some electron-poor aryl triflates, we were baffled by the lack of even trace amounts of coupling 
product and the multiple side.  Considering that the synthesis of racemic reference samples used 
electron-deficient aryl bromides in poor but isolable yield (generally 10–30%), and that the aryl 
triflates were expected to be significantly more reactive than the aryl bromides in this coupling 
reaction, we considered the possibility of alternative side reactions.  Indeed, the stability of the 
aryl triflate itself proved to be the problem due to the formation of highly reactive aryne.  Reacting 
a THF solution of 3-trifluoromethylphenyl triflate with the benzyne trap tetraphenyl 
cyclopentadienone at room temperature led to the isolation of the naphthalene product 60 
(Scheme 2-9). 
 
Scheme 2-9: Incompatibility of some electron-withdrawing aryl triflates was attributed to the formation 
of aryne in solution.  This was verified by trapping the aryne with a cyclopentadienone to yield 
substituted naphthalene. 
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As an illustration of the synthetic utility of our method for the synthesis of enantioenriched 
diarylmethylamines, the purified enantioenriched chromium-coordinated diarylmethylamines was 
decomplexed without loss of ee by exposing a solution of the complex to light and air and filtering 
the suspension.  Alternately, the crude reaction product (Scheme 2-10, 55c) could also be 
demetallated by exposure to light and air and then purified by chromatography to give 61 in 63% 
yield and 85% ee (Scheme 2-10). 
 
Scheme 2-10: Direct decomplexation of the reaction mixture in sunlight access to enantioenriched 
diarylmethylamines without loss of ee. 
 
Finally, the absolute configuration of (−)-55a using the (+)-enantiomer of cyclohexyl Mandyphos 
(solution was recrystallized to >96% ee before crystallization for structural determination) was 
obtained via single-crystal X-ray crystallography, and determined to be (R) (Figure 2-8). 
 
Figure 2-8: X-ray crystal structure of (R)-(−)-55a.  Thermal ellipsoid are at 50% probability.  Full details 
can be found on p. 290. 
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Summary and Conclusions 
In conclusion, we have developed a strategy for enantioselective functionalization of benzylic sp3 
carbons α– to tertiary amines to access core structures present in numerous biologically 
important diarylmethyl amines.  Low-barrier high-throughput experimentation on a 2 µmol scale 
facilitated rapid identification of the ferrocene amine phosphine ligand cyclohexyl Mandyphos as 
the most effective ligand.  Diastereoelective transmetallation of one enantiomer of a rapidly 
equilibrating tricarbonylchromium-coordinated benzyllithium species is the key step in this 
asymmetric cross-coupling with various sp2–hybridized organic triflates and bromides.  It is likely 
that the tertiary amine in the active Mandyphos catalyst is crucial in the enantiodetermining 
transmetallation reactions by coordination to the main group organometallic reagent.  Further 
work is being aimed at expanding this unique asymmetric cross-coupling reaction to other 
benzylic arene systems, such as for chiral triarylmethane synthesis. 
Additionally, work is being done to take the highly enantioenrichced chromium-coordinated 
products from these reactions and employing them as precursors to a family of modular 
diarylmethylamine P∧N ligands employing both planar and central chirality.  This work is 
addressed in Chapter 3.34 
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Experimental Section 
General Methods   
Reactions were performed under nitrogen using oven-dried glassware. Air- and moisture- sensitive 
solutions were handled under nitrogen and transferred via syringe. Dry THF was freshly distilled from 
Na/benzophenone ketyl. Toluene was drawn from a Grubbs column. 1,4-Dioxane was commercially 
available anhydrous stabilized Acro Seal quality. Unless otherwise stated, reagents were commercially 
available and used as purchased without further purification. Chemicals were obtained from Sigma-
Aldrich, Acros, or Strem, and used as received; solvents were purchased from Fisher Scientific. 
Reactions were monitored by thin-layer chromatography using Whatman Partisil® K6F 250 µm 
precoated 60 Å silica gel plates and visualized by short-wave ultra-violet light as well as by treatment 
with potassium permanganate (KMnO4) or ceric ammonium molybdate (CAM) stain. NMR spectra were 
recorded in CDCl3 on either a Bruker 300 MHz or 500 MHz Fourier-transform spectrometer. Chemical 
shifts are reported in ppm referenced to tetramethylsilane (TMS) or the CHCl3 solvent residual peak at 
7.26 ppm for 1H and 77.23 ppm for 13C{1H}; 19F peaks were referenced to an external standard of 
trifluoroacetic acid in CDCl3 at −76.55 ppm. Infrared spectra were obtained on NaCl plates using a 
Perkin-Elmer Spectrum 100 Series FTIR spectrometer. Optical rotations were recorded in HPLC-grade 
CHCl3 using a JASCO DIP-370 digital polarimeter and values were averaged over a minimum of 3 runs. 
Chromium-complexed masses were recorded with Electrospray + (ES+) HRMS methods to within 5 
ppm, and [M]+, [MH]+, [M – (CO)3]+, or [M – C4H8NO]+ was confirmed by the presence of the 
characteristic chromium isotope pattern. Non-chromium-complexed mass was recorded with Chemical 
Ionization + (CI+) HRMS methods to within 5 ppm, and [M]+ was observed.  Where necessary, 
microanalysis for C, H, N composition was obtained and accurate to within 0.5%. 
Compounds 27, 53, 54, and 56 were prepared according to general literature procedure for the 
synthesis of arene tricarbonylchromium complexes from Cr(CO)6 and parent arene.35,36 Aryl 
trifluromethanesulfonates were prepared in good to excellent yield from the corresponding phenol 
according to the general literature procedure.37,38  
Caution: Care should be taken to avoid direct light exposure of reactions, as arene 
tricarbonylchromium complexes can decompose in solution under bright light and air.  In crystalline 
solid form, complexes are reasonably stable to light and can be stored at room temperature in air. 
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General procedure 2-A for the synthesis of benzylamine tricarbonylchromium complexes 
Complexes were prepared according to general literature procedure for the synthesis of arene 
tricarbonylchromium complexes from Cr(CO)6 and parent arene35,36 and were crystallized from 
dichloromethane and hexanes at -20 ºC or purified by flash column chromatography eluting in 
methylene chloride or diethyl ether in hexanes to afford yellow crystalline solids.  The following 
procedure is representative. 
27 – Me2NCH2(η6-C6H5)Cr(CO)3: An oven-dried 50 mL round-bottom flask was 
charged with Cr(CO)6 (1.54 g, 0.70 mmol, 1.0 equiv), fitted with a straight reflux 
condenser, and flushed with dry nitrogen for 30 minutes.  N,N-
Dimethylbenzylamine (2.1 mL, 14 mmol, 2.0 equiv), dry THF (1 mL), and dry 1,4-
dioxane (2.5 mL) were added by syringe through the reflux condenser, and the 
mixture was refluxed in a 115 – 120 ºC oil bath for 2 days.  The yellow-orange solution was allowed to 
cool, and completion of the reaction was verified by the absence of solid Cr(CO)6 on the sides of the 
flask (from sublimation) after refluxing subsided.  The reaction was opened to air, diluted with 
methylene chloride (5 mL) and filtered over a pad of Celite and MgSO4.  The clear yellow solution was 
concentrated under vacuo, layered with hexanes, and crystallized at -20º.  After filtration, rinsing with 
cold hexanes and collecting a second crop of crystals, 27 (1.57 g, 5.8 mmol, 83% yield) was obtained 
as a bright yellow crystalline solid.  Spectral data is consistent with existing characterization.39  
53 – N-(C5H10N)CH2(η6-C6H5)Cr(CO)3: Using General procedure 2-A, Cr(CO)6 
(0.44 g, 2.0 mmol, 1.0 equiv) was reacted with N-benzyl piperidine (0.52g, 
3.0 mmol, 1.5 equiv) in 2.3 mL dioxane and 0.7 mL THF at 100-110 ºC for 5 
days.  Crystallization at -20 ºC yielded 53 (0.46 g, 1.5 mmol, 74% yield) as a 
bright yellow solid. 1H NMR (300 MHz, CDCl3) δ: 5.42 - 5.29 (m, 4H), 5.25 - 
5.21 (m, 1H), 3.18 (s, 2H), 2.45 - 2.42 (m, 4H), 1.64 - 1.51 (m, 4H), 1.49 - 
1.39 (m, 2H) ppm; 13C{1H} NMR (75 MHz, CDCl3) δ: 233.2, 109.0, 94.2, 93.3, 91.5, 62.7, 54.7, 26.1, 
24.3 ppm; IR: 3087, 2937, 2853, 2800, 2686, 1966 and 1878 (strong CO stretches), 1455, 1343, 
1153, 1110, 995, 861, 662, 630, 533 cm-1. HRMS (ES+) calc’d for C15H18CrNO3 312.0692, found 
312.0687 [MH]+. 
54 – N-(C4H8NO)CH2(η6-C6H5)Cr(CO)3: Using General procedure 2-A, Cr(CO)6 
(0.44 g, 2.0 mmol, 1.0 equiv) was reacted with N-benzyl morpholine (0.5 mL, 
3 mmol, 1.5 equiv) in 1.5 mL dioxane and 0.8 mL THF at 120 ºC for 2 days.  
Crystallization at -20 ºC yielded 54 (0.59 g, 1.9 mmol, 94 % yield after 2nd CrOC
CO
CO
N
O
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crop) as a bright yellow crystalline solid.  1H NMR (300 MHz, CDCl3) δ: 5.41 - 5.34 (m, 4H), 5.27 - 5.23 
(m, 1H), 3.72 - 3.69 (m, 4H), 3.24 (s, 2H), 2.53 - 2.50 (m, 4H) ppm; 13C{1H} NMR (75 MHz, CDCl3) δ: 
233.0, 107.7, 94.0, 93.2, 91.6, 67.1, 62.2, 53.7 ppm; IR 3066, 2971, 2867, 2817, 1961 and 1877 
(strong CO stretches), 1458, 1285, 1115, 1007, 865, 662, 630, 531 cm-1.  HRMS (ES+) calc’d for 
C14H16CrNO4 314.0484, found 314.0497 [MH]+. 
56 – N-(C5H10N)CH2(η6-C6H5)Cr(CO)3: Using General procedure 2-A, Cr(CO)6 
(0.44 g, 2.1 mmol, 1.0 equiv) was reacted with N,N-benzyl methylpiperazine 
(0.59 mL, 3.0 mmol, 1.5 equiv) in 1.5 mL dioxane and 0.5 mL THF at 105-
115 ºC for 4 days.  Crystallization at -18 ºC yielded 1d (0.64 g, 1.9 mmol, 93% 
yield) as a yellow powdery solid. 1H NMR (300 MHz, CDCl3) δ: 5.39 - 5.33 (m, 
4H), 5.26 - 5.21 (m, 1H), 3.24 (s, 2H), 2.6 - 2.4 (br m, 8H), 2.28 (s, 3H) ppm; 
13C{1H} NMR (75 MHz, CDCl3) δ: 233.0, 108.1, 94.1, 93.3, 91.6, 61.8, 55.1, 53.1, 46.2 ppm; IR: 
(strong CO stretches), cm-1. HRMS (ES+) calc’d for C15H19CrN2O3 327.0795, found 327.0799 [MH]+. 
 
General procedure 2-B for racemate synthesis 
The following procedure is representative of the synthesis of racemic product standards used for HPLC 
and SFC analysis of asymmetric reactions and reaction screens: 
28f – Me2NCH(4-C6H4-CH3)(η6-C6H5)Cr(CO)3: Racemic 28f was prepared as a 
chromatography reference following the literature procedure for related 
compounds:40  An oven-dried glass reaction tube was charged with a small 
magnetic stirbar and 27 (52 mg, 0.19 mmol, 1.0 equiv), sealed with a 
septum, and purged with nitrogen.  PdCl2(PPh3)2 (7 mg, 0.01 mmol, 5 mol %) and LiHMDS (68 mg, 0.4 
mmol, 2 equiv) were dissolved in dry THF (1.5 mL) under a nitrogen atmosphere, forming an orange 
solution, to which neat 4-bromotoluene (38 µl, 0.3 mmol, 1.5 equiv) was added.  The catalyst, base, 
and aryl bromide solution was taken up by syringe and added to 27, which turned red-orange.  The 
reaction mixture was heated with stirring for 20 h at 43 ºC, then allowed to cool.  The orange solution 
was quenched with two drops of aqueous 2N HCl and allowed to stir for 5 min.  The solution was 
opened to air and diluted with 4 mL diethyl ether, then filtered over a pad of MgSO4 and silica.  The 
pad was rinsed with an additional 1 mL diethyl ether and the solution was concentrated in vacuo, 
loaded directly onto a short silica gel column, and eluted with 50% diethyl ether in hexane.  Racemic 
28f (53.8 mg, 0.15 mmol, 78% yield) was obtained as a yellow-orange solid. 1H NMR (300 MHz, 
CDCl3) δ: 7.15 (appar. s, 4H), 5.91 (dt, J = 6.2, 1.0 Hz, 1H), 5.35 - 5.26 (m, 2H) 5.24 (d, J = 6.7 Hz, 
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2H), 5.16 (dd, J = 5.7, 1.3 Hz, 1H), 4.17 (s, 1H), 2.34 (s, 3H), 2.23 (s, 6H) ppm; 13C{1H} NMR (125 
MHz, CDCl3) δ: 233.1, 137.8, 136.8, 129.3, 129.1, 114.5, 94.7, 94.3, 93.3, 91.3, 91.0, 72.9, 44.2, 
21.3 ppm.  IR: 2924, 2867 2825, 2780, 1963 and 1876 (strong CO stretches), 1610, 1454, 1412, 
1150, 116, 802, 662, 631, 531 cm-1. 
 
General considerations for low-barrier high-throughput experimentation (HTE) 
procedures 
Experimental design was aided by Symyx Library Studio software. Reactions were set up in a dry 
nitrogen atmosphere glovebox under constant purge of N2. Microscale reactions were run in glass vials 
placed in a 96-well aluminum block and sealed using a Teflon lining and silicone rubber gaskets 
compressed by an aluminum top attached by screws. Liquids and solutions were dosed using 
microlitre Eppendorf pipettes and multi-channel pipettors. When evaporation of solvent was 
necessary, a Genevac vacuum centrifuge within the glovebox was used. Anhydrous solvents were used 
as purchased from Aldrich (sure-seal quality).41 
 
General procedure 2-C for screening conditions using HTE methods  
Cr
NMe2
[Cr]
*
NMe2
CH3
1.5 4-Br-Tol
1.3 LiN(SiMe3)2
5 mol% PdCl2[COD]
5 mol% L*
25 °C, THF, 48 h27 28f
Reacton scale:
2 µmol 1a
[1a]0 = 0.1M
2 × 96 well plates
OC
CO
CO
       
Scheme 2-11: General scheme for HTE screening to identify promising ligands for the asymmetric 
cross-coupling of 27 with 4-bromotoluene to yield enantioenriched diarylmethylamine 28f. 2 µmol-
scale (0.5 mg) reactions were run in parallel in 250 µL reaction vials, shown next to 1 mL and 8 mL 
vials for comparison. 
8 mL    1 mL   250 µL 
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28f – (4-C6H4-CH3)-N-(N(CH3)2)CH(η6-C6H5)Cr(CO)3: Two 96-well aluminum blocks containing 96- 250 
µL glass vials predosed with enantioenriched mono- and bidentate ligandsa (either 0.2 µmol for 
monodentate or 0.1 µmol for bidentate ligands) were dosed with 38 µL of dichloro(1,5-
cyclooctadiene)palladium(II) precatalyst [PdCl2(COD)] in THF (0.003 M, 0.1 µmol, 5 mol%) and 
evaporated to dryness using a Genevac vacuum centrifuge.  Small perylene magnetic stirbars were 
added to the reaction vials, and then 20 µL of a THF solution of N,N-dimethylbenzylamine 
tricarbonylchromium (27) (0.1 M, 2 µmol, 1.0 equiv), LiHMDS (0.13 M, 26 µmol, 1.3 equiv), and 4-
bromotoluene (0.15 M, 3 µmol, 1.5 equiv) was added to each vial via multi-channel pipette.  The 96-
well plates were sealed and agitated at ~960 rpm for 48 h at room temperature. 
Work-up: At 48 h the plates were opened to air and immediately quenched with 100 µL of a 0.5 M 
H3PO4 solution added via multi-channel pipet (to neutralize the excess LiHMDS), followed by 300 µL 
acetonitrile (containing 1 µmol 4,4’-di-tert-butylbiphenyl internal standard) and 100 µL DMSO (to 
ensure complete solubilization of the reaction mixture). The plates were then covered and stirred for 
15–20 minutes for complete extraction of the product as well as to ensure good homogenization. 20 
µL portions of the reaction mixture were then transferred by multi-channel pipet into 96-well HPLC 
blocks pre-filled with 750 µL acetonitrile. The blocks were then mounted directly on HPLC instruments 
for analysis using Agilent 1200 Series HPLC instruments with reverse phase C-18 columns and 
acetonitrile/water (buffered with 0.1% H3PO4) as mobile phase. Data processing was done on Agilent 
ChemStation software using the biphenyl as internal standard. Reactions that showed conversion of 
starting material to product (28f) were then run on an Agilent SFC instrument in 4% methanol 
(containing 25 mM isobutylamine additive) in CO2 at 3 mL/min using a Chiralpak OJ-H column for %ee 
determination.  
Five ferrocenyl ligands provided conversion to desired product 28f as well as enantioselectivity.  
Cyclohexyl Taniaphos showed the highest reactivity and moderate enantioselectivity. Cyclohexyl 
Mandyphos (SL-M002) showed the greatest selectivity, though conversion to product was low. 
 
 
                                                      
 
 
a For a complete list of chiral ligands screened with these methods, see p. 331 
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Procedure for detailed study of asymmetric reaction using HTE methods 
Cr
NMe2
[Cr]
*
NMe2
CH3
1.5 4-Br-Tol
X LiHMDS
Y HMDS-H
4.5 mol% PdCl2[COD]
5 mol% SL-M002
25 °C, THF
27 28f
Reacton scale:
16 µmol 1a
[1a]0 = 0.1M
4 mL vials
OC
CO
CO
 
Scheme 2-12:  General scheme for the detailed analysis of asymmetric reaction over time.  Internal 
standard biphenyl was added during the work-up step. 
Reactions were scaled to 16 µmol (8 × microscale size) in 4 mL glass screw-capped vials predosed 
with Mandyphos ligand and palladium precatalyst: THF solutions of chiral ligand Cyclohexyl 
Mandyphos (SL-M002) and PdCl2[COD] were sequentially added to vials and evaporated by Genevac. 
Small PTFE-coated stirbars were then added to the vials.  A solution of 28f (1 equiv.), 4-bromotoluene 
(1.5 equiv.), and varying amounts of LiHMDS and HMDS-H at 0.1 or 0.5 M [Cr] was added, and vials 
were sealed and stirred at room temperature within the glovebox. 20 µL aliquots were periodically 
removed from the vials (at 2, 3.5, 13, 37, 86, and 168 hour intervals), and work-up and 
chromatographic analysis for these aliquots proceeded according to the work-up specified in General 
procedure 2-C. 
 
General procedures and characterizations for benzylic coupling reactions 
The following procedures are representative.  Unless otherwise specified, chromatography was run in 
a mixture of diethyl ether in hexanes, or a combination of hexanes, methylene chloride, and diethyl 
ether. 
General procedure 2-D for optimization of reaction conditions 
Procedure for asymmetric cross-coupling of tricarbonylchromium benzylmorpholine (54) with p-tolyl 
halides to generate enantioenriched tertiary diarylmethylamine (55a). 
 
55a – (R)-(−)-(4-C6H4-CH3)-N-(C4H8NO)CH(η6-C6H5)Cr(CO)3: An oven-dried 
reaction tube was charged with a small magnetic stirbar and η6- 
benzylmorpholine tricarbonylchromium (54) (0.02 – 0.1 mmol scale, 1.0 
equiv), and solid additives (0.5 – 2 equiv) sealed with a septum, and purged Cr
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with dry nitrogen.  Dry toluene and liquid additives were added via syringe. A separate oven-dried vial 
was charged with palladium precatalyst (5 – 10 mol% Pd), cyclohexyl Mandyphos (1.5:1 L*:Pd ratio), 
and LiHMDS (3 – 4 equiv) under nitrogen and sealed with a septum cap.  The precatalyst, ligand, and 
base were dissolved in dry THF.  Then, 4-bromotoluene, 4-tolyl triflate, 4-chlorotoluene, or 4-tolyl 
tosylate (1.5 - 2 equiv) and liquid additives were added via syringe.  The catalyst, base, and aryl halide 
solution was taken up with a syringe and added to the stirring solution of 54 and additives in toluene.  
The reaction was stirred at the specified temperature (between 0 °C and 55 °C) for 7 – 48 h.  The 
solution was then quenched with 2 drops H2O, opened to air, diluted with 3 mL diethyl ether, and 
filtered over a pad of MgSO4 and silica gel.  The pad was rinsed with additional diethyl ether, and the 
solution was analyzed via SFC (10% MeOH/CO2, 4 mL/min, IA column) for conversion and 
enantiomeric excess.  Where isolated yields were obtained, the filtrate was concentrated in vacuo, 
loaded directly onto a silica gel column, and eluted with 20 - 30% diethyl ether in pentane.  The result 
was 55a as a yellow solid.  1H NMR (300 MHz, CDCl3) δ: 7.15 (apparent s, 4H), 5.92 - 5.90 (m, 1H), 
5.35 - 5.29 (m, 2H), 5.26 (d, J = 6.6 Hz, 1H), 5.16 - 5.12 (m, 1H), 4.21 (s, 1H), 3.71 - 3.68 (m, 4H), 
2.57 - 2.40 (m, 4H), 2.34 (s, 3H) ppm; 13C{1H} NMR (75 MHz, CDCl3) δ: 232.9, 138.1, 136.5, 129.4, 
129.1, 113.1, 94.7, 94.5, 93.7, 91.1, 90.5, 72.5, 67.4, 52.5, 21.3 ppm, IR: 2958, 2924, 2853, 
2817, 1964 and 1877 (strong CO stretch), 1455, 1116, 1006, 875, 662, 633 cm-1.  [α]D
2 6 = −26.1° 
(c = 0.38, CHCl3) for an 89 %ee sample.  Analysis calc’d for C21H21CrNO4: C 62.53 H 5.25 N 3.47, 
found C 62.25 H 5.38 N 3.37.  X-ray crystal structure was determined for this compound, see p. 290. 
%ee vs %Tol/v (in THF)
60
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Figure 2-9: Enantiomeric excess variation on solvent composition. 
Reactions were run with the benzylmorpholine complex 54, 1.5 equiv. 4-bromotoluene and 3 equiv. 
LiHMDS at approx. 0.1 M [Cr], varying toluene composition from 0–80% by volume. Maximum 
enantioselectivity is observed at approximately 35–40%.  When the fraction of toluene is increased 
past 40%, a steady decrease in enantioselectivity and conversion is observed.  Conversion to product 
was not observed for pure toluene in the absence of THF. 
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Figure 2-10: Effect of halide salts on enantiomeric excess.  
Reactions were run with the benzylmorpholine complex 54, 1.5 equiv. 4-bromotoluene, 3 equiv. 
LiHMDS, and 0.5 equiv. anhydrous halide source at approx. 0.1 M [54].  %ee were measured after 
reactions had reached 30–50% conversion (approx. 10h). 
 
General procedure 2-E for asymmetric reaction of benzylamine complexes with aryl triflates 
Procedure for cross-coupling of tricarbonylchromium benzylamines (27, 53, 54, 56) with aryl triflates 
to generate enantioenriched tertiary diarylmethylamines or α-vinyl benzylamine. 
55b – (−)-(4-C6H4-t-Bu)-N-(C4H8NO)CH(η6-C6H5)Cr(CO)3: An oven-dried reaction 
tube was charged with a small magnetic stirbar and η6-tricarbonylchromium 
benzylmorpholine (54) (25 mg, 0.080 mmol, 1.0 equiv), sealed with a septum, 
and purged with dry nitrogen.  Dry toluene (0.4 mL) and PMDTA (17 µl, 0.080 
mmol, 1.0 equiv) were added via syringe.  A separate oven-dried vial was 
charged with [(allyl)PdCl]2 (1.2 mg, 0.0032 mmol, 8 mol% Pd), cyclohexyl 
Mandyphos (8 mg, 0.009 mmol, 12 mol%), and LiHMDS (54 mg, 0.32 mmol, 
4.0 equiv) under nitrogen and sealed with a septum cap.  The precatalyst, ligand, and base were 
dissolved in dry THF (0.6 mL), and 4-tert-butylphenyl triflate (27 µl, 0.12 mmol, 1.5 equiv) and 
chlorobenzene (~20 µl, 2%/vol) were added next via syringe.  The catalyst, base, and aryl halide 
solution was taken up with a syringe and added to the stirring mixture of 54, triamine, and toluene.  
The reaction was immediately moved to an ice bath and allowed to warm to room temperature (18 °C) 
with stirring for 16 hours.  The brownish orange solution was quenched with 2 drops H2O, opened to 
air, diluted with 3 mL diethyl ether, and filtered over a pad of MgSO4 and silica gel.  The pad was 
rinsed with additional diethyl ether and the solution was concentrated in vacuo.  The crude mixture 
was then loaded directly onto a silica gel column and eluted with 20 - 25% diethyl ether in pentane.  
The result was 55b (31.2 mg, 0.070 mmol, 88 % yield, 91 %ee) as a yellow solid.  1H NMR (500 MHz, 
CDCl3) δ: 7.35 (d, J = 8.4 Hz, 2H), 7.19 (d, J = 8.3 Hz, 2H), 5.90 (d, J = 6.4 Hz, 1H), 5.35 - 5.31 (m, 
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2H), 5.28 (dt, J = 1.1, 6.3 Hz, 1H), 5.13 (ddd, J = 1.2, 6.0, 6.8 Hz, 1H), 4.18 (s, 1H), 3.73 - 3.66 (m, 
4H), 2.46 - 2.42 (br s), 2.53 - 2.49 (m, 2H), 1.30 (s, 9H) ppm; 13C{1H} NMR (125 MHz, CDCl3) δ: 232.9, 
151.3, 136.5, 128.7, 125.6, 113.1, 95.2, 94.8, 93.9, 90.8, 90.1, 72.5, 67.4, 52.5, 34.8, 31.5 ppm; 
IR: 2958, 2924, 2853, 2817, 1964 and 1877 (strong CO stretch), 1455, 1116, 1006, 875, 662, 633 
cm-1; [α]D
2 3 = −13.6° (c = 0.50, CHCl3).   
55c – (−)-(4-C6H4-OMe)-N-(C4H8NO)CH(η6-C6H5)Cr(CO)3: Using General 
procedure 2-E, 54 (25 mg, 0.080 mmol, 1.0 equiv) and PMDTA (17 µl, 0.08 
mmol, 1 equiv) in 0.4 mL toluene was combined with a solution of LiHMDS (54 
mg, 0.32 mmol, 4 equiv), 4-methoxyphenyl triflate (22 µl, 0.12 mmol, 1.5 
equiv), [(allyl)PdCl]2 (1.2 mg, 0.0032 mmol, 8 mol% Pd), and cyclohexyl 
Mandyphos (7 mg, 0.009 mmol, 10 mol%) in 0.6 mL THF with 20 µl 
chlorobenzene additive.  The reaction was stirred for 10 h at room temperature (18 °C). Compound 
55c (25.2 mg, 0.060 mmol, 75% yield, 86 %ee) was obtained as a yellow crystalline solid after silica 
gel chromatography eluting with 1:1 methylene chloride:hexanes  and then 33% - 50% diethyl ether in 
hexanes.  1H NMR (300 MHz, CDCl3) δ: 7.19 (d, J = 8.7 Hz, 2H), 6.88 (d, J = 8.7 Hz, 2H), 5.89 (d, J = 
5.8 Hz, 1H), 5.35 - 5.25 (m, 3H), 5.17 - 5.12 (m, 1H), 4.19 (s, 1H), 3.80 (s, 3H), 3.71 - 3.68 (m, 4H), 
2.54 - 2.49 (m, 2H), 2.46 - 2.39 (m, 2H) ppm; 13C{1H} NMR (75 MHz, CDCl3) δ: 232.9, 159.6, 131.7, 
130.2, 114.1, 113.3, 94.8, 94.6, 93.7, 91.0, 90.7, 72.2, 67.4, 55.5, 52.5 ppm; IR: 2957, 2918, 
2852, 2815, 1962 and 1876 (strong CO stretch), 1609, 1510, 1454, 1252, 1176, 1116, 1032, 875, 
662, 632 cm-1; Analysis calc’d for C21H21CrNO5: C 60.14 H 5.05 N 3.34, found C 59.90 H 5.13 N 3.24; 
[α]D
2 3 = −45.2° (c = 0.70, CHCl3).   
55d – (−)-(3-C6H4-CH3)-N-(C4H8NO)CH(η6-C6H5)Cr(CO)3: Using General 
procedure 2-E, 54 (25 mg, 0.080 mmol, 1.0 equiv) and PMDTA (17 µl, 0.08 
mmol, 1 equiv) in 0.4 mL toluene was combined with a solution of LiHMDS (50 
mg, 0.30 mmol, 4 equiv), 3-tolyl triflate (30 µl, 0.16 mmol, 2 equiv), 
[(allyl)PdCl]2 (1.2 mg, 0.0032 mmol, 8 mol% Pd), and cyclohexyl Mandyphos (7 
mg, 0.008 mmol, 10 mol%) in 0.6 mL THF with 20 µl chlorobenzene additive.  
The reaction was stirred for 20 h warming from a 0 °C ice bath to room temperature (19 °C).  
Compound 55d (20 mg, 0.050 mmol, 62% yield, 91 %ee) was obtained as an orange oil after silica gel 
chromatography eluting with 1:1:5 methylene chloride:diethyl ether:hexanes, then 1:3 diethyl 
ether:hexanes. 1H NMR (500 MHz, CDCl3) δ: 7.40 (t, J = 8.4 Hz, 1H), 7.09 - 7.05 (m, 3H), 5.87 (d, J = 
6.3 Hz, 1H), 5.32 (t, J = 6.1 Hz, 1H), 5.29 - 5.26 (m, 2H), 5.11 (t, J = 6.2 Hz, 1H), 4.14 (s, 1H), 3.69 - 
3.65 (m, 4H), 2.52 - 2.48 (br s, 2H), 2.45 - 2.42 (m, 2H), 2.32 (s, 3H) ppm; 13C{1H} NMR (125 MHz, 
CDCl3) δ: 232.8, 139.6, 138.5, 129.9, 129.0, 128.6, 126.0, 112.9, 95.1, 94.8, 94.0, 90.8, 90.2, 
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67.3, 52.6, 21.7 ppm; IR: 2968, 2918, 2854, 2814, 1964 and 1880 (strong CO stretch), 1453, 
1116, 1007, 872, 661, 629 cm-1; [α]D
2 6 = −13.5° (c = 1.0, CHCl3).   
55e – (−)-(C6H5)-N-(C4H8NO)CH(η6-C6H5)Cr(CO)3: Using General procedure 2-E, 
54 (25 mg, 0.080 mmol, 1.0 equiv) and PMDTA (17 µl, 0.08 mmol, 1 equiv) in 
0.4 mL toluene was combined with a solution of LiHMDS (54 mg, 0.32 mmol, 
4 equiv), phenyl triflate (26 µl, 0.16 mmol, 2 equiv), [(allyl)PdCl]2 (1.2 mg, 
0.0032 mmol, 8 mol% Pd), and cyclohexyl Mandyphos (7 mg, 0.008 mmol, 10 
mol%) in 0.6 mL THF with 20 µl chlorobenzene additive.  The reaction was 
stirred for 16 h warming from a 0 °C ice bath to room temperature (18 °C).  
Compound 55e (25 mg, 0.064 mmol, 80% yield, 89 %ee) was obtained as a yellow solid after silica gel 
chromatography eluting with 1:1:5 methylene chloride:diethyl ether:hexanes, then 1:1 diethyl 
ether:hexanes. 1H NMR (500 MHz, CDCl3) δ: 7.37 - 7.26 (m, 5H), 5.90 (d, J = 5.9 Hz, 1H), 5.25 (t, J = 
5.8 Hz, 1H), 5.30 - 5.28 (m, 2H), 5.14 (t J = 6.0 Hz, 1H), 4.20 (s, 1H), 3.73 - 3.66 (m, 4H), 2.54 - 2.50 
(m, 2H), 2.46 - 2.42 (m, 2H) ppm; 13C{1H} NMR (125 MHz) δ:  232.8, 139.6, 129.1, 128.8, 128.3, 
112.6, 95.1, 94.7, 94.0, 90.8, 73.0, 67.3, 52.6 ppm; IR: 3084, 3030, 2957, 2918, 2853, 2814, 
1963 and 1878 (strong CO stretches), 1452, 1278, 116, 1006, 874, 751 706 661, 630 cm-1.  [α]D
2 6 
= −21.2° (c = 1.0, CHCl3). 
 
General procedure 2-F for asymmetric reaction of benzylamine complexes with aryl bromides 
Asymmetric cross-coupling of tricarbonylchromium benzylmorpholine (54) with aryl bromides to 
generate enantioenriched tertiary diarylmethylamines (55f, 55g). 
 
55f – (−)-(4-C6H4-N(CH3)2)-N-(C4H8NO)CH(η6-C6H5)Cr(CO)3: An oven-dried 
reaction tube was charged with a small magnetic stirbar and η6-
tricarbonylchromium benzylmorpholine (54) (31.5 mg, 0.10 mmol, 1.0 equiv), 
sealed with a septum, and purged with dry nitrogen.  Dry toluene (0.4 mL) and 
PMDTA (21 µl, 0.10 mmol, 1.0 equiv) were added via syringe.  A separate 
oven-dried vial was charged with [(allyl)PdCl]2 (1.8 mg, 0.005 mmol, 10 mol% 
Pd), cyclohexyl Mandyphos (10 mg, 0.012 mmol, 12 mol%), and LiHMDS (67 mg, 0.40 mmol, 4.0 
equiv) under nitrogen and sealed with a septum cap.  A solution of 4-bromo-N,N-dimethylaniline (26 
mg, 0.13 mmol, 1.3 equiv) in 0.6 mL dry THF was then added to the precatalyst, ligand, and base, and 
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the solution was taken up by syringe and added to the stirring mixture of 54, triamine, and toluene.  
The reaction was stirred at room temperature (18 °C) for 60 hours.  The brown solution was quenched 
with 2 drops H2O, then opened to air and diluted with 3 mL diethyl ether, then filtered over a pad of 
MgSO4 and silica gel.  The pad was rinsed with additional diethyl ether, and the filtrate was 
concentrated in vacuo, loaded directly onto a silica gel column, and eluted with 20 – 40% diethyl ether 
in hexanes.  The result was 55f (25.5 mg, 0.059 mmol, 59 % yield, 84 %ee) as a yellow solid. 1H NMR 
(300 MHz, CDCl3) δ: 7.07 (d, J = 8.8 Hz, 2H), 6.68 (d, J = 8.8 Hz, 2H), 5.94 (d, J = 6.3 Hz, 1H), 5.38 - 
5.28 (m, 2H), 5.25 (d, J = 6.7 Hz, 1H), 5.18 - 5.14 (m, 1H), 4.19 (s, 1H), 3.71 - 3.68 (m, 4H), 2.94 (s, 
6H), 2.59 - 2.54 (m, 2H), 2.46 - 2.39 (m, 2H) ppm; 13C{1H} NMR (75 MHz) δ: 233.2, 150.4, 130.1, 
127.0, 114.2, 112.3, 94.5, 94.1, 93.3, 91.5, 91.1, 71.9, 67.4, 52.5, 40.6 ppm; IR: 3081, 2958, 
2922, 2854, 1962 and 1877 (strong CO stretches), 1612, 1520, 1455, 116, 874, 802, 664, 632 cm-
1; HRMS (ES+) calc’d for C22H25CrN2O4 433.1219 found 433.1205 [MH]+;  [α]D
2 6 = −25.6° (c = 0.55, 
CHCl3). 
55g – (−)-[1-(triisopropylsilyl)-1H-indol-4-yl]-N-(C4H8NO)CH(η6-C6H5)Cr(CO)3: 
Using General procedure 2-F, 54 (31.3 mg, 0.10 mmol, 1.0 equiv) and 
PMDTA (21 µl, 0.10 mmol, 1.0 equiv) in 0.4 mL toluene was combined with 
a solution of LiHMDS (65 mg, 0.4 mmol, 4 equiv), [(allyl)PdCl]2 (1.8 mg, 
0.005 mmol, 10 mol% Pd), and cyclohexyl Mandyphos (10 mg, 0.012 
mmol, 12 mol%), and 5-bromo-N-triisopropylsilylindole (42 mg, 0.12 mmol, 
1.2 equiv) in 0.6 mL THF.  The reaction was stirred for 48 h at room 
temperature (19 °C).  Compound 55g (21 mg, 0.036 mmol, 36% yield, 62 %ee) was obtained as an 
orange oil after silica gel chromatography eluting with 20 – 30% diethyl ether in hexanes. 1H NMR 
(300 MHz, CDCl3) δ: 7.44 (d, J = 8.3 Hz, 1H), 7.26 (d, J = 2.7 Hz, 1H), 7.09 (dd, J = 7.4, 8.2 Hz, 1H), 
6.95 (d, J = 7.1 Hz, 1H), 6.78 (d, J = 2.8 Hz, 1H), 6.05 (d, J = 5.9 Hz, 1H), 5.42 (d, J = 6.7 Hz, 1H), 
5.36 - 5.38 (m, 2H), 5.12 - 5.07 (m, 1H), 4.65 (s, 1H), 3.76 - 3.66 (m, 4H), 2.65 - 2.59 (m, 2H), 2.54 - 
2.48 (m, 1H), 1.69 (7-tet, J = 7.5 Hz, 3H), 1.14 (d, J = 7.5 Hz, 18H) ppm; 13C{1H} NMR (125 MHz) δ: 
233.1, 141.5, 131.7, 131.6, 131.1, 121.2, 120.5, 113.81, 113.79, 103.8, 94.8 94.7, 93.6, 91.1, 
90.5, 70.9, 67.6, 52.7, 18.4, 13.1 ppm; IR: 2951, 2923, 2868, 1964 and 1882 (strong CO 
stretches), 1454, 1427, 1280, 1149, 1118, 882, 755, 661, 630 cm-1; HRMS (ES+) calc’d for 
C27H32CrNO3Si 498.1557, found 498.1545 [M – C4H8NO]+; [α]D
2 5 = −11.3° (c = 1.0, CHCl3). 
28a – (−)-Me2NCH(C6H5)(η6-C6H5)Cr(CO)3: Using General procedure 2-E, 27 
(21.4 mg, 0.079 mmol, 1.0 equiv) and PMDTA (17 µl, 0.08 mmol, 1.0 equiv) in 
0.4 mL toluene was combined with a solution of LiHMDS (54 mg, 0.32 mmol, 
Cr
OC
CO
CO
N
H
O
N
Si(iPr)3
Cr
OC
CO
CO
2i
N
H
CH3
CH3
113 
 
4 equiv), 4-phenyl triflate (26 µl, 0.16 mmol, 2 equiv), [(allyl)PdCl]2 (1.1 mg, 0.003 mmol, 7 mol% Pd), 
and cyclohexyl Mandyphos (6.5 mg, 0.008 mmol, 10 mol%) in 0.6 mL THF with 20 µl chlorobenzene 
additive.  The reaction was stirred for 10 h warming from a 0 °C ice bath to room temperature (19 
°C).  Compound 28a (18.2 mg, 0.052 mmol, 66% yield, 87 %ee) was obtained as a yellow solid after 
silica gel chromatography eluting in 2:1–7:1 methylene chloride : hexanes to 3:1 methylene chloride : 
diethyl ether.  1H NMR (300 MHz, CDCl3) δ: 7.39-7.27 (m, 5H), 5.91 - 5.88 (m, 1H), 5.34 - 5.26 (m, 
3H), 5.17 - 5.12 (m, 1H), 4.15 (s, 1H), 2.24 (s, 6H) ppm; 13C{1H} NMR (75 MHz) δ: 233.0, 140.0, 
129.1, 128.6, 128.1, 114.1, 95.2, 94.5, 93.6, 91.0, 90.6, 73.5, 44.3 ppm; IR: 2946, 2864, 2823, 
2781, 1962 and 1876 (strong CO stretches), 1611, 1521, 1454, 1353, 1016, 812, 663, 632 cm-1.  
HRMS (ES+) calc’d for C15H17Cr 263.0766, found 263.0757 [M -(CO)3]+. Existing literature 
characterization for the racemate is consistent with the characterization data for this compound.40 [α]-
D
2 5 = −21.5° (c = 1.0, CHCl3). 
 
Figure 2-11: Yellow homochiral crystals of 28a formed after evaporation of a solution of purified 28a 
in methylene chloride and hexanes; the image shows crystals after mother liquor was decanted.  The 
photograph was taken on a Canon PowerShot SX100 digital camera (manual focus, ISO 100, 1/8 
second exposure). 
 
57 – (−)-(C6H5)-N-(C5H10N)CH(η6-C6H5)Cr(CO)3: Using General procedure 2-E, 
53 (31.3 mg, 0.10 mmol, 1.0 equiv) and PMDTA (21 µl, 0.10 mmol, 1.0 
equiv) in 0.4 mL toluene was combined with a solution of LiHMDS (67 mg, 
0.4 mmol, 4 equiv), 4-phenyl triflate (19 µl, 0.12 mmol, 1.2 equiv), 
[(allyl)PdCl]2 (1.5 mg, 0.004 mmol, 8 mol% Pd), and cyclohexyl (8 mg, 0.009 
mmol, 9mol%) in 0.6 mL THF.  The reaction was stirred for 10 h at 8 – 10 °C.  
Compound 57 (27.9 mg, 0.072 mmol, 72% yield, 85 %ee) was obtained as a yellow crystalline solid 
after silica gel chromatography eluting 10 – 15% diethyl ether in hexanes.  1H NMR (500 MHz, CDCl3) 
δ: 7.35 (t, J = 7.3 Hz, 2H), 7.31 - 7.28 (m, 1H), 7.24 (d, J = 6.9 Hz, 2H), 5.95 (d, J = 6.5 Hz, 1H), 5.35 
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(dt, J = 6.4, 1.0 Hz, 1H), 5.29 (t, J = 6.1 Hz, 1H), 5.21 (d, J = 6.7 Hz, 1H), 5.19 - 5.16 (m, 1H), 4.37 (s, 
1H), 2.40 - 2.36 (m, 4H), 1.59 - 1.55 (m, 4H), 1.42 - 1.38 (m, 2H) ppm; 13C{1H} NMR (125 MHz) δ: 
33.2, 139.3, 129.4, 128.5, 127.9, 114.4, 94.9, 94.6, 93.3, 91.4, 91.1, 72.7, 52.8, 26.6 24.6 ppm; 
IR: 3084, 3062, 3028, 2934, 2852, 2805, 2753, 1964 and 1880 (strong CO stretches), 1452, 752, 
704, 662 631 cm-1; HRMS (ES+) calc’d for C21H22CrNO3 388.1005, found 388.1017 [MH]+; [α]D
2 5 = 
−28.3° (c = 0.45, CHCl3). 
58 – (−)-(C6H5)-N-(MeNC4H8N)CH(η6-C6H5)Cr(CO)3: Using General procedure 
2-E, 56 (26 mg, 0.080 mmol, 1.0 equiv) and PMDTA (17 µl, 0.080 mmol, 1.0 
equiv) in 0.4 mL toluene was combined with a solution of LiHMDS (55 mg, 
0.32 mmol, 4 equiv), 4-phenyl triflate (19 µl, 0.12 mmol, 1.5 equiv), 
[(allyl)PdCl]2 (1.5 mg, 0.004 mmol, 10 mol% Pd), and cyclohexyl Mandyphos 
(10 mg, 0.012 mmol, 12 mol%) in 0.6 mL THF with 30 µl chlorobenzene 
additive.  The reaction was stirred for 24 h warming from a 0 °C ice bath to room temperature (19 
°C).  Compound 58 (22 mg, 0.055 mmol, 69% yield, 88 %ee) was obtained as a yellow solid after 
silica gel chromatography eluting 5% methanol in methylene chloride.  1H NMR (500 MHz, CDCl3) δ: 
7.37 - 7.26 (m, 5H), 5.90 (d, J = 6.0 Hz, 1H), 5.35 - 5.27 (m, 3H), 5.16 - 5.12 (m, 1H), 4.28 (s, 1H), 
2.55 - 2.45 (m, 8H), 2.27 (s, 3H) ppm; 13C{1H} NMR (125 MHz) δ 232.6, 139.3, 128.9, 128.4, 127.9, 
113.0, 94.9, 94.4, 93.5, 90.6, 90.1, 72.1, 53.5, 51.3, 45.8 ppm; IR: 3030, 2933, 2797, 1962 and 
1878 (strong CO stretches), 1454, 1290, 1143, 1008, 751, 706, 663, 630, 534 cm-1; HRMS (ES+) 
calc’d for C21H23CrN2O3 403.1114, found 403.1129 [MH]+; [α]D
2 6 = −14.4° (c = 0.60, CHCl3). 
59 – (−)-(C6H9)-N-(C5H8NO)CH(η6-C6H5)Cr(CO)3: Using General procedure 2-E, 
54 (31.3 mg, 0.10 mmol, 1.0 equiv) and PMDTA (21 µl, 0.10 mmol, 1.0 
equiv) in 0.4 mL toluene was combined with a solution of LiHMDS (67 mg, 
0.4 mmol, 4 equiv), 4-phenyl triflate (19 µl, 0.12 mmol, 1.2 equiv), 
[(allyl)PdCl]2 (1.5 mg, 0.004 mmol, 8 mol% Pd), and cyclohexyl Mandyphos (8 
mg, 0.009 mmol, 9mol%) in 0.6 mL THF with 20 µl chlorobenzene additive.  
The reaction was stirred for 18 h at 8 – 10 °C.  Compound 59 (27.2 mg, 0.088 mmol, 88% yield, 53 
%ee) was obtained as a pale yellow solid after silica gel chromatography eluting with 10 – 15% diethyl 
ether in hexanes. 1H NMR (500 MHz, CDCl3) δ: 7.35 (t, J = 7.3 Hz, 2H), 7.31 - 7.28 (m, 1H), 7.24 (d, 
J = 6.9 Hz, 2H), 5.95 (d, J = 6.5 Hz, 1H), 5.35 (dt, J = 6.4, 1.0 Hz, 1H), 5.29 (t, J = 6.1 Hz, 1H), 5.21 (d, 
J = 6.7 Hz, 1H), 5.19 - 5.16 (m, 1H), 4.37 (s, 1H), 2.40 - 2.36 (m, 4H), 1.59 - 1.55 (m, 4H), 1.42 - 1.38 
(m, 2H) ppm; 13C{1H} NMR (125 MHz) δ: 33.2, 139.3, 129.4, 128.5, 127.9, 114.4, 94.9, 94.6, 93.3, 
91.4, 91.1, 72.7, 52.8, 26.6 24.6 ppm; IR: 3084, 3062, 3028, 2934, 2852, 2805, 2753, 1964 and 
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1880 (strong CO stretches), 1452, 752, 704, 662 631 cm-1; HRMS (ES+) calc’d for C16H15CrO3 
307.0426, found 307.0426 [M – C4H8NO]+; [α]D
2 6 = −17.6° (c = 0.80, CHCl3). 
 
Procedures for directly obtaining decomplexed diarylmethylbenzylamines 
General procedure 2-G: One-pot coupling and decomplexation in light and air. 
Free diarylmethyl benzylamines can be obtained by exposure of a dilute solution of the crude 
asymmetric coupling reaction mixture to air and bright light, then filtration and column 
chromatography to obtain pure diarylmethyl benzylamine:40 
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Scheme 2-13: General scheme for the one-pot coupling reaction and subsequent decomplexation to 
yield the free diarylmethylbenzylamine. 
 
61 – (−)-(4-C6H4-OMe)PhCH-N-(C4H8NO): An oven-dried reaction tube was charged with a small 
magnetic stirbar and η6-tricarbonylchromium benzylmorpholine (54) (36.3 mg, 0.116 mmol, 1.0 
equiv), sealed with a septum, and purged with dry nitrogen.  Dry toluene (0.6ml) and PMDTA (25 µl, 
0.12 mmol, 1.0 equiv) were added via syringe.  A separate vial was charged with [(allyl)PdCl]2 (2.2 mg, 
0.006 mmol,  12 mol% Pd), cyclohexyl Mandyphos (13 mg, 0.015 mmol, 12 mol%), and LiHMDS (80 
mg, 0.48 mmol, 4 equiv) under a nitrogen atmosphere, sealed with a septum cap, and dissolved in 
0.9 mL dry THF.  4-anisole triflate (32 µl, 0.18 mmol, 1.5 equiv) and chlorobenzene (~30 µl, 2%/vol) 
were added next via syringe.  This THF solution was taken up with a syringe and added to the stirring 
mixture of 54, triamine, and toluene.  The reaction was allowed to stir at to room temperature (20 °C) 
with stirring for 12 hours.  The brownish orange solution was quenched with 2 drops H2O, then opened 
to air, diluted with 3 mL diethyl ether, and then filtered over a pad of MgSO4 and silica gel.  The pad 
was rinsed with an additional 3 mL diethyl ether, and the yellow solution was diluted with hexane (~10 
mL) and placed in sunlight for 4 hours. The cloudy solution was filtered over another pad of MgSO4 
and silica gel, concentrated in vacuo, loaded directly onto a silica gel column, and eluted with 0 - 20% 
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ethyl acetate in pentane.  The result was 61 (20.3 mg, .072 mmol, 62 % yield, 85 %ee) as a colorless 
solid.  1H NMR (500 MHz, CDCl3) δ: 7.41 (d, J = 7.4 Hz, 2H), 7.32 (d, J = 8.7 Hz, 2H), 7.27 (t, J = 7.5 
Hz, 2H), 7.17 (t, J = 7.3 Hz, 1H), 6.81 (d, J = 8.7 Hz, 2H), 4.15 (s, 1H), 3.75 (s, 3H), 3.71 - 3.69 (m, 
4H), 2.38 - 2.37 (m, 4H) ppm; 13C{1H} NMR (125 MHz, CDCl3) δ: 158.8, 143.0, 134.7, 129.2, 128.7, 
128.0, 127.1, 114.1, 76.2, 67.5, 55.4, 52.9 ppm; HRMS (CI+): calc’dfor C18H21NO2 283.1572, obs 
283.1574 [M]+; [α]D
2 6 = −25.4° (c = 0.70 CHCl3).  Spectral data is consistent with existing 
characterization.42,43 
 
General procedure 2-H: Decomplexation from purified complex using light and air. 
Alternately, the free complex can be obtained directly from the purified parent tricarbonylchromium 
complex by exposing a solution of the purified complex to air and bright direct light, then filtration and 
evaporation of solvent to obtain pure diarylmethyl benzylamine:40 
A sample of 55c (8.5 mg, 0.020 mmol, 83% ee) was dissolved in 0.4 mL methylene chloride, diluted 
with 1.6 mL hexanes, and placed in bright sunlight for 4 hours. During this time, the yellow color faded 
and a grayish green precipitate formed.  The solution was filtered thorugh a plug of cotton and 
anhydrous MgSO4, then solvent was evaporated under reduced pressure to yield 61 (4.2 mg, 0.015 
mmol, 75% yield, 83% ee).  Spectral data is consistent with that obtained for 61 using General 
procedure 2-G, above. 
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Chapter 3  
A new family of P∧N arene tricarbonylchromium ligands 
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Introduction and Background 
 
“…the identification of new privileged ligands and catalysts remains enormously difficult 
and often requires a degree of serendipity.” 
Yoon and Jacobsen, Science 2003, 299, 1693. 
 
Widespread use of asymmetric catalysis would not be possible without easy and efficient access 
to enantioenriched ligands and catalysts.  These ligands may incorporate central chirality, axial 
chirality (also known as helicity), or planar chirality (Figure 3-1).  While in organic chemistry, the 
focus of asymmetry is often on central chirality about a carbon center, the most popular ligand 
scaffolds in asymmetric catalysis that are used to generate these stereogenic centers tend to 
incorporate other modes of chirality.  For example, many ligands contain axial or planar chirality, 
or a combination of chirality modes.1,2  Historically, C2 symmetric ligands with axial chirality have 
dominated the field of asymmetric catalysis, but non-symmetric (especially polydentate) ligands 
have been known to increase asymmetric induction and in some cases have even provided 
higher ee than the most effective C2-symmetric ligands.3  Thus, the development of new 
enantioenriched C1-symmetric ligands is an important area to pursue. 
 
Figure 3-1: The three kinds of molecular chirality, illustrated in some common catalysts and ligands. 
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In order for the synthesis of chiral ligands to be practical, they should be made stereoselectively 
or the stereoisomers need to be separable.4  A small number catalysts (such as MIBa) are known 
to exhibit positive nonlinear effects that partially offset the lower selectivity of a non-
enantiomerically pure ligand.5  Oftentimes, however, even a small reduction in the catalyst ee is 
detrimental to the performance of enantioselective catalysts.  Additionally, even minor catalyst 
impurities can lead to compromised ee and lower yields, which may be amplified on industrial 
scale.6   
Planar chiral ferrocenyl complexes, first synthesized stereoselectively 60 years ago, have found 
widespread use as ligand scaffolds in asymmetric catalysis, including large-scale industrial 
processes.7  As noted in Chapter 2, the chiral ferrocenyl phosphine amines possessing both 
planar and central chirality (cyclohexyl Mandyphosb) proved to be the key to enabling the 
asymmetric cross-coupling of tricaronbylchromium-coordinated benzylic organolithiums.  While in 
theory many chiral ferrocenyl scaffolds are possible, the majority of chiral ferrocene-based 
phosphine ligands are based on diastereoselective lithiations and other functionalizations of a 
single optically pure parent ferrocenylamine complex called Ugi’s Amine (Figure 3-2).8  This was 
due to Ugi’s straightforward preparation of the amine in four steps and in high enantiomeric 
purity achieved by tartaric acid resolution, followed by recrystallization.9,10  And, unlike some 
other ferrocenyl complexes, the amine complex could be diastereoselectivey metalated using the 
amino group as directing group (DOM, directed ortho metalation) and quenched with 
electrophiles with very high diastereoselectivity.9     
    
Figure 3-2: Ugi’s Amine and related chiral ferrocene-based ligands Josiphos, Bophoz, and Walphos. 
                                                      
 
 
a MIB = (2S)-(−)-3-exo-(morpholino)isoborneol 
b Ligands in the Mandyphos family are known for asymmetric hydrogenations, and due to demand, some of 
these ligands are now produced in multi-kilogram scale (Aldrich). 
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Tricarobonylchromium complexes can also exhibit planar chirality, and looking to the ferrocene 
ligands as an example, a structurally analogous and highly enantioenriched arene-chromium 
ligand scaffold precursor similar in to Ugi’s Amine has been prepared (A, Figure 3-3).  Unlike Ugi’s 
Amine, however, the complex’s parent arene is commercially available as enantiopure α-methyl 
benzylamine.  The commercial availability of enantiopure starting material relieved the synthetic 
chemist of the need to resolve the enantiomers of the parent complex. Diastereoselective DOM 
and electrophilic phosphine quench on the tricarbonylchromium-complexed α-methylbenzylamine 
was demonstrated by Uemura and Hayashi 20 years ago.11,12,13 The resulting phosphine-
quenched tricarbonylchromium P∧N ligands, as well as bis-phosphine ligands such as Daniphos 
developed by Togni and coworkers14 are shown in Figure 3-3.  These chromium-complexed 
ligands are significantly easier to synthesize.  They typically also perform better in catalysis than 
the non-coordinated arene ligands,15,a and thus these newer planar- and central- chiral ligands 
have found applications in a variety of catalytic reactions.16 
 
Figure 3-3: Variations on α-methylbenzylamine tricarbonylchromium ligand derivatives focus on 
changing the donating groups on the arene’s benzylic position and ortho position, but preserves the 
α–methyl. 
 
Interestingly, while other substitutions on the α-methylbenzylamine-coordinated 
tricarbonylchromium complex have been used as modular elements that could be varied in order 
to tune reactivity and selectivity (Figure 3-3), the chiral α-methyl substitution — an original part of 
the commercially available starting material — has not been used as a variable in tuning 
reactivity.  A family of ligands with α– aryl substitution would likely have markedly different chiral 
environment compared with the known ligands with α– methyl substitution.  Additionally, the 
                                                      
 
 
a Various chiral α-methyl benzylamine P∧N ligands without chromium have been synthesized by other 
groups, but tend to show low selectivity and low yields in synthesis due to difficulties in the DOM step.15 
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potential to easily install a number of different aryl groups at the α–position would add a 
desirable element of ligand modularity and tenability (Figure 3-4).17 
"soft" P ( -donor with -acceptor properties)
"hard" N (strong -donor)
4 points of ligand tunability: R, R", Ar, and CO/L
Cr
*
NR2
R"2P
R'
OC/L
CO
CO
 
Figure 3-4: Notable aspects of the proposed family of P∧N ligands. 
 
We expected our synthesis to proceed similar to the synthesis of Uemura’s ligand, using 
diastereoselective ortho-lithiation of our diarylbenzylamine and then electrophilic quench with a 
chlorophosphine to yield the α-arylated P∧N ligand (Scheme 3-1). 
    
Scheme 3-1: Overview of the proposed P∧N ligand synthesis. 
 
Ortho lithiation of the arene ringa 
Using the methods developed in Chapter 2, an enantioenriched diarylmethyl tricarbonylchromium 
complex 28a was synthesized from 27 and phenyl triflate and then exposed to standard DOM 
conditions for α-methyl benzylamine chromium complexes.  However, we were shocked to find 
that even when using excess s-butyllithium, exclusively unreacted starting material was recovered 
(Scheme 3-2).  It was possible that either the steric bulk of the more bulky diarylmethylamine 
                                                      
 
 
a Deprotonation work was done in collaboration with C. Stanciu. 
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complex was preventing the lithiated species from quenching with the chlorodiphenylphosphine, 
or that the lithiation itself was not proceeding due to sterics or other unknown factors. 
 
Scheme 3-2: Initial attempts at lithiation and quench of 28a using standard literature procedure for a 
similar complex with α-methyl, not α-aryl, substitution, failed to provide product. 
 
To test whether lithiation was occurring, several lithiation procedures were screened, starting with 
ones that have typically been successful on arene tricarbonylchromium complexes (Table 3-1, 
entries 1–5).  However, no more than 25% deuterium incorporation could be achieved even with 
TMEDAa additive (entries 1 – 4), harsher conditions and large excess of base, or extended 
reaction times that would lead to degradation of even ethereal solvents.  LDA did effect some 
deprotonation, but was not selective (entries 6 and 7).  Schlosser’s superbase18 (“LiCKOR”), a 1:1 
mixture of n-butyllithium and tBuOK, did succeed in deprotonating the complex, but the 
metalation was not regioselective, and moreover averaged more than 1 deuterium per ring 
(entries 9 and 10).  Compound 28a was even combined with 8 equivalents of s-butyllithium in 
ether and hexanes and heated at 45 °C for 48h, but no activity was observed for this complex, 
and the reaction remained yellow and homogeneous (entry 11).  It seemed that the typical 
deprotonation reagents were not useful in the deprotonation of this complex.  The diarylmethyl 
benzylmorpholine complex 55e was also tested for deprotonation, but it did not react. 
 
Scheme 3-3: Monitoring extent of deprotonation was done through deuterium quench studies. 
                                                      
 
 
a TMEDA = N,N,N′,N′-tetramethylethylenediamine 
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Figure 3-5: Protons Ha (green) and Hb (blue) are monitored for deuterium incorporation.  
 
Table 3-1: Optimization of ortho-lithiation conditions (Scheme 3-3). 
Entry Conditions* Base Equiv T (°C) Time (h) %Da %Db Notes 
1 Hex, TMEDA s-BuLi 3 −78 → RT 5 < 5   – CD3OD quench. 
2 THF, TMEDA s-BuLi 3 −78 → RT 5 >10   –  “ ” 
3 THF, TMEDA n-BuLi 3    RT 5 h <20 < 5  “ ” 
4 THF, TMEDA n-BuLi 13    RT 24 ~25   –  “ ” 
5 Et2O t-BuLi 3 −78 → RT 6 h   – ~25 >30% dec.# 
6 THF LDA 4    0 →  RT 24 ~30 <10 D2O quench. 
7 Et2O LDA 8    0 →  RT 24   –   – Some dec. 
8 Hex s-BuLi 3 −78 → RT  ~15 < 5 CD3OD quench. 
9 “LiCKOR"† n-BuLi 
t-BuOK 
1.7 
1.7 
−78 → 0  see note ~30% dec., unselective 
(~1.3 D per arene). 
10 “LiCKOR” n-BuLi 
t-BuOK 
5 
5 
−78 → −35  see note No dec., but unselective 
(>1.5 D per arene). 
11 Hex/Et2O s-BuLi 8    RT → 45 48   – ~5 48h heating, no rxn. 
12 Hex/Et2O s-BuLi 
n-BuLi 
8 
6 
   RT <30 min N/A  Complete dec. upon 
addition of n-BuLi 
13 6:1 Hex:Et2O s-BuLi 
n-BuLi 
8 
6 
−78 → 0 1   – ~20 Clean & selective! 
 no dec. 
14 “s&n”‡ s-BuLi 
n-BuLi 
3 
3 
−78 → 5º 2   – ~60 Clean incorporation. 
15◊ “s&n” s-BuLi 
n-BuLi 
3 
3 
−78 → 5º 2 N/A  >80% conversion to 
desired phosphine 
ligand. 
* Abbreviations: Hex = Hexanes; TMEDA = N,N,N′,N′-tetramethylethylenediamine. # dec. = decomposition. † 
“LiCKOR” = Schlosser’s base, a superbasic 1:1 mixuture of n-butyllithium and t-BuOK, believed to generate an 
organopotassium species after deprotonation. ‡ “s&n” = a 1:1 mixture of s-butyllithium and n-butyllithium. ◊ 
reaction was quenched with excess chlorodiphenylphosphine to generate 62. 
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Finally, to a stirring mixture of 28a and s-butyllithium, some n-butyllithium was added (Table 3-1, 
entry 12).  Immediately the yellow solution turned orange and then to brown; after quenching and 
work-up the starting complex was found to have completely decomposed (>5 products in 
observed by 1H NMR).  Repeating these conditions, but this time starting carefully at -78 °C and 
warming to 0° and immediate quenching with methanol-D showed clean and selective 
incorporation of deuterium (20% D) on a different ortho proton (Hb) than observed with the 
previous conditions (Table 3-1, entry 13).  Improved deuterium incorporation (60% D) could be 
obtained by running the lithiation for a longer period of time (~2h), while still reducing the amount 
of the two bases that were added (entry 14).  Finally, the lithiation was conducted using the 
conditions described in entry 14, but this time quenching with ClPPh2 to generate phosphine 
amine complex 62.  1H NMR analysis of the crude reaction mixture showed >80% conversion to 
phosphine (entry 14) in a single regioisomer.  Through-space coupling of the benzylic proton to 
the phosphorus (I=1/2, doublet observed in 1H NMR) indicated that the substitution was at the 
side that would allow stabilization of the organolithium by tertiary amine yet minimize steric 
interaction from the uncoordinated phenyl ring (Scheme 3-4).  X-ray quality crystals from this 
reaction were obtained by crystallization at low temperature using chloroform and hexanes (see 
full report on p. 297).  
 
Scheme 3-4: The expected geometry for diastereoselective directed ortho lithiation. [Cr] is below the 
plane of the paper.  The lithiated species is shown as monomeric for clarity. 
 
Interestingly, when these same lithiation conditions (1:1 s-butyllithium:n-butyllithium in hexanes 
and diethyl ether) were attempted on the unsubstituted tertiary benzylamine complex 27, 
deuterium incorporation was not observed, indicating that the custom base developed for the 
diastereoselective lithiation is a system extremely selective for the α–arylated benzylamine 28a. 
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A New Superbase: “s&n” 
Our 1:1 mixture of s-butyllithium and n-butyllithium — which exhibits uniquely enhanced reactivity 
on our diarylmethylamine complex (28a) versus either of these bases separately — is a new 
variety of unimetallic superbase, according to Caubere’s definition.19  Our novel superbase, which 
we will refer to as the “s&n” base, has unique advantages aside from its diastereoselective ortho-
lithiation of 28a.  Because both n- and s- butyllithium are reasonably priced and commercially 
available in solutions as well as reasonably stable under inert atmosphere, the generation and 
use of this superbase is remarkably inexpensive and convenient.  It does not need to be 
generated in a glovebox or use multiple stages and reagent additions at variable temperature,20 
nor does it require low-temperature transfer of slurries, such as in the case of Schlosser’s base 
(LiCKOR).18 Additionally, the two alkyllithium reagents can be added sequentially without 
premixing, thus circumventing potentially long reaction times for generation of the active species, 
such as in the case of some LiCl TMPa metal amide bases,21 or for the premixing of highly 
reactive and expensive reagents.  For example, in one case of monometallic superbase use, 
premixing a 1:1 solution of tert-butyllithium and expensive isopropyllithiumb was required in order 
to achieve optimum reactivity an order of magnitude higher than tert-butyllithium on its own).19,22  
It is hoped that the unimetallic superbase that we have developed here will find adoption as a 
useful tool in the selective lithiation of difficult or sterically congested substrates, though further 
exploration of the scope of lithiation substrates is still necessary.  Our “s&n” base may also be 
considered a safer alternative to tert-butyllithium, which has recently received negative publicity 
after a 2009 lab accident involving transfer of a large quantity of tert-butyllithium solution led to 
the death of a student. 
 
Crystal structure and discussion of lithiation stereochemistry 
The crystal structure for the phosphine-quenched product (62) from Table 3-1 (entry 14) was 
determined (Figure 3-6), and the regioselectivity of the reaction was confirmed.  The high level of 
                                                      
 
 
a TMP = 1,1,6,6-tetramethylpiperidine 
b isopropyllithium solution costs more than $200/100 mL : September 2011 data, Sigma-Aldrich. 
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diastereoselectivity in lithiation is attributed to the tertiary amine, which indeed serves as 
directing group (Scheme 3-4).  Directed metalation of Ha (Figure 3-5) was not observed in 1H NMR 
of the crude reaction mixtures.  Additionally, nearly enantiopure ligand (>>98% ee) can be 
obtained by using recrystallized starting material 28a (a single crystallization can take material at 
75–85% ee and enantioenrich it to 95–98% ee) and isolating crystals of ligand product (62) 
through crystallization in hexanes and DCM at −16 °C. 
  
Figure 3-6: X-ray crystal structure of the racemic PN ligand. Thermal ellipsoids are at 30% probability. 
 
Towards the synthesis of other Ligands in the family 
Encouraged by the successful synthesis of ligand 62, we hoped to expand our single ligand into 
an entire ligand family.  Thus, other variations of the PN ligand were attempted using a procedure 
similar to that used to synthesize 62 in the final entry of Table 3-1.  First, different phosphine 
chlorides were used to quench the lithiated complex.  Chlorodicyclohexylphosphine was also a 
suitable electrophile, though it took slightly longer to quench completely.  Thus, the 
alkylphosphine-quenched product 63 was isolated after 2–3 hours of stirring for full consumption 
of the lithiated starting material.  The crystal structure of 63 was obtained, and is shown in Figure 
3-7. 
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63 62 
 
Figure 3-7: X-ray crystal structure of 63 (left), compared against the structure of 62 (right).  Thermal 
ellipsoids are at 50% probability. 
We next turned to a more electron-rich and bulky phosphine.  However, quenching with di-tert-
butylchlorophosphine led to exclusive isolation of the starting material, even after allowing the 
phosphine quenching step to proceed for 24h at room temperature.  It seems that the two tert-
butyl groups make the chlorophosphine simply too bulky to react with the organolithium 
intermediate.  A slightly smaller ligand, the non-symmetrical racemic tert-
butylchlorophenylphosphine, was used, in hopes that a diastereoselective quench of the lithiated 
species would result.  However, this electrophile was also unsuccessful.  In order to expand this 
ligand family using the phosphine center, it is likely that a smaller chlorophosphine electrophile 
will be necessary.  Alternately, using diarylchlorophosphines with more electron-rich or electron-
poor substitution on the two aryl groups would lead to ligands with tunable electronics and 
sterics.  Further exploration on the synthesis of ligands with phosphine variants is ongoing. 
The variation of this ligand class by changing the identity of the tertiary amine also unfortunately 
met with difficulties.  In the case of morpholino- or piperidino- substituted chiral 
diarylmethylamines 55e and 57, using “s&n” base conditions and quenching with either 
chlorodicylohexylphosphine or chlorodiphenylphosphine led to isolation of starting material only.  
As in the earlier case of the dimethylbenzylamine derivative, we asked ourselves whether the 
complex was deprotonating and failing to quench due to steric reasons, or if the complex was not 
deprotonating in the first place.  Unfortunately, deutherum quenches with either of these 
substrates showed no detectable incorporation of D in the molecule (determined by integration of 
1H NMR).  Apparently even the “s&n” superbase, which had been highly successful in the 
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dimethyl-substituted tertiary amine, was not effective here.  In the case of the morpholino 
complex, using higher equivalents or allowing the temperature to raise above 0 °C merely led to 
slow conversion of the starting material to decomposition products, likely due to the base 
attacking the more acidic protons next to the morpholno oxygen.  A different base or superbase 
may be required to open access to ligands with different amine substitution. 
 
Synthesis of palladium-bound precatalysts from P∧N ligands 
Planar-chiral metal-coordinated P∧N ligands with ferrocene- and (arene)tricarbonylchromium- 
scaffolds are known to bind to catalytically active metals, such as palladium(II) and rhodium(I), 
and a limited number of crystal structures have been determined.   In most cases, these ligands 
bind to the metal center in a bidentate fashion, through both the P and N donor atoms.  We 
expected that a convenient palladium-bound precatalyst could be synthesized by combining our 
diarylmethylamine phosphine ligand with a simple palladium precatalyst. 
Initially, the palladium(II) complex with norbornadiene [PdCl2(norb)] was chosen, due to the low 
boiling point of norbornadiene, which would allow easy removal of the displaced neutral ligand.  
Thus, a 1:1 mixture of bright yellow ligand 62 was combined with PdCl2[norb] in THF at room 
temperature to yield a deep orange solution, which upon evaporation of solvent provided the red-
orange palladium-complexed 64.  However, THF proved to be difficult to remove completely, and 
subsequent syntheses of palladium bound complex 64 relied upon DCM as the solvent.  The 
ligand-displacement reaction in DCM went rapidly (<1 h), and traces of solvent were easily 
removed under reduced pressure to yield desired 1:1 complex in quantitative (95%) yield.  The 
dicyclohexylphosphine-substituted ligand 63 was also complexed to palladium using the same 
procedure as above to yield 65. 
 
132 
 
[Cr] P
N
R
R
H
Pd
CH3
CH3[Cr] P
N
R R
H
CH3
CH3
PdCl2[norb]
DCM, rt
(quantitative)
Cl
Cl
62 (R = Ph)
63 (R = Cy)
64 (R = Ph)
65 (R = Cy)  
Scheme 3-5: Coordination of (arene)tricarbonylchromium PN ligands 62 and 63 with a palladium (II) 
source to yield pallaldium-bound complexes 64 and 65 in good (93–95%) yield. 
 
In both complexes 64 and 65, The coordination of the nitrogen to the palladium center was 
supported by the presence of diasterotopic amine methyl resonances observed in 1H NMR.  We 
worked to verify this observation with a crystal structure.  However, while the ligand 62 (like many 
tricarbonylchromium complexes) is a highly crystalline solid, the amorphous orange powder 64 
proved extremely difficult to crystallize.  X-ray diffraction-quality crystals were finally obtained 
using slow evaporation from a DCM solution at 0°C, and the binding of the ligand at both P and N 
donor sites was confirmed (Figure 3-8, see full report on pg. 318). 
 
Figure 3-8: X-ray crystal structure of 64. Thermal ellipsoids are at 50% probability. 
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Comparison with existing complexes 
First, the structure of our new phosphine-amine ligand 62 is compared against the crystal 
structure of an α-methyl substituted diphosphine tricarbonylchromium ligand (Daniphos), Figure 
3-9, below.   The left-hand side of the chromium complexes show very different geometries. 
 
Figure 3-9: Comparision of two (arene)tricarbonylchromium ligands.  Daniphos, a bis phosphine ligand 
derived from ligand precursor A (Figure 3-3), left, is compared against the new α-phenyl substituted PN 
ligand 62, right.  Non-benzylic hydrogens are omitted for clarity. 
Next, the ligands are compared against each other upon coordination to a square-planar metal 
center.  The α-methyl substituted diphosphine ligand Daniphos complexed to a pseudo-square 
planar rhodium23 center is compared against the palladium-complexed precatalyst 64.  The 
geometry of the 6-membered ring comprising the substituted benzylic 
(arene)tricarbonylchromium ring carbons, benzylic carbon, two donor ligands, and metal center is 
extremely different between the two complexes.  The comparisons are illustrated in Figure 3-10 
(side view) and Figure 3-11 (front view) below.  This difference in geometry around the metal 
center is likely due to the very large difference in steric demands at the benzylic center between a 
methyl and phenyl group interacting with the tricarbonylchromium group, which is a major 
influence in the geometry of the bound ligand.  Considering this difference in configuration, it is 
likely that this new family of ligands will perform markedly different from each other in similar 
catalytic reactions. 
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Figure 3-10: Comparision of side views of the structures of diphosphine Rh[COD]-bound ligand with α-
methyl substitution on the benzylic position (left), versus the PdCl2-bound PN ligand 64 with α-phenyl 
substitution on the benzylic position (right). Extremely different geometries are observed, despite both 
catalyst metal centers having pseudo-square planar configuration.  Hydrogens are omitted for clarity. 
 
Figure 3-11: Comparison of front views of the structures of diphosphine Rh[COD]-bound ligand with α-
methyl substitution on the benzylic position (Daniphos, left), versus PN ligand bound PdCl2 complex 
with α–phenyl substitution 64 (right).  Hydrogens and COD on rhodium are omitted for clarity. 
 
The structure of the palladium-bound P∧N ligand developed by Uemura and coworkers (the ligand 
is shown in Figure 3-3, p.123) is also desired for comparison with our palladium-bound complex 
(64), but its X-ray crystal structure had not previously been determined.  It is currently being 
synthesized based on existing literature procedure12 in order to obtain crystallographic data that 
could provide a more direct structural comparision. 
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Application of P∧N Ligands in Asymmetric Reactiona 
As noted earlier, the existing enantioenriched α-methyl substituted ferrocenyl and 
tricarbonylchromium analogues of ligands 62 and 63 have been successfully used in a variety of 
reactions, ranging from hydrogenation and asymmetric addition reactions to allylic alkylation and 
cross-coupling processes with high enantioselectivity.  The palladium-bound precatalysts 64 and 
65 were employed in a test reaction to determine if catalytic activity and (ideally) some level of 
enantioselectivity could be obtained from reactions utilizing these new catalysts. 
 
Palladium-catalyzed allylic alkylation reaction 
A well-used test reaction, the enantioselective allylic allylic alkylation reaction, was used to 
examine the catalytic activity of the new asymmetric ligand.  The α-methyl substituted analogue 
(Uemura’s ligand) has been known to be a successful catalyst for these reactions.13  Thus, 1,3-
diphenyl-1-acetoxypropene (compound 66) was reacted with sodium dimethyl malonate (67-Na) 
using ligand 62 bound to palladium (catalyst 64).  The catalyst showed good activity at room 
temperature, and the allylation product (E)-dimethyl 2-(1,3-diphenylallyl)malonate 68 was 
successfully obtained in 82% yield.  The ee for this reaction was only 15%, a very different value 
of selectivity compared with Uemura’s α–methyl substituted analogue.  However, more data is 
necessary before further conclusions can be made. 
 
                                                      
 
 
a Palladium-catalyzed reactions using 64 and 65 were done in collaboration with graduate researcher J. 
Zhang. 
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Scheme 3-6: Attempted asymmetric allylation reaction using 66 and 67-Na to give 68. 
 
Asymmetric Kumada or Negishi coupling reactions 
It seems that choosing catalytic asymmetric reactions in which Uemura’s ligands were not 
optimal would be a better illustrator of the different activity of our new catalyst.  The asymmetric 
Kumada and Negishi couplings of secondary benzylic Grignard reagents with vinyl bromides had 
been attempted by Uemura and coworkers.11  In this case, the enantioselectivities of their 
palladium-bound P∧N catalyst was 13-61%, depending on the main group metal (Mg or Zn) used 
in the coupling partner and on the identity of the vinyl. Work is underway to compare this 
reaction, as well as several others.24  
 
Summary and Conclusions 
In summary, we have successfully demonstrated the synthesis of the first members of a new 
family of P∧N ligands incorporating both planar chirality and at least one central chiral center.  
While the starting diarylmethylamine complex was inert to most typical deprotonation protocols, a 
novel mixed butyllithium superbase nicknamed “s&n” was developed.  This new superbase 
effects clean and diastereoselective deprotonation of the parent complex, allowing a subsequent 
quench with chlorophosphine electrophiles to generate a bidentate asymmetric P∧N ligand.  
These ligands could be easily combined with a simple palladium(II) source to form a 1:1 Pd:L 
complex bound through both P and N donor atoms.  Work is currently bing carried out to expand 
the members of the ligand family, as well as test these ligands in various metal-catalyzed 
reactions to gauge their utility in asymmetric catalysis. 
 
“Work to develop the next GenPhos are ongoing” –J.Z. 
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Experimental Section 
General methods.  
Reactions were performed under nitrogen or argon using oven-dried glassware and oven-dried vials 
fitted with PTFE-lined septum caps.  Air- and moisture- sensitive solutions were handled under nitrogen 
or argon and transferred via syringe. Dry THF and diethyl ether were freshly distilled from 
Na/benzophenone ketyl.  Dry toluene and hexanes were drawn from a Grubbs column.  Unless 
otherwise stated, reagents were commercially available and used as purchased without further 
purification. Chemicals were obtained from Sigma-Aldrich, Acros, or Strem, and used as received; 
solvents were purchased from Fisher Scientific. Reactions were monitored by thin-layer 
chromatography using Whatman Partisil® K6F 250 µm precoated 60 Å silica gel plates and visualized 
by short-wave ultra-violet light as well as by treatment with potassium permanganate (KMnO4) or ceric 
ammonium molybdate (CAM) stain.  NMR spectra were recorded in CDCl3 on either a Bruker 300 MHz 
or 500 MHz Fourier-transform spectrometer. Chemical shifts are reported in ppm referenced to 
tetramethylsilane (TMS) or the CHCl3 solvent residual peak at 7.26 ppm for 1H and 77.23 ppm for 
13C{1H}; 19F peaks were referenced to an external standard of trifluoroacetic acid in CDCl3 at −76.55 
ppm. Infrared spectra were obtained on NaCl plates using a Perkin-Elmer Spectrum 100 Series FTIR 
spectrometer. Optical rotations were recorded in HPLC-grade CHCl3 using a JASCO DIP-370 digital 
polarimeter and values were averaged over a minimum of 3 runs.  Chromium-complexed masses were 
recorded with Electrospray + (ES+) HRMS methods to within 5 ppm, and [M]+, [MH]+, or [M –Cl]+ was 
confirmed by the presence of the characteristic isotope patterns.  Non-chromium-complexed mass 
was recorded with Chemical Ionization + (CI+) HRMS methods to within 5 ppm, and [M]+ was 
observed. 
Compound 27, 53, and 54 were prepared according to general literature procedure for the synthesis 
of arene tricarbonylchromium complexes from Cr(CO)6 and parent arene (See Chapter 2, p 103).25,26 
Compound 28a, 55e, and 57 were prepared using our method for the asymmetric synthesis of 
diarylmethylamines (see Chapter 2). Racemic 1,3-diphenyl-1-acetoxypropene (66) was prepared 
according to the general literature procedure.27   
Caution: Care should be taken to avoid direct light exposure of reactions, as arene 
tricarbonylchromium complexes can decompose in solution under bright light and air.  In crystalline 
solid form, complexes are reasonably stable to light and can be stored at room temperature in air. 
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General procedure 3-A: Small-scale synthesis of P∧N ligands by directed ortho-lithiation and 
phosphine quench. 
Ligand syntheses: due to the precious nature of the chiral starting materials, the reactions were 
generally run on 20 mg scale (about 60 µmol). Argon was used as an inert gas on the Schlenk 
line and both the diethyl ether and the hexane used as solvents were dried on a Grubb’s type 
solvent system (SDS). Hexanes were degassed by 3 freeze/thaw cycles and stored under argon. 
The reaction was kept away from light by using aluminum foil to avoid decomposition of the 
chromium complex. 
A typical procedure is described below:  
62: In a 4 mL vial provided with stir bar and PTFE-lined septum cap, 20 mg (58 
µmol, 1 equiv) of the chromium phenyl dimethylamino compound were added 
and the vial was closed.  An inert argon atmosphere was established with 3 
vacuum/back-fill cycles through a needle inserted into the septum cap.  Dry 
diethyl ether (300 µL) and dry hexanes (300 µL) were then added by syringe (in 
this order, to ensure solubility of the starting material) and the reaction mixture was cooled to -78˚C in 
a dry ice/acetone bath.  At this temperature, 1.4 M s-buthyllithium in heptane (130 µL, 180 µmol, 3 
equiv) and 2.5 M n-buthyllithium in hexanes (72 µL,  ca. 180 µmol, 3 equiv) were added by syringe 
and the reaction was allowed to warm to 5–10˚C. No change in color was observed until the reaction 
temperature was -10˚C when the solution started to turn from bright yellow to orange to amber at the 
final temperature, which was indicative of the ortho-lithiation occurring. The vial was kept at 5–10˚C 
for an additional 2 h. Chlorodiphenylphosphine (108 µL, 600 µmol, 4 equiv. excess) was added neat, 
and the reaction was allowed to warm to room temperature for 4 h under argon.  The mixture was 
quenched with 1 mL DI water and extracted with five 2 mL-portions of diethyl ether.  The organic layers 
were combined, dried over MgSO4, filtered through filter paper, and then evaporated and purified on a 
short alumina column using diethyl ether as eluent. The solvent was removed and the solids were 
dissolved in a 10:1 hexane:dichloromethane mixture and placed in a -30˚C freezer. X-ray quality single 
crystals grew over 3-4 days (see full report for 62 on p. 297). Yields are around 45%.  1H NMR (300 
MHz, CDCl3) δ: 7.50 - 7.45 (m, 2H), 7.42 - 7.32 (m, 13H), 5.36 (t, J = 6.4 Hz, 1H), 5.32 (d, J = 5.2 Hz, 
1H), 5.14 - 5.10 (m, 2H), 4.98 (dt, J = 1.2, 6.4 Hz, 1H), 1.72 (s, 6H) ppm. 13C{1H} NMR (125 MHz, 
CDCl3) δ: 232.5, 137.1 (d, JCP = 4.6 Hz), 136.8 (d, JCP = 16.0 Hz), 135.5, 134.8 (d, JCP = 19.5 Hz), 
132.9 (d, JCP = 21.7 Hz), 130.2, 129.1, 128.7, 128.58, 128.57 (d, JCP = 5.4 Hz), 128.44 (d, JCP = 8.3 
Hz, 128.2, 120.0 (d, JCP = 18.6 Hz), 106.0 (d, JCP = 25.2 Hz), 99.5 (d, JCP = 3.8 Hz), 93.1, 91.6 (d, JCP = 
3.8 Hz), 90.9 (d, JCP = 2.2 Hz), 69.6 (d, JCP = 13.2 Hz), 40.0 ppm. {CHECK} 31P{1H} NMR (121 MHz, 
139 
 
CDCl3) δ ⁻13.0 ppm; IR 3054, 2961, 2926, 2855, 2827, 2784, 1964 and 1885 (strong CO stretches), 
1434, 1092, 1027, 877, 745, 698, 661, 621 cm-1. HRMS (ES+) calc’d for C30H26CrNO3P 531.1055, 
found 532.1144 [MH]+. 
 
General procedure 3-B: larger-scale modification of ligand synthesis. 
A 4 dram screw-capped vial was charged with PTFE stirbar and 28a (104 mg, 0.3 mmol, 1 equiv) and 
purged with Nitrogen.  Diethyl ether (2 ml) and hexanes (2 mL) were added in succession, resulting in 
a clear, deep yellow solution.  The reaction was cooled to −78 °C and sec-butyllithium (0.43 mL, 1.4 
M, 0.60 mmol, 2 equiv) and then n-butyllithium (0.24 ml, 2.5 M, 0.60 mmol, 2 equiv) were added and 
slowly warmed to −20 °C over 1.2 h.  The reaction was cooled to −40 °C, and 
chlorodiphenylphosphine (0.3 mL, 1.6 mmol, 5.3 equiv) was added to the reaction and allowed to stir 
for an additional 2 hours warming to 5 °C.  The cloudy deep red/brown mixture was quenched with 
1.5 mL of saturated aqueous NaHCO3 and diluted with 2 mL diethyl ether.  The layers were separated, 
and the aqueous layer was extracted three times with 3 mL diethyl ether, then the combined organic 
layers were dried over anhydrous Na2SO4 and filtered over a plug of silica.  The resulting solution was 
concentrated under vacuo and then purified over silica gel using 20% diethyl ether in hexanes to yield 
62 (73.5 mg, 0.138 mmol, 46% yield) after recrystallization.  Characterization data is in agreement 
with spectra obtained using General procedure 3-A. 
 
General procedure 3-C for enantioenrichment of Cr-coordinated diarylmethylamine starting material. 
After chromatography, complex (R)-(−)-28a (74–88% ee) was enantioenriched by crystallization.  The 
complex was dissolved in a minimum (~0.2–0.4 mL per 50 mg) of dichloromethane, and then hexanes 
are added slowly (1.6–3.0 mL per 50 mg).  Upon crystallization overnight in a −16 °C freezer, long 
yellow prisms of the homochiral material (R)-(−)-28a were obtained in high purity after the mother 
liquor is decanted (typically ≥97% ee is obtained, verified by re-dissolution of the entire crystalline 
sample and analysis by SFC, typically 30 – 50% isolated yield).  28a obtained from the decanted 
mother liquor exhibits low ee as expected (10–45%); this material was used for test reactions with 
various chlorophosphines. 
When highly enantioenriched diarylmethylamine (≥97% ee) is used for P∧N ligand starting material, 
crystallized ligand appears to be a single enantiomer by SFC analysis. 
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Figure 3-12: Nearly enantiopure diarylmethylamine (R)-(−)-28a (≥97% ee after dissolution of crystals 
and analysis on chiral SFC) can be isolated through a single recrystallization. 
 
General procedure 3-D: Synthesis of palladium-bound P∧N ligand complexes. 
64 (Using THF): In a nitrogen-filled glovebox, a sample of the 
diphenylphosphine-derivative of the P∧N ligand (62, 27 mg, 0.050 mmol, 1.0 
equiv) was combined with PdCl2[norbornadiene] (13 mg, 0.05 mmol, 1.0 
equiv).  To the solids, dry THF (3 mL) was added with stirring, and the 
suspension quickly became orange as the palladium source dissolves (the 
reaction is exothermic, which likely helps with the dissolution of palladium 
source).  The reaction was stirred for 1 h and then the solvent was removed 
from the reddish solution in vacuo.  A higher than expected mass (36 mg, 35 mg theor.) and 1H NMR 
indicated persistent presence of THF in the product.  Rinsing the complex with dry diethyl ether and 
stripping solvent under vacuum led to 64 as a powdery orange solid in approximately quantitative 
yield. 1H NMR (500 MHz, CDCl3) δ: 8.69 (ddd, J = 1.5, 7.9, 13.0 Hz, 2H), 7.78 – 7.73 (m, 3H), 7.60 
(dd, J = 7.6, 12.7 Hz, 2H), 7.56 – 7.53 (m, 1H), 7.45 – 7.35 (m, 6H), 5.63 (t, J = 6.4 Hz, 1H), 5.41 (dd, 
J = 2.7, 6.4 Hz, 1H), 5.15 (t, J = 6.2 Hz, 1H), 5.05 (t, J = 6.3 Hz, 1H), 4.64 (d, J = 1.9 Hz, 1H), 3.16 (s, 
3H), 3.11 (s, 3H) ppm; 13C{1H} NMR (125 MHz, CDCl3) δ: 229.6, 136.4 (d, JCP = 1.0 Hz), 134.9 (d, JCP = 
10.0 Hz) 133.6 (d, JCP = 2 Hz), 132.3, 132.1 (d, JCP = 2.4 Hz), 130.3, 129.7, 129.6, 129.5, 128.8 (d, 
JCP = 8.1 Hz), 127.1 (d, JCP = 68 Hz), 126.1 (d, JCP = 55 Hz), 112.4 (d, JCP = 14.0 Hz), 97.1, 94.8, 93.6 
(d, JCP = 35.3 Hz), 89.4 (d, JCP = 6.3 Hz), 87.9, 76.5 (d, JCP = 9.5 Hz), 53.6, 47.7 ppm; 31P{1H} NMR 
(MHz, CDCl3) δ: 24.9 (s) ppm; HRMS (CI+) calc’d. for C30H26NO3ClCrPdP 671.9779, found 671.9785 
[M –Cl]+.  [α]D
2 6 = −18.0° (c = 0.50, CHCl3) for a ≥98 %ee sample. X-ray crystal structure was 
determined for the racemic compound, see p. 318. 
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64 (Alternately, using DCM): In a nitrogen-filled glovebox, a sample of the diphenylphosphine-
derivative of the P∧N ligand (62, 24 mg, 0.045 mmol, 1.0 equiv) was combined with 
PdCl2[norbornadiene] (12 mg, 0.045 mmol, 1.0 equiv) and dissolved in methylene chloride (3.0 mL).  
The resulting bright red-orange solution was stirred for 1.5 h under a nitrogen atmosphere.  Hexanes 
(3 mL) were added to the solution while stirring, and a suspension formed.  The solvent was then 
evaporated with a stream of dry nitrogen.  Compound 64 was obtained as a powedery orange solid (30 
mg, 0.042 mmol, 93% yield).  Characterization data is consistent with the spectra obtained from 64 
synthesized using THF as solvent. 
65: In a nitrogen-filled glovebox, a sample of the dicyclohexylphosphine-
derivative of the P∧N ligand (63, 21 mg, 0.039 mmol, 1.0 equiv.) was 
combined with PdCl2[norbornadiene] (10 mg, 0.039 mmol, 1.0 equiv) in 3 mL 
THF and stirred for 1.5 h under a nitrogen atmosphere.  Compound 65 was 
obtained as a pale orange powdery solid in 95% yield (27 mg, 0.037 mmol) 
after redissolving the sticky solid in 1 mL methylene chloride, and re-
evaporation of the solvent over a stream of dry nitrogen. HRMS (CI+) calc’d. for 
C30H36NO3ClCrPdP 684.0718, found 684.0726 [M –Cl]+. 
 
General procedure 3-E: Procedure for attempted asymmetric allylation reaction using complex. 
Asymmetric alkylation of the allyl acetate below followed the literature procedure.13 
   
Scheme 3-7: General scheme for the asymmetric alkylation of allyl acetate 66 with malonate 
nucelophile to yield 68. 
 
68: To a mixture of racemic 1,3-diphenyl-1-acetoxypropene (66) (25.2 mg, 0.10 mmol, 1.0 equiv.) and 
Palldium catalyst (64, 3.6 mg, 5 mol %) in dry THF (0.3 mL) was added a solution of sodium dimethyl 
malonate (prepared in situ by adding equimolar amounts of NaH (3.0 mg, 0.12 mmol) and dimethyl 
malonate (67) (14 µL, 0.12 mmol) in dry THF (0.25 mL)) at room temperature under a nitrogen 
atmosphere.  The reaction mixture was stirred at rt for 24 h.  The reaction mixture was then quenched 
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with 2 drops of H2O, diluted with 3 mL of ethyl acetate, and filtered over a pad of MgSO4 and silica gel. 
The pad was rinsed with additional ethyl acetate and the solution was concentrated in vacuo. The 
crude material was loaded onto a silica gel column and purified by flash chromatography (eluted with 
5–20% ethyl acetate in hexanes) to give the product (24.5 mg, 82% yield, 15% ee) as a yellow solid.  
NMR spectra is consistent with the spectra of the known compound in literature the previously 
published data.27 
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Appendix I  
NMR Spectra 
Triarylmethanes from CrDPM (4a) 
Figure I-1: 1H, 13C{1H} NMR spectra of 5a. 
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Figure I-2: 1H, 13C{1H} NMR spectra of 5b. 
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Figure I-3: 1H, 13C{1H}NMR spectra of 5c. 
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Figure I-4: 1H, 13C{1H} NMR spectra of 5d. 
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Figure I-5: 1H, 13C{1H}, {1H}19F NMR spectra of 5e.  
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Figure I-6: 1H, {1H}19F NMR spectra of 5f.  
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-7: 1H, 13C{1H} NMR spectra of 5g. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Figure I-8: 1H, 13C{1H} NMR spectra of 5h. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Figure I-9: 1H, 13C{1H} NMR spectra of 5i. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Figure I-10: 1H, 13C{1H} NMR spectra of 5j. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Figure I-11: 1H, 13C{1H} NMR spectra of 5k. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Triarylmethanes from CrTol (3). 
Figure I-12: 1H, 13C{1H}, 19F NMR spectra of 5l. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Figure I-13: 1H, 13C{1H} NMR spectra of 5m. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Figure I-14: 1H, 13C{1H} NMR spectra of 5n. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
2
.
3
2
8
5
.
0
9
3
5
.
1
1
4
5
.
1
6
6
5
.
2
0
0
5
.
2
2
1
5
.
2
4
2
5
.
3
1
9
5
.
3
4
0
5
.
3
6
0
7
.
0
4
0
7
.
0
6
7
7
.
1
1
1
7
.
1
3
8
7
.
2
6
0
6
.
1
5
7
2
.
0
2
8
1
.
0
6
8
2
.
0
2
9
1
.
0
0
0
8
.
0
8
8
300MHz CDCl3  
 
220 200 180 160 140 120 100 80 60 40 20 ppm
2
1
.
2
6
1
5
4
.
1
9
9
7
6
.
8
1
1
7
7
.
2
3
5
7
7
.
4
3
6
7
7
.
6
5
7
9
1
.
3
9
3
9
3
.
1
1
0
9
5
.
4
8
1
1
1
5
.
6
9
5
1
2
9
.
4
2
3
1
2
9
.
4
3
9
1
3
6
.
9
4
9
1
3
8
.
8
4
6
2
3
3
.
1
7
6
13C CDCl3  
Cr
OC
CO
CO
CH3
CH3
159 
 
Figure I-15: 1H, 13C{1H} NMR spectra of 5o. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Figure I-16: 1H, 13C{1H} NMR spectra of 5p. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Figure I-17: 1H, 13C{1H}NMR spectra of 5p′ 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Figure I-18: 1H, 13C{1H} NMR spectra of 5q. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Figure I-19: 1H, 13C{1H} NMR spectra of 5r. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Diarylmethanes from CrTol (3) 
Figure I-20: 1H, 13C{1H} NMR spectra of 4b. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Figure I-21: 1H, 13C{1H} NMR spectra of 4c. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Figure I-22: 1H, 13C{1H} NMR spectra of 7. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Polyarylmethanes from multiple activated benzylic centers. 
Figure I-23: 1H, 13C{1H} NMR spectra of 11. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Figure I-24: 1H, 13C{1H}, 19F{1H} NMR spectra of 12. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Figure I-25: 1H, 13C{1H} NMR spectra of 17. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Figure I-26: 1H, 13C{1H} NMR spectra of 19. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Figure I-27: 1H, 13C{1H} NMR spectra of 20. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-28: 1H, 13C{1H} NMR spectra of 21. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Diarylmethyl ethers from CrBnOPr (23). 
Figure I-29: 1H, 13C{1H} NMR spectra of 24a. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
0
.
9
3
6
0
.
9
6
0
0
.
9
8
5
1
.
5
3
8
1
.
6
2
0
1
.
6
4
2
1
.
6
6
7
1
.
6
8
9
3
.
3
9
0
3
.
3
9
8
3
.
4
2
0
3
.
4
4
2
3
.
4
6
4
3
.
4
7
2
5
.
0
1
0
5
.
0
9
7
5
.
1
0
1
5
.
1
0
6
5
.
1
2
2
5
.
1
8
1
5
.
1
9
7
5
.
2
0
2
5
.
2
1
7
5
.
2
2
2
5
.
2
3
3
5
.
2
3
7
5
.
3
1
7
5
.
3
2
2
5
.
3
3
9
5
.
3
4
3
5
.
3
5
9
5
.
6
9
8
5
.
7
1
9
7
.
2
6
1
7
.
3
2
8
7
.
3
3
2
7
.
3
4
1
7
.
3
4
9
7
.
3
5
6
7
.
3
7
3
7
.
3
8
6
7
.
3
9
1
3
.
0
7
2
.
1
2
2
.
1
0
1
.
0
0
1
.
0
2
2
.
0
6
1
.
0
2
1
.
0
0
5
.
1
2
300MHz CDCl3  
 
220 200 180 160 140 120 100 80 60 40 20 ppm
1
0
.
9
1
2
3
.
1
9
7
1
.
6
3
7
6
.
8
1
7
7
.
2
3
7
7
.
6
5
8
1
.
5
0
9
1
.
6
8
9
1
.
9
4
9
1
.
9
6
9
2
.
1
5
9
2
.
2
8
1
1
3
.
9
3
1
2
7
.
4
3
1
2
8
.
7
1
1
2
8
.
9
8
1
4
0
.
5
3
2
3
3
.
1
6
13C CDCl3  
Cr
OC
CO
CO
O
174 
 
Figure I-30: 1H, 13C{1H} 19F{1H} NMR spectra of 24b. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-31: 1H, 13C{1H} NMR spectra of 24c. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-32: 1H, 13C{1H} NMR spectra of 24d. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-33: 1H, 13C{1H} NMR spectra of 24e. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Triarylmethyl ethers from CrBnOPr (23). 
Figure I-34: 1H, 13C{1H} NMR spectra of 26a. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-35: 1H, 13C{1H}, 19F{1H} NMR spectra of 26b. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-36: 1H, 13C{1H}, 19F{1H} NMR spectra of 26d. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-37: 1H, 13C{1H}, 19F{1H} NMR spectra of 26e. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-38: 1H, 13C{1H} NMR spectra of 26f. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-39: 1H, 13C{1H} NMR spectra of 26g. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Diarylmethylamines from dimethyl benzyl amine (27). 
Figure I-40: 1H, 13C{1H} NMR spectra of 28a. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-41: 1H, 13C{1H}, 19F NMR spectra of 28b. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-42: 1H, 13C{1H} NMR spectra of 28c. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-43: 1H, 13C{1H} NMR spectra of 28d. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Products from tricarbonylchomium ethylbenzene derivatives. 
Figure I-44: 1H, 13C{1H} NMR spectra of 31b. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
1
.
5
4
4
1
.
5
6
8
3
.
8
1
2
3
.
8
3
6
5
.
0
9
2
5
.
1
1
2
5
.
2
1
2
5
.
2
2
8
5
.
2
3
2
5
.
2
4
7
5
.
2
6
5
5
.
2
8
5
5
.
3
3
8
5
.
3
4
3
5
.
3
6
0
5
.
3
7
9
5
.
3
8
4
5
.
4
2
8
5
.
4
4
9
6
.
8
4
7
6
.
8
7
6
7
.
1
3
3
7
.
1
6
2
7
.
2
6
0
3
.
2
2
4
.
2
6
1
.
0
0
2
.
0
4
1
.
1
5
1
.
0
8
2
.
0
4
2
.
0
0
300MHz CDCl3  
 
220 200 180 160 140 120 100 80 60 40 20 ppm
2
1
.
3
2
4
3
.
0
4
5
5
.
5
0
7
6
.
8
1
7
7
.
2
3
7
7
.
6
6
9
1
.
4
2
9
2
.
0
6
9
2
.
4
5
9
2
.
8
1
9
4
.
4
2
1
1
4
.
3
3
1
1
7
.
9
2
1
2
8
.
6
2
1
3
6
.
5
6
1
5
8
.
7
5
2
3
3
.
3
4
13C CDCl3  
Cr
OC
CO
CO
CH3
OMe
189 
 
Figure I-45: 1H NMR spectrum of quaternary side-product 35. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-46: 1H, 13C{1H} NMR spectra of 37. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Products from Diarylindanes (39) and Tetrahydronaphthalenes (40). 
Figure I-47: 1H, 13C{1H} NMR spectra of 41a. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Figure I-48: 1H, 13C{1H}, 19F{1H} NMR spectra of 41b. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Figure I-49: 1H, 13C{1H} NMR spectra of 41c. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-50: 1H, 13C{1H} NMR spectra of 42a. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Figure I-51: 1H, 13C{1H}, 19F{1H} NMR spectra of 42b. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Figure I-52: 1H, 13C{1H} NMR spectra of 42c. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Figure I-53: 1H, 13C{1H} NMR spectra of 43a. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-54: 1H, 13C{1H} NMR spectra of 43b. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-55: 1H, 13C{1H} NMR spectra of 43c. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-56: 1H, 13C{1H}NMR spectra of 44b. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-57: 1H, 13C{1H} NMR spectra of 44c. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-58: 1H, 13C{1H}NMR spectra of 45. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Products from Phthalan 
Figure I-59: 1H, 13C{1H} NMR spectra of 47a. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-60: 1H, 13C{1H} NMR spectra of 47b. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-61: 1H, 13C{1H} NMR spectra of 49. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Walking Product 
Figure I-62: 1H, 13C{1H} NMR spectra of 50. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
0
.
8
8
6
1
.
2
5
9
1
.
5
3
2
2
.
3
1
3
4
.
9
9
8
5
.
1
6
6
5
.
2
0
0
7
.
0
4
0
7
.
0
6
6
7
.
0
9
9
7
.
1
2
7
7
.
1
5
9
7
.
1
8
2
7
.
1
8
7
7
.
2
6
0
7
.
2
8
2
7
.
3
0
1
7
.
3
0
8
7
.
3
1
3
7
.
3
3
0
7
.
3
3
4
9
.
0
0
3
.
9
3
0
.
9
5
1
.
0
4
1
2
.
3
3
2
.
6
3
5
.
5
1
1H CDCl3 300MHz
DCM
 
220 200 180 160 140 120 100 80 60 40 20 ppm
2
1
.
2
3
2
9
.
9
3
5
3
.
7
9
5
4
.
1
6
7
6
.
8
0
7
7
.
2
3
7
7
.
4
3
7
7
.
6
5
9
4
.
1
4
9
4
.
2
2
9
4
.
2
9
1
1
5
.
3
5
1
1
5
.
8
3
1
2
7
.
2
6
1
2
8
.
6
6
1
2
8
.
7
4
1
2
8
.
9
2
1
2
9
.
3
6
1
2
9
.
4
3
1
2
9
.
5
0
1
3
3
.
8
3
1
3
4
.
0
9
1
3
6
.
9
2
1
3
7
.
0
1
1
3
8
.
6
2
1
3
8
.
8
2
1
4
1
.
8
3
2
3
3
.
3
9
13C CDCl3 75MHz  
207 
 
Benzylamine starting materials 
Figure I-63: 1H, 13C{1H} NMR spectra of 53. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-64: 1H, 13C{1H} NMR spectra of 54. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-65: 1H, 13C{1H} NMR spectra of 56. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Products from the asymmetric cross-coupling of tertiary benzylamines 
Figure I-66: 1H, 13C{1H} NMR spectra of 28f. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-67: 1H, 13C{1H} NMR spectra of 55a. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-68: 1H, 13C{1H} NMR spectra of 55b. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-69: 1H, 13C{1H} NMR spectra of 55c. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-70: 1H, 13C{1H} NMR spectra of 55d. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-71: 1H, 13C{1H} NMR spectra of 55e. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-72: 1H, 13C{1H} NMR spectra of 55f. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-73: 1H, 13C{1H} NMR spectra of 55g. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-74: 1H, 13C{1H} NMR spectra of 57. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-75: 1H, 13C{1H} NMR spectra of 58. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure I-76: 1H, 13C{1H} NMR spectra of 59. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Deuterium-quenched ortho-lithiated benzylamine 
Figure I-77: 1H NMR spectra of 28a-D (60% D) vs reference spectrum (Table 3-1, entry 14). 
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Planar- and central-chiral phosphine-amine ligands 
Figure I-78: 1H, 13C{1H}, 31P{1H} NMR spectra of 62. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Palladium(II)-complexed PN ligands 
Figure I-79: 1H, 13C{1H}, 31P NMR spectra of 64. 
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Product from asymmetric allylation using 64 (cat). 
Figure I-80: 1H, 13C{1H} NMR spectra of 68. 
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Appendix II  
IR spectra 
The following spectra are representative of tricarbonylchromium-coordinated arene complexes.  CO 
ligands typically shift a few wavenumbers upon coordination to electron-richer or –poorer arene rings. 
Figure II-1: IR spectrum of unsymmetrical triarylmethane complex 5i. 
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Figure II-2: IR Spectrum of unsymmetrical triarylmethane complex 5k. 
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Figure II-3: IR spectrum of symmetrical triarylmethane complex 5m. 
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Figure II-4: IR spectrum of polyarylmethane complex 11. 
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Figure II-5: IR spectrum of polyarylmethane complex 19. 
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Figure II-6: IR spectrum of polyarylmethane complex 21. 
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Figure II-7: IR spectrum of diarylmethyl ether complex 24a. 
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Figure II-8: IR spectrum of triarylmethyl ether complex 26b. 
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Figure II-9: IR spectrum of tertiary diarylethane complex 31b. 
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Figure II-10: IR spectrum of cis-diaryl indane complex 41b. 
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Figure II-11: IR spectrum of cis-diaryl tetrahydronaphthalene complex 42c. 
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Figure II-12: IR spectrum of 1-aryl indane complex 43c. 
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Figure II-13: IR spectrum of 1-aryl tetrahydronaphthalene complex 44b. 
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Figure II-14: IR spectrum of arylated phthalan complex 47a. 
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Figure II-15: IR spectrum of benzylpiperidine complex 53. 
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Figure II-16: IR spectrum of benzyl piperazine complex 56. 
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Figure II-17: IR spectrum of diarylmethylamine complex 28a. 
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Figure II-18: IR spectrum of diarylmethylamine complex  55b. 
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Figure II-19: IR spectrum of diarylmethylamine complex 57. 
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Figure II-20: IR spectrum of diarylmethylamine complex 58. 
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Figure II-21: IR spectrum of α–substituted benzylamine complex 59. 
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Figure II-22: IR spectrum of PN ligand 62. 
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Appendix III  
Conditions for Chromatographic Resolution of Chiral Compounds 
Conditions for Determination of Enantiomeric Excess on Merck & Co instruments: 
The enantiomeric excess for 28f was determined by chiral SFC using a Chirapak OJ-H column with 25 
mM isobutylamine in methanol in supercritical cabon dioxide on an Agilent SFC using Agilent 
ChemStation software for instrument operation and spectrum analysis. Conditions for the resolution of 
the racemate are as follows: 
28f– Me2NCH(4-CH3-C6H4)(η6-C6H5)Cr(CO)3: t1 = 3.1 min, t2 = 3.5 min (OJ-H column, methanol 
containing 25 mM isobutylamine/CO2 10/90, 3 mL/min) 
 
Conditions for Determination of Enantiomeric Excess on Walsh Lab instruments: 
The enantiomeric excess for the following compounds were determined by chiral SFC using a Chiralcel 
IA, AS-H, or OJ-H column with either methanol in supercritical cabon dioxide or 0.5% isopropylamine in 
methanol in supercritical carbondioxide on a JASCO SFC using JASCO ChomNAV software for 
instrument operation and spectrum analysis. Conditions for the resolution of the racemates are as 
follows: 
28a – (C6H5)-N-(NMe2)CH(η6-C6H5)Cr(CO)3: t1 = 2.6 min, t2 = 3.4 min (OJ-H column, methanol/CO2 
10/90, 4 mL/min) 
55a – (4-C6H4-CH3)-N-(C4H8NO)CH(η6-C6H5)Cr(CO)3: t1 = 3.4 min, t2 = 3.6 min (IA column, 
methanol/CO2 10/90, 4 mL/min) 
55b – (4-C6H4-tBu)-N-(C4H8NO)CH(η6-C6H5)Cr(CO)3: t1 = 4.6 min, t2 = 4.9 min (IA column, 
methanol/CO2 7/93, 4 mL/min) 
55c – (4-C6H4-OCH3)-N-(C4H8NO)CH(η6-C6H5)Cr(CO)3: t1 = 2.9 min, t2 = 3.2 min (IA column, 
methanol/CO2 15/85, 4 mL/min) 
55d – (3-C6H4-CH3)-N-(C4H8NO)CH(η6-C6H5)Cr(CO)3: t1 = 5.4 min, t2 = 6.0 min (OJ-H column, 
methanol/CO2 7/93, 4 mL/min) 
55e – (C6H5)-N-(C4H8NO)CH(η6-C6H5)Cr(CO)3: t1 = 3.5 min, t2 = 4.1 min (OJ-H column, methanol/CO2 
15/85, 4 mL/min) 
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55f – (4-C6H4-NMe2)-N-(C4H8NO)CH(η6-C6H5)Cr(CO)3: t1 = 2.2 min, t2 = 2.5 min (IA column, 
methanol/CO2 25/75, 4 mL/min) 
55g  – [1-(triisopropylsilyl)-1H-indol-4-yl]-N-(C4H8NO)CH(η6-C6H5)Cr(CO)3: t1 = 2.7 min, t2 = 3.1 min (IA 
column, methanol/CO2 20/80, 4 mL/min) 
57 – (C6H5)-N-(C5H10N)CH(η6-C6H5)Cr(CO)3: t1 = 6.0 min, t2 = 6.7 min (OJ-H column, methanol/CO2 
7/93, 4 mL/min) 
59 – (1-C6H9)-N-(C5H8NO)CH(η6-C6H5)Cr(CO)3: t1 = 2.1 min, t2 = 2.4 min (AS-H column, methanol/CO2 
10/90, 4 mL/min) 
61 – (4-C6H4-OMe)PhCH-N-(C4H8NO): t1 = 2.1 min, t2 = 2.5 min (OJ-H column, methanol containing 
0.5% isopropylamine/CO2 20/80, 4 mL/min 
62 – (C6H5)-N-(NMe2)CH(η6-o-C6H4-PPh2)Cr(CO)3: t1 = 9.3 min, t2 = 10.1 min (OJ-H column, methanol 
containing 0.5% isopropylamine/CO2 6/94, 4 mL/min) 
68 – (E)-dimethyl-2-(1,3-diphenylallyl)malonate: t1 = 13.2 min, t2 = 14.3 min (IA column, 
methanol/CO2 2/98, 2mL/min) 
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Appendix IV  
X-ray Structure Reports 
Note: CIF files for 17 (CCDC 775771) and 41b (CCDC 765716) can be obtained from the Cambridge 
Crystallographic Data Centre free of charge at www.ccdc.cam.ac.uk/data_request/cif.) 
X-ray Structure Determination of 5i – Compound 6150 
 
Figure IV-1: ORTEP of 5i, Compound 6150.  Thermal Ellipsoids are at 50% probability. 
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Figure IV-2: ORTEP of 5i.  Hydrogens have been omitted for clarity. 
Compound 5i, C23H18O4Cr, crystallizes in the triclinic space group P1
_
 with a=7.7736(7)Å, 
b=10.4752(7)Å, c=12.5974(11)Å, α=74.799(5)°, β=88.249(6)°, γ=79.433(6)°, V=972.96(14)Å3, 
Z=2, and dcalc=1.401 g/cm3 . X-ray intensity data were collected on a Rigaku Mercury CCD area 
detector employing graphite-monochromated Mo-Kα radiation (λ=0.71073 Å) at a temperature of 
150(1)K. Preliminary indexing was performed from a series of twelve 0.5° rotation images with 
exposures of 30 seconds. A total of 460 rotation images were collected with a crystal to detector 
distance of 35 mm, a 2θ swing angle of -12°, rotation widths of 0.5° and exposures of 20 seconds: 
scan no. 1 was a  φ-scan from 0° to 120° at ω = 10° and χ = 20°; scan no. 2 was a  φ-scan from 
146.25° to 341.25° at ω = 0° and χ = -30°; scan no. 3 was an ω-scan from -20° to 20° at χ = -90° 
and  φ = 225°; scan no. 4 was an ω-scan from -20° to 20° at χ = -90° and  φ = 0°; scan no. 5 was an 
ω-scan from -20° to 20° at χ = -90° and  φ = 45°; scan no. 6 was an ω-scan from -20° to 20° at χ = 
-90° and  φ = 135°; scan no. 7 was an ω-scan from -20° to 20° at χ = -90° and  φ = 315°; scan no. 
8 was an ω-scan from -20° to 20° at χ = -90° and  φ = 90°; scan no. 9 was an ω-scan from -20° to 
20° at χ = -90° and  φ = 180°; scan no. 10 was an ω-scan from -20° to 20° at χ = -90° and  φ = 
270°. Rotation images were processed using CrystalClear1, producing a listing of unaveraged F2 and 
σ(F2) values which were then passed to the CrystalStructure2 program package for further processing 
and structure solution on a Dell Pentium 4 computer. A total of 18198 reflections were measured over 
the ranges 2.67 ≤ θ ≤ 27.45°, -9 ≤ h ≤ 10, -13 ≤ k ≤ 13, -16 ≤ l ≤ 16 yielding 4369 unique reflections 
(Rint = 0.0257). The intensity data were corrected for Lorentz and polarization effects and for 
absorption using REQAB3 (minimum and maximum transmission 0.8762, 1.0000). 
The structure was solved by direct methods (SIR974). Refinement was by full-matrix least squares 
based on F2 using SHELXL-97.5 All reflections were used during refinement. The weighting scheme 
used was w=1/[σ2(Fo2 )+ 0.0609P2 + 0.4358P P = (Fo 2 + 2Fc2)/3. Non-hydrogen atoms were refined 
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anisotropically and hydrogen atoms were refined using a riding model.  Refinement converged to 
R1=0.0441 and wR2=0.1095 for 3986 observed reflections for which F > 4σ(F) and R1=0.0486 and 
wR2=0.1142 and GOF =1.069 for all 4369 unique, non-zero reflections and 255 variables.a The 
maximum ∆/σ in the final cycle of least squares was 0.001 and the two most prominent peaks in the 
final difference Fourier were +0.575 and -0.462 e/Å3. Table IV-1. lists cell information, data collection 
parameters, and refinement data. Final positional and equivalent isotropic thermal parameters are 
given in Table IV-2 and  
Table IV-3.  Anisotropic thermal parameters are in Table IV-4.  Table IV-5 and Table IV-6 list bond 
distances and bond angles.  Figure IV-3 is an ORTEP6 representation of the molecule with 30% 
probability thermal ellipsoids displayed. 
 
Figure IV-3: ORTEP drawing of the title compound with 30% probability thermal ellipsoids. 
   
Table IV-1.  Summary of Structure Determination of 5i, Compound 6150 
Empirical formula   C23H18O4Cr 
Formula weight    410.37 
                                                      
 
 
a  R1 = Σ||Fo| - |Fc|| / Σ |Fo| 
 wR2 = [Σw(Fo2 - Fc2)2/Σw(Fo2)2] 
 GOF = [Σw(Fo2 - Fc2)2/(n - p)]½ 
  where n = the number of reflections and p = the number of parameters refined. 
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Temperature    143(1) K 
Wavelength    0.71073 Å 
Crystal system    triclinic 
Space group    P1
_
  
Cell constants:   
 a    7.7736(7) Å 
 b    10.4752(7) Å 
 c    12.5974(11) Å 
 α   74.799(5)° 
 β   88.249(6)° 
 γ   79.433(6)° 
Volume    972.96(14) Å3 
Z    2 
Density (calculated)  1.401 Mg/m3 
Absorption coefficient  0.614 mm-1 
F(000)    424 
Crystal size   0.28 x o.25 x 0.04 mm3 
Theta range for data collection 2.67 to 27.45° 
Index ranges   -9 ≤ h ≤ 10, -13 ≤ k ≤ 13, -16 ≤ l ≤ 16 
Reflections collected  18198 
Independent reflections  4369 [R(int) = 0.0257] 
Completeness to theta = 27.45° 98.4 %  
Absorption correction  Semi-empirical from equivalents 
Max. and min. transmission 1.0000 and 0.8762 
Refinement method  Full-matrix least-squares on F2 
Data / restraints / parameters 4369 / 0 / 255 
Goodness-of-fit on F2  1.069 
Final R indices [I>2sigma(I)] R1 = 0.0441,  wR2 = 0.1095 
R indices (all data)  R1 = 0.0486,  wR2 = 0.1142 
Largest diff. peak and hole 0.575 and -0.462 e.Å-3 
 
Table IV-2. Refined Positional Parameters for 5i, Compound 6150 
Atom x y z Ueq,Å2 
Cr1 0.72320(4) 0.23582(3) 0.55370(2) 0.02729(12) 
C1 0.8567(2) 0.31375(18) 0.39595(14) 0.0268(4) 
C2 0.9589(2) 0.19246(19) 0.45528(15) 0.0274(4) 
C3 1.0135(2) 0.1757(2) 0.56539(15) 0.0298(4) 
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C4 0.9649(2) 0.2799(2) 0.61622(15) 0.0319(4) 
C5 0.8595(3) 0.4017(2) 0.55814(16) 0.0325(4) 
C6 0.8067(2) 0.41849(19) 0.44961(15) 0.0300(4) 
C7 0.8036(2) 0.34255(18) 0.27514(14) 0.0273(4) 
C8 0.8139(3) 0.2169(2) 0.23336(15) 0.0321(4) 
C9 0.6628(3) 0.1631(2) 0.23238(18) 0.0428(5) 
C10 0.6684(4) 0.0494(3) 0.1929(2) 0.0561(7) 
C11 0.8223(4) -0.0091(2) 0.1546(2) 0.0566(7) 
C12 0.9735(4) 0.0412(2) 0.15716(18) 0.0526(6) 
C13 0.9688(3) 0.1549(2) 0.19695(17) 0.0403(5) 
C14 0.9080(2) 0.44435(18) 0.20675(14) 0.0265(4) 
C15 0.8263(2) 0.54821(19) 0.11867(15) 0.0278(4) 
C16 0.9169(3) 0.6464(2) 0.06058(16) 0.0330(4) 
C17 1.0908(3) 0.6403(2) 0.08697(17) 0.0364(4) 
C18 1.1753(3) 0.5360(2) 0.17067(17) 0.0351(4) 
C19 1.0823(2) 0.4399(2) 0.23034(16) 0.0316(4) 
C20 0.5682(3) 0.6521(2) 0.00938(17) 0.0394(5) 
C21 0.6895(3) 0.0603(2) 0.5903(2) 0.0412(5) 
C22 0.5123(3) 0.2826(2) 0.47977(19) 0.0393(5) 
C23 0.6040(3) 0.2535(3) 0.6785(2) 0.0492(6) 
O1 0.65677(17) 0.54504(14) 0.09581(11) 0.0344(3) 
O2 0.6648(2) -0.04924(17) 0.6147(2) 0.0689(6) 
O3 0.3799(2) 0.31342(19) 0.43270(18) 0.0626(5) 
O4 0.5249(3) 0.2635(3) 0.75601(19) 0.0891(8) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cos γ+2U13aa*cc*cos β+2U23bb*cc*cosα] 
 
Table IV-3. Positional Parameters for Hydrogens in 5i, Compound 6150 
Atom x y z Uiso,Å2 
H2 0.9912 0.1223 0.4221 0.036 
H3 1.0819 0.0951 0.6037 0.040 
H4 1.0016 0.2692 0.6881 0.042 
H5 0.8253 0.4707 0.5923 0.043 
H6 0.7379 0.4991 0.4119 0.040 
H7 0.6806 0.3871 0.2684 0.036 
H9 0.5584 0.2028 0.2579 0.057 
H10 0.5677 0.0134 0.1926 0.075 
H11 0.8243 -0.0833 0.1267 0.075 
H12 1.0779 0.0000 0.1327 0.070 
H13 1.0707 0.1890 0.1989 0.054 
H16 0.8609 0.7165 0.0039 0.044 
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H17 1.1508 0.7066 0.0482 0.048 
H18 1.2929 0.5301 0.1869 0.047 
H19 1.1387 0.3709 0.2876 0.042 
H20a 0.5581 0.7356 0.0292 0.059 
H20b 0.4535 0.6358 -0.0021 0.059 
H20c 0.6334 0.6569 -0.0571 0.059 
 
Table IV-4.   Refined Thermal Parameters (U's) for 5i, Compound 6150 
Atom U11 U22 U33 U23 U13 U12 
Cr1 0.03064(18)  0.02582(18) 0.02590(18)  -0.00742(13) 0.00110(12)  -0.00550(12) 
C1 0.0314(8)  0.0265(9) 0.0224(8)  -0.0048(7) 0.0012(7)  -0.0071(7) 
C2 0.0293(8)  0.0268(9) 0.0249(9)  -0.0064(7) 0.0005(7)  -0.0032(7) 
C3 0.0285(8)  0.0314(10) 0.0265(9)  -0.0035(7) -0.0032(7)  -0.0030(7) 
C4 0.0372(9)  0.0359(10) 0.0243(9)  -0.0074(8) -0.0040(7)  -0.0112(8) 
C5 0.0414(10)  0.0285(10) 0.0314(10)  -0.0112(8) 0.0011(8)  -0.0114(8) 
C6 0.0392(10)  0.0223(9) 0.0278(9)  -0.0043(7) -0.0007(7)  -0.0070(7) 
C7 0.0315(9)  0.0258(9) 0.0237(9)  -0.0044(7) -0.0026(7)  -0.0058(7) 
C8 0.0470(11)  0.0280(10) 0.0205(8)  -0.0032(7) -0.0051(7)  -0.0084(8) 
C9 0.0557(13)  0.0367(11) 0.0377(11)  -0.0067(9) -0.0101(9)  -0.0155(9) 
C10 0.0813(18)  0.0417(14) 0.0508(15)  -0.0115(11) -0.0181(13)  -0.0226(13) 
C11 0.105(2)  0.0334(12) 0.0356(12)  -0.0128(10) -0.0128(13)  -0.0144(13) 
C12 0.0885(19)  0.0347(12) 0.0293(11)  -0.0063(9) 0.0054(11)  -0.0011(12) 
C13 0.0600(13)  0.0330(11) 0.0266(10)  -0.0055(8) 0.0028(9)  -0.0089(9) 
C14 0.0321(9)  0.0250(9) 0.0230(8)  -0.0072(7) 0.0005(7)  -0.0052(7) 
C15 0.0314(9)  0.0279(9) 0.0242(8)  -0.0083(7) 0.0006(7)  -0.0038(7) 
C16 0.0410(10)  0.0281(10) 0.0275(9)  -0.0030(8) 0.0037(8)  -0.0066(8) 
C17 0.0414(10)  0.0365(11) 0.0350(10)  -0.0107(9) 0.0086(8)  -0.0154(8) 
C18 0.0329(9)  0.0437(12) 0.0331(10)  -0.0141(9) 0.0026(8)  -0.0127(8) 
C19 0.0338(9)  0.0342(10) 0.0266(9)  -0.0085(8) -0.0018(7)  -0.0050(7) 
C20 0.0364(10)  0.0430(12) 0.0311(10)  -0.0007(9) -0.0034(8)  0.0004(8) 
C21 0.0308(10)  0.0360(11) 0.0552(14)  -0.0104(10) 0.0082(9)  -0.0055(8) 
C22 0.0383(10)  0.0325(11) 0.0485(12)  -0.0137(9) 0.0010(9)  -0.0054(8) 
C23 0.0550(13)  0.0577(15) 0.0469(13)  -0.0259(12) 0.0137(11)  -0.0244(11) 
O1 0.0326(7)  0.0360(8) 0.0298(7)  -0.0007(6) -0.0043(5)  -0.0049(5) 
O2 0.0515(10)  0.0323(9) 0.1203(19)  -0.0125(10) 0.0195(11)  -0.0149(7) 
O3 0.0413(9)  0.0558(11) 0.0908(15)  -0.0240(10) -0.0255(9)  0.0019(8) 
O4 0.1044(17)  0.126(2) 0.0716(15)  -0.0647(15) 0.0553(13)  -0.0615(16) 
The form of the anisotropic displacement parameter is: 
exp[-2π2(a*2U11h2+b*2U22k2+c*2U33l2+2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)] 
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Table IV-5. Bond Distances in 5i, Compound 6150, Å 
Cr1-C22  1.832(2) Cr1-C23  1.835(2) Cr1-C21  1.840(2) 
Cr1-C5  2.2076(19) Cr1-C6  2.2111(19) Cr1-C2  2.2254(18) 
Cr1-C4  2.2275(18) Cr1-C3  2.2276(18) Cr1-C1  2.2420(18) 
C1-C2  1.404(2) C1-C6  1.424(3) C1-C7  1.526(2) 
C2-C3  1.420(2) C3-C4  1.394(3) C4-C5  1.414(3) 
C5-C6  1.397(3) C7-C14  1.526(2) C7-C8  1.529(3) 
C8-C13  1.385(3) C8-C9  1.394(3) C9-C10  1.399(3) 
C10-C11  1.375(4) C11-C12  1.379(4) C12-C13  1.403(3) 
C14-C19  1.386(3) C14-C15  1.405(2) C15-O1  1.365(2) 
C15-C16  1.389(3) C16-C17  1.388(3) C17-C18  1.383(3) 
C18-C19  1.392(3) C20-O1  1.428(2) C21-O2  1.158(3) 
C22-O3  1.153(3) C23-O4  1.156(3)   
 
Table IV-6. Bond Angles in 5i, Compound 6150, ° 
C22-Cr1-C23 88.10(11) C22-Cr1-C21 87.94(10) C23-Cr1-C21 87.12(11) 
C22-Cr1-C5 116.66(9) C23-Cr1-C5 90.90(9) C21-Cr1-C5 155.26(9) 
C22-Cr1-C6 90.14(9) C23-Cr1-C6 116.64(10) C21-Cr1-C6 156.09(9) 
C5-Cr1-C6 36.85(7) C22-Cr1-C2 116.36(9) C23-Cr1-C2 155.54(10) 
C21-Cr1-C2 93.28(8) C5-Cr1-C2 78.61(7) C6-Cr1-C2 66.39(7) 
C22-Cr1-C4 153.83(9) C23-Cr1-C4 91.90(9) C21-Cr1-C4 118.21(9) 
C5-Cr1-C4 37.17(7) C6-Cr1-C4 66.56(7) C2-Cr1-C4 66.40(7) 
C22-Cr1-C3 153.55(9) C23-Cr1-C3 118.35(10) C21-Cr1-C3 92.99(8) 
C5-Cr1-C3 66.40(7) C6-Cr1-C3 78.45(7) C2-Cr1-C3 37.19(6) 
C4-Cr1-C3 36.46(7) C22-Cr1-C1 89.83(8) C23-Cr1-C1 153.86(10) 
C21-Cr1-C1 118.84(9) C5-Cr1-C1 66.92(7) C6-Cr1-C1 37.29(7) 
C2-Cr1-C1 36.64(6) C4-Cr1-C1 78.81(7) C3-Cr1-C1 66.63(7) 
C2-C1-C6 118.35(16) C2-C1-C7 123.69(16) C6-C1-C7 117.88(16) 
C2-C1-Cr1 71.04(10) C6-C1-Cr1 70.18(10) C7-C1-Cr1 132.96(12) 
C1-C2-C3 120.74(17) C1-C2-Cr1 72.32(10) C3-C2-Cr1 71.49(10) 
C4-C3-C2 120.12(17) C4-C3-Cr1 71.76(11) C2-C3-Cr1 71.32(10) 
C3-C4-C5 119.76(17) C3-C4-Cr1 71.77(10) C5-C4-Cr1 70.65(11) 
C6-C5-C4 120.14(18) C6-C5-Cr1 71.71(11) C4-C5-Cr1 72.18(11) 
C5-C6-C1 120.87(17) C5-C6-Cr1 71.44(11) C1-C6-Cr1 72.53(10) 
C1-C7-C14 108.57(14) C1-C7-C8 114.33(15) C14-C7-C8 113.50(15) 
C13-C8-C9 119.2(2) C13-C8-C7 121.91(18) C9-C8-C7 118.90(19) 
C8-C9-C10 119.9(2) C11-C10-C9 120.2(2) C10-C11-C12 120.5(2) 
C11-C12-C13 119.5(2) C8-C13-C12 120.6(2) C19-C14-C15 118.13(17) 
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C19-C14-C7 121.87(16) C15-C14-C7 119.98(16) O1-C15-C16 123.71(17) 
O1-C15-C14 115.93(16) C16-C15-C14 120.36(17) C17-C16-C15 120.16(18) 
C18-C17-C16 120.25(18) C17-C18-C19 119.22(18) C14-C19-C18 121.80(18) 
O2-C21-Cr1 178.4(2) O3-C22-Cr1 179.3(2) O4-C23-Cr1 178.1(2) 
C15-O1-C20 117.20(15)     
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X-ray Structure Determination of 5n – Compound 6140 
Cr
C
C C
O
O O
 
Figure IV-4: ORTEP of 5n, compound 6140.  Thermal Ellipsoids are at 50% probability. 
 
Figure IV-5: Observation of arene end-on π interactions within the crystal structure of 5n. 
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Compound 6140 (5n), C24H20O3Cr, crystallizes in the triclinic space group P1
_
 with a=7.674(2)Å, 
b=10.772(3)Å, c=13.579(4)Å, α=102.847(5)°, β=105.255(7)°, γ=101.177(3)°, V=1017.2(5)Å3, Z=2 
and dcalc=1.333 g/cm
3.  X-ray intensity data were collected on a Rigaku Mercury CCD area detector 
employing graphite-monochromated Mo-Kα radiation (λ=0.71073 Å) at a temperature of 143K. 
Preliminary indexing was performed from a series of twelve 0.5° rotation images with exposures of 30 
seconds. A total of 742 rotation images were collected with a crystal to detector distance of 35 mm, a 
2θ swing angle of  -14°, rotation widths of 0.5° and exposures of 60 seconds: scan no. 1 was a φ-scan 
from 150° to 300° at ω = 10° and χ = 20°; scan no. 2 was a φ-scan from 240° to 360° at ω = 0° 
and χ = -30°; scan no. 3 was an ω-scan from -20° to 4° at χ = -90° and  φ = 315°; scan no. 4 was 
an ω-scan from -20° to 17° at χ = -90° and  φ = 135°; scan no. 5 was an ω-scan from -20° to 20° at 
χ = -90° and  φ = 45°.  Rotation images were processed using CrystalClear1, producing a listing of 
unaveraged F2 and σ(F2) values which were then passed to the CrystalStructure2 program package for 
further processing and structure solution on a Dell Pentium III computer. A total of 10895 reflections 
were measured over the ranges 5.6 ≤ 2θ ≤ 54.94 °,  -7 ≤ h ≤ 9,  -13 ≤ k ≤ 12,  -17 ≤ l ≤ 17 yielding 
4553 unique reflections (Rint = 0.0307). The intensity data were corrected for Lorentz and polarization 
effects and for absorption using REQAB3 (minimum and maximum transmission 0.693, 1.000). 
The structure was solved by direct methods (SIR974). Refinement was by full-matrix least squares 
based on F2 using SHELXL-97 5. All reflections were used during refinement (F2 ’s that were 
experimentally negative were replaced by F2 = 0). The weighting scheme used was w=1/[σ2(Fo2 )+ 
0.0839P2 + 0.3721P] where P = (F o2  + 2F c2 )/3 . Non-hydrogen atoms were refined anisotropically and 
hydrogen atoms were refined using a “riding” model.  Refinement converged to R1=0.0542 and 
wR2=0.1410 for 3578 reflections for which F > 4σ(F) and R1=0.0698, wR2=0.1572 and GOF = 1.066 
for all 4553 unique, non-zero reflections and 256 variables a. The maximum ∆/σ in the final cycle of 
least squares was 0.016 and the two most prominent peaks in the final difference Fourier were 
+0.610 and -0.664 e/Å3. 
                                                      
 
 
a  R1 = ∑ ||Fo| - |Fc|| / ∑ |Fo| 
 wR2 = { ∑ w (F o2  - F c2 )2 / ∑ w(F o2 )2}1/2 
 GOF = { ∑ w (F o2  - F c2 )2 / (n - p)}1/2 
  where n = the number of reflections and p = the number of parameters refined. 
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Table 1. lists cell information, data collection parameters, and refinement data.  Final positional and 
equivalent isotropic thermal parameters are given in Table 2.  Anisotropic thermal parameters are in 
Table 3.  Tables 4. and 5. list bond distances and bond angles.  Figure IV-3 is an ORTEP6 
representation of the molecule with 30% probability thermal ellipsoids displayed. 
 
Figure IV-6: ORTEP drawing of the title compound 5n with 30% probability thermal ellipsoids. 
 
Table IV-7:  Summary of Structure Determination of 5n, Compound 6140 
Formula:   C24H20O3Cr 
Formula weight:   408.40 
Crystal class:   triclinic 
Space group:   P1
_
  (#2) 
Z    2 
Cell constants:  
 a   7.674(2)Å 
 b    10.772(3)Å 
 c   13.579(4)Å 
 α   102.847(5)° 
 β   105.255(7)° 
 γ   101.177(3)° 
 V    1017.2(5)Å3  
 µ   5.83 cm- 1  
crystal size, mm   0.40 x 0.10 x 0.02 
Dcalc    1.333 g/cm3  
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F(000)    424 
Radiation:   Mo-Kα (λ=0.71073Å) 
2θ range   5.6 – 54.94 ° 
hkl collected:   -7≤ h ≤9;  -13≤ k ≤12;  -17≤ l ≤17 
No. reflections measured:  10895 
No. unique reflections:  4553 (Rint=0.0307) 
No. observed reflections  3578 (F>4σ) 
No. reflections used in refinement 4553 
No. parameters   256 
R indices (F>4σ)   R1=0.0542,  wR2=0.1410 
R indices (all data)  R1=0.0698,  wR2=0.1572 
GOF:    1.066 
Final Difference Peaks, e/Å3  +0.610, -0.664 
 
Table IV-8.  Refined Positional Parameters for 5n, Compound 6140 
 Atom                       x                                  y                             z                             Ueq, Å2 
Cr1 0.75239(6) 0.76079(4) 0.55069(3) 0.0318(2) 
C1 0.8015(4) 0.6804(3) 0.3961(2) 0.0302(5) 
C2 0.7814(4) 0.5803(3) 0.4491(2) 0.0338(6) 
H2 0.6919 0.4998 0.4137 0.045 
C3 0.8953(4) 0.6024(3) 0.5537(2) 0.0377(6) 
H3 0.8819 0.5365 0.5874 0.050 
C4 1.0303(4) 0.7244(3) 0.6082(2) 0.0396(6) 
H4 1.1067 0.7386 0.6775 0.053 
C5 1.0497(4) 0.8236(3) 0.5584(2) 0.0383(6) 
H5 1.1380 0.9044 0.5947 0.051 
C6 0.9343(4) 0.8015(3) 0.4521(2) 0.0324(5) 
H6 0.9473 0.8683 0.4193 0.043 
C7 0.6831(4) 0.6472(2) 0.2790(2) 0.0303(5) 
H7 0.5566 0.5980 0.2719 0.040 
C8 0.6644(4) 0.7695(3) 0.2419(2) 0.0325(5) 
C9 0.5197(4) 0.8257(3) 0.2538(2) 0.0392(6) 
H9 0.4364 0.7896 0.2853 0.052 
C10 0.4993(5) 0.9355(3) 0.2187(2) 0.0468(7) 
H10 0.4018 0.9718 0.2273 0.062 
C11 0.6194(5) 0.9917(3) 0.1717(2) 0.0434(7) 
C12 0.7659(5) 0.9376(3) 0.1619(2) 0.0466(7) 
H12 0.8504 0.9750 0.1316 0.062 
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C13 0.7882(4) 0.8272(3) 0.1970(2) 0.0409(6) 
H13 0.8877 0.7924 0.1901 0.054 
C14 0.5932(6) 1.1099(3) 0.1321(3) 0.0598(10) 
H14a 0.6963 1.1410 0.1083 0.090 
H14b 0.5885 1.1791 0.1889 0.090 
H14c 0.4781 1.0845 0.0739 0.090 
C15 0.7605(4) 0.5548(3) 0.2092(2) 0.0315(5) 
C16 0.6398(4) 0.4630(3) 0.1152(2) 0.0375(6) 
H16 0.5119 0.4559 0.0963 0.050 
C17 0.7083(5) 0.3811(3) 0.0486(2) 0.0432(7) 
H17 0.6255 0.3213 -0.0146 0.057 
C18 0.8979(5) 0.3874(3) 0.0751(2) 0.0418(7) 
C19 1.0180(4) 0.4796(3) 0.1689(2) 0.0426(7) 
H19 1.1456 0.4857 0.1881 0.057 
C20 0.9511(4) 0.5635(3) 0.2351(2) 0.0370(6) 
H20 1.0347 0.6257 0.2969 0.049 
C21 0.9721(6) 0.2961(4) 0.0044(3) 0.0584(9) 
H21a 1.0393 0.2480 0.0452 0.088 
H21b 1.0548 0.3474 -0.0227 0.088 
H21c 0.8692 0.2351 -0.0539 0.088 
C22 0.4993(4) 0.7120(3) 0.4854(2) 0.0411(6) 
C23 0.7368(4) 0.9326(3) 0.5836(3) 0.0470(7) 
C24 0.7079(5) 0.7440(4) 0.6741(3) 0.0584(9) 
O1 0.3385(3) 0.6809(3) 0.4442(2) 0.0651(7) 
O2 0.7252(4) 1.0398(2) 0.6023(3) 0.0737(8) 
O3 0.6771(6) 0.7290(4) 0.7499(2) 0.108(2) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cos+2U13aa*cc*cos+2U23bb*cc*cos] 
 
Table IV-9.   Refined Thermal Parameters (U's) for 5n, Compound 6140 
Atom                 U11                    U22                   U33                     U23                    U13                  U12 
Cr1 0.0328(3) 0.0344(3) 0.0344(3) 0.0149(2) 0.0127(2) 0.0145(2) 
C1 0.0309(12) 0.0329(13) 0.0315(12) 0.0132(10) 0.0110(10) 0.0135(10) 
C2 0.0373(14) 0.0309(13) 0.0383(14) 0.0143(10) 0.0123(11) 0.0155(11) 
C3 0.046(2) 0.041(2) 0.0377(14) 0.0196(11) 0.0153(12) 0.0253(13) 
C4 0.0354(14) 0.051(2) 0.0337(14) 0.0131(12) 0.0046(11) 0.0211(13) 
C5 0.0298(13) 0.043(2) 0.0390(14) 0.0076(11) 0.0091(11) 0.0092(11) 
C6 0.0302(13) 0.0351(14) 0.0364(13) 0.0144(10) 0.0131(11) 0.0112(11) 
C7 0.0325(13) 0.0285(12) 0.0316(13) 0.0105(10) 0.0089(10) 0.0118(10) 
C8 0.0376(13) 0.0360(14) 0.0262(12) 0.0117(10) 0.0072(10) 0.0162(11) 
C9 0.044(2) 0.045(2) 0.0360(14) 0.0163(12) 0.0123(12) 0.0228(13) 
C10 0.058(2) 0.049(2) 0.041(2) 0.0153(13) 0.0121(14) 0.034(2) 
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C11 0.065(2) 0.037(2) 0.0298(13) 0.0110(11) 0.0073(13) 0.0250(14) 
C12 0.067(2) 0.042(2) 0.041(2) 0.0218(12) 0.021(2) 0.018(2) 
C13 0.051(2) 0.044(2) 0.041(2) 0.0203(12) 0.0203(13) 0.0250(13) 
C14 0.095(3) 0.044(2) 0.042(2) 0.0190(14) 0.011(2) 0.030(2) 
C15 0.0375(13) 0.0293(13) 0.0317(12) 0.0155(10) 0.0086(10) 0.0138(10) 
C16 0.043(2) 0.0331(14) 0.0332(13) 0.0110(10) 0.0030(11) 0.0132(12) 
C17 0.059(2) 0.037(2) 0.0328(14) 0.0103(11) 0.0091(13) 0.0176(14) 
C18 0.062(2) 0.037(2) 0.039(2) 0.0189(12) 0.0230(14) 0.0238(14) 
C19 0.046(2) 0.052(2) 0.043(2) 0.0224(13) 0.0193(13) 0.0268(14) 
C20 0.0389(14) 0.040(2) 0.0360(14) 0.0136(11) 0.0106(11) 0.0175(12) 
C21 0.085(3) 0.055(2) 0.054(2) 0.019(2) 0.037(2) 0.038(2) 
C22 0.042(2) 0.038(2) 0.050(2) 0.0201(12) 0.0180(13) 0.0146(12) 
C23 0.044(2) 0.043(2) 0.064(2) 0.0170(14) 0.031(2) 0.0127(13) 
C24 0.068(2) 0.083(3) 0.055(2) 0.038(2) 0.032(2) 0.052(2) 
O1 0.0294(12) 0.067(2) 0.097(2) 0.0310(14) 0.0126(12) 0.0119(11) 
O2 0.078(2) 0.0347(13) 0.132(2) 0.0223(13) 0.068(2) 0.0223(12) 
O3 0.156(3) 0.179(4) 0.082(2) 0.092(2) 0.085(2) 0.123(3) 
The form of the anisotropic displacement parameter is: 
exp[-2π2(a*2U11h2+b*2U22k2+c*2U33l2+ 2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)]. 
 
Table IV-10.  Bond Distances in 5n, Compound 6140, Å 
Cr1-C22 1.824(3) Cr1-C24 1.835(3) Cr1-C23 1.840(3) 
Cr1-C3 2.202(3) Cr1-C2 2.207(3) Cr1-C4 2.213(3) 
Cr1-C5 2.217(3) Cr1-C6 2.223(3) Cr1-C1 2.243(2) 
C1-C6 1.398(4) C1-C2 1.430(4) C1-C7 1.530(3) 
C2-C3 1.398(4) C3-C4 1.409(4) C4-C5 1.390(4) 
C5-C6 1.420(4) C7-C8 1.531(4) C7-C15 1.533(3) 
C8-C13 1.379(4) C8-C9 1.392(4) C9-C10 1.390(4) 
C10-C11 1.375(5) C11-C12 1.386(4) C11-C14 1.516(4) 
C12-C13 1.399(4) C15-C16 1.389(4) C15-C20 1.391(4) 
C16-C17 1.395(4) C17-C18 1.388(4) C18-C19 1.386(4) 
C18-C21 1.516(4) C19-C20 1.396(4) C22-O1 1.158(4) 
C23-O2 1.151(4) C24-O3 1.153(4)   
 
Table IV-11.   Bond Angles in 5n, Compound 6140, ° 
C22-Cr1-C24 88.2(2) C22-Cr1-C23 87.17(14) C24-Cr1-C23 90.1(2) 
C22-Cr1-C3 117.53(12) C24-Cr1-C3 88.79(12) C23-Cr1-C3 155.22(14) 
C22-Cr1-C2 91.36(12) C24-Cr1-C2 114.97(14) C23-Cr1-C2 154.86(12) 
C3-Cr1-C2 36.96(10) C22-Cr1-C4 154.73(13) C24-Cr1-C4 89.91(13) 
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C23-Cr1-C4 118.04(13) C3-Cr1-C4 37.22(11) C2-Cr1-C4 66.75(10) 
C22-Cr1-C5 154.86(12) C24-Cr1-C5 116.95(14) C23-Cr1-C5 92.12(12) 
C3-Cr1-C5 66.57(11) C2-Cr1-C5 78.77(10) C4-Cr1-C5 36.57(11) 
C22-Cr1-C6 117.57(12) C24-Cr1-C6 154.23(14) C23-Cr1-C6 92.02(12) 
C3-Cr1-C6 78.72(10) C2-Cr1-C6 66.52(10) C4-Cr1-C6 66.53(10) 
C5-Cr1-C6 37.31(10) C22-Cr1-C1 91.46(11) C24-Cr1-C1 152.43(14) 
C23-Cr1-C1 117.44(12) C3-Cr1-C1 67.03(9) C2-Cr1-C1 37.46(9) 
C4-Cr1-C1 78.85(10) C5-Cr1-C1 66.64(10) C6-Cr1-C1 36.47(9) 
C6-C1-C2 118.5(2) C6-C1-C7 123.2(2) C2-C1-C7 118.3(2) 
C6-C1-Cr1 70.96(14) C2-C1-Cr1 69.89(14) C7-C1-Cr1 133.4(2) 
C3-C2-C1 120.5(3) C3-C2-Cr1 71.3(2) C1-C2-Cr1 72.6(2) 
C2-C3-C4 120.1(3) C2-C3-Cr1 71.7(2) C4-C3-Cr1 71.8(2) 
C5-C4-C3 120.1(2) C5-C4-Cr1 71.9(2) C3-C4-Cr1 71.0(2) 
C4-C5-C6 119.9(3) C4-C5-Cr1 71.5(2) C6-C5-Cr1 71.5(2) 
C1-C6-C5 120.8(2) C1-C6-Cr1 72.6(2) C5-C6-Cr1 71.2(2) 
C1-C7-C8 113.4(2) C1-C7-C15 109.5(2) C8-C7-C15 112.3(2) 
C13-C8-C9 118.4(3) C13-C8-C7 121.9(2) C9-C8-C7 119.7(2) 
C10-C9-C8 120.2(3) C11-C10-C9 121.7(3) C10-C11-C12 118.1(3) 
C10-C11-C14 121.1(3) C12-C11-C14 120.8(3) C11-C12-C13 120.8(3) 
C8-C13-C12 120.7(3) C16-C15-C20 118.4(2) C16-C15-C7 119.8(2) 
C20-C15-C7 121.8(2) C15-C16-C17 120.7(3) C18-C17-C16 121.2(3) 
C19-C18-C17 117.9(3) C19-C18-C21 120.8(3) C17-C18-C21 121.3(3) 
C18-C19-C20 121.3(3) C15-C20-C19 120.5(3) O1-C22-Cr1 179.8(3) 
O2-C23-Cr1 178.8(3) O3-C24-Cr1 177.7(4)   
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X-ray Structure Determination of 17 – Compound 6147 
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Figure IV-7: ORTEP of 17, compound 6147. Thermal ellipsoids are at 30% probability. 
Compound 6147 (17), C54H48O9Cr, crystallizes in the triclinic space group P1
_
 with a=11.3010(5)Å, 
b=11.7896(4)Å, c=19.8964(14)Å, α=72.920(6)°, β=82.244(7)°, γ=63.018(5)°, V=2258.1(2)Å3, 
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Z=2, and dcalc=1.313 g/cm3. X-ray intensity data were collected on a Rigaku Mercury CCD area 
detector employing graphite-monochromated Mo-Kα radiation (λ=0.71073 Å) at a temperature of 
143(1)K. Preliminary indexing was performed from a series of twelve 0.5° rotation images with 
exposures of 30 seconds. A total of 1120 rotation images were collected with a crystal to detector 
distance of 35 mm, a 2θ swing angle of -12°, rotation widths of 0.5° and exposures of 30 seconds: 
scan no. 1 was a φ-scan from 0° to 240° at ω = 10° and χ = 20°; scan no. 2 was an ω-scan from -
20° to 20° at χ = -90° and φ = 0°; scan no. 3 was an ω-scan from -20° to 20° at χ = -90° and  φ = 
45°; scan no. 4 was an ω-scan from -20° to 20° at χ = -90° and  φ = 90°; scan no. 5 was an ω-scan 
from -20° to 20° at χ = -90° and  φ = 135°; scan no. 6 was an ω-scan from -20° to 20° at χ = -90° 
and  φ = 180°; scan no. 7 was an ω-scan from -20° to 20° at χ = -90° and  φ = 225°; scan no. 8 was 
an ω-scan from -20° to 20° at χ = -90° and  φ = 270°; scan no. 9 was an ω-scan from -20° to 20° at 
χ = -90° and  φ = 315°. Rotation images were processed using CrystalClear1, producing a listing of 
unaveraged F2 and σ(F2) values which were then passed to the CrystalStructure2 program package for 
further processing and structure solution on a Dell Pentium 4 computer. A total of 32470 reflections 
were measured over the ranges 2.51 ≤ θ ≤ 25.01°, -13 ≤ h ≤ 13, -14 ≤ k ≤ 14, -23 ≤ l ≤ 23 yielding 
7932 unique reflections (Rint = 0.0284). The intensity data were corrected for Lorentz and 
polarization effects and for absorption using REQAB3 (minimum and maximum transmission 0.8578, 
1.0000). 
The structure was solved by direct methods (SIR974). The C45-C46-C47-C48-C49-C50-O5-C51 moiety 
is disordered by an opening of the C38-C37-C45 bond angle from 109.0(2)° to 123.4(4)° as shown in 
Figure IV-8: 
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Figure IV-8: The disordered anisole group in 17 is pictured. 
The occupancy factors were 0.70:0.30. In addition, the carbonyl ligand C54-O9 was disordered 
through two positions also with occupancy factors of 0.70:0.30. The minor disorder contribution 
increases the C52-Cr1-C54 angle from 82.9(2)° to 96.0(5)° and decreases the C53-Cr1-C54 angle 
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from 93.4(2)° to 77.9(5)°. These two different disordered moieties are, perhaps, related. Below are 
two space-filling models (Figure IV-9): 
                  
Figure IV-9: The disordered anisole and carbonyl, pictured in space-filling models. 
The model on the left displays both minor disorder contributions (primed atoms). The one on the right 
displays the major disorder contribution for the carbonyl C54-O9 plus the minor contribution for the 
C45’-C46’-C47’-C48’-C49’-C50’-O6-C51’ system. The space-filling model on the right shows a short 
contact between O9 and the H on C50’ (2.1Å) while the H50’-O9’ distance in the left molecule is a 
more reasonable 3.0 Å. 
Refinement was by full-matrix least squares based on F2 using SHELXL-97.5 All reflections were used 
during refinement. The weighting scheme used was w=1/[σ2(Fo2 )+ 0.0808P2 + 1.2532 P = (Fo 2 + 
2Fc2)/3. Non-hydrogen atoms were refined anisotropically and hydrogen atoms were refined using a 
riding model.  Refinement converged to R1=0.0532 and wR2=0.1427 for 6816 observed reflections 
for which F > 4σ(F) and R1=0.0617 and wR2=0.1517 and GOF =1.048 for all 7932 unique, non-zero 
reflections and 640 variables.a The maximum ∆/σ in the final cycle of least squares was 0.012 and 
the two most prominent peaks in the final difference Fourier were +0.281 and -0.888 e/Å3.  
                                                      
 
 
a  R1 = Σ||Fo| - |Fc|| / Σ |Fo| 
wR2 = [Σw(Fo2 - Fc2)2/Σw(Fo2)2]½ 
GOF = [Σw(Fo2 - Fc2)2/(n - p)]½ 
  where n = the number of reflections and p = the number of parameters refined. 
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Table IV-12 lists cell information, data collection parameters, and refinement data. Final positional and equivalent 
isotropic thermal parameters are given in Table IV-13 and Table IV-14.  Anisotropic thermal parameters are in 
Table IV-15 
Table IV-15.  Table IV-16 and Table IV-17 list bond distances and bond angles.  Figure IV-10 is an 
ORTEP6 representation of the molecule with 30% probability thermal ellipsoids displayed. 
 
Figure IV-10: ORTEP drawing of the title compound 17 with 30% probability thermal ellipsoids. 
 
Table IV-12:  Summary of Structure Determination of 17, Compound 6147 
Empirical formula   C54H48O9Cr 
Formula weight    892.92 
Temperature    143(1) K 
Wavelength    0.71073 Å 
Crystal system    triclinic 
Space group    P1
_
  
Cell constants:   
 a    11.3010(5) Å 
 b    11.7896(4) Å 
 c    19.8964(14) Å 
 α   72.920(6)° 
 β   82.244(7)° 
 γ   63.018(5)° 
Volume    2258.1(2) Å3 
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Z    2 
Density (calculated)  1.313 Mg/m3 
Absorption coefficient  0.312 mm-1 
F(000)    936 
Crystal size   0.38 x 0.25 x 0.06 mm3 
Theta range for data collection 2.51 to 25.01° 
Index ranges   -13 ≤ h ≤ 13, -14 ≤ k ≤ 14, -23 ≤ l ≤ 23 
Reflections collected  32470 
Independent reflections  7932 [R(int) = 0.0284] 
Completeness to theta = 25.01° 99.6 %  
Absorption correction  Semi-empirical from equivalents 
Max. and min. transmission 1.0000 and 0.8578 
Refinement method  Full-matrix least-squares on F2 
Data / restraints / parameters 7932 / 90 / 640 
Goodness-of-fit on F2  1.048 
Final R indices [I>2sigma(I)] R1 = 0.0532, wR2 = 0.1427 
R indices (all data)  R1 = 0.0617, wR2 = 0.1517 
Largest diff. peak and hole 0.281 and -0.888 e/Å-3 
 
Table IV-13: Refined Positional Parameters for 17, Compound 6147 
Atom x y z Ueq,Å2 
Cr1 0.22008(4) 0.47296(4) 0.28570(2) 0.04252(15) 
C1 0.3067(2) 0.2646(2) 0.28048(12) 0.0339(5) 
C2 0.3336(2) 0.3394(2) 0.21734(13) 0.0345(5) 
C3 0.4006(2) 0.4180(2) 0.21489(13) 0.0360(5) 
C4 0.4348(2) 0.4238(2) 0.27784(13) 0.0376(5) 
C5 0.4107(2) 0.3478(2) 0.34388(13) 0.0369(5) 
C6 0.3471(2) 0.2696(2) 0.34424(13) 0.0362(5) 
C7 0.2350(2) 0.1804(2) 0.28352(12) 0.0347(5) 
C8 0.3303(2) 0.0337(2) 0.29649(12) 0.0337(5) 
C9 0.4543(2) -0.0125(2) 0.26522(12) 0.0371(5) 
C10 0.5336(2) -0.1476(2) 0.27444(13) 0.0393(5) 
C11 0.4888(2) -0.2363(2) 0.31597(13) 0.0409(6) 
C12 0.3670(3) -0.1921(3) 0.34894(15) 0.0481(6) 
C13 0.2885(2) -0.0583(2) 0.33908(14) 0.0439(6) 
O1 0.55685(18) -0.37192(16) 0.32781(10) 0.0525(5) 
C14 0.6841(3) -0.4232(3) 0.29643(17) 0.0570(7) 
C15 0.1466(2) 0.2327(2) 0.21924(12) 0.0351(5) 
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C16 0.0150(2) 0.3254(3) 0.22107(14) 0.0435(6) 
C17 -0.0650(2) 0.3838(3) 0.16226(15) 0.0496(6) 
C18 -0.0155(2) 0.3494(3) 0.09979(14) 0.0458(6) 
C19 0.1136(2) 0.2546(2) 0.09716(14) 0.0440(6) 
C20 0.1936(2) 0.1971(2) 0.15719(13) 0.0394(5) 
O2 -0.10289(19) 0.4150(2) 0.04456(10) 0.0590(5) 
C21 -0.0611(3) 0.3759(3) -0.01909(16) 0.0657(8) 
C22 0.4449(2) 0.4763(2) 0.14303(13) 0.0385(5) 
C23 0.5663(2) 0.3636(2) 0.12206(13) 0.0375(5) 
C24 0.6762(2) 0.2863(2) 0.16597(13) 0.0422(6) 
C25 0.7873(2) 0.1847(2) 0.14726(14) 0.0440(6) 
C26 0.7908(3) 0.1601(2) 0.08313(14) 0.0446(6) 
C27 0.6820(3) 0.2366(3) 0.03844(14) 0.0469(6) 
C28 0.5713(3) 0.3358(2) 0.05831(13) 0.0438(6) 
O3 0.8950(2) 0.06334(19) 0.05864(11) 0.0596(5) 
C29 1.0084(3) -0.0196(3) 0.10333(17) 0.0657(8) 
C30 0.4665(2) 0.5980(2) 0.13572(13) 0.0394(5) 
C31 0.3676(3) 0.7079(2) 0.15639(15) 0.0471(6) 
C32 0.3816(3) 0.8223(3) 0.14432(15) 0.0491(6) 
C33 0.4938(3) 0.8318(3) 0.11104(14) 0.0489(6) 
C34 0.5929(3) 0.7255(3) 0.09056(14) 0.0485(6) 
C35 0.5787(2) 0.6090(2) 0.10318(13) 0.0417(6) 
O4 0.4963(2) 0.95084(19) 0.10084(11) 0.0643(6) 
C36 0.6173(4) 0.9583(4) 0.0757(2) 0.0890(12) 
C37 0.4561(2) 0.3551(3) 0.41088(14) 0.0423(6) 
C38 0.6070(2) 0.2981(2) 0.41344(12) 0.0354(5) 
C39 0.6917(2) 0.2111(2) 0.37475(13) 0.0400(5) 
C40 0.8281(2) 0.1592(3) 0.38072(13) 0.0442(6) 
C41 0.8833(2) 0.1909(2) 0.42644(13) 0.0407(6) 
C42 0.8009(2) 0.2777(3) 0.46492(14) 0.0448(6) 
C43 0.6642(2) 0.3308(3) 0.45767(14) 0.0432(6) 
O5 1.01942(16) 0.1314(2) 0.42968(10) 0.0541(5) 
C44 1.0794(3) 0.1456(3) 0.48296(16) 0.0604(8) 
C45 0.4046(3) 0.2791(2) 0.48139(14) 0.0316(11) 
C46 0.4775(2) 0.1450(2) 0.51281(16) 0.0381(10) 
C47 0.4259(2) 0.0811(2) 0.57084(13) 0.0396(8) 
C48 0.3014(2) 0.1514(3) 0.59744(12) 0.0373(7) 
C49 0.2284(2) 0.2855(3) 0.56601(15) 0.0440(13) 
C50 0.2800(2) 0.3493(2) 0.50798(15) 0.0407(8) 
O6 0.2609(3) 0.0792(3) 0.65550(14) 0.0484(6) 
C45' 0.3826(6) 0.3302(7) 0.4657(3) 0.035(2) 
C46' 0.4359(5) 0.2021(6) 0.5095(3) 0.032(2) 
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C47' 0.3631(7) 0.1659(7) 0.5670(3) 0.053(2) 
C48' 0.2370(7) 0.2578(9) 0.5807(3) 0.050(3) 
C49' 0.1836(5) 0.3858(8) 0.5368(4) 0.066(3) 
C50' 0.2564(7) 0.4220(6) 0.4793(4) 0.053(2) 
O6' 0.1531(8) 0.2426(8) 0.6347(4) 0.078(2) 
C51 0.1482(5) 0.1391(5) 0.6849(3) 0.1000(13) 
C52 0.0789(3) 0.4580(3) 0.33658(15) 0.0486(6) 
O7 -0.0103(2) 0.4474(2) 0.37004(12) 0.0668(6) 
C53 0.1023(3) 0.5918(3) 0.21510(17) 0.0529(7) 
O8 0.0239(2) 0.6669(2) 0.17237(13) 0.0764(7) 
C54 0.1857(6) 0.5979(6) 0.3335(3) 0.0478(14) 
O9 0.1626(4) 0.6755(4) 0.3645(3) 0.0716(11) 
C54' 0.1881(17) 0.6297(16) 0.2999(8) 0.054(4) 
O9' 0.1651(10) 0.7265(9) 0.3144(7) 0.086(3) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cos γ+2U13aa*cc*cos β+2U23bb*cc*cosα] 
 
Table IV-14: Positional Parameters for Hydrogens in 17, Compound 6147 
Atom x y z Uiso,Å2 
H2 0.3071 0.3381 0.1754 0.046 
H4 0.4742 0.4784 0.2770 0.050 
H6 0.3306 0.2198 0.3870 0.048 
H7 0.1756 0.1893 0.3244 0.046 
H9 0.4852 0.0473 0.2377 0.049 
H10 0.6162 -0.1774 0.2527 0.052 
H12 0.3377 -0.2523 0.3778 0.064 
H13 0.2064 -0.0292 0.3613 0.058 
H14a 0.6761 -0.3891 0.2463 0.086 
H14b 0.7210 -0.5177 0.3085 0.086 
H14c 0.7415 -0.3974 0.3133 0.086 
H16 -0.0197 0.3485 0.2628 0.058 
H17 -0.1522 0.4463 0.1645 0.066 
H19 0.1470 0.2292 0.0559 0.058 
H20 0.2803 0.1335 0.1552 0.052 
H21a 0.0165 0.3889 -0.0367 0.099 
H21b -0.1309 0.4281 -0.0532 0.099 
H21c -0.0406 0.2844 -0.0103 0.099 
H22 0.3740 0.5034 0.1101 0.051 
H24 0.6751 0.3033 0.2089 0.056 
H25 0.8591 0.1332 0.1778 0.059 
H27 0.6840 0.2208 -0.0049 0.062 
H28 0.4985 0.3852 0.0284 0.058 
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H29a 1.0426 0.0337 0.1146 0.099 
H29b 1.0756 -0.0803 0.0795 0.099 
H29c 0.9831 -0.0679 0.1458 0.099 
H31 0.2914 0.7033 0.1786 0.063 
H32 0.3151 0.8939 0.1586 0.065 
H34 0.6688 0.7310 0.0685 0.065 
H35 0.6462 0.5373 0.0894 0.055 
H36a 0.6886 0.8908 0.1065 0.134 
H36b 0.6098 1.0433 0.0745 0.134 
H36c 0.6352 0.9458 0.0292 0.134 
H37 0.4189 0.4482 0.4106 0.056 
H37' 0.4283 0.4498 0.4025 0.056 
H39 0.6563 0.1875 0.3445 0.053 
H40 0.8832 0.1025 0.3538 0.059 
H42 0.8366 0.3004 0.4955 0.060 
H43 0.6094 0.3902 0.4833 0.057 
H44a 1.0661 0.2353 0.4728 0.091 
H44b 1.1728 0.0882 0.4846 0.091 
H44c 1.0399 0.1227 0.5276 0.091 
H46 0.5606 0.0981 0.4951 0.051 
H47 0.4746 -0.0083 0.5918 0.053 
H49 0.1454 0.3323 0.5837 0.058 
H50 0.2314 0.4387 0.4870 0.054 
H46' 0.5200 0.1409 0.5004 0.043 
H47' 0.3987 0.0806 0.5963 0.071 
H49' 0.0995 0.4470 0.5459 0.088 
H50' 0.2208 0.5074 0.4501 0.071 
H51a 0.1334 0.0769 0.7245 0.150 
H51b 0.0778 0.1766 0.6515 0.150 
H51c 0.1503 0.2079 0.7005 0.150 
H51a' 0.0713 0.1698 0.7139 0.150 
H51b' 0.2267 0.0951 0.7134 0.150 
H51c' 0.1432 0.0787 0.6632 0.150 
 
Table IV-15:  Refined Thermal Parameters (U's) for 17, Compound 6147 
Atom U11 U22 U33 U23 U13 U12 
Cr1 0.0338(2)  0.0332(2) 0.0653(3)  -0.01982(19) -0.00877(18)  -0.01221(17) 
C1 0.0295(10)  0.0285(11) 0.0458(13)  -0.0135(10) -0.0066(9)  -0.0104(9) 
C2 0.0318(11)  0.0294(11) 0.0450(13)  -0.0107(10) -0.0097(9)  -0.0125(9) 
C3 0.0310(11)  0.0268(11) 0.0510(14)  -0.0095(10) -0.0101(9)  -0.0110(9) 
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C4 0.0322(11)  0.0308(11) 0.0560(15)  -0.0166(11) -0.0089(10)  -0.0134(9) 
C5 0.0294(11)  0.0357(12) 0.0491(14)  -0.0191(10) -0.0055(9)  -0.0110(9) 
C6 0.0328(11)  0.0329(11) 0.0443(13)  -0.0142(10) -0.0041(9)  -0.0120(9) 
C7 0.0351(11)  0.0323(11) 0.0423(13)  -0.0127(10) -0.0037(9)  -0.0166(9) 
C8 0.0392(12)  0.0307(11) 0.0374(12)  -0.0103(9) -0.0064(9)  -0.0180(10) 
C9 0.0383(12)  0.0331(12) 0.0412(13)  -0.0070(10) -0.0058(9)  -0.0171(10) 
C10 0.0386(12)  0.0349(12) 0.0450(13)  -0.0119(10) -0.0051(10)  -0.0142(10) 
C11 0.0494(14)  0.0294(11) 0.0458(14)  -0.0081(10) -0.0131(10)  -0.0167(10) 
C12 0.0576(15)  0.0381(13) 0.0555(16)  -0.0090(12) 0.0001(12)  -0.0289(12) 
C13 0.0458(13)  0.0394(13) 0.0524(15)  -0.0137(11) 0.0027(11)  -0.0234(11) 
O1 0.0579(11)  0.0291(9) 0.0671(12)  -0.0091(8) -0.0066(9)  -0.0165(8) 
C14 0.0559(16)  0.0345(13) 0.0717(19)  -0.0124(13) -0.0107(14)  -0.0103(12) 
C15 0.0364(11)  0.0318(11) 0.0445(13)  -0.0092(10) -0.0065(9)  -0.0200(10) 
C16 0.0370(12)  0.0470(14) 0.0538(15)  -0.0179(12) -0.0035(10)  -0.0208(11) 
C17 0.0342(12)  0.0518(15) 0.0635(17)  -0.0142(13) -0.0100(11)  -0.0172(11) 
C18 0.0431(13)  0.0472(14) 0.0523(15)  -0.0039(12) -0.0143(11)  -0.0259(12) 
C19 0.0518(14)  0.0441(14) 0.0466(14)  -0.0103(11) -0.0071(11)  -0.0290(12) 
C20 0.0406(12)  0.0339(12) 0.0484(14)  -0.0103(10) -0.0076(10)  -0.0186(10) 
O2 0.0521(11)  0.0691(13) 0.0545(12)  -0.0036(10) -0.0210(9)  -0.0275(10) 
C21 0.0713(19)  0.078(2) 0.0526(18)  -0.0013(15) -0.0188(14)  -0.0418(17) 
C22 0.0373(12)  0.0328(12) 0.0487(14)  -0.0057(10) -0.0132(10)  -0.0177(10) 
C23 0.0396(12)  0.0307(11) 0.0464(14)  -0.0059(10) -0.0090(10)  -0.0191(10) 
C24 0.0443(13)  0.0400(13) 0.0436(14)  -0.0092(11) -0.0064(10)  -0.0191(11) 
C25 0.0428(13)  0.0380(13) 0.0480(15)  -0.0059(11) -0.0060(10)  -0.0165(11) 
C26 0.0516(14)  0.0332(12) 0.0503(15)  -0.0087(11) 0.0032(11)  -0.0219(11) 
C27 0.0627(16)  0.0409(13) 0.0444(14)  -0.0118(11) -0.0027(12)  -0.0277(12) 
C28 0.0547(14)  0.0356(12) 0.0452(14)  -0.0025(10) -0.0138(11)  -0.0243(11) 
O3 0.0613(12)  0.0501(11) 0.0567(12)  -0.0185(9) 0.0040(9)  -0.0137(9) 
C29 0.0608(18)  0.0498(16) 0.068(2)  -0.0168(15) 0.0058(15)  -0.0097(14) 
C30 0.0444(13)  0.0307(11) 0.0466(14)  -0.0030(10) -0.0165(10)  -0.0192(10) 
C31 0.0459(14)  0.0362(13) 0.0605(16)  -0.0098(12) -0.0091(11)  -0.0184(11) 
C32 0.0600(16)  0.0349(13) 0.0557(16)  -0.0090(11) -0.0088(12)  -0.0227(12) 
C33 0.0723(18)  0.0373(13) 0.0467(15)  -0.0043(11) -0.0147(12)  -0.0323(13) 
C34 0.0580(15)  0.0492(15) 0.0487(15)  -0.0039(12) -0.0123(12)  -0.0344(13) 
C35 0.0454(13)  0.0357(12) 0.0482(14)  -0.0058(10) -0.0127(10)  -0.0210(11) 
O4 0.1042(16)  0.0481(11) 0.0628(13)  -0.0112(9) -0.0015(11)  -0.0537(12) 
C36 0.135(3)  0.082(3) 0.093(3)  -0.015(2) 0.003(2)  -0.089(3) 
C37 0.0346(12)  0.0460(14) 0.0545(15)  -0.0270(12) -0.0026(10)  -0.0157(11) 
C38 0.0363(12)  0.0350(12) 0.0396(12)  -0.0106(10) -0.0043(9)  -0.0180(10) 
C39 0.0418(13)  0.0394(13) 0.0413(13)  -0.0145(10) -0.0068(10)  -0.0156(10) 
C40 0.0404(13)  0.0442(14) 0.0437(14)  -0.0133(11) -0.0021(10)  -0.0133(11) 
C41 0.0351(12)  0.0429(13) 0.0427(13)  -0.0033(11) -0.0061(10)  -0.0191(10) 
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C42 0.0430(13)  0.0516(15) 0.0499(15)  -0.0157(12) -0.0079(11)  -0.0256(12) 
C43 0.0406(13)  0.0452(13) 0.0501(14)  -0.0220(11) -0.0031(10)  -0.0177(11) 
O5 0.0344(9)  0.0664(12) 0.0574(11)  -0.0137(9) -0.0060(8)  -0.0186(9) 
C44 0.0457(15)  0.072(2) 0.0624(18)  -0.0053(15) -0.0155(13)  -0.0280(14) 
C45 0.0296(19)  0.032(3) 0.032(2)  -0.010(2) -0.0090(18)  -0.009(2) 
C46 0.028(2)  0.037(2) 0.041(2)  -0.0112(19) -0.0018(16)  -0.0062(18) 
C47 0.0343(18)  0.0391(19) 0.0406(19)  -0.0088(16) -0.0043(14)  -0.0118(15) 
C48 0.0370(18)  0.0399(19) 0.041(2)  -0.0173(16) 0.0016(15)  -0.0183(16) 
C49 0.038(2)  0.037(2) 0.056(3)  -0.023(2) 0.0065(19)  -0.0113(19) 
C50 0.041(2)  0.037(2) 0.048(2)  -0.0199(17) 0.0038(17)  -0.0151(17) 
O6 0.0519(15)  0.0502(15) 0.0486(15)  -0.0168(12) 0.0099(11)  -0.0273(12) 
C45' 0.042(5)  0.035(6) 0.030(5)  -0.011(4) -0.016(4)  -0.012(4) 
C46' 0.026(5)  0.041(6) 0.026(5)  -0.014(4) 0.000(4)  -0.010(5) 
C47' 0.060(5)  0.072(6) 0.039(5)  -0.009(5) -0.007(4)  -0.040(5) 
C48' 0.054(6)  0.083(8) 0.033(5)  -0.024(5) 0.015(4)  -0.046(6) 
C49' 0.068(6)  0.071(6) 0.060(6)  -0.035(5) 0.015(5)  -0.025(5) 
C50' 0.056(5)  0.046(5) 0.049(5)  -0.015(4) 0.000(4)  -0.014(4) 
O6' 0.081(5)  0.079(5) 0.066(5)  -0.017(4) 0.021(4)  -0.036(4) 
C51 0.111(3)  0.100(3) 0.100(3)  -0.013(3) 0.016(3)  -0.067(3) 
C52 0.0392(14)  0.0416(14) 0.0625(17)  -0.0198(12) -0.0100(12)  -0.0092(11) 
O7 0.0482(11)  0.0631(13) 0.0796(15)  -0.0163(11) 0.0047(10)  -0.0192(10) 
C53 0.0444(14)  0.0384(14) 0.0743(19)  -0.0117(13) -0.0029(13)  -0.0180(12) 
O8 0.0653(13)  0.0530(12) 0.0862(16)  0.0051(12) -0.0241(12)  -0.0128(11) 
C54 0.036(2)  0.042(3) 0.069(4)  -0.021(3) -0.010(3)  -0.013(2) 
O9 0.0586(19)  0.064(2) 0.114(3)  -0.059(3) -0.004(2)  -0.0223(18) 
C54' 0.055(6)  0.048(9) 0.063(9)  -0.022(7) -0.010(8)  -0.020(6) 
O9' 0.083(6)  0.054(6) 0.131(9)  -0.052(6) -0.002(7)  -0.021(5) 
The form of the anisotropic displacement parameter is: 
exp[-2π2(a*2U11h2+b*2U22k2+c*2U33l2+2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)] 
 
Table IV-16: Bond Distances in 17, Compound 6147, Å 
Cr1-C54'  1.816(18) Cr1-C52  1.821(3) Cr1-C53  1.834(3) 
Cr1-C54  1.851(7) Cr1-C6  2.203(2) Cr1-C4  2.218(2) 
Cr1-C2  2.220(2) Cr1-C5  2.224(2) Cr1-C1  2.224(2) 
Cr1-C3  2.265(2) C1-C2  1.392(3) C1-C6  1.430(3) 
C1-C7  1.525(3) C2-C3  1.426(3) C3-C4  1.388(3) 
C3-C22  1.519(3) C4-C5  1.427(4) C5-C6  1.401(3) 
C5-C37  1.529(3) C7-C15  1.529(3) C7-C8  1.531(3) 
C8-C9  1.385(3) C8-C13  1.390(3) C9-C10  1.397(3) 
C10-C11  1.376(4) C11-C12  1.380(4) C11-O1  1.384(3) 
C12-C13  1.382(4) O1-C14  1.419(3) C15-C20  1.381(3) 
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C15-C16  1.393(3) C16-C17  1.381(4) C17-C18  1.387(4) 
C18-O2  1.372(3) C18-C19  1.383(4) C19-C20  1.401(3) 
O2-C21  1.422(4) C22-C30  1.524(3) C22-C23  1.530(3) 
C23-C28  1.388(4) C23-C24  1.391(3) C24-C25  1.386(3) 
C25-C26  1.381(4) C26-O3  1.370(3) C26-C27  1.390(4) 
C27-C28  1.378(4) O3-C29  1.432(4) C30-C35  1.387(4) 
C30-C31  1.404(4) C31-C32  1.377(4) C32-C33  1.385(4) 
C33-O4  1.371(3) C33-C34  1.376(4) C34-C35  1.401(4) 
O4-C36  1.424(4) C37-C45'  1.324(5) C37-C38  1.525(3) 
C37-C45  1.620(3) C38-C43  1.386(3) C38-C39  1.391(3) 
C39-C40  1.383(3) C40-C41  1.386(4) C41-O5  1.373(3) 
C41-C42  1.380(4) C42-C43  1.388(3) O5-C44  1.419(3) 
C45-C46  1.3950 C45-C50  1.3950 C46-C47  1.3950 
C47-C48  1.3950 C48-O6  1.378(3) C48-C49  1.3950 
C49-C50  1.3950 O6-C51  1.299(5) C45'-C50'  1.3950 
C45'-C46'  1.3950 C46'-C47'  1.3949 C47'-C48'  1.3950 
C48'-O6'  1.361(9) C48'-C49'  1.3950 C49'-C50'  1.3950 
O6'-C51  1.348(9) C52-O7  1.166(3) C53-O8  1.158(3) 
C54-O9  1.166(7) C54'-O9'  1.165(18)   
 
Table IV-17: Bond Angles in 17, Compound 6147, ° 
C54'-Cr1-C52 96.0(5) C54'-Cr1-C53 77.9(5) C52-Cr1-C53 87.32(12) 
C54'-Cr1-C54 20.9(4) C52-Cr1-C54 82.9(2) C53-Cr1-C54 93.4(2) 
C54'-Cr1-C6 130.4(5) C52-Cr1-C6 88.49(10) C53-Cr1-C6 151.72(11) 
C54-Cr1-C6 113.75(19) C54'-Cr1-C4 88.5(5) C52-Cr1-C4 150.05(11) 
C53-Cr1-C4 122.50(11) C54-Cr1-C4 91.8(2) C6-Cr1-C4 66.66(9) 
C54'-Cr1-C2 142.0(5) C52-Cr1-C2 120.28(10) C53-Cr1-C2 92.06(11) 
C54-Cr1-C2 156.4(2) C6-Cr1-C2 66.26(8) C4-Cr1-C2 66.05(8) 
C54'-Cr1-C5 98.5(5) C52-Cr1-C5 112.70(11) C53-Cr1-C5 159.98(11) 
C54-Cr1-C5 88.70(19) C6-Cr1-C5 36.90(9) C4-Cr1-C5 37.48(9) 
C2-Cr1-C5 78.61(8) C54'-Cr1-C1 165.9(5) C52-Cr1-C1 91.44(10) 
C53-Cr1-C1 114.47(11) C54-Cr1-C1 151.28(19) C6-Cr1-C1 37.70(8) 
C4-Cr1-C1 79.14(8) C2-Cr1-C1 36.52(9) C5-Cr1-C1 67.52(8) 
C54'-Cr1-C3 106.8(5) C52-Cr1-C3 157.11(10) C53-Cr1-C3 95.56(11) 
C54-Cr1-C3 119.5(2) C6-Cr1-C3 78.23(8) C4-Cr1-C3 36.05(8) 
C2-Cr1-C3 37.07(8) C5-Cr1-C3 66.33(8) C1-Cr1-C3 66.66(8) 
C2-C1-C6 117.8(2) C2-C1-C7 122.4(2) C6-C1-C7 119.8(2) 
C2-C1-Cr1 71.61(13) C6-C1-Cr1 70.36(12) C7-C1-Cr1 128.40(14) 
C1-C2-C3 122.1(2) C1-C2-Cr1 71.88(13) C3-C2-Cr1 73.16(13) 
C4-C3-C2 118.5(2) C4-C3-C22 124.0(2) C2-C3-C22 117.0(2) 
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C4-C3-Cr1 70.15(13) C2-C3-Cr1 69.77(13) C22-C3-Cr1 138.49(15) 
C3-C4-C5 121.5(2) C3-C4-Cr1 73.79(13) C5-C4-Cr1 71.46(13) 
C6-C5-C4 118.4(2) C6-C5-C37 123.1(2) C4-C5-C37 118.5(2) 
C6-C5-Cr1 70.74(13) C4-C5-Cr1 71.06(12) C37-C5-Cr1 129.87(15) 
C5-C6-C1 121.6(2) C5-C6-Cr1 72.36(13) C1-C6-Cr1 71.94(13) 
C1-C7-C15 111.64(19) C1-C7-C8 112.27(17) C15-C7-C8 112.90(18) 
C9-C8-C13 118.2(2) C9-C8-C7 123.1(2) C13-C8-C7 118.6(2) 
C8-C9-C10 121.0(2) C11-C10-C9 119.6(2) C10-C11-C12 120.2(2) 
C10-C11-O1 124.9(2) C12-C11-O1 114.9(2) C11-C12-C13 119.9(2) 
C12-C13-C8 121.1(2) C11-O1-C14 117.4(2) C20-C15-C16 117.8(2) 
C20-C15-C7 122.6(2) C16-C15-C7 119.5(2) C17-C16-C15 121.4(2) 
C16-C17-C18 120.1(2) O2-C18-C19 125.3(3) O2-C18-C17 115.2(2) 
C19-C18-C17 119.6(2) C18-C19-C20 119.5(2) C15-C20-C19 121.5(2) 
C18-O2-C21 117.5(2) C3-C22-C30 116.4(2) C3-C22-C23 106.90(18) 
C30-C22-C23 113.4(2) C28-C23-C24 117.7(2) C28-C23-C22 121.2(2) 
C24-C23-C22 121.0(2) C25-C24-C23 121.6(2) C26-C25-C24 119.7(2) 
O3-C26-C25 125.1(2) O3-C26-C27 115.4(2) C25-C26-C27 119.5(2) 
C28-C27-C26 120.1(2) C27-C28-C23 121.4(2) C26-O3-C29 117.5(2) 
C35-C30-C31 117.5(2) C35-C30-C22 121.5(2) C31-C30-C22 120.8(2) 
C32-C31-C30 121.1(3) C31-C32-C33 120.5(3) O4-C33-C34 124.7(3) 
O4-C33-C32 115.6(3) C34-C33-C32 119.8(2) C33-C34-C35 119.6(3) 
C30-C35-C34 121.5(2) C33-O4-C36 117.0(3) C45'-C37-C38 123.4(4) 
C45'-C37-C5 111.4(4) C38-C37-C5 111.18(19) C45'-C37-C45 18.0(3) 
C38-C37-C45 109.0(2) C5-C37-C45 112.3(2) C43-C38-C39 117.6(2) 
C43-C38-C37 119.1(2) C39-C38-C37 123.3(2) C40-C39-C38 120.9(2) 
C39-C40-C41 120.6(2) O5-C41-C42 124.7(2) O5-C41-C40 115.9(2) 
C42-C41-C40 119.4(2) C41-C42-C43 119.5(2) C38-C43-C42 122.1(2) 
C41-O5-C44 117.7(2) C46-C45-C50 120.0 C46-C45-C37 121.70(16) 
C50-C45-C37 118.17(16) C45-C46-C47 120.0 C48-C47-C46 120.0 
O6-C48-C47 115.2(2) O6-C48-C49 124.8(2) C47-C48-C49 120.0 
C50-C49-C48 120.0 C45-C50-C49 120.0 C51-O6-C48 118.8(3) 
C37-C45'-C50' 123.8(4) C37-C45'-C46' 116.2(4) C50'-C45'-C46' 120.0 
C47'-C46'-C45' 120.0 C46'-C47'-C48' 120.0 O6'-C48'-C47' 128.6(7) 
O6'-C48'-C49' 111.3(7) C47'-C48'-C49' 120.0 C50'-C49'-C48' 120.0 
C49'-C50'-C45' 120.0 C51-O6'-C48' 135.1(8) O6-C51-O6' 80.1(4) 
O7-C52-Cr1 179.0(3) O8-C53-Cr1 177.3(3) O9-C54-Cr1 178.6(6) 
O9'-C54'-Cr1 174.7(15)     
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X-ray Structure Determination of 28c – Compound 6172 
Cr
C
C
C
O
O O
N
CH3
CH3
N CH3
H3C
H
 
Figure IV-11: ORTEP of 28c (Compound 6172).  Non-benzylic hydrogens omitted for clarity. 
Compound 6172, 28c, C20H22N2O3Cr, crystallizes in the triclinic space group P1
_
 with a=7.4340(3)Å, 
b=11.2179(5)Å, c=11.9275(5)Å, α=69.553(2)°, β=85.657(2)°, γ=84.310(2)°, V=926.52(7)Å3, Z=2, 
and dcalc=1.399 g/cm3 . X-ray intensity data were collected on a Bruker APEXII CCD area detector 
employing graphite-monochromated Mo-Kα radiation (λ=0.71073 Å) at a temperature of 143(1)K. 
Preliminary indexing was performed from a series of thirty-six 0.5° rotation frames with exposures of 
10 seconds. A total of 3272 frames were collected with a crystal to detector distance of 37.602 mm, 
rotation widths of 0.5° and exposures of 10 seconds (Table IV-18):  
Table IV-18: Compound 6172 (28c) data collection details. 
scan type 2θ ω φ χ frames 
φ 24.50 7.41 -347.52 28.88 739 
φ -23.00 -25.79 -313-20 73.66 701 
φ 19.50 59.55 -1.00 -26.26 692 
φ 015.50 258.48 -351.72 19.46 739 
ω 17.00 -36.93 -41.64 83.36 109 
φ 9.50 3.52 69.52 96.28 292 
 
Rotation frames were integrated using SAINT7, producing a listing of unaveraged F2 and σ(F2) values 
which were then passed to the SHELXTL8 program package for further processing and structure 
277 
 
solution. A total of 30767 reflections were measured over the ranges 1.82 ≤ θ ≤ 27.61°, -9 ≤ h ≤ 9, -
14 ≤ k ≤ 14, -15 ≤ l ≤ 15 yielding 4246 unique reflections (Rint = 0.0202). The intensity data were 
corrected for Lorentz and polarization effects and for absorption using SADABS9 (minimum and 
maximum transmission 0.6805, 0.7456). 
The structure was solved by direct methods (SHELXS-9710). Refinement was by full-matrix least 
squares based on F2 using SHELXL-97.10 All reflections were used during refinement. The weighting 
scheme used was w=1/[σ2(Fo2 )+ (0.0364P)2 + 0.4191P] where P = (Fo 2 + 2Fc2)/3. Non-hydrogen 
atoms were refined anisotropically and hydrogen atoms were refined using a riding model.  
Refinement converged to R1=0.0258 and wR2=0.0739 for 4079 observed reflections for which F > 
4σ(F) and R1=0.0269 and wR2=0.0750 and GOF =1.071 for all 4246 unique, non-zero reflections 
and 240 variables.a The maximum ∆/σ in the final cycle of least squares was 0.001 and the two most 
prominent peaks in the final difference Fourier were +0.362 and -0.261 e/Å3.  
Table IV-19 lists cell information, data collection parameters, and refinement data. Final positional 
and equivalent isotropic thermal parameters are given in Table IV-20 and Table IV-21.  Anisotropic 
thermal parameters are in Table IV-22.  Table IV-23 and Table IV-24 list bond distances and bond 
angles.  Figure IV-12 is an ORTEP6 representation of the molecule with 30% probability thermal 
ellipsoids displayed. 
                                                      
 
 
a  R1 = Σ||Fo| - |Fc|| / Σ |Fo| 
wR2 = [Σw(Fo2 - Fc2)2/Σw(Fo2)2]½ 
GOF = [Σw(Fo2 - Fc2)2/(n - p)]½ 
  where n = the number of reflections and p = the number of parameters refined. 
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Figure IV-12: ORTEP drawing of the title compound 28c with 30% probability thermal ellipsoids. 
 
Table IV-19: Summary of Structure Determination of 28c, Compound 6172 
Empirical formula   C20H22N2O3Cr 
Formula weight    390.40 
Temperature    143(1) K 
Wavelength    0.71073 Å 
Crystal system    triclinic 
Space group    P1
_
  
Cell constants:   
 a    7.4340(3) Å 
 b    11.2179(5) Å 
 c    11.9275(5) Å 
 α   69.553(2)° 
 β   85.657(2)° 
 γ   84.310(2)° 
Volume    926.52(7) Å3 
Z    2 
Density (calculated)  1.399 Mg/m3 
Absorption coefficient  0.639 mm-1 
F(000)    408 
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Crystal size   0.30 x 0.25 x 0.10 mm3 
Theta range for data collection 1.82 to 27.61° 
Index ranges   -9 ≤ h ≤ 9, -14 ≤ k ≤ 14, -15 ≤ l ≤ 15 
Reflections collected  30767 
Independent reflections  4246 [R(int) = 0.0202] 
Completeness to theta = 27.61° 98.7 %  
Absorption correction  Semi-empirical from equivalents 
Max. and min. transmission 0.7456 and 0.6805 
Refinement method  Full-matrix least-squares on F2 
Data / restraints / parameters 4246 / 0 / 240 
Goodness-of-fit on F2  1.071 
Final R indices [I>2sigma(I)] R1 = 0.0258,  wR2 = 0.0739 
R indices (all data)  R1 = 0.0269,  wR2 = 0.0750 
Largest diff. peak and hole 0.362 and -0.261 e.Å-3 
 
Table IV-20: Refined Positional Parameters for 28c, Compound 6172 
  Atom x y z Ueq, Å2 
Cr1 0.49378(2) 0.214571(19) 0.073169(17) 0.02191(7) 
C1 0.43441(15) 0.21945(12) 0.25942(10) 0.0210(2) 
C2 0.32561(17) 0.31712(13) 0.17606(11) 0.0253(2) 
C3 0.21343(17) 0.28844(14) 0.10160(12) 0.0300(3) 
C4 0.21017(18) 0.16095(15) 0.10664(13) 0.0326(3) 
C5 0.31934(19) 0.06456(14) 0.18574(12) 0.0308(3) 
C6 0.43141(17) 0.09386(12) 0.26280(11) 0.0249(2) 
C7 0.53710(16) 0.25756(11) 0.34612(11) 0.0208(2) 
C8 0.74574(18) 0.18126(13) 0.50930(12) 0.0285(3) 
C9 0.83305(18) 0.15298(14) 0.32468(13) 0.0300(3) 
C10 0.39727(16) 0.28511(11) 0.43567(11) 0.0210(2) 
C11 0.29701(17) 0.18915(12) 0.51434(11) 0.0232(2) 
C12 0.17910(17) 0.21175(12) 0.60189(11) 0.0240(2) 
C13 0.15438(17) 0.33369(12) 0.61240(11) 0.0244(2) 
C14 0.25025(18) 0.43059(12) 0.52963(12) 0.0281(3) 
C15 0.36994(17) 0.40592(12) 0.44383(12) 0.0253(2) 
C16 0.0453(2) 0.47492(15) 0.72360(15) 0.0372(3) 
C17 -0.0568(3) 0.25719(18) 0.78383(16) 0.0477(4) 
C18 0.67705(19) 0.09700(14) 0.05987(13) 0.0303(3) 
C19 0.66607(18) 0.32872(13) 0.04491(12) 0.0281(3) 
C20 0.4704(2) 0.26357(19) -0.08993(14) 0.0444(4) 
N1 0.67782(14) 0.15859(10) 0.40677(10) 0.0237(2) 
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N2 0.04007(17) 0.35707(12) 0.70029(12) 0.0353(3) 
O1 0.79650(16) 0.02648(12) 0.05139(12) 0.0484(3) 
O2 0.77713(15) 0.39915(11) 0.02784(11) 0.0427(3) 
O3 0.4601(2) 0.2934(2) -0.19190(12) 0.0808(6) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cos γ+2U13aa*cc*cos β+2U23bb*cc*cosα] 
 
Table IV-21: Positional Parameters for Hydrogens in 28c, Compound 6172 
  Atom x y z Uiso, Å2 
H2 0.3293 0.4014 0.1711 0.034 
H3 0.1412 0.3531 0.0489 0.040 
H4 0.1355 0.1413 0.0574 0.043 
H5 0.3189 -0.0192 0.1881 0.041 
H6 0.5031 0.0290 0.3157 0.033 
H7 0.5949 0.3362 0.3012 0.028 
H8a 0.8316 0.1123 0.5489 0.043 
H8b 0.6466 0.1864 0.5643 0.043 
H8c 0.8034 0.2599 0.4818 0.043 
H9a 0.8846 0.2340 0.2952 0.045 
H9b 0.7938 0.1334 0.2587 0.045 
H9c 0.9223 0.0879 0.3665 0.045 
H11 0.3094 0.1084 0.5080 0.031 
H12 0.1156 0.1456 0.6543 0.032 
H14 0.2334 0.5129 0.5322 0.037 
H15 0.4331 0.4718 0.3907 0.034 
H16a 0.1681 0.4875 0.7336 0.056 
H16b -0.0261 0.4705 0.7953 0.056 
H16c -0.0028 0.5449 0.6574 0.056 
H17a -0.1291 0.2223 0.7413 0.072 
H17b -0.1338 0.2908 0.8359 0.072 
H17c 0.0274 0.1913 0.8305 0.072 
 
Table IV-22: Refined Thermal Parameters (U's) for 28c, Compound 6172 
Atom U11 U22 U33 U23 U13 U12 
Cr1 0.01851(11) 0.02856(12) 0.01900(11) -0.00940(8) -0.00008(7) 0.00048(7) 
C1 0.0173(5) 0.0270(6) 0.0192(5) -0.0092(4) 0.0023(4) -0.0016(4) 
C2 0.0206(5) 0.0304(6) 0.0249(6) -0.0114(5) 0.0005(5) 0.0033(5) 
C3 0.0187(6) 0.0444(8) 0.0264(6) -0.0130(6) -0.0021(5) 0.0045(5) 
C4 0.0218(6) 0.0527(9) 0.0296(7) -0.0209(6) 0.0005(5) -0.0084(6) 
C5 0.0320(7) 0.0346(7) 0.0302(7) -0.0154(6) 0.0034(5) -0.0115(5) 
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C6 0.0253(6) 0.0263(6) 0.0224(6) -0.0075(5) 0.0015(5) -0.0043(5) 
C7 0.0195(5) 0.0212(5) 0.0214(5) -0.0073(4) -0.0002(4) -0.0015(4) 
C8 0.0252(6) 0.0326(7) 0.0276(6) -0.0093(5) -0.0068(5) -0.0015(5) 
C9 0.0211(6) 0.0363(7) 0.0330(7) -0.0141(6) -0.0017(5) 0.0040(5) 
C10 0.0189(5) 0.0254(6) 0.0201(5) -0.0097(4) -0.0019(4) -0.0008(4) 
C11 0.0238(6) 0.0231(5) 0.0254(6) -0.0114(5) -0.0017(5) -0.0023(4) 
C12 0.0222(6) 0.0262(6) 0.0245(6) -0.0092(5) 0.0002(5) -0.0049(4) 
C13 0.0206(5) 0.0296(6) 0.0252(6) -0.0128(5) 0.0001(5) -0.0003(5) 
C14 0.0304(6) 0.0237(6) 0.0321(7) -0.0132(5) 0.0027(5) -0.0012(5) 
C15 0.0257(6) 0.0237(6) 0.0264(6) -0.0085(5) 0.0018(5) -0.0041(5) 
C16 0.0352(7) 0.0417(8) 0.0415(8) -0.0254(7) 0.0067(6) 0.0007(6) 
C17 0.0538(10) 0.0508(10) 0.0413(9) -0.0218(7) 0.0245(8) -0.0148(8) 
C18 0.0289(6) 0.0352(7) 0.0308(7) -0.0170(6) 0.0011(5) -0.0022(5) 
C19 0.0252(6) 0.0290(6) 0.0261(6) -0.0065(5) 0.0027(5) 0.0026(5) 
C20 0.0247(7) 0.0760(12) 0.0294(7) -0.0154(7) -0.0019(6) 0.0015(7) 
N1 0.0202(5) 0.0259(5) 0.0252(5) -0.0092(4) -0.0032(4) 0.0005(4) 
N2 0.0352(6) 0.0357(6) 0.0383(7) -0.0195(5) 0.0138(5) -0.0046(5) 
O1 0.0395(6) 0.0477(7) 0.0647(8) -0.0323(6) 0.0035(6) 0.0097(5) 
O2 0.0350(6) 0.0373(6) 0.0501(7) -0.0075(5) 0.0052(5) -0.0106(5) 
O3 0.0491(8) 0.1584(18) 0.0246(6) -0.0199(8) -0.0075(6) 0.0006(9) 
The form of the anisotropic displacement parameter is: 
exp[-2π2(a*2U11h2+b*2U22k2+c*2U33l2+2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)] 
 
Table IV-23: Bond Distances in 28c, Compound 6172, Å 
Cr1-C19  1.8309(14) Cr1-C18  1.8380(14) Cr1-C20  1.8444(16) 
Cr1-C2  2.2048(12) Cr1-C3  2.2118(13) Cr1-C5  2.2151(14) 
Cr1-C4  2.2187(13) Cr1-C6  2.2339(12) Cr1-C1  2.2505(12) 
C1-C6  1.3977(17) C1-C2  1.4241(17) C1-C7  1.5258(16) 
C2-C3  1.3973(19) C3-C4  1.413(2) C4-C5  1.395(2) 
C5-C6  1.4242(18) C7-N1  1.4743(15) C7-C10  1.5217(16) 
C8-N1  1.4668(16) C9-N1  1.4669(16) C10-C15  1.3864(17) 
C10-C11  1.3936(17) C11-C12  1.3876(17) C12-C13  1.4096(17) 
C13-N2  1.3794(16) C13-C14  1.4005(18) C14-C15  1.3881(18) 
C16-N2  1.4476(19) C17-N2  1.428(2) C18-O1  1.1522(18) 
C19-O2  1.1570(18) C20-O3  1.150(2)   
 
Table IV-24: Bond Angles in 28c, Compound 6172, ° 
C19-Cr1-C18 87.46(6) C19-Cr1-C20 88.89(7) C18-Cr1-C20 88.12(7) 
C19-Cr1-C2 89.86(5) C18-Cr1-C2 152.18(6) C20-Cr1-C2 119.53(6) 
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C19-Cr1-C3 115.47(6) C18-Cr1-C3 157.07(6) C20-Cr1-C3 92.33(6) 
C2-Cr1-C3 36.89(5) C19-Cr1-C5 155.30(6) C18-Cr1-C5 92.67(6) 
C20-Cr1-C5 115.81(7) C2-Cr1-C5 78.61(5) C3-Cr1-C5 66.56(5) 
C19-Cr1-C4 152.63(6) C18-Cr1-C4 119.89(6) C20-Cr1-C4 90.77(6) 
C2-Cr1-C4 66.68(5) C3-Cr1-C4 37.19(6) C5-Cr1-C4 36.69(6) 
C19-Cr1-C6 117.98(5) C18-Cr1-C6 90.77(6) C20-Cr1-C6 153.05(7) 
C2-Cr1-C6 66.25(5) C3-Cr1-C6 78.58(5) C5-Cr1-C6 37.34(5) 
C4-Cr1-C6 66.62(5) C19-Cr1-C1 91.10(5) C18-Cr1-C1 115.08(5) 
C20-Cr1-C1 156.79(6) C2-Cr1-C1 37.26(4) C3-Cr1-C1 66.83(5) 
C5-Cr1-C1 66.52(5) C4-Cr1-C1 78.77(5) C6-Cr1-C1 36.32(4) 
C6-C1-C2 118.55(11) C6-C1-C7 123.84(11) C2-C1-C7 117.46(11) 
C6-C1-Cr1 71.20(7) C2-C1-Cr1 69.63(7) C7-C1-Cr1 134.68(8) 
C3-C2-C1 121.15(12) C3-C2-Cr1 71.83(7) C1-C2-Cr1 73.11(7) 
C2-C3-C4 119.78(12) C2-C3-Cr1 71.28(7) C4-C3-Cr1 71.67(8) 
C5-C4-C3 119.77(12) C5-C4-Cr1 71.52(8) C3-C4-Cr1 71.14(8) 
C4-C5-C6 120.29(13) C4-C5-Cr1 71.80(8) C6-C5-Cr1 72.05(7) 
C1-C6-C5 120.44(12) C1-C6-Cr1 72.49(7) C5-C6-Cr1 70.62(7) 
N1-C7-C10 111.44(10) N1-C7-C1 112.56(10) C10-C7-C1 106.87(9) 
C15-C10-C11 117.99(11) C15-C10-C7 120.80(11) C11-C10-C7 121.18(11) 
C12-C11-C10 121.29(11) C11-C12-C13 120.83(11) N2-C13-C14 121.20(12) 
N2-C13-C12 121.50(12) C14-C13-C12 117.30(11) C15-C14-C13 121.13(12) 
C10-C15-C14 121.38(12) O1-C18-Cr1 177.45(13) O2-C19-Cr1 178.84(13) 
O3-C20-Cr1 178.40(15) C8-N1-C9 107.56(10) C8-N1-C7 112.16(10) 
C9-N1-C7 111.28(10) C13-N2-C17 120.45(12) C13-N2-C16 119.72(12) 
C17-N2-C16 118.67(12)     
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X-ray Structure Determination of 41b – Compound 6146 
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Figure IV-13: ORTEP of 6146.  Thermal ellipsoids are at 50% probability. 
Compound 6146, 41b, C24H16O3F2Cr, crystallizes in the monoclinic space group C 2/c (systematic 
absences hkl: h+k=odd, and h0l: l=odd) with a=24.939(2)Å, b=7.0155(6)Å, c=22.123(2)Å, 
β=96.174(2)°, V=3848.2(6)Å3, Z=8, and dcalc=1.527 g/cm3. X-ray intensity data were collected on a 
Rigaku Mercury CCD area detector employing graphite-monochromated Mo-Kα radiation (λ=0.71073 
Å) at a temperature of 143(1)K. Preliminary indexing was performed from a series of twelve 0.5° 
rotation images with exposures of 30 seconds. A total of 860 rotation images were collected with a 
crystal to detector distance of 35 mm, a 2θ swing angle of -12°, rotation widths of 0.5° and 
exposures of 20 seconds: scan no. 1 was a φ-scan from 0° to 270° at ω = 10° and χ = 20°; scan no. 
2 was an ω-scan from -20° to 20° at χ = -90° and φ = 0°; scan no. 3 was an ω-scan from -20° to 
20° at χ = -90° and  φ = 45°; scan no. 4 was an ω-scan from -20° to 20° at χ = -90° and  φ = 135°; 
scan no. 5 was an ω-scan from -20° to 20° at χ = -90° and  φ = 225°. Rotation images were 
processed using CrystalClear1, producing a listing of unaveraged F2 and σ(F2) values which were then 
passed to the CrystalStructure2 program package for further processing and structure solution on a 
Dell Pentium 4 computer. A total of 25535 reflections were measured over the ranges 2.60 ≤ θ ≤ 
27.48°, -31 ≤ h ≤ 32, -8 ≤ k ≤ 9, -28 ≤ l ≤ 28 yielding 4388 unique reflections (Rint = 0.0245). The 
intensity data were corrected for Lorentz and polarization effects and for absorption using REQAB3 
(minimum and maximum transmission 0.8845, 1.0000). 
284 
 
The structure was solved by direct methods (SIR974). Refinement was by full-matrix least squares 
based on F2 using SHELXL-97.2 All reflections were used during refinement. The weighting scheme 
used was w=1/[σ2(Fo2 )+ 0.0527P2 + 3.9864 P = (Fo 2 + 2Fc2)/3. Non-hydrogen atoms were refined 
anisotropically and hydrogen atoms were refined using a riding model.  Refinement converged to 
R1=0.0399 and wR2=0.1019 for 3935 observed reflections for which F > 4σ(F) and R1=0.0453 and 
wR2=0.1062 and GOF =1.081 for all 4388 unique, non-zero reflections and 272 variables.a The 
maximum ∆/σ in the final cycle of least squares was 0.001 and the two most prominent peaks in the 
final difference Fourier were +0.358 and -0.456 e/Å3. 
Table IV-25 lists cell information, data collection parameters, and refinement data. Final positional 
and equivalent isotropic thermal parameters are given in Table IV-26 and Table IV-273.  Anisotropic 
thermal parameters are in Table IV-28.  Table IV-29 and Table IV-30 list bond distances and bond 
angles.  Figure IV-14 is an ORTEP6 representation of the molecule with 30% probability thermal 
ellipsoids displayed. 
 
Figure IV-14. ORTEP drawing of the title compound 41b with 30% probability thermal ellipsoids. 
                                                      
 
 
a  R1 = Σ||Fo| - |Fc|| / Σ |Fo| 
wR2 = [Σw(Fo2 - Fc2)2/Σw(Fo2)2]½ 
GOF = [Σw(Fo2 - Fc2)2/(n - p)]½ 
   where n = the number of reflections and p = the number of parameters refined. 
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Table IV-25.  Summary of Structure Determination of 41b, Compound 6146 
Empirical formula   C24H16O3F2Cr 
Formula weight    442.37 
Temperature    143(1) K 
Wavelength    0.71073 Å 
Crystal system    monoclinic 
Space group    C 2/c       
Cell constants:    
 a    24.939(2) Å 
 b    7.0155(6) Å 
 c    22.123(2) Å 
 β   96.174(2)° 
Volume    3848.2(6) Å3 
Z    8 
Density (calculated)  1.527 Mg/m3 
Absorption coefficient  0.637 mm-1 
F(000)    1808 
Crystal size   0.32 x 0.22 x 0.20 mm3 
Theta range for data collection 2.60 to 27.48°. 
Index ranges   -31 ≤ h ≤ 32, -8 ≤ k ≤ 9, -28 ≤ l ≤ 28 
Reflections collected  25535 
Independent reflections  4388 [R(int) = 0.0245] 
Completeness to theta = 27.48° 99.6 %  
Absorption correction  Semi-empirical from equivalents 
Max. and min. transmission 1.0000 and 0.8845 
Refinement method  Full-matrix least-squares on F2 
Data / restraints / parameters 4388 / 0 / 272 
Goodness-of-fit on F2  1.081 
Final R indices [I>2sigma(I)] R1 = 0.0399, wR2 = 0.1019 
R indices (all data)  R1 = 0.0453,  wR2 = 0.1062 
Largest diff. peak and hole 0.358 and -0.456 e.Å-3 
 
Table IV-26. Refined Positional Parameters for 41b, Compound 6146 
Atom x y z Ueq,Å2 
Cr1 0.363037(11) 0.61187(4) 0.496441(12) 0.02815(11) 
C1 0.40850(7) 0.7832(2) 0.43538(7) 0.0263(3) 
C2 0.42260(8) 0.8477(3) 0.49575(8) 0.0304(4) 
C3 0.38170(8) 0.9042(3) 0.53048(8) 0.0330(4) 
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C4 0.32692(8) 0.8990(3) 0.50581(8) 0.0323(4) 
C5 0.31281(7) 0.8347(3) 0.44616(8) 0.0291(4) 
C6 0.35401(7) 0.7773(2) 0.41063(7) 0.0256(3) 
C7 0.34841(7) 0.6965(3) 0.34683(7) 0.0264(3) 
C8 0.40516(7) 0.6078(3) 0.34256(8) 0.0298(4) 
C9 0.44553(7) 0.7113(3) 0.39047(8) 0.0284(4) 
C10 0.47860(7) 0.8686(3) 0.36465(8) 0.0283(4) 
C11 0.46822(8) 1.0603(3) 0.37159(9) 0.0348(4) 
C12 0.49903(8) 1.1997(3) 0.34719(10) 0.0399(5) 
C13 0.54066(8) 1.1426(3) 0.31529(9) 0.0366(4) 
C14 0.55301(8) 0.9553(3) 0.30756(10) 0.0415(5) 
C15 0.52206(8) 0.8185(3) 0.33283(9) 0.0370(4) 
C16 0.33158(7) 0.8413(3) 0.29718(8) 0.0271(4) 
C17 0.32854(8) 1.0351(3) 0.30719(9) 0.0345(4) 
C18 0.31347(8) 1.1610(3) 0.25983(10) 0.0412(5) 
C19 0.30100(8) 1.0866(3) 0.20245(9) 0.0393(5) 
C20 0.30270(8) 0.8966(3) 0.19048(9) 0.0396(5) 
C21 0.31840(8) 0.7738(3) 0.23809(8) 0.0343(4) 
C22 0.31621(8) 0.4297(3) 0.46254(10) 0.0374(4) 
C23 0.41655(8) 0.4322(3) 0.49842(9) 0.0346(4) 
C24 0.35055(10) 0.5254(3) 0.57254(10) 0.0483(5) 
F1 0.57046(5) 1.2803(2) 0.29085(6) 0.0543(3) 
F2 0.28576(5) 1.2088(2) 0.15585(6) 0.0567(4) 
O1 0.28722(7) 0.3159(2) 0.43932(9) 0.0568(4) 
O2 0.45045(6) 0.3197(2) 0.49826(8) 0.0483(4) 
O3 0.34419(11) 0.4625(3) 0.61938(8) 0.0806(7) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cos γ+2U13aa*cc*cos β+2U23bb*cc*cosα] 
 
Table IV-27. Positional Parameters for Hydrogens in 41b, Compound 6146 
Atom x y z Uiso,Å2 
H2 0.4585 0.8523 0.5120 0.040 
H3 0.3906 0.9458 0.5702 0.044 
H4 0.3002 0.9383 0.5292 0.043 
H5 0.2768 0.8298 0.4301 0.039 
H7 0.3217 0.5936 0.3445 0.035 
H8A 0.4158 0.6257 0.3021 0.040 
H8B 0.4046 0.4723 0.3511 0.040 
H9 0.4702 0.6167 0.4107 0.038 
H11 0.4399 1.0969 0.3931 0.046 
H12 0.4917 1.3284 0.3523 0.053 
H14 0.5814 0.9203 0.2859 0.055 
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H15 0.5304 0.6903 0.3285 0.049 
H17 0.3367 1.0823 0.3464 0.046 
H18 0.3119 1.2915 0.2667 0.055 
H20 0.2935 0.8504 0.1513 0.053 
H21 0.3202 0.6436 0.2305 0.046 
 
Table IV-28.   Refined Thermal Parameters (U's) for 41b, Compound 6146  
Atom U11 U22 U33 U23 U13 U12 
Cr1 0.03367(18)  0.02876(18) 0.02193(16)  0.00161(10) 0.00262(12)  0.00441(11) 
C1 0.0298(8)  0.0250(9) 0.0239(8)  0.0018(6) 0.0016(6)  0.0026(7) 
C2 0.0338(9)  0.0311(9) 0.0252(8)  -0.0007(7) -0.0017(7)  0.0008(7) 
C3 0.0456(11)  0.0307(10) 0.0222(8)  -0.0037(7) 0.0014(8)  0.0025(8) 
C4 0.0408(10)  0.0301(10) 0.0271(9)  -0.0008(7) 0.0086(8)  0.0083(8) 
C5 0.0307(8)  0.0290(9) 0.0277(8)  0.0022(7) 0.0029(7)  0.0062(7) 
C6 0.0309(8)  0.0249(8) 0.0206(7)  0.0019(6) 0.0007(6)  0.0040(7) 
C7 0.0301(8)  0.0266(9) 0.0220(8)  -0.0009(6) 0.0011(6)  0.0019(7) 
C8 0.0323(9)  0.0298(10) 0.0270(9)  -0.0034(7) 0.0017(7)  0.0051(7) 
C9 0.0296(8)  0.0304(9) 0.0247(8)  -0.0019(7) 0.0006(7)  0.0057(7) 
C10 0.0253(8)  0.0350(10) 0.0238(8)  -0.0022(7) -0.0006(6)  0.0049(7) 
C11 0.0300(9)  0.0376(10) 0.0380(10)  -0.0016(8) 0.0090(8)  0.0062(8) 
C12 0.0364(10)  0.0345(11) 0.0494(12)  0.0013(9) 0.0082(9)  0.0017(8) 
C13 0.0292(9)  0.0464(12) 0.0341(10)  -0.0013(8) 0.0030(7)  -0.0065(8) 
C14 0.0322(10)  0.0533(13) 0.0405(11)  -0.0103(10) 0.0107(8)  -0.0009(9) 
C15 0.0331(9)  0.0385(11) 0.0405(10)  -0.0088(8) 0.0085(8)  0.0037(8) 
C16 0.0239(8)  0.0332(9) 0.0242(8)  0.0017(7) 0.0025(6)  0.0012(7) 
C17 0.0392(10)  0.0337(10) 0.0298(9)  -0.0005(8) -0.0009(8)  0.0046(8) 
C18 0.0434(11)  0.0353(11) 0.0445(11)  0.0095(9) 0.0032(9)  0.0061(9) 
C19 0.0298(9)  0.0533(13) 0.0346(10)  0.0200(9) 0.0020(8)  0.0042(8) 
C20 0.0396(10)  0.0548(14) 0.0235(9)  0.0040(8) -0.0006(8)  -0.0039(9) 
C21 0.0389(10)  0.0375(10) 0.0260(8)  -0.0008(8) 0.0011(7)  -0.0029(8) 
C22 0.0380(10)  0.0332(10) 0.0404(10)  0.0064(8) 0.0006(8)  0.0067(8) 
C23 0.0367(9)  0.0360(10) 0.0301(9)  0.0024(8) -0.0014(7)  0.0005(8) 
C24 0.0712(15)  0.0381(12) 0.0380(11)  0.0022(9) 0.0165(10)  0.0069(11) 
F1 0.0470(7)  0.0568(9) 0.0619(8)  0.0016(7) 0.0177(6)  -0.0146(6) 
F2 0.0538(8)  0.0679(10) 0.0474(7)  0.0322(7) 0.0007(6)  0.0082(7) 
O1 0.0559(9)  0.0398(9) 0.0700(11)  0.0025(8) -0.0147(8)  -0.0060(8) 
O2 0.0438(8)  0.0417(9) 0.0583(10)  0.0022(7) 0.0003(7)  0.0133(7) 
O3 0.144(2)  0.0624(12) 0.0417(10)  0.0168(9) 0.0402(12)  0.0117(13) 
The form of the anisotropic displacement parameter is: 
exp[-2π2(a*2U11h2+b*2U22k2+c*2U33l2+2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)] 
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Table IV-29 Bond Distances in 41b, Compound 6146, Å 
Cr1-C23  1.833(2) Cr1-C22  1.836(2) Cr1-C24  1.847(2) 
Cr1-C1  2.2102(17) Cr1-C6  2.2157(16) Cr1-C3  2.2171(19) 
Cr1-C2  2.2246(19) Cr1-C5  2.2249(18) Cr1-C4  2.2252(18) 
C1-C6  1.410(2) C1-C2  1.418(2) C1-C9  1.514(2) 
C2-C3  1.399(3) C3-C4  1.416(3) C4-C5  1.403(3) 
C5-C6  1.418(2) C6-C7  1.513(2) C7-C16  1.522(2) 
C7-C8  1.558(2) C8-C9  1.560(2) C9-C10  1.525(3) 
C10-C11  1.381(3) C10-C15  1.399(2) C11-C12  1.388(3) 
C12-C13  1.376(3) C13-C14  1.365(3) C13-F1  1.365(2) 
C14-C15  1.386(3) C16-C17  1.381(3) C16-C21  1.396(2) 
C17-C18  1.391(3) C18-C19  1.377(3) C19-C20  1.360(3) 
C19-F2  1.363(2) C20-C21  1.384(3) C22-O1  1.159(3) 
C23-O2  1.157(2) C24-O3  1.153(3)   
 
Table IV-30. Bond Angles in 41b,  Compound 6146, ° 
C23-Cr1-C22 87.73(9) C23-Cr1-C24 86.91(10) C22-Cr1-C24 88.95(10) 
C23-Cr1-C1 88.20(8) C22-Cr1-C1 118.32(8) C24-Cr1-C1 152.07(9) 
C23-Cr1-C6 112.78(8) C22-Cr1-C6 90.74(8) C24-Cr1-C6 160.28(9) 
C1-Cr1-C6 37.15(6) C23-Cr1-C3 120.17(8) C22-Cr1-C3 152.10(8) 
C24-Cr1-C3 92.52(9) C1-Cr1-C3 66.53(7) C6-Cr1-C3 78.75(7) 
C23-Cr1-C2 91.53(8) C22-Cr1-C2 155.60(8) C24-Cr1-C2 115.38(9) 
C1-Cr1-C2 37.30(6) C6-Cr1-C2 67.11(6) C3-Cr1-C2 36.71(7) 
C23-Cr1-C5 149.82(8) C22-Cr1-C5 89.18(8) C24-Cr1-C5 123.05(9) 
C1-Cr1-C5 67.07(6) C6-Cr1-C5 37.23(6) C3-Cr1-C5 66.80(7) 
C2-Cr1-C5 79.31(7) C23-Cr1-C4 157.12(9) C22-Cr1-C4 114.97(8) 
C24-Cr1-C4 95.90(8) C1-Cr1-C4 78.69(7) C6-Cr1-C4 66.48(6) 
C3-Cr1-C4 37.18(7) C2-Cr1-C4 66.71(7) C5-Cr1-C4 36.75(7) 
C6-C1-C2 120.41(15) C6-C1-C9 111.45(14) C2-C1-C9 128.12(15) 
C6-C1-Cr1 71.63(10) C2-C1-Cr1 71.90(10) C9-C1-Cr1 127.52(12) 
C3-C2-C1 119.09(17) C3-C2-Cr1 71.35(11) C1-C2-Cr1 70.80(10) 
C2-C3-C4 120.73(16) C2-C3-Cr1 71.93(11) C4-C3-Cr1 71.72(11) 
C5-C4-C3 120.32(16) C5-C4-Cr1 71.61(10) C3-C4-Cr1 71.10(11) 
C4-C5-C6 119.31(16) C4-C5-Cr1 71.64(10) C6-C5-Cr1 71.03(10) 
C1-C6-C5 120.13(15) C1-C6-C7 111.21(14) C5-C6-C7 128.60(16) 
C1-C6-Cr1 71.21(9) C5-C6-Cr1 71.73(10) C7-C6-Cr1 126.41(12) 
C6-C7-C16 114.44(15) C6-C7-C8 102.28(13) C16-C7-C8 113.86(14) 
C7-C8-C9 107.29(14) C1-C9-C10 113.41(15) C1-C9-C8 101.90(14) 
C10-C9-C8 114.68(14) C11-C10-C15 117.71(18) C11-C10-C9 123.20(16) 
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C15-C10-C9 119.08(17) C10-C11-C12 121.64(17) C13-C12-C11 118.30(19) 
C14-C13-F1 119.47(18) C14-C13-C12 122.49(19) F1-C13-C12 118.04(19) 
C13-C14-C15 118.25(18) C14-C15-C10 121.59(19) C17-C16-C21 118.20(17) 
C17-C16-C7 123.87(16) C21-C16-C7 117.93(17) C16-C17-C18 121.32(19) 
C19-C18-C17 118.0(2) C20-C19-F2 118.8(2) C20-C19-C18 122.84(19) 
F2-C19-C18 118.4(2) C19-C20-C21 118.29(19) C20-C21-C16 121.35(19) 
O1-C22-Cr1 177.8(2) O2-C23-Cr1 178.41(18) O3-C24-Cr1 176.3(2) 
290 
 
X-ray Structure Determination of (R)-(−)-55a – Compound 6164 
      
Figure IV-15: ORTEP of (R)-(−)-55a (Compound 6164).  Non-benzylic Hydrogens are omitted for clarity. 
Compound 6164, C21H21NO4Cr, crystallizes in the monoclinic space group C2 (systematic absences 
hkl:  h+k=odd) with a=13.0670(18)Å, b=11.7445(16)Å, c=13.2607(19)Å, β=112.443(6)°, 
V=1880.9(5)Å3, Z=4, and dcalc=1.424 g/cm3 . X-ray intensity data were collected on a Bruker APEXII 
CCD area detector employing graphite-monochromated Mo-Kα radiation (λ=0.71073 Å) at a 
temperature of 143(1)K. Preliminary indexing was performed from a series of thirty-six 0.5° rotation 
frames with exposures of 5 seconds. A total of 2582 frames were collected with a crystal to detector 
distance of 37.600 mm, rotation widths of 0.5° and exposures of 5 seconds (Table IV-31):  
Table IV-31: Compound (R)-(−)-55a (6164) data collection details. 
scan type 2θ ω φ χ frames 
φ -23.000 315.83 -347.52 28.88 739 
ω -25.50 -29.49 47.91 -56.95 173 
ω 17.00 -38.50 -175.56 82.07 116 
ω 17.00 -33.20 -41.64 83.36 76 
φ -23.00 -25.79 -321.05 73.66 739 
φ 19.50 59.55 -11.29 -26.26 739 
 
Rotation frames were integrated using SAINT7, producing a listing of unaveraged F2 and σ(F2) values 
which were then passed to the SHELXTL8 program package for further processing and structure 
solution on a Dell Pentium 4 computer. A total of 22873 reflections were measured over the ranges 
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1.66 ≤ θ ≤ 27.59°, -16 ≤ h ≤ 16, -15 ≤ k ≤ 15, -17 ≤ l ≤ 17 yielding 4252 unique reflections (Rint = 
0.0256). The intensity data were corrected for Lorentz and polarization effects and for absorption 
using SADABS9 (minimum and maximum transmission 0.6459, 0.7456). 
The structure was solved by direct methods (SHELXS-9710). Refinement was by full-matrix least 
squares based on F2 using SHELXL-97.10 All reflections were used during refinement. The weighting 
scheme used was w=1/[σ2(Fo2 )+ (0.0907P)2 + 0.3133P] where P = (Fo 2 + 2Fc2)/3. Non-hydrogen 
atoms were refined anisotropically and hydrogen atoms were refined using a riding model.  
Refinement converged to R1=0.0212 and wR2=0.0611 for 4167 observed reflections for which F > 
4σ(F) and R1=0.0228 and wR2=0.0690 and GOF =1.159 for all 4252 unique, non-zero reflections 
and 246 variables.a The maximum ∆/σ in the final cycle of least squares was 0.011 and the two most 
prominent peaks in the final difference Fourier were +0.374 and -0.397 e/Å3. 
Table IV-32 lists cell information, data collection parameters, and refinement data. Final positional 
and equivalent isotropic thermal parameters are given in Table IV-33 and Table IV-34.  Anisotropic 
thermal parameters are in Table IV-35.  Table IV-36 and Table IV-37 list bond distances and bond 
angles.  Figure IV-16 is an ORTEP6 representation of the molecule with 30% probability thermal 
ellipsoids displayed. 
                                                      
 
 
a  R1 = Σ||Fo| - |Fc|| / Σ |Fo| 
wR2 = [Σw(Fo2 - Fc2)2/Σw(Fo2)2]½ 
GOF = [Σw(Fo2 - Fc2)2/(n - p)]½ 
  where n = the number of reflections and p = the number of parameters refined. 
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Figure IV-16: ORTEP drawing of the title compound (R)-(−)-55a with 30% probability thermal ellipsoids. 
 
Table IV-32: Summary of Structure Determination of (R)-(−)-55a, Compound 6164 
Empirical formula   C21H21NO4Cr 
Formula weight    403.39 
Temperature    143(1) K 
Wavelength    0.71073 Å 
Crystal system    monoclinic 
Space group    C2       
Cell constants:   
 a    13.0670(18) Å 
 b    11.7445(16) Å 
 c    13.2607(19) Å 
 β   112.443(6)° 
Volume    1880.9(5) Å3 
Z    4 
Density (calculated)  1.424 Mg/m3 
Absorption coefficient  0.635 mm-1 
F(000)    840 
Crystal size   0.30 x 0.18 x 0.12 mm3 
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Theta range for data collection 1.66 to 27.59° 
Index ranges   -16 ≤ h ≤ 16, -15 ≤ k ≤ 15, -17 ≤ l ≤ 17 
Reflections collected  22873 
Independent reflections  4252 [R(int) = 0.0256] 
Completeness to theta = 27.59° 98.9 %  
Absorption correction  Semi-empirical from equivalents 
Max. and min. transmission 0.7456 and 0.6459 
Refinement method  Full-matrix least-squares on F2 
Data / restraints / parameters 4252 / 1 / 246 
Goodness-of-fit on F2  1.159 
Final R indices [I>2sigma(I)] R1 = 0.0212,  wR2 = 0.0611 
R indices (all data)  R1 = 0.0228,  wR2 = 0.0690 
Absolute structure parameter 0.030(12) 
Largest diff. peak and hole 0.374 and -0.397 e.Å-3 
 
Table IV-33: Refined Positional Parameters for (R)-(−)-55a, Compound 6164 
  Atom x y z Ueq, Å2 
Cr1 0.216130(15) 0.59473(2) 0.844746(15) 0.01760(7) 
C1 0.35432(11) 0.57262(12) 0.77968(11) 0.0183(3) 
C2 0.35622(12) 0.68460(14) 0.82039(12) 0.0199(3) 
C3 0.36387(13) 0.70279(14) 0.92752(13) 0.0223(3) 
C4 0.36675(11) 0.60925(16) 0.99530(11) 0.0248(3) 
C5 0.36072(14) 0.49890(16) 0.95434(14) 0.0260(4) 
C6 0.35431(13) 0.48056(14) 0.84646(14) 0.0225(3) 
C7 0.37143(11) 0.55924(12) 0.67238(12) 0.0190(3) 
C8 0.35744(14) 0.43843(15) 0.51976(13) 0.0282(4) 
C9 0.30065(15) 0.33590(16) 0.45398(15) 0.0321(4) 
C10 0.14376(17) 0.3691(2) 0.49099(17) 0.0430(5) 
C11 0.19862(13) 0.47059(19) 0.56152(15) 0.0340(4) 
C12 0.49774(12) 0.55857(13) 0.70689(11) 0.0197(3) 
C13 0.55980(13) 0.46133(14) 0.75156(13) 0.0249(3) 
C14 0.67480(13) 0.46374(16) 0.78495(14) 0.0308(4) 
C15 0.72954(14) 0.56261(16) 0.77617(14) 0.0328(4) 
C16 0.66750(14) 0.65851(17) 0.73453(15) 0.0317(4) 
C17 0.55190(13) 0.65719(14) 0.69919(13) 0.0259(3) 
C18 0.85466(15) 0.5622(2) 0.8113(2) 0.0518(6) 
C19 0.13046(13) 0.47004(15) 0.84658(15) 0.0286(3) 
C20 0.10648(13) 0.63857(16) 0.71478(13) 0.0275(3) 
C21 0.14124(13) 0.67826(14) 0.91096(14) 0.0259(3) 
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N1 0.31994(10) 0.45683(11) 0.60992(10) 0.0212(2) 
O1 0.18416(10) 0.34909(12) 0.40756(10) 0.0325(3) 
O2 0.07897(12) 0.39205(12) 0.85048(15) 0.0484(4) 
O3 0.03417(11) 0.66639(16) 0.63594(11) 0.0445(4) 
O4 0.09438(12) 0.73255(13) 0.95255(13) 0.0422(3) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cos γ+2U13aa*cc*cos β+2U23bb*cc*cosα] 
 
Table IV-34: Positional Parameters for Hydrogens in (R)-(−)-55a, Compound 6164 
  Atom x y z Uiso, Å2 
H2 0.3524 0.7467 0.7755 0.027 
H3 0.3670 0.7766 0.9539 0.030 
H4 0.3726 0.6210 1.0667 0.033 
H5 0.3609 0.4370 0.9981 0.035 
H6 0.3501 0.4067 0.8199 0.030 
H7 0.3412 0.6264 0.6269 0.025 
H8a 0.4370 0.4270 0.5489 0.038 
H8b 0.3408 0.5052 0.4732 0.038 
H9a 0.3278 0.3236 0.3962 0.043 
H9b 0.3190 0.2692 0.5007 0.043 
H10a 0.1564 0.3019 0.5366 0.057 
H10b 0.0645 0.3821 0.4581 0.057 
H11a 0.1801 0.5393 0.5176 0.045 
H11b 0.1707 0.4787 0.6193 0.045 
H13 0.5246 0.3950 0.7591 0.033 
H14 0.7155 0.3982 0.8135 0.041 
H16 0.7030 0.7257 0.7297 0.042 
H17 0.5115 0.7229 0.6705 0.034 
H18a 0.8756 0.5046 0.7715 0.078 
H18b 0.8886 0.5463 0.8880 0.078 
H18c 0.8788 0.6353 0.7967 0.078 
 
Table IV-35: Refined Thermal Parameters (U's) for (R)-(−)-55a, Compound 6164 
Atom U11 U22 U33 U23 U13 U12 
Cr1 0.01573(10) 0.01960(11) 0.01721(10) -0.00149(9) 0.00601(7) 0.00030(9) 
C1 0.0133(5) 0.0229(9) 0.0166(6) -0.0023(5) 0.0032(5) 0.0012(5) 
C2 0.0167(7) 0.0222(8) 0.0193(7) 0.0014(6) 0.0050(5) 0.0006(5) 
C3 0.0189(7) 0.0232(8) 0.0229(8) -0.0054(6) 0.0059(6) -0.0012(6) 
C4 0.0193(6) 0.0369(10) 0.0155(6) -0.0023(7) 0.0036(5) 0.0009(6) 
C5 0.0225(7) 0.0302(9) 0.0245(8) 0.0083(7) 0.0080(6) 0.0058(6) 
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C6 0.0191(7) 0.0207(8) 0.0269(8) 0.0000(6) 0.0081(6) 0.0036(5) 
C7 0.0168(6) 0.0203(6) 0.0183(6) 0.0006(5) 0.0051(5) 0.0017(5) 
C8 0.0263(8) 0.0370(9) 0.0234(8) -0.0104(7) 0.0116(6) -0.0067(6) 
C9 0.0331(9) 0.0366(10) 0.0282(8) -0.0114(7) 0.0138(7) -0.0024(7) 
C10 0.0347(10) 0.0609(13) 0.0401(10) -0.0281(10) 0.0218(9) -0.0225(10) 
C11 0.0203(7) 0.0470(11) 0.0338(9) -0.0204(8) 0.0092(7) -0.0055(7) 
C12 0.0167(6) 0.0264(7) 0.0155(6) -0.0036(5) 0.0055(5) 0.0010(5) 
C13 0.0235(7) 0.0246(7) 0.0254(7) -0.0029(6) 0.0080(6) 0.0003(6) 
C14 0.0221(7) 0.0340(9) 0.0320(8) -0.0049(7) 0.0054(6) 0.0107(7) 
C15 0.0186(7) 0.0510(11) 0.0283(8) -0.0132(7) 0.0082(6) -0.0019(6) 
C16 0.0251(8) 0.0395(10) 0.0310(8) -0.0034(7) 0.0114(7) -0.0104(7) 
C17 0.0252(8) 0.0266(8) 0.0233(7) 0.0031(6) 0.0064(6) 0.0004(6) 
C18 0.0197(8) 0.0750(18) 0.0585(13) -0.0204(11) 0.0124(8) -0.0036(8) 
C19 0.0224(7) 0.0263(8) 0.0376(9) -0.0023(7) 0.0119(7) 0.0017(6) 
C20 0.0209(7) 0.0382(8) 0.0247(7) -0.0006(6) 0.0101(6) 0.0009(6) 
C21 0.0239(7) 0.0239(7) 0.0310(8) -0.0024(6) 0.0117(6) -0.0028(6) 
N1 0.0190(6) 0.0253(6) 0.0192(6) -0.0051(5) 0.0072(5) -0.0032(5) 
O1 0.0299(6) 0.0406(7) 0.0260(6) -0.0146(5) 0.0097(5) -0.0088(5) 
O2 0.0405(8) 0.0289(7) 0.0797(11) -0.0010(7) 0.0272(8) -0.0079(6) 
O3 0.0269(6) 0.0685(10) 0.0301(7) 0.0093(7) 0.0020(5) 0.0094(7) 
O4 0.0431(8) 0.0363(7) 0.0594(9) -0.0140(6) 0.0335(7) -0.0005(6) 
The form of the anisotropic displacement parameter is: 
exp[-2π2(a*2U11h2+b*2U22k2+c*2U33l2+2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)] 
 
Table IV-36: Bond Distances in (R)-(−)-55a, Compound 6164, Å 
Cr1-C21  1.8295(16) Cr1-C20  1.8447(16) Cr1-C19  1.8491(17) 
Cr1-C5  2.2027(17) Cr1-C4  2.2110(14) Cr1-C3  2.2191(16) 
Cr1-C2  2.2407(16) Cr1-C6  2.2422(16) Cr1-C1  2.2939(14) 
C1-C6  1.398(2) C1-C2  1.418(2) C1-C7  1.5304(19) 
C2-C3  1.402(2) C3-C4  1.411(2) C4-C5  1.396(3) 
C5-C6  1.417(2) C7-N1  1.4697(19) C7-C12  1.5353(19) 
C8-N1  1.4709(19) C8-C9  1.506(2) C9-O1  1.416(2) 
C10-O1  1.416(2) C10-C11  1.515(3) C11-N1  1.475(2) 
C12-C17  1.381(2) C12-C13  1.395(2) C13-C14  1.395(2) 
C14-C15  1.392(3) C15-C16  1.374(3) C15-C18  1.519(2) 
C16-C17  1.400(2) C19-O2  1.149(2) C20-O3  1.157(2) 
C21-O4  1.159(2)     
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Table IV-37: Bond Angles in (R)-(−)-55a, Compound 6164, ° 
C21-Cr1-C20 86.09(7) C21-Cr1-C19 88.91(7) C20-Cr1-C19 88.58(8) 
C21-Cr1-C5 116.01(7) C20-Cr1-C5 157.47(7) C19-Cr1-C5 87.58(7) 
C21-Cr1-C4 88.86(7) C20-Cr1-C4 158.16(7) C19-Cr1-C4 112.58(7) 
C5-Cr1-C4 36.87(7) C21-Cr1-C3 88.83(7) C20-Cr1-C3 121.42(7) 
C19-Cr1-C3 149.67(7) C5-Cr1-C3 66.47(6) C4-Cr1-C3 37.14(6) 
C21-Cr1-C2 115.64(7) C20-Cr1-C2 96.88(7) C19-Cr1-C2 155.09(7) 
C5-Cr1-C2 78.09(6) C4-Cr1-C2 66.37(6) C3-Cr1-C2 36.64(6) 
C21-Cr1-C6 153.13(7) C20-Cr1-C6 120.77(7) C19-Cr1-C6 90.89(6) 
C5-Cr1-C6 37.17(6) C4-Cr1-C6 66.49(6) C3-Cr1-C6 77.99(6) 
C2-Cr1-C6 65.43(6) C21-Cr1-C1 152.04(6) C20-Cr1-C1 97.03(6) 
C19-Cr1-C1 118.87(6) C5-Cr1-C1 65.81(6) C4-Cr1-C1 77.95(5) 
C3-Cr1-C1 65.78(5) C2-Cr1-C1 36.43(5) C6-Cr1-C1 35.87(5) 
C6-C1-C2 118.71(13) C6-C1-C7 123.03(13) C2-C1-C7 117.49(13) 
C6-C1-Cr1 70.05(8) C2-C1-Cr1 69.74(8) C7-C1-Cr1 140.96(9) 
C3-C2-C1 120.74(15) C3-C2-Cr1 70.84(9) C1-C2-Cr1 73.83(9) 
C2-C3-C4 120.08(15) C2-C3-Cr1 72.52(9) C4-C3-Cr1 71.12(9) 
C5-C4-C3 119.43(13) C5-C4-Cr1 71.24(9) C3-C4-Cr1 71.74(9) 
C4-C5-C6 120.45(15) C4-C5-Cr1 71.89(9) C6-C5-Cr1 72.93(9) 
C1-C6-C5 120.52(15) C1-C6-Cr1 74.08(8) C5-C6-Cr1 69.90(9) 
N1-C7-C1 114.21(12) N1-C7-C12 111.87(12) C1-C7-C12 104.21(11) 
N1-C8-C9 110.17(13) O1-C9-C8 112.01(14) O1-C10-C11 112.55(15) 
N1-C11-C10 111.04(15) C17-C12-C13 119.12(14) C17-C12-C7 119.77(13) 
C13-C12-C7 121.02(14) C12-C13-C14 119.95(16) C15-C14-C13 121.06(16) 
C16-C15-C14 118.31(15) C16-C15-C18 121.77(18) C14-C15-C18 119.92(18) 
C15-C16-C17 121.38(16) C12-C17-C16 120.14(16) O2-C19-Cr1 178.23(18) 
O3-C20-Cr1 176.62(14) O4-C21-Cr1 179.05(16) C7-N1-C8 110.82(12) 
C7-N1-C11 109.90(13) C8-N1-C11 107.38(12) C10-O1-C9 109.77(14) 
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X-ray Structure Determination of 62 – Compound 6168 / 6170 
 
 
Figure IV-17: ORTEP of 62 (Compound 6168).  Thermal elipsoids are at 50% probability. 
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Figure IV-18: Structure of 62, compound 6170.  Non-benzylic hydrogens are omitted for clarity. 
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Compound 6170, C30H26PNO3Cr, crystallizes in the monoclinic space group P21/c (systematic 
absences 0k0: k=odd and h0l: l=odd) with a=12.6326(12)Å, b=22.959(2)Å, c=17.7411(17)Å, 
β=90.424(5)°, V=5145.3(8)Å3, Z=8, and dcalc=1.372 g/cm3 . X-ray intensity data were collected on a 
Bruker APEXII CCD area detector employing graphite-monochromated Mo-Kα radiation (λ=0.71073 Å) 
at a temperature of 100(1)K. Preliminary indexing was performed from a series of thirty-six 0.5° 
rotation frames with exposures of 30 seconds. A total of 1153 frames were collected with a crystal to 
detector distance of 37.6008 mm, rotation widths of 0.5° and exposures of 30 seconds (Table IV-38):  
Table IV-38: Compound 6170 (62) data collection details. 
scan type 2θ ω φ χ frames 
φ 19.50 59.55 -11.29 -26.26 739 
ω 17.00 -37.62 -175.56 82.07 114 
φ -23.00 -25.79 -321.05 73.66 300 
 
Rotation frames were integrated using SAINT7, producing a listing of unaveraged F2 and σ(F2) values 
which were then passed to the SHELXTL8 program package for further processing and structure 
solution. A total of 54860 reflections were measured over the ranges 1.77 ≤ θ ≤ 27.61°, -15 ≤ h ≤ 16, 
-29 ≤ k ≤ 29, -21 ≤ l ≤ 22 yielding 11677 unique reflections (Rint = 0.0604). The intensity data were 
corrected for Lorentz and polarization effects and for absorption using SADABS (minimum and 
maximum transmission 0.5874, 0.7456). 
The structure was solved by direct methods (SHELXS-9710). Refinement was by full-matrix least 
squares based on F2 using SHELXL-97. 10 All reflections were used during refinement. The weighting 
scheme used was w=1/[σ2(Fo2 )+ (0.0548P)2 + 14.3472P] where P = (Fo 2 + 2Fc2)/3. Non-hydrogen 
atoms were refined anisotropically and hydrogen atoms were refined using a riding model.  
Refinement converged to R1=0.0676 and wR2=0.1583 for 8873 observed reflections for which F > 
4σ(F) and R1=0.0930 and wR2=0.1720 and GOF =1.078 for all 11677 unique, non-zero reflections 
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and 655 variables.a The maximum ∆/σ in the final cycle of least squares was 0.001 and the two most 
prominent peaks in the final difference Fourier were +0.464 and -1.076 e/Å3. 
Table IV-39 lists cell information, data collection parameters, and refinement data. Final positional 
and equivalent isotropic thermal parameters are given in Table IV-40 and Table IV-41.  Anisotropic 
thermal parameters are in Table IV-42.  Table IV-43 and Table IV-44 list bond distances and bond 
angles.  Figure IV-19 and Figure IV-20 are ORTEP6 representations of the molecule with 30% 
probability thermal ellipsoids displayed. 
 
Figure IV-19: ORTEP drawing of molecule no. 1 of the asymmetric unit with 30% probability thermal 
ellipsoids. 
                                                      
 
 
a  R1 = Σ||Fo| - |Fc|| / Σ |Fo| 
  wR2 = [Σw(Fo2 - Fc2)2/Σw(Fo2)2]½ 
GOF = [Σw(Fo2 - Fc2)2/(n - p)]½ 
  where n = the number of reflections and p = the number of parameters refined. 
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Figure IV-20: ORTEP drawing of molecule no. 2 of the asymmetric unit with 30% probability thermal 
ellipsoids. 
 
Table IV-39 Summary of Structure Determination of 62, Compound 6170 
Empirical formula   C30H26PNO3Cr 
Formula weight    531.49 
Temperature    100(1) K 
Wavelength    0.71073 Å 
Crystal system    monoclinic 
Space group    P21/c 
Cell constants:   
 a    12.6326(12) Å 
 b    22.959(2) Å 
 c    17.7411(17) Å 
 β   90.424(5)° 
Volume    5145.3(8) Å3 
Z    8 
Density (calculated)  1.372 Mg/m3 
Absorption coefficient  0.539 mm-1 
F(000)    2208 
Crystal size   0.32 x 0.25 x 0.05 mm3 
Theta range for data collection 1.77 to 27.61° 
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Index ranges   -15 ≤ h ≤ 16, -29 ≤ k ≤ 29, -21 ≤ l ≤ 22 
Reflections collected  54860 
Independent reflections  11677 [R(int) = 0.0604] 
Completeness to theta = 27.61° 97.7 %  
Absorption correction  Semi-empirical from equivalents 
Max. and min. transmission 0.7456 and 0.5874 
Refinement method  Full-matrix least-squares on F2 
Data / restraints / parameters 11677 / 0 / 655 
Goodness-of-fit on F2  1.078 
Final R indices [I>2sigma(I)] R1 = 0.0676,  wR2 = 0.1583 
R indices (all data)  R1 = 0.0930,  wR2 = 0.1720 
Largest diff. peak and hole 0.464 and -1.076 e.Å-3 
 
Table IV-40: Refined Positional Parameters for 62, Compound 6170 
  Atom x y z Ueq, Å2 
Cr1 0.74037(9) 0.65890(3) 0.47911(4) 0.0260(2) 
C1 0.8433(5) 0.6667(2) 0.5820(3) 0.0248(12) 
C2 0.8417(6) 0.6064(2) 0.5581(3) 0.0274(14) 
C3 0.8674(5) 0.5934(2) 0.4836(3) 0.0255(13) 
C4 0.8965(6) 0.6376(2) 0.4320(3) 0.0289(14) 
C5 0.8983(6) 0.6955(2) 0.4558(3) 0.0321(15) 
C6 0.8724(5) 0.7098(2) 0.5306(3) 0.0288(13) 
C7 0.8078(5) 0.6793(2) 0.6621(3) 0.0256(12) 
C8 0.9839(6) 0.6613(2) 0.7203(4) 0.0336(14) 
C9 0.8266(7) 0.6416(3) 0.7895(3) 0.0431(19) 
C10 0.7917(5) 0.7436(2) 0.6809(3) 0.0287(13) 
C11 0.8735(7) 0.7846(2) 0.6837(3) 0.0389(16) 
C12 0.8533(8) 0.8410(3) 0.7062(4) 0.049(2) 
C13 0.7527(9) 0.8578(3) 0.7247(4) 0.055(2) 
C14 0.6701(7) 0.8191(3) 0.7203(4) 0.050(2) 
C15 0.6906(6) 0.7612(3) 0.6989(3) 0.0385(16) 
C16 0.9368(5) 0.5275(2) 0.6614(3) 0.0251(13) 
C17 0.9443(5) 0.5043(2) 0.7333(3) 0.0290(13) 
C18 1.0419(6) 0.4901(3) 0.7660(4) 0.0370(16) 
C19 1.1317(7) 0.4983(3) 0.7258(4) 0.0390(16) 
C20 1.1274(6) 0.5207(2) 0.6545(3) 0.0306(13) 
C21 1.0290(6) 0.5354(2) 0.6226(3) 0.0318(14) 
C22 0.7710(6) 0.4866(2) 0.5624(3) 0.0278(14) 
C23 0.8367(6) 0.4384(2) 0.5541(3) 0.0286(13) 
302 
 
C24 0.7985(6) 0.3901(2) 0.5133(3) 0.0346(15) 
C25 0.6980(6) 0.3902(2) 0.4808(3) 0.0329(14) 
C26 0.6344(6) 0.4381(3) 0.4886(4) 0.0364(15) 
C27 0.6721(6) 0.4862(2) 0.5305(3) 0.0331(14) 
C28 0.6844(7) 0.7244(3) 0.4322(4) 0.0418(17) 
C29 0.6228(6) 0.6594(3) 0.5382(4) 0.0361(16) 
C30 0.6674(6) 0.6110(2) 0.4124(3) 0.0326(15) 
N1 0.8735(5) 0.6461(2) 0.7143(2) 0.0302(12) 
O1 0.6497(6) 0.7649(2) 0.4035(3) 0.0688(18) 
O2 0.5493(5) 0.6602(2) 0.5756(3) 0.0522(14) 
O3 0.6194(4) 0.58078(19) 0.3717(3) 0.0436(12) 
P1 0.80551(14) 0.54892(5) 0.62589(8) 0.0251(3) 
Cr1' 0.76283(9) 0.33838(3) -0.02722(4) 0.0252(2) 
C1' 0.6618(5) 0.3264(2) 0.0726(3) 0.0238(13) 
C2' 0.6612(5) 0.3876(2) 0.0522(3) 0.0194(11) 
C3' 0.6341(6) 0.4032(2) -0.0221(3) 0.0298(14) 
C4' 0.6063(6) 0.3616(2) -0.0768(3) 0.0313(15) 
C5' 0.6043(5) 0.3022(2) -0.0568(3) 0.0289(13) 
C6' 0.6331(5) 0.2853(2) 0.0180(3) 0.0253(12) 
C7' 0.6986(6) 0.3098(2) 0.1523(3) 0.0269(13) 
C8' 0.5218(6) 0.3282(3) 0.2075(4) 0.0375(16) 
C9' 0.6807(7) 0.3456(3) 0.2806(3) 0.0369(15) 
C10' 0.7081(6) 0.2446(2) 0.1686(3) 0.0311(14) 
C11' 0.6236(6) 0.2058(2) 0.1653(3) 0.0331(14) 
C12' 0.6379(7) 0.1484(3) 0.1864(3) 0.0393(16) 
C13' 0.7335(7) 0.1282(2) 0.2117(4) 0.0431(17) 
C14' 0.8190(7) 0.1657(3) 0.2141(4) 0.0455(18) 
C15' 0.8062(6) 0.2239(2) 0.1933(3) 0.0345(14) 
C16' 0.5690(6) 0.4627(2) 0.1583(3) 0.0278(13) 
C17' 0.5611(6) 0.4817(2) 0.2327(3) 0.0357(16) 
C18' 0.4636(6) 0.4951(3) 0.2612(4) 0.0433(18) 
C19' 0.3728(6) 0.4892(3) 0.2175(4) 0.0382(16) 
C20' 0.3795(6) 0.4705(2) 0.1439(4) 0.0371(16) 
C21' 0.4754(5) 0.4577(2) 0.1144(3) 0.0296(13) 
C22' 0.7333(6) 0.5063(2) 0.0674(3) 0.0282(14) 
C23' 0.6721(6) 0.5569(2) 0.0644(3) 0.0334(15) 
C24' 0.7084(6) 0.6065(2) 0.0279(4) 0.0391(17) 
C25' 0.8053(6) 0.6063(3) -0.0052(3) 0.0390(16) 
C26' 0.8673(7) 0.5562(3) -0.0023(4) 0.0407(17) 
C27' 0.8325(6) 0.5066(3) 0.0343(3) 0.0327(14) 
C28' 0.8232(6) 0.2765(3) -0.0761(3) 0.0358(15) 
C29' 0.8798(6) 0.3378(2) 0.0359(3) 0.0314(14) 
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C30' 0.8345(7) 0.3887(3) -0.0892(3) 0.0373(18) 
N1' 0.6338(5) 0.34307(18) 0.2054(2) 0.0270(11) 
O1' 0.8623(4) 0.2375(2) -0.1055(3) 0.0509(14) 
O2' 0.9561(5) 0.3365(2) 0.0741(3) 0.0475(13) 
O3' 0.8792(5) 0.4196(2) -0.1274(3) 0.0525(14) 
P1' 0.70019(14) 0.44188(5) 0.12531(8) 0.0257(3) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cos γ+2U13aa*cc*cos β+2U23bb*cc*cosα] 
 
Table IV-41: Positional Parameters for Hydrogens in 62, Compound 6170 
  Atom x y z Uiso, Å2 
H3 0.8654 0.5549 0.4675 0.034 
H4 0.9142 0.6281 0.3827 0.038 
H5 0.9167 0.7248 0.4222 0.043 
H6 0.8747 0.7485 0.5460 0.038 
H7 0.7373 0.6619 0.6657 0.034 
H8A 1.0128 0.6657 0.6707 0.050 
H8B 1.0213 0.6310 0.7466 0.050 
H8C 0.9911 0.6972 0.7475 0.050 
H9A 0.8219 0.6797 0.8116 0.065 
H9B 0.8703 0.6172 0.8208 0.065 
H9C 0.7571 0.6250 0.7854 0.065 
H11 0.9418 0.7737 0.6705 0.052 
H12 0.9083 0.8679 0.7089 0.065 
H13 0.7402 0.8958 0.7404 0.073 
H14 0.6015 0.8309 0.7312 0.067 
H15 0.6354 0.7345 0.6970 0.051 
H17 0.8827 0.4980 0.7606 0.039 
H18 1.0452 0.4753 0.8148 0.049 
H19 1.1968 0.4885 0.7470 0.052 
H20 1.1892 0.5261 0.6273 0.041 
H21 1.0264 0.5509 0.5741 0.042 
H22 0.7942 0.5189 0.5895 0.037 
H23 0.9045 0.4382 0.5751 0.038 
H24 0.8413 0.3574 0.5080 0.046 
H25 0.6742 0.3579 0.4538 0.044 
H26 0.5673 0.4389 0.4667 0.048 
H27 0.6286 0.5185 0.5366 0.044 
H3' 0.6347 0.4424 -0.0354 0.040 
H4' 0.5894 0.3731 -0.1257 0.042 
H5' 0.5843 0.2742 -0.0921 0.038 
H6' 0.6327 0.2460 0.0308 0.034 
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H7' 0.7705 0.3254 0.1575 0.036 
H8'1 0.5129 0.2919 0.2337 0.056 
H8'2 0.4949 0.3246 0.1570 0.056 
H8'3 0.4838 0.3583 0.2334 0.056 
H9'1 0.6444 0.3743 0.3100 0.055 
H9'2 0.7541 0.3560 0.2769 0.055 
H9'3 0.6745 0.3083 0.3044 0.055 
H11' 0.5575 0.2185 0.1489 0.044 
H12' 0.5809 0.1228 0.1833 0.052 
H13' 0.7410 0.0897 0.2271 0.057 
H14' 0.8851 0.1522 0.2296 0.061 
H15' 0.8636 0.2492 0.1960 0.046 
H17' 0.6215 0.4854 0.2626 0.048 
H18' 0.4582 0.5083 0.3106 0.058 
H19' 0.3071 0.4980 0.2379 0.051 
H20' 0.3186 0.4667 0.1146 0.049 
H21' 0.4798 0.4455 0.0646 0.039 
H22' 0.7081 0.4730 0.0912 0.038 
H23' 0.6060 0.5575 0.0872 0.044 
H24' 0.6666 0.6398 0.0260 0.052 
H25' 0.8300 0.6394 -0.0296 0.052 
H26' 0.9332 0.5560 -0.0253 0.054 
H27' 0.8753 0.4737 0.0367 0.043 
 
Table IV-42: Refined Thermal Parameters (U's) for 62, Compound 6170 
  Atom U11 U22 U33 U23 U13 U12 
Cr1 0.0409(6) 0.0173(4) 0.0197(4) 0.0001(3) -0.0003(5) -0.0009(4) 
C1 0.027(3) 0.021(2) 0.026(3) 0.000(2) 0.004(2) -0.005(2) 
C2 0.050(4) 0.017(2) 0.016(2) 0.0018(19) 0.002(3) 0.000(2) 
C3 0.035(4) 0.018(2) 0.024(3) 0.009(2) 0.005(3) 0.004(2) 
C4 0.043(4) 0.029(3) 0.014(2) 0.003(2) 0.005(3) 0.001(3) 
C5 0.050(4) 0.023(3) 0.023(3) 0.011(2) 0.007(3) -0.002(3) 
C6 0.036(4) 0.023(2) 0.027(3) -0.002(2) 0.000(3) -0.007(2) 
C7 0.034(3) 0.022(2) 0.020(2) -0.0041(18) 0.003(2) -0.005(2) 
C8 0.044(4) 0.026(3) 0.031(3) 0.004(2) -0.002(3) -0.011(3) 
C9 0.078(6) 0.027(3) 0.024(3) 0.002(2) 0.010(3) -0.011(3) 
C10 0.046(4) 0.019(2) 0.021(2) -0.0038(19) 0.003(2) -0.009(2) 
C11 0.063(5) 0.023(3) 0.031(3) -0.006(2) 0.002(3) -0.004(3) 
C12 0.085(6) 0.026(3) 0.035(3) -0.005(3) -0.008(4) -0.009(3) 
C13 0.094(7) 0.029(3) 0.040(3) -0.010(3) 0.005(4) 0.001(4) 
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C14 0.069(5) 0.037(4) 0.046(4) -0.003(3) 0.015(4) 0.014(4) 
C15 0.053(4) 0.031(3) 0.032(3) -0.002(2) 0.012(3) -0.001(3) 
C16 0.038(4) 0.015(2) 0.022(3) -0.0008(19) -0.005(2) -0.007(2) 
C17 0.035(4) 0.020(3) 0.032(3) 0.005(2) 0.001(3) -0.008(2) 
C18 0.052(5) 0.029(3) 0.030(3) 0.008(2) -0.007(3) -0.007(3) 
C19 0.054(5) 0.030(3) 0.033(3) -0.007(2) 0.001(3) -0.001(3) 
C20 0.035(4) 0.027(3) 0.031(3) -0.005(2) 0.003(3) -0.001(2) 
C21 0.047(4) 0.024(3) 0.024(3) -0.001(2) 0.002(3) -0.002(3) 
C22 0.046(4) 0.018(2) 0.019(2) 0.0017(19) 0.002(3) -0.009(2) 
C23 0.034(3) 0.024(3) 0.028(3) -0.002(2) 0.000(3) -0.002(2) 
C24 0.054(4) 0.020(2) 0.029(3) -0.005(2) 0.008(3) -0.001(3) 
C25 0.053(4) 0.018(2) 0.028(3) -0.001(2) -0.002(3) -0.010(3) 
C26 0.034(4) 0.035(3) 0.039(3) 0.000(3) -0.011(3) -0.011(3) 
C27 0.039(4) 0.024(3) 0.036(3) 0.000(2) -0.005(3) -0.001(2) 
C28 0.054(5) 0.026(3) 0.045(4) 0.005(3) -0.009(4) -0.001(3) 
C29 0.042(4) 0.033(3) 0.033(3) -0.010(2) -0.006(3) -0.007(3) 
C30 0.043(4) 0.028(3) 0.027(3) 0.000(2) 0.005(3) 0.005(3) 
N1 0.050(3) 0.024(2) 0.016(2) 0.0000(17) 0.002(2) -0.012(2) 
O1 0.089(5) 0.040(3) 0.077(4) 0.018(3) -0.020(4) 0.012(3) 
O2 0.039(3) 0.064(3) 0.054(3) -0.021(3) 0.012(3) -0.008(3) 
O3 0.055(3) 0.037(2) 0.039(2) -0.010(2) -0.007(3) -0.013(2) 
P1 0.0377(9) 0.0177(6) 0.0198(6) 0.0021(5) 0.0023(7) -0.0042(6) 
Cr1' 0.0421(6) 0.0178(4) 0.0158(4) -0.0003(3) 0.0041(4) -0.0010(4) 
C1' 0.040(4) 0.015(2) 0.017(2) 0.0042(18) 0.009(2) -0.001(2) 
C2' 0.018(3) 0.019(2) 0.021(2) -0.0044(18) 0.000(2) -0.0017(19) 
C3' 0.049(4) 0.017(2) 0.023(3) 0.006(2) 0.003(3) -0.001(2) 
C4' 0.056(5) 0.019(3) 0.019(3) 0.002(2) 0.003(3) 0.001(3) 
C5' 0.032(4) 0.030(3) 0.025(3) -0.006(2) 0.001(3) -0.004(2) 
C6' 0.031(3) 0.021(2) 0.025(3) -0.001(2) 0.001(3) -0.004(2) 
C7' 0.043(4) 0.018(2) 0.020(2) 0.0001(18) 0.006(2) -0.005(2) 
C8' 0.049(4) 0.028(3) 0.036(3) -0.007(2) 0.017(3) -0.013(3) 
C9' 0.056(4) 0.034(3) 0.020(3) 0.001(2) -0.001(3) 0.000(3) 
C10' 0.059(4) 0.019(2) 0.015(2) 0.0028(18) 0.000(3) -0.004(3) 
C11' 0.038(4) 0.027(3) 0.034(3) 0.000(2) 0.007(3) -0.004(2) 
C12' 0.061(5) 0.024(3) 0.033(3) 0.004(2) 0.006(3) -0.004(3) 
C13' 0.069(5) 0.018(2) 0.043(3) 0.006(2) 0.011(4) 0.002(3) 
C14' 0.069(5) 0.031(3) 0.036(3) 0.008(3) -0.003(4) 0.012(3) 
C15' 0.052(4) 0.025(3) 0.027(3) 0.000(2) -0.002(3) -0.003(3) 
C16' 0.043(4) 0.015(2) 0.026(3) -0.0025(19) 0.006(3) -0.004(2) 
C17' 0.056(4) 0.021(3) 0.030(3) -0.006(2) 0.010(3) -0.007(3) 
C18' 0.056(5) 0.038(3) 0.036(4) -0.012(3) 0.016(3) -0.004(3) 
C19' 0.038(4) 0.028(3) 0.049(4) -0.002(3) 0.018(3) -0.001(3) 
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C20' 0.050(4) 0.024(3) 0.038(3) 0.005(2) 0.007(3) -0.002(3) 
C21' 0.045(4) 0.020(2) 0.024(3) 0.001(2) 0.005(3) -0.003(2) 
C22' 0.046(4) 0.016(2) 0.023(2) -0.0016(19) 0.005(3) -0.009(2) 
C23' 0.055(5) 0.014(2) 0.032(3) -0.004(2) 0.009(3) -0.002(2) 
C24' 0.061(5) 0.018(2) 0.038(3) -0.003(2) 0.015(4) -0.002(3) 
C25' 0.059(5) 0.025(3) 0.033(3) 0.003(2) 0.006(3) -0.012(3) 
C26' 0.050(5) 0.032(3) 0.041(3) 0.003(3) 0.007(3) -0.010(3) 
C27' 0.035(4) 0.028(3) 0.035(3) 0.001(2) 0.001(3) -0.002(2) 
C28' 0.041(4) 0.036(3) 0.031(3) -0.002(2) 0.010(3) 0.000(3) 
C29' 0.040(4) 0.028(3) 0.026(3) 0.007(2) 0.006(3) 0.001(3) 
C30' 0.068(6) 0.027(3) 0.017(3) 0.000(2) 0.003(3) -0.002(3) 
N1' 0.042(3) 0.020(2) 0.019(2) -0.0002(16) 0.003(2) -0.002(2) 
O1' 0.056(3) 0.034(2) 0.064(3) -0.018(2) 0.021(3) 0.008(2) 
O2' 0.051(4) 0.054(3) 0.037(3) 0.013(2) 0.000(3) -0.005(3) 
O3' 0.071(4) 0.053(3) 0.034(3) 0.014(2) 0.010(3) -0.017(3) 
P1' 0.0401(9) 0.0172(6) 0.0200(6) -0.0037(5) 0.0047(7) -0.0052(6) 
The form of the anisotropic displacement parameter is: 
exp[-2π2(a*2U11h2+b*2U22k2+c*2U33l2+2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)] 
 
Table IV-43: Bond Distances in 62, Compound 6170, Å 
Cr1-C29  1.824(8) Cr1-C30  1.856(7) Cr1-C28  1.857(7) 
Cr1-C3  2.200(6) Cr1-C4  2.203(7) Cr1-C5  2.206(7) 
Cr1-C6  2.226(6) Cr1-C1  2.241(6) Cr1-C2  2.241(6) 
C1-C6  1.396(7) C1-C2  1.447(7) C1-C7  1.520(7) 
C2-C3  1.396(7) C2-P1  1.846(5) C3-C4  1.417(7) 
C4-C5  1.395(8) C5-C6  1.408(8) C7-N1  1.456(8) 
C7-C10  1.526(7) C8-N1  1.440(9) C9-N1  1.467(8) 
C10-C15  1.379(9) C10-C11  1.398(9) C11-C12  1.381(9) 
C12-C13  1.370(13) C13-C14  1.373(12) C14-C15  1.406(9) 
C16-C21  1.371(9) C16-C17  1.385(8) C16-P1  1.836(7) 
C17-C18  1.397(9) C18-C19  1.358(10) C19-C20  1.367(9) 
C20-C21  1.403(9) C22-C27  1.367(9) C22-C23  1.391(8) 
C22-P1  1.871(5) C23-C24  1.409(8) C24-C25  1.390(10) 
C25-C26  1.370(9) C26-C27  1.413(8) C28-O1  1.145(8) 
C29-O2  1.145(9) C30-O3  1.168(8) Cr1'-C28'  1.834(6) 
Cr1'-C30'  1.837(6) Cr1'-C29'  1.848(8) Cr1'-C6'  2.199(6) 
Cr1'-C3'  2.206(7) Cr1'-C1'  2.208(5) Cr1'-C2'  2.223(5) 
Cr1'-C4'  2.223(7) Cr1'-C5'  2.228(7) C1'-C6'  1.397(7) 
C1'-C2'  1.451(7) C1'-C7'  1.533(8) C2'-C3'  1.406(8) 
C2'-P1'  1.863(5) C3'-C4'  1.406(8) C4'-C5'  1.409(8) 
C5'-C6'  1.428(8) C7'-N1'  1.467(7) C7'-C10'  1.528(7) 
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C8'-N1'  1.457(9) C9'-N1'  1.457(8) C10'-C11'  1.392(9) 
C10'-C15'  1.395(10) C11'-C12'  1.382(8) C12'-C13'  1.366(11) 
C13'-C14'  1.381(11) C14'-C15'  1.396(8) C16'-C17'  1.394(8) 
C16'-C21'  1.416(9) C16'-P1'  1.825(7) C17'-C18'  1.370(10) 
C18'-C19'  1.386(11) C19'-C20'  1.378(9) C20'-C21'  1.355(10) 
C22'-C27'  1.388(9) C22'-C23'  1.397(8) C22'-P1'  1.851(5) 
C23'-C24'  1.389(8) C24'-C25'  1.362(10) C25'-C26'  1.392(10) 
C26'-C27'  1.383(8) C28'-O1'  1.148(7) C29'-O2'  1.174(8) 
C30'-O3'  1.136(8)     
 
Table IV-44: Bond Angles in 62, Compound 6170, ° 
C29-Cr1-C30 88.1(3) C29-Cr1-C28 86.8(3) C30-Cr1-C28 90.5(3) 
C29-Cr1-C3 125.4(3) C30-Cr1-C3 88.7(3) C28-Cr1-C3 147.7(3) 
C29-Cr1-C4 162.6(3) C30-Cr1-C4 93.9(3) C28-Cr1-C4 110.4(3) 
C3-Cr1-C4 37.5(2) C29-Cr1-C5 147.8(2) C30-Cr1-C5 123.5(3) 
C28-Cr1-C5 87.1(3) C3-Cr1-C5 66.8(2) C4-Cr1-C5 36.9(2) 
C29-Cr1-C6 111.8(3) C30-Cr1-C6 160.0(3) C28-Cr1-C6 92.4(3) 
C3-Cr1-C6 78.5(2) C4-Cr1-C6 66.6(2) C5-Cr1-C6 37.0(2) 
C29-Cr1-C1 90.1(3) C30-Cr1-C1 148.1(2) C28-Cr1-C1 121.2(3) 
C3-Cr1-C1 66.8(2) C4-Cr1-C1 79.1(2) C5-Cr1-C1 66.6(2) 
C6-Cr1-C1 36.43(19) C29-Cr1-C2 96.2(3) C30-Cr1-C2 111.0(2) 
C28-Cr1-C2 158.4(3) C3-Cr1-C2 36.6(2) C4-Cr1-C2 67.0(2) 
C5-Cr1-C2 79.0(2) C6-Cr1-C2 66.6(2) C1-Cr1-C2 37.67(19) 
C6-C1-C2 119.2(5) C6-C1-C7 123.8(5) C2-C1-C7 117.0(5) 
C6-C1-Cr1 71.2(4) C2-C1-Cr1 71.2(3) C7-C1-Cr1 127.1(4) 
C3-C2-C1 118.7(5) C3-C2-P1 121.6(4) C1-C2-P1 119.7(4) 
C3-C2-Cr1 70.1(3) C1-C2-Cr1 71.2(3) P1-C2-Cr1 130.5(4) 
C2-C3-C4 121.4(5) C2-C3-Cr1 73.3(4) C4-C3-Cr1 71.3(3) 
C5-C4-C3 119.3(5) C5-C4-Cr1 71.7(4) C3-C4-Cr1 71.1(4) 
C4-C5-C6 120.3(5) C4-C5-Cr1 71.4(4) C6-C5-Cr1 72.3(4) 
C1-C6-C5 121.0(5) C1-C6-Cr1 72.3(4) C5-C6-Cr1 70.7(4) 
N1-C7-C1 108.9(5) N1-C7-C10 116.3(5) C1-C7-C10 115.4(4) 
C15-C10-C11 118.6(5) C15-C10-C7 117.4(5) C11-C10-C7 124.0(6) 
C12-C11-C10 120.3(8) C13-C12-C11 120.4(7) C12-C13-C14 120.7(6) 
C13-C14-C15 119.0(8) C10-C15-C14 120.9(7) C21-C16-C17 117.5(6) 
C21-C16-P1 124.1(4) C17-C16-P1 118.4(5) C16-C17-C18 121.8(6) 
C19-C18-C17 119.2(6) C18-C19-C20 120.8(7) C19-C20-C21 119.5(7) 
C16-C21-C20 121.3(5) C27-C22-C23 119.8(5) C27-C22-P1 117.5(5) 
C23-C22-P1 122.3(5) C22-C23-C24 118.5(6) C25-C24-C23 121.4(6) 
C26-C25-C24 119.6(5) C25-C26-C27 119.0(6) C22-C27-C26 121.7(6) 
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O1-C28-Cr1 179.7(8) O2-C29-Cr1 179.3(6) O3-C30-Cr1 178.3(6) 
C8-N1-C7 117.8(5) C8-N1-C9 110.3(5) C7-N1-C9 112.6(5) 
C16-P1-C2 100.8(3) C16-P1-C22 102.0(3) C2-P1-C22 102.3(2) 
C28'-Cr1'-C30' 89.7(3) C28'-Cr1'-C29' 87.0(3) C30'-Cr1'-C29' 88.4(3) 
C28'-Cr1'-C6' 93.3(3) C30'-Cr1'-C6' 159.8(3) C29'-Cr1'-C6' 111.7(2) 
C28'-Cr1'-C3' 148.4(3) C30'-Cr1'-C3' 88.2(3) C29'-Cr1'-C3' 124.5(3) 
C6'-Cr1'-C3' 78.9(2) C28'-Cr1'-C1' 121.8(2) C30'-Cr1'-C1' 148.1(2) 
C29'-Cr1'-C1' 88.7(3) C6'-Cr1'-C1' 37.0(2) C3'-Cr1'-C1' 67.7(2) 
C28'-Cr1'-C2' 159.7(2) C30'-Cr1'-C2' 110.5(2) C29'-Cr1'-C2' 94.7(2) 
C6'-Cr1'-C2' 67.30(19) C3'-Cr1'-C2' 37.0(2) C1'-Cr1'-C2' 38.23(18) 
C28'-Cr1'-C4' 111.7(3) C30'-Cr1'-C4' 93.1(3) C29'-Cr1'-C4' 161.2(2) 
C6'-Cr1'-C4' 67.3(2) C3'-Cr1'-C4' 37.0(2) C1'-Cr1'-C4' 80.2(2) 
C2'-Cr1'-C4' 67.2(2) C28'-Cr1'-C5' 88.6(3) C30'-Cr1'-C5' 122.7(3) 
C29'-Cr1'-C5' 148.6(2) C6'-Cr1'-C5' 37.6(2) C3'-Cr1'-C5' 66.4(2) 
C1'-Cr1'-C5' 67.6(2) C2'-Cr1'-C5' 79.4(2) C4'-Cr1'-C5' 36.9(2) 
C6'-C1'-C2' 118.7(5) C6'-C1'-C7' 123.1(4) C2'-C1'-C7' 118.1(5) 
C6'-C1'-Cr1' 71.2(3) C2'-C1'-Cr1' 71.4(3) C7'-C1'-Cr1' 126.7(5) 
C3'-C2'-C1' 118.8(5) C3'-C2'-P1' 122.9(4) C1'-C2'-P1' 118.3(4) 
C3'-C2'-Cr1' 70.9(3) C1'-C2'-Cr1' 70.3(3) P1'-C2'-Cr1' 129.1(3) 
C4'-C3'-C2' 122.2(5) C4'-C3'-Cr1' 72.1(4) C2'-C3'-Cr1' 72.1(3) 
C3'-C4'-C5' 119.3(5) C3'-C4'-Cr1' 70.9(4) C5'-C4'-Cr1' 71.7(4) 
C4'-C5'-C6' 119.4(5) C4'-C5'-Cr1' 71.4(4) C6'-C5'-Cr1' 70.1(4) 
C1'-C6'-C5' 121.6(5) C1'-C6'-Cr1' 71.9(3) C5'-C6'-Cr1' 72.3(4) 
N1'-C7'-C10' 115.5(4) N1'-C7'-C1' 107.2(5) C10'-C7'-C1' 116.2(4) 
C11'-C10'-C15' 118.3(5) C11'-C10'-C7' 124.1(6) C15'-C10'-C7' 117.5(6) 
C12'-C11'-C10' 120.1(7) C13'-C12'-C11' 121.6(7) C12'-C13'-C14' 119.3(6) 
C13'-C14'-C15' 119.9(8) C10'-C15'-C14' 120.7(7) C17'-C16'-C21' 118.7(6) 
C17'-C16'-P1' 117.2(6) C21'-C16'-P1' 124.0(4) C18'-C17'-C16' 119.4(7) 
C17'-C18'-C19' 120.9(6) C20'-C19'-C18' 120.3(7) C21'-C20'-C19' 119.6(7) 
C20'-C21'-C16' 121.1(6) C27'-C22'-C23' 118.8(5) C27'-C22'-P1' 116.6(5) 
C23'-C22'-P1' 124.0(5) C24'-C23'-C22' 120.9(7) C25'-C24'-C23' 119.9(6) 
C24'-C25'-C26' 119.6(6) C27'-C26'-C25' 121.1(7) C26'-C27'-C22' 119.6(6) 
O1'-C28'-Cr1' 178.7(7) O2'-C29'-Cr1' 177.6(6) O3'-C30'-Cr1' 179.7(8) 
C8'-N1'-C9' 111.9(5) C8'-N1'-C7' 116.2(5) C9'-N1'-C7' 112.6(5) 
C16'-P1'-C22' 100.3(3) C16'-P1'-C2' 99.3(3) C22'-P1'-C2' 102.0(2) 
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X-ray Structure Determination of 63– Compound 6176 
 
Figure IV-21: Ortep of 63, (6176), ellipsoids at 50% probability. 
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Figure IV-22: Ortep of 63, compound 6176.  Hydrogens have been omitted for clarity. 
Compound 6176, C30H38PNO3Cr, crystallizes in the triclinic space group P1
_
  with a=7.9887(5)Å, 
b=12.8657(8)Å, c=14.8683(8)Å, α=82.084(3)°, β=76.229(3)°, γ=72.184(3)°, V=1409.58(15)Å3, 
Z=2, and dcalc=1.281 g/cm3 . X-ray intensity data were collected on a Bruker APEXII CCD area detector 
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employing graphite-monochromated Mo-Kα radiation (λ=0.71073 Å) at a temperature of 143(1)K. 
Preliminary indexing was performed from a series of thirty-six 0.5° rotation frames with exposures of 
10 seconds. A total of 6459 frames were collected with a crystal to detector distance of 60.000 mm, 
rotation widths of 0.5° and exposures of 10 seconds (Table IV-45):  
Table IV-45: Compound 6176 (63) data collection details. 
scan type 2θ ω φ χ frames 
φ 32.00 44.52 -7.34 -24.38 732 
ω -30.50 -48.67 -113.49 -76.00 110 
ω 17.00 118.95 -9.70 -74.54 83 
ω 37.00 19.02 -158.86 -31.86 270 
ω -25.50 -143.45 -50.02 28.88 302 
φ -20.50 38.83 -243.10 -48.25 460 
φ -25.50 14.38 -291.60 25.13 485 
φ -38.00 203.97 -294.06 59.32 554 
φ -28.00 -11.47 -25.82 -55.24 716 
φ -35.50 -32.13 -192.47 85.83 399 
ω -30.50 -203.72 39.52 96.28 100 
ω 19.50 121.66 -82.44 -97.28 150 
ω -38.00 -55.58 63.99 -90.90 135 
ω 39.50 145.10 -135.73 -99.82 139 
φ -33.00 126.21 24.24 -92.80 353 
ω 24.50 122.57 -139.95 -99.10 173 
φ -30.50 197.97 -200.70 96.28 559 
φ 39.50 188.53 -72.44 -97.28 739 
 
During preliminary investigation of the crystals under the microscope, an unusual polarization pattern 
was noticed. The crystal grew as a non-merohedral twin; the program CELL_NOW11 was used to index 
the diffraction images and to determine the twinning mechanism. The crystal was twinned by a 
rotation of 180° about the 100 direct axis.  Rotation frames were integrated using SAINT7, producing 
a listing of unaveraged F2 and σ(F2) values which were then passed to the SHELXTL8 program 
package for further processing and structure solution. A total of 49113 reflections were measured 
over the ranges 1.67 ≤ θ ≤ 27.52°, -9 ≤ h ≤ 10, -16 ≤ k ≤ 16, 0 ≤ l ≤ 19 yielding 6558 unique 
reflections (Rint = 0.0507). The intensity data were corrected for Lorentz and polarization effects and 
for absorption using TWINABS12 (minimum and maximum transmission 0.6510, 0.7456). 
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The structure was solved by direct methods (SHELXS-9710). Refinement was by full-matrix least 
squares based on F2 using SHELXL-97.10 All reflections were used during refinement. The weighting 
scheme used was w=1/[σ2(Fo2 )+ (0.0561P)2 + 0.0496P] where P = (Fo 2 + 2Fc2)/3. Non-hydrogen 
atoms were refined anisotropically and hydrogen atoms were refined using a riding model.  
Refinement converged to R1=0.0317 and wR2=0.0820 for 6076 observed reflections for which F > 
4σ(F) and R1=0.0363 and wR2=0.0841 and GOF =1.073 for all 6558 unique, non-zero reflections 
and 329 variables.a The maximum ∆/σ in the final cycle of least squares was 0.001 and the two most 
prominent peaks in the final difference Fourier were +0.465 and -0.357 e/Å3. The twinning parameter 
refined to a value of 0.3897(8). 
Table IV-46 lists cell information, data collection parameters, and refinement data. Final positional 
and equivalent isotropic thermal parameters are given in Table IV-47 and Table IV-48. Anisotropic 
thermal parameters are in Table IV-49.  Table IV-50 and Table IV-51 list bond distances and bond 
angles.  Figure IV-23 is an ORTEP6 representation of the molecule with 30% probability thermal 
ellipsoids displayed. 
 
Figure IV-23: ORTEP drawing of the title compound 63 with 30% probability thermal ellipsoids. 
                                                      
 
 
a  R1 = Σ||Fo| - |Fc|| / Σ |Fo| 
wR2 = [Σw(Fo2 - Fc2)2/Σw(Fo2)2]½ 
GOF = [Σw(Fo2 - Fc2)2/(n - p)]½ 
  where n = the number of reflections and p = the number of parameters refined. 
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Table IV-46:  Summary of Structure Determination of 63, Compound 6176 
Empirical formula   C30H38PNO3Cr  
Formula weight    543.58 
Temperature    143(1) K 
Wavelength    0.71073 Å 
Crystal system    triclinic 
Space group    P1
_
  
Cell constants:    
a    7.9887(5) Å 
b    12.8657(8) Å 
c    14.8683(8) Å 
α   82.084(3)° 
β    76.229(3)° 
γ   72.184(3)° 
Volume    1409.58(15) Å3 
Z    2 
Density (calculated)  1.281 Mg/m3 
Absorption coefficient  0.493 mm-1 
F(000)    576 
Crystal size   0.40 x 0.18 x 0.08 mm3 
Theta range for data collection 1.67 to 27.52° 
Index ranges   -9 ≤ h ≤ 10, -16 ≤ k ≤ 16, 0 ≤ l ≤ 19 
Reflections collected  49113 
Independent reflections  6558 [R(int) = 0.0507] 
Completeness to theta = 27.52° 99.8 %  
Absorption correction  Semi-empirical from equivalents 
Max. and min. transmission 0.7456 and 0.6510 
Refinement method  Full-matrix least-squares on F2 
Data / restraints / parameters 6558 / 0 / 329 
Goodness-of-fit on F2  1.073 
Final R indices [I>2sigma(I)] R1 = 0.0317, wR2 = 0.0820 
R indices (all data)  R1 = 0.0363, wR2 = 0.0841 
Largest diff. peak and hole  0.465 and -0.357 e.Å-3 
 
Table IV-47: Refined Positional Parameters for 63, Compound 6176 
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  Atom x y z Ueq, Å2 
Cr1 0.63070(4) 0.47432(2) 0.772530(17) 0.01871(8) 
C1 0.6377(3) 0.30693(13) 0.83712(11) 0.0192(3) 
C2 0.6078(2) 0.31214(14) 0.74393(12) 0.0192(3) 
C3 0.4657(3) 0.39719(15) 0.71833(13) 0.0221(4) 
C4 0.3489(3) 0.47509(16) 0.78127(14) 0.0251(4) 
C5 0.3764(3) 0.46831(15) 0.87059(13) 0.0249(4) 
C6 0.5213(3) 0.38467(15) 0.89874(12) 0.0228(4) 
C7 0.7930(3) 0.21644(14) 0.86563(11) 0.0206(4) 
C8 0.6003(4) 0.0923(2) 0.93161(16) 0.0458(6) 
C9 0.9149(4) 0.01871(17) 0.86514(17) 0.0425(6) 
C10 0.8527(3) 0.23580(14) 0.95062(12) 0.0225(4) 
C11 0.7546(3) 0.22848(16) 1.04197(12) 0.0275(4) 
C12 0.8171(3) 0.24617(16) 1.11600(13) 0.0328(5) 
C13 0.9779(3) 0.27207(16) 1.10143(14) 0.0334(5) 
C14 1.0761(3) 0.27962(16) 1.01167(14) 0.0349(4) 
C15 1.0144(3) 0.26071(17) 0.93732(13) 0.0294(4) 
C16 0.5748(3) 0.12468(15) 0.68514(14) 0.0252(4) 
C17 0.6633(3) 0.00116(17) 0.67647(17) 0.0370(5) 
C18 0.5224(4) -0.06197(19) 0.7068(2) 0.0473(6) 
C19 0.3738(4) -0.0189(2) 0.6518(2) 0.0516(7) 
C20 0.2879(3) 0.1041(2) 0.6592(2) 0.0489(6) 
C21 0.4266(3) 0.16798(19) 0.62931(16) 0.0350(5) 
C22 0.7573(3) 0.26583(15) 0.54783(11) 0.0226(4) 
C23 0.8500(3) 0.17576(16) 0.47936(12) 0.0279(4) 
C24 0.8816(3) 0.22440(19) 0.37858(13) 0.0328(5) 
C25 0.9906(3) 0.30455(19) 0.36586(13) 0.0349(5) 
C26 0.8996(4) 0.39555(18) 0.43239(13) 0.0360(5) 
C27 0.8680(3) 0.34725(16) 0.53260(11) 0.0280(4) 
C28 0.6563(3) 0.57844(18) 0.83716(13) 0.0311(4) 
C29 0.8782(3) 0.42901(15) 0.73983(13) 0.0235(4) 
C30 0.6210(3) 0.57622(15) 0.67155(13) 0.0280(4) 
N1 0.7554(3) 0.11162(11) 0.86551(10) 0.0261(3) 
O1 0.6762(3) 0.64421(16) 0.87564(12) 0.0507(5) 
O2 1.0329(2) 0.39981(13) 0.72137(10) 0.0342(3) 
O3 0.6140(3) 0.63969(13) 0.60928(11) 0.0461(4) 
P1 0.74858(6) 0.19985(4) 0.66797(3) 0.01897(10) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cos γ+2U13aa*cc*cos β+2U23bb*cc*cosα] 
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Table IV-48 Positional Parameters for Hydrogens in 63, Compound 6176 
  Atom x y z Uiso, Å2 
H3 0.4471 0.4029 0.6582 0.029 
H4 0.2547 0.5302 0.7626 0.033 
H5 0.2999 0.5186 0.9123 0.033 
H6 0.5396 0.3812 0.9587 0.030 
H7 0.8958 0.2157 0.8140 0.027 
H8a 0.6316 0.0674 0.9909 0.069 
H8b 0.5626 0.0377 0.9103 0.069 
H8c 0.5040 0.1591 0.9373 0.069 
H9a 0.8859 -0.0473 0.8609 0.064 
H9b 0.9567 0.0138 0.9214 0.064 
H9c 1.0074 0.0284 0.8129 0.064 
H11 0.6461 0.2115 1.0529 0.037 
H12 0.7506 0.2406 1.1761 0.044 
H13 1.0194 0.2842 1.1513 0.044 
H14 1.1838 0.2974 1.0011 0.046 
H15 1.0829 0.2648 0.8775 0.039 
H16 0.5126 0.1318 0.7503 0.033 
H17a 0.7240 -0.0120 0.6126 0.049 
H17b 0.7525 -0.0248 0.7149 0.049 
H18a 0.5797 -0.1390 0.6975 0.063 
H18b 0.4706 -0.0549 0.7725 0.063 
H19a 0.2825 -0.0568 0.6751 0.069 
H19b 0.4234 -0.0337 0.5871 0.069 
H20a 0.1992 0.1297 0.6205 0.065 
H20b 0.2263 0.1178 0.7229 0.065 
H21a 0.3683 0.2449 0.6389 0.047 
H21b 0.4789 0.1612 0.5637 0.047 
H22 0.6354 0.3035 0.5384 0.030 
H23a 0.9644 0.1333 0.4944 0.037 
H23b 0.7759 0.1268 0.4858 0.037 
H24a 0.9442 0.1658 0.3376 0.044 
H24b 0.7666 0.2613 0.3618 0.044 
H25a 1.0039 0.3362 0.3024 0.046 
H25b 1.1096 0.2664 0.3772 0.046 
H26a 0.9748 0.4439 0.4256 0.048 
H26b 0.7856 0.4383 0.4171 0.048 
H27a 0.8060 0.4062 0.5733 0.037 
H27b 0.9832 0.3106 0.5492 0.037 
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Table IV-49:   Refined Thermal Parameters (U's) for 63, Compound 6176 
Atom U11 U22 U33 U23 U13 U12 
Cr1 0.01881(16) 0.01728(13) 0.02139(13) -0.00128(9) -0.00471(12) -0.00672(13) 
C1 0.0179(8) 0.0174(7) 0.0228(7) 0.0009(6) -0.0029(7) -0.0076(7) 
C2 0.0169(8) 0.0192(8) 0.0226(8) -0.0017(6) -0.0027(7) -0.0078(7) 
C3 0.0210(9) 0.0204(9) 0.0281(9) -0.0019(7) -0.0086(7) -0.0080(8) 
C4 0.0178(9) 0.0192(8) 0.0381(10) 0.0000(7) -0.0053(8) -0.0062(8) 
C5 0.0194(9) 0.0193(8) 0.0330(9) -0.0056(7) 0.0002(8) -0.0037(8) 
C6 0.0233(9) 0.0224(9) 0.0221(8) -0.0017(6) -0.0016(7) -0.0078(8) 
C7 0.0203(9) 0.0209(8) 0.0196(7) 0.0021(6) -0.0023(7) -0.0076(7) 
C8 0.0601(17) 0.0476(14) 0.0365(11) -0.0002(10) 0.0052(11) -0.0381(14) 
C9 0.0589(16) 0.0207(10) 0.0481(12) 0.0021(8) -0.0235(12) -0.0038(11) 
C10 0.0256(10) 0.0180(8) 0.0224(8) 0.0009(6) -0.0078(7) -0.0031(8) 
C11 0.0286(10) 0.0242(9) 0.0267(9) 0.0023(7) -0.0070(8) -0.0042(8) 
C12 0.0442(13) 0.0244(10) 0.0214(8) -0.0028(7) -0.0062(9) 0.0022(10) 
C13 0.0451(13) 0.0245(10) 0.0319(10) -0.0068(7) -0.0182(9) -0.0016(9) 
C14 0.0370(12) 0.0335(10) 0.0413(10) -0.0042(8) -0.0171(10) -0.0129(10) 
C15 0.0288(11) 0.0320(10) 0.0279(9) -0.0015(7) -0.0060(8) -0.0093(9) 
C16 0.0222(9) 0.0231(9) 0.0320(9) -0.0076(7) -0.0009(8) -0.0104(8) 
C17 0.0351(12) 0.0211(10) 0.0569(14) -0.0101(9) -0.0043(10) -0.0117(9) 
C18 0.0528(16) 0.0292(11) 0.0647(15) -0.0119(10) 0.0000(13) -0.0240(12) 
C19 0.0473(15) 0.0536(15) 0.0669(16) -0.0243(12) 0.0023(13) -0.0352(14) 
C20 0.0295(12) 0.0543(15) 0.0723(17) -0.0162(12) -0.0075(12) -0.0225(12) 
C21 0.0244(10) 0.0357(11) 0.0507(12) -0.0095(9) -0.0101(10) -0.0123(9) 
C22 0.0223(9) 0.0247(9) 0.0214(8) -0.0021(6) -0.0061(7) -0.0062(8) 
C23 0.0261(10) 0.0312(10) 0.0283(9) -0.0086(7) -0.0028(8) -0.0101(8) 
C24 0.0303(11) 0.0467(12) 0.0239(9) -0.0110(8) -0.0039(8) -0.0122(10) 
C25 0.0380(12) 0.0447(12) 0.0217(8) -0.0023(8) -0.0008(9) -0.0152(11) 
C26 0.0477(14) 0.0344(10) 0.0240(9) 0.0033(7) -0.0046(9) -0.0137(11) 
C27 0.0381(12) 0.0302(9) 0.0199(8) -0.0006(7) -0.0048(8) -0.0173(9) 
C28 0.0285(11) 0.0387(11) 0.0284(9) -0.0094(8) 0.0018(8) -0.0157(10) 
C29 0.0307(11) 0.0206(9) 0.0218(8) 0.0033(7) -0.0066(8) -0.0122(8) 
C30 0.0245(10) 0.0269(8) 0.0357(9) 0.0009(7) -0.0120(9) -0.0087(9) 
N1 0.0320(9) 0.0182(7) 0.0280(7) 0.0025(5) -0.0046(7) -0.0100(7) 
O1 0.0518(11) 0.0618(11) 0.0513(10) -0.0312(9) 0.0052(9) -0.0348(10) 
O2 0.0207(8) 0.0401(8) 0.0402(8) 0.0059(6) -0.0045(6) -0.0114(7) 
O3 0.0456(11) 0.0417(8) 0.0528(9) 0.0247(7) -0.0210(9) -0.0188(9) 
P1 0.0166(2) 0.0190(2) 0.0220(2) -0.00243(15) -0.00335(18) -0.00619(18) 
The form of the anisotropic displacement parameter is: 
exp[-2π2(a*2U11h2+b*2U22k2+c*2U33l2+2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)] 
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Table IV-50: Bond Distances in 63, Compound 6176, Å 
Cr1-C28  1.837(2) Cr1-C29  1.844(2) Cr1-C30  1.8519(18) 
Cr1-C6  2.2035(18) Cr1-C3  2.2134(19) Cr1-C5  2.217(2) 
Cr1-C4  2.2209(19) Cr1-C1  2.2238(16) Cr1-C2  2.2545(17) 
C1-C6  1.408(2) C1-C2  1.450(2) C1-C7  1.518(2) 
C2-C3  1.401(3) C2-P1  1.8649(17) C3-C4  1.422(3) 
C4-C5  1.384(3) C5-C6  1.421(3) C7-N1  1.469(2) 
C7-C10  1.527(3) C8-N1  1.451(3) C9-N1  1.456(3) 
C10-C15  1.387(3) C10-C11  1.404(3) C11-C12  1.383(3) 
C12-C13  1.384(4) C13-C14  1.385(3) C14-C15  1.389(3) 
C16-C21  1.529(3) C16-C17  1.539(3) C16-P1  1.874(2) 
C17-C18  1.532(3) C18-C19  1.523(4) C19-C20  1.528(4) 
C20-C21  1.525(3) C22-C27  1.529(3) C22-C23  1.539(2) 
C22-P1  1.8643(17) C23-C24  1.536(3) C24-C25  1.508(3) 
C25-C26  1.528(3) C26-C27  1.527(2) C28-O1  1.152(3) 
C29-O2  1.152(3) C30-O3  1.147(2)   
 
Table IV-51: Bond Angles in 63, Compound 6176, ° 
C28-Cr1-C29 86.74(9) C28-Cr1-C30 87.42(9) C29-Cr1-C30 90.77(9) 
C28-Cr1-C6 93.77(8) C29-Cr1-C6 113.16(8) C30-Cr1-C6 156.07(9) 
C28-Cr1-C3 152.19(9) C29-Cr1-C3 120.92(8) C30-Cr1-C3 89.28(8) 
C6-Cr1-C3 78.59(7) C28-Cr1-C5 91.28(8) C29-Cr1-C5 150.43(8) 
C30-Cr1-C5 118.64(9) C6-Cr1-C5 37.49(7) C3-Cr1-C5 66.33(7) 
C28-Cr1-C4 115.06(9) C29-Cr1-C4 158.18(8) C30-Cr1-C4 91.21(9) 
C6-Cr1-C4 66.64(7) C3-Cr1-C4 37.40(7) C5-Cr1-C4 36.34(7) 
C28-Cr1-C1 121.10(8) C29-Cr1-C1 88.61(8) C30-Cr1-C1 151.37(8) 
C6-Cr1-C1 37.08(6) C3-Cr1-C1 66.84(7) C5-Cr1-C1 67.30(7) 
C4-Cr1-C1 79.38(7) C28-Cr1-C2 158.87(8) C29-Cr1-C2 92.38(7) 
C30-Cr1-C2 113.71(7) C6-Cr1-C2 67.19(6) C3-Cr1-C2 36.54(7) 
C5-Cr1-C2 79.14(6) C4-Cr1-C2 67.00(7) C1-Cr1-C2 37.79(6) 
C6-C1-C2 119.33(16) C6-C1-C7 121.94(15) C2-C1-C7 118.73(14) 
C6-C1-Cr1 70.67(10) C2-C1-Cr1 72.25(9) C7-C1-Cr1 129.69(12) 
C3-C2-C1 117.96(15) C3-C2-P1 123.46(13) C1-C2-P1 118.41(13) 
C3-C2-Cr1 70.14(10) C1-C2-Cr1 69.96(9) P1-C2-Cr1 135.46(9) 
C2-C3-C4 122.13(17) C2-C3-Cr1 73.33(10) C4-C3-Cr1 71.59(11) 
C5-C4-C3 119.51(18) C5-C4-Cr1 71.66(11) C3-C4-Cr1 71.02(11) 
C4-C5-C6 120.14(17) C4-C5-Cr1 72.00(11) C6-C5-Cr1 70.75(11) 
C1-C6-C5 120.91(17) C1-C6-Cr1 72.24(10) C5-C6-Cr1 71.76(10) 
N1-C7-C1 107.81(15) N1-C7-C10 117.23(14) C1-C7-C10 115.42(14) 
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C15-C10-C11 117.80(18) C15-C10-C7 118.36(16) C11-C10-C7 123.83(18) 
C12-C11-C10 120.9(2) C11-C12-C13 120.56(19) C12-C13-C14 119.2(2) 
C13-C14-C15 120.4(2) C10-C15-C14 121.21(19) C21-C16-C17 111.20(18) 
C21-C16-P1 117.86(14) C17-C16-P1 111.03(15) C18-C17-C16 110.72(19) 
C19-C18-C17 111.1(2) C18-C19-C20 111.3(2) C21-C20-C19 112.0(2) 
C20-C21-C16 110.48(19) C27-C22-C23 109.09(16) C27-C22-P1 109.33(12) 
C23-C22-P1 108.03(13) C24-C23-C22 111.48(16) C25-C24-C23 111.36(16) 
C24-C25-C26 110.77(18) C27-C26-C25 110.48(17) C26-C27-C22 112.66(16) 
O1-C28-Cr1 178.07(19) O2-C29-Cr1 178.51(18) O3-C30-Cr1 179.6(2) 
C8-N1-C9 112.06(18) C8-N1-C7 117.61(15) C9-N1-C7 112.38(18) 
C22-P1-C2 104.27(8) C22-P1-C16 104.80(9) C2-P1-C16 96.08(8) 
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X-ray Structure Determination of 64 – Compound 6177 
 
Figure IV-24: Crystal structure of 64, Compound 6177, including co-crystallized methylene chloride in 
the asymmetric unit.  Hydrogens are omitted for clarity.  Thermal ellipsoids are at 50% probability. 
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Figure IV-25: One molecule in 64 (6177), thermal ellipsoids at 30% probability.  Hydrogens and 
methylene chloride are omitted for clarity. 
Compound 6177 (64) C30H26Cl2CrNO3PPd•½CH2Cl2, crystallizes in the monoclinic space group P21/n 
(systematic absences 0k0: k=odd and h0l: h+l=odd) with a=9.7931(7)Å, b=36.732(3)Å, 
c=17.2211(12)Å, β=103.145(4)°, V=6032.5(8)Å3, Z=8, and dcalc=1.654 g/cm3 . X-ray intensity data 
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were collected on a Bruker APEXII CCD area detector employing graphite-monochromated Mo-Kα 
radiation (λ=0.71073 Å) at a temperature of 143(1)K. Preliminary indexing was performed from a 
series of thirty-six 0.5° rotation frames with exposures of 10 seconds. A total of 3490 frames were 
collected with a crystal to detector distance of 46.000 mm, rotation widths of 0.5° and exposures of 
10 seconds:  
Table IV-52: Compound 6177 (64) data collection details. 
scan type 2θ ω φ χ frames 
φ -25.50 -38.99 -345.79 32.61 739 
φ 17.00 -21.84 -22.08 69.08 69 
ω -23.00 -36.18 66.68 -41.06 98 
ω -20.50 10.56 -199.91 -39.24 147 
ω 32.00 -37.54 32.82 78.00 149 
φ 32.00 38.60 -71.53 75.13 242 
ω -28.00 -146.26 -242.50 57.63 254 
φ 27.00 38.57 21.50 47.18 288 
φ -28.00 -32.64 -138.81 30.75 323 
φ 32.00 128.69 -15.62 -35.57 739 
φ 32.00 -38.01 -227.10 88.14 242 
ω -20.50 -50.08 -38.09 98.49 75 
ω 12.00 -42.83 61.66 91.29 125 
 
Rotation frames were integrated using SAINT7, producing a listing of unaveraged F2 and σ(F2) values 
which were then passed to the SHELXTL8 program package for further processing and structure 
solution. A total of 160579 reflections were measured over the ranges 1.64 ≤ θ ≤ 27.63°, -12 ≤ h ≤ 
12, -47 ≤ k ≤ 47, -22 ≤ l ≤ 22 yielding 13999 unique reflections (Rint = 0.0307). The intensity data 
were corrected for Lorentz and polarization effects and for absorption using SADABS9 (minimum and 
maximum transmission 0.6517, 0.7456). 
The structure was solved by direct methods (SHELXS-9710). Refinement was by full-matrix least 
squares based on F2 using SHELXL-97.10 All reflections were used during refinement. The weighting 
scheme used was w=1/[σ2(Fo2 )+ (0.0408P)2 + 29.7477P] where P = (Fo 2 + 2Fc2)/3. Non-hydrogen 
atoms were refined anisotropically and hydrogen atoms were refined using a riding model.  
Refinement converged to R1=0.0497 and wR2=0.1252 for 13161 observed reflections for which F > 
4σ(F) and R1=0.0527 and wR2=0.1269 and GOF =1.192 for all 13999 unique, non-zero reflections 
320 
 
and 735 variables.a The maximum ∆/σ in the final cycle of least squares was 0.003 and the two most 
prominent peaks in the final difference Fourier were +3.756 and -1.669 e/Å3.  
Table IV-53 lists cell information, data collection parameters, and refinement data. Final positional 
and equivalent isotropic thermal parameters are given in Table IV-54 and Table IV-55.  Anisotropic 
thermal parameters are in Table IV-56.  Table IV-57 and Table IV-58 list bond distances and bond 
angles.  Figure IV-26 and Figure IV-27 are ORTEP6 representations of the molecule with 30% 
probability thermal ellipsoids displayed. 
 
Figure IV-26: ORTEP drawing of molecule no. 1 of the asymmetric unit with 30% probability thermal 
ellipsoids. 
                                                      
 
 
a  R1 = Σ||Fo| - |Fc|| / Σ |Fo| 
  wR2 = [Σw(Fo2 - Fc2)2/Σw(Fo2)2]½ 
  GOF = [Σw(Fo2 - Fc2)2/(n - p)]½ 
   where n = the number of reflections and p = the number of parameters refined. 
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Figure IV-27: ORTEP drawing of molecule no. 2 of the asymmetric unit with 30% probability thermal 
ellipsoids. 
 
Table IV-53: Summary of Structure Determination of 64, Compound 6177 
Empirical formula   C61H54Cl6Cr2N2O6P2Pd2 
Formula weight    1502.50 
Temperature    143(1) K 
Wavelength    0.71073 Å 
Crystal system    monoclinic 
Space group    P21/n      
Cell constants:   
a    9.7931(7) Å 
b    36.732(3) Å 
c    17.2211(12) Å 
β   103.145(4)° 
Volume    6032.5(8) Å3 
Z    4 
Density (calculated)  1.654 Mg/m3 
Absorption coefficient  1.309 mm-1 
F(000)    3016 
Crystal size   0.32 x 0.20 x 0.12 mm3 
Theta range for data collection 1.64 to 27.63° 
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Index ranges   -12 ≤ h ≤ 12, -47 ≤ k ≤ 47, -22 ≤ l ≤ 22 
Reflections collected  160579 
Independent reflections  13999 [R(int) = 0.0307] 
Completeness to theta = 27.63° 99.7 %  
Absorption correction  Semi-empirical from equivalents 
Max. and min. transmission 0.7456 and 0.6517 
Refinement method  Full-matrix least-squares on F2 
Data / restraints / parameters 13999 / 0 / 735 
Goodness-of-fit on F2  1.192 
Final R indices [I>2sigma(I)] R1 = 0.0497, wR2 = 0.1252 
R indices (all data)  R1 = 0.0527, wR2 = 0.1269 
Largest diff. peak and hole  3.756 and -1.669 e.Å-3 
 
Table IV-54: Refined Positional Parameters for 64, Compound 6177 
  Atom x y z Ueq, Å2 
Pd1 0.56114(3) 0.158899(8) 0.670998(18) 0.01752(8) 
Cl1 0.80145(11) 0.16557(4) 0.67748(8) 0.0388(3) 
Cl2 0.53142(11) 0.21712(3) 0.62333(7) 0.0267(2) 
Cr1 0.17618(7) 0.077934(18) 0.74675(4) 0.02058(14) 
P1 0.32745(10) 0.15850(3) 0.65251(6) 0.01605(18) 
N1 0.5844(4) 0.10813(10) 0.7300(2) 0.0223(7) 
C1 0.3361(4) 0.08107(11) 0.6707(2) 0.0190(7) 
C2 0.2536(4) 0.11309(10) 0.6583(2) 0.0174(7) 
C3 0.1038(4) 0.10962(11) 0.6380(2) 0.0209(8) 
C4 0.0379(4) 0.07568(12) 0.6267(3) 0.0249(8) 
C5 0.1214(5) 0.04377(12) 0.6401(3) 0.0260(9) 
C6 0.2677(5) 0.04646(11) 0.6621(3) 0.0237(8) 
C7 0.4958(4) 0.07776(11) 0.6868(3) 0.0220(8) 
C8 0.5524(5) 0.11534(13) 0.8094(3) 0.0278(9) 
C9 0.7322(5) 0.09438(15) 0.7482(3) 0.0359(11) 
C10 0.5379(4) 0.06846(12) 0.6087(3) 0.0234(8) 
C11 0.5126(5) 0.09218(12) 0.5441(3) 0.0267(9) 
C12 0.5484(6) 0.08286(14) 0.4735(3) 0.0337(10) 
C13 0.6100(6) 0.04974(14) 0.4661(3) 0.0381(11) 
C14 0.6397(7) 0.02658(15) 0.5309(4) 0.0496(16) 
C15 0.6025(6) 0.03556(14) 0.6015(3) 0.0414(13) 
C16 0.2360(4) 0.17207(11) 0.5528(2) 0.0192(7) 
C17 0.2075(4) 0.14662(12) 0.4912(3) 0.0239(8) 
C18 0.1527(5) 0.15744(14) 0.4125(3) 0.0314(10) 
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C19 0.1257(5) 0.19390(15) 0.3958(3) 0.0362(11) 
C20 0.1506(5) 0.21934(13) 0.4568(3) 0.0341(11) 
C21 0.2054(5) 0.20874(12) 0.5347(3) 0.0261(9) 
C22 0.2672(4) 0.18847(10) 0.7213(2) 0.0191(7) 
C23 0.1259(4) 0.19730(12) 0.7110(3) 0.0265(9) 
C24 0.0822(5) 0.21866(12) 0.7671(3) 0.0305(10) 
C25 0.1790(5) 0.23275(13) 0.8309(3) 0.0309(10) 
C26 0.3196(5) 0.22504(14) 0.8408(3) 0.0339(10) 
C27 0.3642(4) 0.20257(12) 0.7861(3) 0.0269(9) 
C28 0.3078(5) 0.06467(13) 0.8376(3) 0.0303(9) 
C29 0.1275(5) 0.11576(13) 0.8085(3) 0.0293(9) 
C30 0.0526(5) 0.04921(13) 0.7859(3) 0.0296(9) 
O1 0.3856(4) 0.05668(11) 0.8957(2) 0.0433(9) 
O2 0.0964(5) 0.13702(10) 0.8485(2) 0.0446(9) 
O3 -0.0233(4) 0.03081(11) 0.8093(3) 0.0449(9) 
Pd1' 0.53953(3) 0.082469(8) 0.217642(18) 0.01978(8) 
Cl1' 0.34817(11) 0.10238(3) 0.26056(7) 0.0327(2) 
Cl2' 0.47738(13) 0.02239(3) 0.24554(8) 0.0371(3) 
Cr1' 0.83350(7) 0.165431(18) 0.07867(4) 0.02058(14) 
P1' 0.58848(10) 0.14133(3) 0.21461(6) 0.01730(19) 
N1' 0.6980(4) 0.06693(9) 0.1582(2) 0.0207(7) 
C1' 0.8540(4) 0.12502(11) 0.1789(2) 0.0182(7) 
C2' 0.7547(4) 0.15165(11) 0.1879(2) 0.0181(7) 
C3' 0.7933(5) 0.18941(11) 0.1883(2) 0.0235(8) 
C4' 0.9263(5) 0.20010(12) 0.1822(2) 0.0256(9) 
C5' 1.0264(4) 0.17360(13) 0.1737(2) 0.0265(9) 
C6' 0.9895(4) 0.13698(12) 0.1706(2) 0.0226(8) 
C7' 0.8406(4) 0.08376(11) 0.1838(2) 0.0192(7) 
C8' 0.6360(5) 0.07596(13) 0.0726(2) 0.0278(9) 
C9' 0.7215(5) 0.02677(12) 0.1606(3) 0.0299(9) 
C10' 0.9188(4) 0.07133(10) 0.2672(2) 0.0197(7) 
C11' 0.8636(4) 0.07492(12) 0.3340(2) 0.0238(8) 
C12' 0.9420(5) 0.06508(13) 0.4088(3) 0.0302(9) 
C13' 1.0774(5) 0.05215(13) 0.4172(3) 0.0318(10) 
C14' 1.1332(5) 0.04841(13) 0.3513(3) 0.0311(10) 
C15' 1.0539(5) 0.05763(12) 0.2764(3) 0.0255(8) 
C16' 0.6209(4) 0.16148(11) 0.3129(2) 0.0200(7) 
C17' 0.7578(4) 0.16162(12) 0.3611(3) 0.0247(8) 
C18' 0.7820(5) 0.17393(14) 0.4390(3) 0.0308(10) 
C19' 0.6728(5) 0.18680(13) 0.4697(3) 0.0306(10) 
C20' 0.5372(5) 0.18736(12) 0.4224(3) 0.0289(9) 
C21' 0.5110(4) 0.17453(12) 0.3449(3) 0.0251(8) 
324 
 
C22' 0.4556(4) 0.16850(12) 0.1500(2) 0.0223(8) 
C23' 0.4460(5) 0.20589(13) 0.1618(3) 0.0315(10) 
C24' 0.3483(5) 0.22681(15) 0.1103(3) 0.0393(12) 
C25' 0.2602(5) 0.21057(16) 0.0461(3) 0.0402(12) 
C26' 0.2653(5) 0.17385(17) 0.0337(3) 0.0393(12) 
C27' 0.3629(5) 0.15199(14) 0.0854(3) 0.0295(9) 
C28' 0.8499(5) 0.13058(14) 0.0042(3) 0.0318(10) 
C29' 0.6576(5) 0.17539(14) 0.0147(3) 0.0299(9) 
C30' 0.8949(5) 0.19781(14) 0.0116(3) 0.0303(10) 
O1' 0.8590(5) 0.10958(12) -0.0437(2) 0.0479(10) 
O2' 0.5541(4) 0.18095(13) -0.0290(2) 0.0494(11) 
O3' 0.9262(4) 0.21750(12) -0.0334(2) 0.0451(10) 
C31 0.1944(8) 0.0213(3) 0.0880(5) 0.077(2) 
Cl3 0.3140(3) 0.00227(8) 0.04210(15) 0.1011(9) 
Cl4 0.1067(5) 0.05833(10) 0.03509(18) 0.1470(16) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cos γ+2U13aa*cc*cos β+2U23bb*cc*cosα] 
 
Table IV-55: Positional Parameters for Hydrogens in 64, Compound 6177 
  Atom x y z Uiso, Å2 
H3 0.0490 0.1306 0.6321 0.028 
H4 -0.0592 0.0740 0.6107 0.033 
H5 0.0788 0.0210 0.6342 0.035 
H6 0.3213 0.0253 0.6713 0.032 
H7 0.5199 0.0563 0.7208 0.029 
H8a 0.4550 0.1215 0.8023 0.042 
H8b 0.6090 0.1352 0.8349 0.042 
H8c 0.5725 0.0940 0.8421 0.042 
H9a 0.7376 0.0721 0.7778 0.054 
H9b 0.7929 0.1122 0.7793 0.054 
H9c 0.7609 0.0901 0.6993 0.054 
H11 0.4710 0.1146 0.5485 0.036 
H12 0.5308 0.0990 0.4308 0.045 
H13 0.6313 0.0431 0.4181 0.051 
H14 0.6854 0.0047 0.5272 0.066 
H15 0.6211 0.0194 0.6442 0.055 
H17 0.2252 0.1221 0.5026 0.032 
H18 0.1346 0.1403 0.3717 0.042 
H19 0.0906 0.2014 0.3435 0.048 
H20 0.1303 0.2437 0.4453 0.045 
H21 0.2221 0.2260 0.5751 0.035 
H23 0.0610 0.1889 0.6666 0.035 
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H24 -0.0127 0.2235 0.7618 0.041 
H25 0.1492 0.2476 0.8675 0.041 
H26 0.3845 0.2348 0.8838 0.045 
H27 0.4589 0.1970 0.7930 0.036 
H3' 0.7275 0.2071 0.1927 0.031 
H4' 0.9495 0.2247 0.1837 0.034 
H5' 1.1161 0.1806 0.1701 0.035 
H6' 1.0547 0.1197 0.1630 0.030 
H7' 0.8948 0.0740 0.1473 0.025 
H8'1 0.6972 0.0674 0.0402 0.042 
H8'2 0.6249 0.1019 0.0667 0.042 
H8'3 0.5462 0.0644 0.0560 0.042 
H9'1 0.7905 0.0208 0.1310 0.045 
H9'2 0.6351 0.0146 0.1375 0.045 
H9'3 0.7540 0.0191 0.2150 0.045 
H11' 0.7733 0.0840 0.3287 0.032 
H12' 0.9035 0.0672 0.4532 0.040 
H13' 1.1305 0.0460 0.4675 0.042 
H14' 1.2241 0.0397 0.3569 0.041 
H15' 1.0916 0.0546 0.2318 0.034 
H17' 0.8322 0.1534 0.3405 0.033 
H18' 0.8725 0.1735 0.4708 0.041 
H19' 0.6898 0.1951 0.5221 0.041 
H20' 0.4640 0.1964 0.4429 0.038 
H21' 0.4199 0.1746 0.3139 0.033 
H23' 0.5063 0.2169 0.2049 0.042 
H24' 0.3421 0.2517 0.1190 0.052 
H25' 0.1961 0.2248 0.0105 0.054 
H26' 0.2034 0.1633 -0.0095 0.052 
H27' 0.3661 0.1270 0.0771 0.039 
H31a 0.2419 0.0293 0.1409 0.102 
H31b 0.1262 0.0029 0.0939 0.102 
 
Table IV-56: Refined Thermal Parameters (U's) for 64, Compound 6177 
Atom U11 U22 U33 U23 U13 U12 
Pd1 0.01246(13) 0.02048(15) 0.01989(14) -0.00123(11) 0.00421(10) -0.00117(10) 
Cl1 0.0140(5) 0.0473(7) 0.0544(7) 0.0103(6) 0.0065(5) -0.0032(4) 
Cl2 0.0265(5) 0.0192(4) 0.0376(6) -0.0010(4) 0.0144(4) -0.0022(4) 
Cr1 0.0215(3) 0.0198(3) 0.0218(3) 0.0002(2) 0.0078(2) -0.0013(2) 
P1 0.0132(4) 0.0162(4) 0.0185(4) 0.0002(3) 0.0030(3) 0.0000(3) 
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N1 0.0161(15) 0.0265(18) 0.0241(17) 0.0050(14) 0.0039(13) 0.0024(13) 
C1 0.0189(18) 0.0206(18) 0.0187(18) 0.0005(14) 0.0065(14) 0.0011(14) 
C2 0.0147(17) 0.0188(18) 0.0186(17) -0.0006(14) 0.0035(14) -0.0007(14) 
C3 0.0154(17) 0.026(2) 0.0212(19) -0.0009(15) 0.0033(14) -0.0021(15) 
C4 0.0205(19) 0.030(2) 0.025(2) -0.0018(17) 0.0056(16) -0.0053(16) 
C5 0.033(2) 0.022(2) 0.025(2) -0.0042(16) 0.0110(17) -0.0091(17) 
C6 0.029(2) 0.0185(19) 0.027(2) -0.0016(16) 0.0122(17) 0.0005(16) 
C7 0.0204(19) 0.0206(19) 0.027(2) 0.0043(16) 0.0095(16) 0.0044(15) 
C8 0.025(2) 0.036(2) 0.022(2) 0.0027(17) 0.0021(16) -0.0012(18) 
C9 0.018(2) 0.044(3) 0.044(3) 0.011(2) 0.0034(19) 0.0093(19) 
C10 0.0200(19) 0.024(2) 0.029(2) 0.0023(16) 0.0108(16) 0.0033(15) 
C11 0.028(2) 0.026(2) 0.027(2) -0.0004(17) 0.0068(17) 0.0066(17) 
C12 0.043(3) 0.035(2) 0.028(2) 0.0038(19) 0.017(2) 0.001(2) 
C13 0.051(3) 0.034(3) 0.037(3) -0.001(2) 0.025(2) 0.004(2) 
C14 0.077(4) 0.031(3) 0.054(3) 0.010(2) 0.041(3) 0.025(3) 
C15 0.059(3) 0.029(2) 0.045(3) 0.012(2) 0.031(3) 0.019(2) 
C16 0.0154(17) 0.0214(19) 0.0195(18) 0.0011(15) 0.0012(14) -0.0017(14) 
C17 0.0222(19) 0.025(2) 0.025(2) -0.0016(16) 0.0052(16) -0.0004(16) 
C18 0.028(2) 0.041(3) 0.022(2) -0.0028(19) 0.0005(17) -0.0048(19) 
C19 0.032(2) 0.049(3) 0.021(2) 0.012(2) -0.0068(18) -0.005(2) 
C20 0.034(2) 0.028(2) 0.035(3) 0.0124(19) -0.004(2) -0.0030(19) 
C21 0.025(2) 0.022(2) 0.028(2) 0.0020(16) -0.0017(17) 0.0004(16) 
C22 0.0196(18) 0.0175(18) 0.0216(18) 0.0001(14) 0.0073(15) 0.0002(14) 
C23 0.0180(19) 0.025(2) 0.035(2) -0.0060(18) 0.0028(17) -0.0002(16) 
C24 0.026(2) 0.024(2) 0.045(3) -0.0044(19) 0.015(2) 0.0033(17) 
C25 0.041(3) 0.029(2) 0.026(2) -0.0025(18) 0.0129(19) 0.0101(19) 
C26 0.035(2) 0.037(3) 0.026(2) -0.0089(19) -0.0008(19) 0.006(2) 
C27 0.0193(19) 0.032(2) 0.028(2) -0.0038(18) 0.0006(16) 0.0052(17) 
C28 0.030(2) 0.030(2) 0.033(2) 0.0025(19) 0.0110(19) -0.0034(18) 
C29 0.036(2) 0.027(2) 0.026(2) 0.0024(18) 0.0098(19) -0.0007(18) 
C30 0.028(2) 0.029(2) 0.033(2) 0.0056(18) 0.0094(18) 0.0024(18) 
O1 0.045(2) 0.047(2) 0.0330(19) 0.0122(16) -0.0020(16) -0.0022(17) 
O2 0.066(3) 0.037(2) 0.0350(19) -0.0069(16) 0.0212(19) 0.0053(18) 
O3 0.039(2) 0.042(2) 0.061(3) 0.0155(19) 0.0256(19) -0.0033(16) 
Pd1' 0.01847(14) 0.01954(15) 0.02056(15) 0.00285(11) 0.00283(11) -0.00395(11) 
Cl1' 0.0216(5) 0.0396(6) 0.0394(6) 0.0040(5) 0.0125(4) -0.0043(4) 
Cl2' 0.0405(6) 0.0257(5) 0.0447(7) 0.0112(5) 0.0087(5) -0.0084(5) 
Cr1' 0.0197(3) 0.0242(3) 0.0179(3) 0.0053(2) 0.0044(2) 0.0000(2) 
P1' 0.0161(4) 0.0184(5) 0.0174(4) 0.0010(4) 0.0039(4) -0.0001(4) 
N1' 0.0249(17) 0.0167(16) 0.0196(16) -0.0008(12) 0.0033(13) -0.0012(13) 
C1' 0.0200(18) 0.0214(18) 0.0128(16) 0.0019(14) 0.0029(14) 0.0005(15) 
C2' 0.0192(18) 0.0201(18) 0.0155(17) 0.0015(14) 0.0052(14) -0.0015(14) 
327 
 
C3' 0.030(2) 0.0190(19) 0.0226(19) 0.0025(15) 0.0084(16) 0.0000(16) 
C4' 0.029(2) 0.026(2) 0.0213(19) 0.0033(16) 0.0044(16) -0.0086(17) 
C5' 0.0192(19) 0.039(2) 0.0202(19) 0.0066(17) 0.0027(15) -0.0081(17) 
C6' 0.0179(18) 0.030(2) 0.0196(18) 0.0054(16) 0.0036(15) 0.0014(16) 
C7' 0.0202(18) 0.0191(18) 0.0187(18) 0.0017(14) 0.0056(14) 0.0039(14) 
C8' 0.033(2) 0.028(2) 0.0188(19) -0.0007(16) -0.0007(17) -0.0014(18) 
C9' 0.039(2) 0.018(2) 0.033(2) -0.0015(17) 0.0070(19) 0.0010(18) 
C10' 0.0239(19) 0.0142(17) 0.0201(18) 0.0011(14) 0.0036(15) 0.0007(14) 
C11' 0.0226(19) 0.026(2) 0.0219(19) 0.0031(16) 0.0035(16) 0.0059(16) 
C12' 0.032(2) 0.037(2) 0.022(2) 0.0026(18) 0.0051(18) 0.0043(19) 
C13' 0.030(2) 0.035(2) 0.026(2) 0.0073(18) -0.0034(18) 0.0023(19) 
C14' 0.023(2) 0.034(2) 0.035(2) 0.0100(19) 0.0042(18) 0.0078(18) 
C15' 0.025(2) 0.025(2) 0.028(2) 0.0046(17) 0.0084(17) 0.0038(16) 
C16' 0.0218(19) 0.0194(18) 0.0193(18) 0.0002(14) 0.0059(15) -0.0008(15) 
C17' 0.0210(19) 0.026(2) 0.028(2) -0.0011(17) 0.0083(16) -0.0002(16) 
C18' 0.029(2) 0.039(3) 0.022(2) -0.0008(18) 0.0018(17) -0.0013(19) 
C19' 0.046(3) 0.029(2) 0.021(2) -0.0036(17) 0.0139(19) -0.006(2) 
C20' 0.035(2) 0.028(2) 0.029(2) -0.0031(18) 0.0176(19) -0.0017(18) 
C21' 0.0216(19) 0.027(2) 0.028(2) 0.0009(17) 0.0097(16) -0.0005(16) 
C22' 0.0158(17) 0.030(2) 0.0201(19) 0.0056(16) 0.0029(15) 0.0043(15) 
C23' 0.029(2) 0.031(2) 0.034(2) 0.0050(19) 0.0061(19) 0.0064(18) 
C24' 0.032(2) 0.038(3) 0.047(3) 0.015(2) 0.008(2) 0.013(2) 
C25' 0.027(2) 0.057(3) 0.037(3) 0.023(2) 0.008(2) 0.016(2) 
C26' 0.023(2) 0.068(4) 0.026(2) 0.004(2) 0.0025(18) 0.003(2) 
C27' 0.025(2) 0.041(3) 0.023(2) 0.0013(18) 0.0060(17) 0.0016(19) 
C28' 0.033(2) 0.040(3) 0.022(2) 0.0062(19) 0.0053(18) 0.006(2) 
C29' 0.026(2) 0.038(3) 0.027(2) 0.0068(19) 0.0092(18) 0.0011(18) 
C30' 0.024(2) 0.038(2) 0.029(2) 0.0100(19) 0.0046(17) 0.0005(18) 
O1' 0.063(3) 0.054(2) 0.0262(18) -0.0057(17) 0.0109(17) 0.013(2) 
O2' 0.0283(18) 0.084(3) 0.0330(19) 0.021(2) 0.0006(15) 0.0083(19) 
O3' 0.040(2) 0.057(2) 0.039(2) 0.0250(18) 0.0097(16) -0.0046(18) 
C31 0.056(4) 0.117(7) 0.057(4) 0.010(5) 0.012(3) 0.021(4) 
Cl3 0.0944(17) 0.130(2) 0.0785(15) -0.0494(15) 0.0186(12) 0.0190(15) 
Cl4 0.203(4) 0.146(3) 0.0797(17) -0.0071(17) 0.007(2) 0.113(3) 
The form of the anisotropic displacement parameter is: 
exp[-2π2(a*2U11h2+b*2U22k2+c*2U33l2+2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)] 
 
Table IV-57: Bond Distances in 64, Compound 6177, Å 
Pd1-N1  2.111(4) Pd1-P1  2.2378(10) Pd1-Cl2  2.2854(11) 
Pd1-Cl1  2.3434(11) Cr1-C30  1.845(5) Cr1-C28  1.851(5) 
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Cr1-C29  1.876(5) Cr1-C3  2.183(4) Cr1-C5  2.189(4) 
Cr1-C4  2.201(4) Cr1-C6  2.204(4) Cr1-C2  2.256(4) 
Cr1-C1  2.262(4) P1-C22  1.812(4) P1-C16  1.816(4) 
P1-C2  1.830(4) N1-C8  1.496(6) N1-C9  1.498(5) 
N1-C7  1.502(6) C1-C2  1.416(5) C1-C6  1.429(6) 
C1-C7  1.530(5) C2-C3  1.435(5) C3-C4  1.397(6) 
C4-C5  1.418(6) C5-C6  1.400(6) C7-C10  1.532(6) 
C10-C15  1.382(6) C10-C11  1.390(6) C11-C12  1.383(6) 
C12-C13  1.377(7) C13-C14  1.381(8) C14-C15  1.385(7) 
C16-C17  1.394(6) C16-C21  1.400(6) C17-C18  1.397(6) 
C18-C19  1.382(7) C19-C20  1.385(7) C20-C21  1.382(6) 
C22-C27  1.390(6) C22-C23  1.393(6) C23-C24  1.386(6) 
C24-C25  1.378(7) C25-C26  1.378(7) C26-C27  1.395(6) 
C28-O1  1.149(6) C29-O2  1.128(6) C30-O3  1.144(6) 
Pd1'-N1'  2.122(4) Pd1'-P1'  2.2180(10) Pd1'-Cl1'  2.2853(11) 
Pd1'-Cl2'  2.3672(11) Cr1'-C28'  1.844(5) Cr1'-C30'  1.851(5) 
Cr1'-C29'  1.858(5) Cr1'-C3'  2.198(4) Cr1'-C6'  2.199(4) 
Cr1'-C4'  2.211(4) Cr1'-C5'  2.220(4) Cr1'-C2'  2.247(4) 
Cr1'-C1'  2.250(4) P1'-C22'  1.808(4) P1'-C16'  1.808(4) 
P1'-C2'  1.829(4) N1'-C9'  1.492(5) N1'-C8'  1.499(5) 
N1'-C7'  1.499(5) C1'-C2'  1.412(5) C1'-C6'  1.436(5) 
C1'-C7'  1.525(5) C2'-C3'  1.437(5) C3'-C4'  1.387(6) 
C4'-C5'  1.413(7) C5'-C6'  1.391(6) C7'-C10'  1.534(5) 
C10'-C11'  1.385(6) C10'-C15'  1.390(6) C11'-C12'  1.389(6) 
C12'-C13'  1.385(7) C13'-C14'  1.374(7) C14'-C15'  1.389(6) 
C16'-C21'  1.401(6) C16'-C17'  1.407(6) C17'-C18'  1.384(6) 
C18'-C19'  1.381(7) C19'-C20'  1.391(7) C20'-C21'  1.383(6) 
C22'-C23'  1.394(6) C22'-C27'  1.404(6) C23'-C24'  1.381(6) 
C24'-C25'  1.374(8) C25'-C26'  1.368(8) C26'-C27'  1.402(7) 
C28'-O1'  1.148(6) C29'-O2'  1.135(6) C30'-O3'  1.152(6) 
C31-Cl3  1.704(8) C31-Cl4  1.751(9)   
 
Table IV-58: Bond Angles in 64, Compound 6177, ° 
N1-Pd1-P1 93.30(10) N1-Pd1-Cl2 172.08(10) P1-Pd1-Cl2 84.98(4) 
N1-Pd1-Cl1 94.14(10) P1-Pd1-Cl1 172.29(4) Cl2-Pd1-Cl1 87.92(4) 
C30-Cr1-C28 86.0(2) C30-Cr1-C29 86.8(2) C28-Cr1-C29 86.2(2) 
C30-Cr1-C3 120.43(18) C28-Cr1-C3 153.30(18) C29-Cr1-C3 90.96(18) 
C30-Cr1-C5 85.58(19) C28-Cr1-C5 123.3(2) C29-Cr1-C5 148.8(2) 
C3-Cr1-C5 67.37(16) C30-Cr1-C4 90.41(19) C28-Cr1-C4 160.95(19) 
C29-Cr1-C4 112.27(19) C3-Cr1-C4 37.16(15) C5-Cr1-C4 37.68(17) 
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C30-Cr1-C6 109.92(19) C28-Cr1-C6 96.37(19) C29-Cr1-C6 163.20(18) 
C3-Cr1-C6 79.25(16) C5-Cr1-C6 37.15(16) C4-Cr1-C6 67.34(16) 
C30-Cr1-C2 157.42(18) C28-Cr1-C2 116.40(17) C29-Cr1-C2 97.27(17) 
C3-Cr1-C2 37.68(13) C5-Cr1-C2 79.47(15) C4-Cr1-C2 67.46(15) 
C6-Cr1-C2 66.68(15) C30-Cr1-C1 147.04(18) C28-Cr1-C1 93.53(18) 
C29-Cr1-C1 126.11(18) C3-Cr1-C1 66.95(14) C5-Cr1-C1 67.23(15) 
C4-Cr1-C1 79.46(15) C6-Cr1-C1 37.30(14) C2-Cr1-C1 36.52(14) 
C22-P1-C16 106.71(19) C22-P1-C2 109.08(18) C16-P1-C2 100.71(18) 
C22-P1-Pd1 112.17(13) C16-P1-Pd1 113.66(13) C2-P1-Pd1 113.71(13) 
C8-N1-C9 105.2(3) C8-N1-C7 111.5(3) C9-N1-C7 106.0(3) 
C8-N1-Pd1 105.2(3) C9-N1-Pd1 113.1(3) C7-N1-Pd1 115.5(2) 
C2-C1-C6 119.0(4) C2-C1-C7 128.2(4) C6-C1-C7 112.6(3) 
C2-C1-Cr1 71.5(2) C6-C1-Cr1 69.2(2) C7-C1-Cr1 134.9(3) 
C1-C2-C3 118.7(4) C1-C2-P1 123.1(3) C3-C2-P1 117.5(3) 
C1-C2-Cr1 72.0(2) C3-C2-Cr1 68.4(2) P1-C2-Cr1 139.2(2) 
C4-C3-C2 121.8(4) C4-C3-Cr1 72.1(2) C2-C3-Cr1 73.9(2) 
C3-C4-C5 119.0(4) C3-C4-Cr1 70.7(2) C5-C4-Cr1 70.7(2) 
C6-C5-C4 120.2(4) C6-C5-Cr1 72.0(2) C4-C5-Cr1 71.6(2) 
C5-C6-C1 121.2(4) C5-C6-Cr1 70.8(2) C1-C6-Cr1 73.5(2) 
N1-C7-C1 118.8(3) N1-C7-C10 111.1(3) C1-C7-C10 109.1(3) 
C15-C10-C11 118.6(4) C15-C10-C7 119.6(4) C11-C10-C7 121.8(4) 
C12-C11-C10 120.9(4) C13-C12-C11 120.3(5) C12-C13-C14 119.1(5) 
C13-C14-C15 120.9(5) C10-C15-C14 120.3(5) C17-C16-C21 118.7(4) 
C17-C16-P1 120.4(3) C21-C16-P1 120.6(3) C16-C17-C18 120.9(4) 
C19-C18-C17 119.3(4) C18-C19-C20 120.2(4) C21-C20-C19 120.6(4) 
C20-C21-C16 120.3(4) C27-C22-C23 119.5(4) C27-C22-P1 119.1(3) 
C23-C22-P1 121.3(3) C24-C23-C22 119.9(4) C25-C24-C23 120.1(4) 
C26-C25-C24 120.6(4) C25-C26-C27 119.7(4) C22-C27-C26 120.0(4) 
O1-C28-Cr1 177.3(5) O2-C29-Cr1 176.0(4) O3-C30-Cr1 178.6(5) 
N1'-Pd1'-P1' 93.73(9) N1'-Pd1'-Cl1' 170.18(10) P1'-Pd1'-Cl1' 83.87(4) 
N1'-Pd1'-Cl2' 95.58(10) P1'-Pd1'-Cl2' 168.66(4) Cl1'-Pd1'-Cl2' 88.00(5) 
C28'-Cr1'-C30' 85.4(2) C28'-Cr1'-C29' 86.6(2) C30'-Cr1'-C29' 83.8(2) 
C28'-Cr1'-C3' 159.38(19) C30'-Cr1'-C3' 115.17(19) C29'-Cr1'-C3' 96.15(19) 
C28'-Cr1'-C6' 90.82(18) C30'-Cr1'-C6' 118.92(18) C29'-Cr1'-C6' 156.85(18) 
C3'-Cr1'-C6' 78.65(16) C28'-Cr1'-C4' 151.09(19) C30'-Cr1'-C4' 90.04(19) 
C29'-Cr1'-C4' 121.4(2) C3'-Cr1'-C4' 36.67(16) C6'-Cr1'-C4' 66.57(16) 
C28'-Cr1'-C5' 114.3(2) C30'-Cr1'-C5' 91.72(18) C29'-Cr1'-C5' 158.3(2) 
C3'-Cr1'-C5' 66.55(17) C6'-Cr1'-C5' 36.68(16) C4'-Cr1'-C5' 37.20(17) 
C28'-Cr1'-C2' 121.74(18) C30'-Cr1'-C2' 152.77(19) C29'-Cr1'-C2' 95.28(17) 
C3'-Cr1'-C2' 37.71(14) C6'-Cr1'-C2' 66.73(15) C4'-Cr1'-C2' 67.13(15) 
C5'-Cr1'-C2' 79.08(15) C28'-Cr1'-C1' 93.93(18) C30'-Cr1'-C1' 156.56(17) 
C29'-Cr1'-C1' 119.56(17) C3'-Cr1'-C1' 66.91(15) C6'-Cr1'-C1' 37.64(14) 
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C4'-Cr1'-C1' 79.22(15) C5'-Cr1'-C1' 67.15(15) C2'-Cr1'-C1' 36.59(14) 
C22'-P1'-C16' 107.39(19) C22'-P1'-C2' 106.74(18) C16'-P1'-C2' 100.02(18) 
C22'-P1'-Pd1' 115.05(15) C16'-P1'-Pd1' 111.70(13) C2'-P1'-Pd1' 114.66(13) 
C9'-N1'-C8' 105.7(3) C9'-N1'-C7' 105.8(3) C8'-N1'-C7' 109.9(3) 
C9'-N1'-Pd1' 112.2(3) C8'-N1'-Pd1' 103.8(3) C7'-N1'-Pd1' 118.8(2) 
C2'-C1'-C6' 118.3(4) C2'-C1'-C7' 127.8(4) C6'-C1'-C7' 113.7(3) 
C2'-C1'-Cr1' 71.6(2) C6'-C1'-Cr1' 69.2(2) C7'-C1'-Cr1' 134.8(3) 
C1'-C2'-C3' 118.8(4) C1'-C2'-P1' 123.9(3) C3'-C2'-P1' 116.5(3) 
C1'-C2'-Cr1' 71.8(2) C3'-C2'-Cr1' 69.3(2) P1'-C2'-Cr1' 138.8(2) 
C4'-C3'-C2' 121.5(4) C4'-C3'-Cr1' 72.2(3) C2'-C3'-Cr1' 73.0(2) 
C3'-C4'-C5' 119.9(4) C3'-C4'-Cr1' 71.2(2) C5'-C4'-Cr1' 71.8(3) 
C6'-C5'-C4' 119.3(4) C6'-C5'-Cr1' 70.8(2) C4'-C5'-Cr1' 71.0(2) 
C5'-C6'-C1' 122.0(4) C5'-C6'-Cr1' 72.5(2) C1'-C6'-Cr1' 73.1(2) 
N1'-C7'-C1' 118.6(3) N1'-C7'-C10' 112.7(3) C1'-C7'-C10' 108.5(3) 
C11'-C10'-C15' 118.8(4) C11'-C10'-C7' 122.9(4) C15'-C10'-C7' 118.3(4) 
C10'-C11'-C12' 120.5(4) C13'-C12'-C11' 120.1(4) C14'-C13'-C12' 119.9(4) 
C13'-C14'-C15' 120.0(4) C14'-C15'-C10' 120.7(4) C21'-C16'-C17' 118.8(4) 
C21'-C16'-P1' 121.4(3) C17'-C16'-P1' 119.6(3) C18'-C17'-C16' 120.2(4) 
C19'-C18'-C17' 120.5(4) C18'-C19'-C20' 120.0(4) C21'-C20'-C19' 120.2(4) 
C20'-C21'-C16' 120.4(4) C23'-C22'-C27' 119.2(4) C23'-C22'-P1' 121.1(3) 
C27'-C22'-P1' 119.6(3) C24'-C23'-C22' 121.0(5) C25'-C24'-C23' 119.4(5) 
C26'-C25'-C24' 121.0(5) C25'-C26'-C27' 120.6(5) C26'-C27'-C22' 118.8(5) 
O1'-C28'-Cr1' 178.1(4) O2'-C29'-Cr1' 175.1(4) O3'-C30'-Cr1' 176.1(4) 
Cl3-C31-Cl4 112.6(5)     
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Appendix V  
HTE chiral predosed catalysts 
The following is a list of chiral catalysts predosed into wells and screened for converstion with low-
barrier high-throughput experimentation (HTE) conditions: 
Table V-1: SDD Plate 1   
 A 1 (R)-Solphos A001-1 
 A 2 (S)-xylyl-binap 
 A 3 (S)-Cl,MeO-Biphep 
 A 4 (R,R)-Me-DuPhos 
 A 5 EtBPE 
 A 6 SL-J002-1 : (R,S)-Ph2P-Fc-P(tBu)2 
 A 7 SL-J007-1 
 A 8 SL-J009-1 
 A 9 SL-J012-1 
 A 10 (R)-CTH-JAFAPHOS 
 A 11 (R,R)-Et-FerroTANE 
 A 12 (R,R,S,S)-Tangphos 
 B 1 (R)-(S)-Me-BoPhoz 
 B 2 SL-W001-1 
 B 3 SL-W006-1 
 B 4 SL-W005-1 
 B 5 CTH-(R)-3,5-xylyl-PHANEPHOS 
 B 6 (S,S)-SL-M002-1 
 B 7 (S,S)-SL-M001-1 
 B 8 (S,S)-SL-T001-1 
 B 9 (S)-(+)-(2,6-Dimethyl-3,5-dioxa-4-phospha-cyclohepta[2,1-a;3,4-
a']dinaphthalen-4-yl)dimethylamine 
 B 10 (R)-MONOPHOS 
 B 11 catASium D(R) 
 B 12 catASium I 
 C 1 (2S,4S)-tBu-(-)-4-(Diphenylphosphino)-2-
(diphenylphosphinomethyl)pyrrolidine carboxylate 
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 C 2 (3S,4S)-(-)-1-Benzyl-3,4-bis(diphenylphosphino)pyrrolidine 
 C 3 (1R,1R',2R,2R')-(-)-2,2'-DIPHENYLPHOSPHINO-1,1'-BICYCLOPENTYL 
 C 4 SL-T021-2: Ph2P-Fc-CH(OH)Ph-PPh2 
 C 5 (R,R)-SL-M004-1 
 C 6 Walphos 9-1 
 C 7 (R,R) SL-W018-1 
 C 8 (R,R)-SL-W019-1 
 C 9 (R,R) SL-W020-1 
 C 10 (R,R)-SL-W021-1 
 C 11 SL-T025-2: xyl2P-Fc-CH(OH)Ph-Pxyl2 
 C 12 (4S,5S)-(+)-4,5-Bis(diphenylphosphinomethyl)-2,2-dimethyl-1,3-dioxolane 
 D 1 (S,S)-SL-M001-1 
 D 2 (S,S)-SL-M002-1 
 D 3 (S,S)-SL-M003-1 
 D 4 (3S,3'S,4S,4'S,11bS,11'bS)-(+)-4,4'-Di-t-butyl-4,4',5,5'-tetrahydro-3,3'-bi-3H-
dinaphtho[2,1-c:1',2'-e]phosphepin 
 D 5 (S,S)-SL-T001-1 
 D 6 (R,S)-SL-T002-1 
 D 7 SL-T026-2: Ph2P-Fc-CH(OH)Ph-P(3,5-Me-4-MeO)2 
 D 8 (S)-(-)-2,2'-Bis(N-diphenylphosphinoamino)-5,5',6,6',7,7',8,8'-octahydro-1,1'-
binaphthyl 
 D 9 R,S-(o-tolyl)2P-F-C-P(o-tolyl)2 
 D 10 (R)-(S)-Et2P-F-C-PtBu2 
 D 11 s-f-binaphane 
 D 12 SL-T027-2: xyl2P-Fc-CH(OH)Ph-P(3,5-CF3-Ph)2 
 E 1 (S)-CTH-JAFAPHOS 
 E 2 (R,R)-Me-DuPhos 
 E 3 (+)-1,2-Bis((2R,5R)-2,5-di-i-propylphospholano)benzene 
 E 4 (R,R) Et-DuPhos 
 E 5 (R)-(+)-BIS-(1,2-DIPHENYLPHOSPHINO)PROPANE 
 E 6 SL-W023-1: (3,5-Me-4-MeO)2PPh-Fc-CHMe-P(Nor)2 
 E 7 SL-W-A1: Ph2PPh-Fc-CHMe-PtBu2 
 E 8 SL-J215-2: (S)-(R)-Fur2P-Fc-Pcy2 
 E 9 SL-J302-1: (R)-(S)-Et2P-Fc-PCy2 
 E 10 SL-J011-1: (R)-(S)-(4-CF3-Ph)2-PFc-PtBu2 
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 E 11 SL-J304-1: (R)-(S)-Ph,Me-PFc-PCy2 
 E 12 SL-J408-1: (R)-(S)-xyl2P-Fc-Pxyl2 
 F 1 SL-J411-2: (S)-(R)-Fur2P-Fc-P(3,5-Me2-4-OMe-Ph)2 
 F 2 SL-J412-1: (R)-(S)-xyl2P-Fc-P(3,5-(CF3)2-Ph)2 
 F 3 SL-W022-1 
 F 4 SL-F011-2 (Twinphos, analog of Me-BoPhoz) 
 F 5 SL-F013-2 (Twinphos, analog of P(cyco)-BoPhoz) 
 F 6 SL-J851-2 
 F 7 SL-J852-2 
 F 8 SL-J853-2 
 F 9 (S,S)-Ph-BPE 
 F 10 SL-W016-1 
 F 11 [(1R,2R,3S)-(+)-1,2-Dimethyl-2,3-
bis(diphenylphosphinomethyl)cyclopentyl]methanol 
 F 12 SL-W017-1 
 G 1 (R)-(-)-1-[(S)-2-
(DIPHENYLPHOSPHINO)FERROCENYL]ETHYLDICYLCOHEXYLPHOSPHINE 
 G 2 (R)-(-)-1-[(S)-2-(DIPHENYLPHOSPHINO)FERROCENYL]ETHYLDI-T-
BUTYLPHOSPHINE 
 G 3 (R)-(-)-1-[(S)-2-
(DICYCLOHEXYLPHOSPHINO)FERROCENYL]ETHYLDIPHENYLPHOSPHINE 
 G 4 (R)-(S)-(3,5-(CF3)2Ph)2PF-Pcy2 
 G 5 (R)-(S)-(3,5-(CF3)2Ph)2PF-Pxyl2 
 G 6 (R)-(S)-(4-CF3-Ph)2-PFc-PCy2 
 G 7 (R)-(S)-(3,5-Me2-4-MeOPh)2PF-PtBu2 
 G 8 (R)-(S)-Fur2PF-PtBu2 
 G 9 (R)-(S)-oTol2PF-Pxyl2 
 G 10 (R)-(S)-(3,5-Me2-4-MeOPh)2PF-PoTol2 
 G 11 (2-Furyl)2P-Fc-P(o-Tolyl)2 
 G 12 SL-J503-1: (R)-(S)-Et2P-Fc-P(o-Tolyl)2 
 H 1 (R)-(S)-xyl2P-Fc-PtBu2 
 H 2 (R)-(-)-1-[(S)-2-
(DICYCLOHEXYLPHOSPHINO)FERROCENYL]ETHYLDICYCLOHEXYLPHOSPHINE 
 H 3 (R)-(S)-Ph2P-Fc-P(4-CF3-Ph)2 
 H 4 (R)-(S)-(4-MeO-3,5-Me2Ph)2PF-Pcy2 
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 H 5 (R)-(S)-cy2PF-PtBu2 
 H 6 (R)-(S)-(p-Tol)2PF-PtBu2 
 H 7 (S)-(R)-Fur2P-Fc-Pxyl2 
 H 8 (R)-(S)-(3,5-Me2-4-MeOPh)2PF-Pxyl2 
 H 9 (R)-(S)-cy2PF-Po-Tol2 
 H 10 (R)-(R)-(S)-PhMePF-Pcy2 
 H 11 SL-J507-1: (R)-(S)-Et2P-Fc-P(xylyl)2 
 H 12 SL-J034-1: (R)-(R)-Ph2P-(2-TMS-Fc)-P(cHex)2 
   
Table V-2: SDD Plate 2   
 A 1 Catasium MN An(R) 
 A 2 Catasium MNN (R) 
 A 3 Catasium MN MesF (R) 
 A 4 Catasium MN Mes (R) 
 A 5 (S,S)-Me-UCAP-DTBM 
 A 6 (R,R)-QuinoxP* 
 A 7 SL-P051-1: (R,R,R)-Me-KEPHOS 
 A 8 SL-P053-2: (S,S,R)-Me-KEPHOS 
 A 9 SL-J005-1: Ph2P-Fc-Pxyl2 
 A 10 SL-J014-1: (R)-(S)-(4-F-Ph)2P-Fc-PtBu2 
 A 11 SL-J031-1: PPh2-Fc-P(cyclopentyl)2 
 A 12 SL-J211-1: (o-Tol)2P-Fc-PtBu2 
 B 1 SL-J213-1: (3,5-CF3-Ph)2P-Fc-P(cyclopentyl)2 
 B 2 SL-J216-1: (1-naphthyl)2P-Fc-PtBu2 
 B 3 SL-J219-1: (2-MeO-Ph)2P-Fc-PtBu2 
 B 4 SL-J220-1: (3,5-Me-4-MeO-Ph)2P-Fc-P(cyclopentyl)2 
 B 5 SL-J221-1: (3,5-Me-4-MeO-Ph)2P-Fc-P(2,4,4-Me-pentyl)2 
 B 6 SL-J222-1: (3,5-Me-4-MeO-Ph)2P-Fc-P(neopentyl)2 
 B 7 SL-J305-1: Cy2P-Fc-P(norbornyl)2 
 B 8 SL-J404-1: (R)-(S)-(1-napthyl)2P-Fc-Pxyl2 
 B 9 SL-J409-1: (R)-(S)-(1-Naphthyl)2PF-PPh2 
 B 10 SL-J502-1: tBu2P-Fc-PPh2 
 B 11 SL-J505-1: tBu2P-Fc-P(o-Tol)2 
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 B 12 SL-J506-1: tBu2P-Fc-P(4-CF3-Ph)2 
 C 1 (-)-TMBTP 
 C 2 (R)-(+)-2,2'-BIS(DI-P-TOLYLPHOSPHINO)-1,1'-BINAPHTHYL (note structure 
incorrect) 
 C 3 (R)-Hexaphemp 
 C 4 (S)-(-)-6,6'-Bis(diphenylphosphino)-1,1'-biphenyl-2,2'-diylbis(acetate), 
 C 5 (R)-(+)-5,5'-DICHLORO-6,6'-DIMETHOXY-2,2'-BIS(DIPHENYLPHOSPHINO)-1,1'-
BIPHENYL 
 C 6 (R)-segphos 
 C 7 SL-A109-2 
 C 8 (R)-(+)-2,2',6,6'-Tetramethoxy-4,4'-bis(diphenylphosphino)-3,3'-bipyridine 
 C 9 (R)-DTBM-SEGPHOS 
 C 10 s-c1-tunaphos 
 C 11 s-c3-tunaphos 
 C 12 s-c5-tunaphos 
 D 1 (S)-(+)-2,2'-BIS(DIPHENYLPHOSPHINO)-1,1'-BINAPHTHYL 
 D 2 (R)-(+)-2,2'-BIS[DI(3,5-XYLYL)PHOSPHINO]-1,1'-BINAPHTHYL 
 D 3 (1R)-(+)-[Di(3,5-dimethylphenyl)phosphino]-2-(4-diphenylphosphino-2,5-
dimethylthien-3-yl)-1,7,7-trimethylbicyclo[2.2.1]hept-2-ene [catASium T2] 
 D 4 (R)-DM-SEGPHOS 
 D 5 (R)-(-)-5,5'-Bis(diphenylphosphino)-2,2,2',2'-tetrafluoro-4,4'-bi-1,3-
benzodioxole 
 D 6 SL-A120-2 
 D 7 (R)-H8-BINAP 
 D 8 (S)-(-)-2,2',6,6'-Tetramethoxy-4,4'-bis(di(3,5-xylyl)phosphino)-3,3'-bipyridine 
 D 9 (S)-(-)-6,6'-Bis(diphenylphosphino)-1,1'-biphenyl-2,2'-
diylbis(cyclohexylcarboxylate), 
 D 10 c2-tunaphos 
 D 11 s-C4-tunaphos 
 D 12 s-c6-tunaphos 
 E 1 (R)-MP2-SEGPHOS 
 E 2 (R)-P3-SEGPHOS 
 E 3 (+)-Cy-SEGPHOS 
 E 4 SL-A102-1 
 E 5 SL-A107-1 
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 E 6 SL-A104-1 
 E 7 SL-A121-1 
 E 8 SL-A108-1 
 E 9 SL-A116-1 
 E 10 SL-A118-1 
 E 11 (1R,2R)-(+)-1,2-Diaminocyclohexane-N,N'-bis(2'-diphenylphosphinobenzoyl) 
 E 12 (1R,2R)-(+)-1,2-Diaminocyclohexane-N,N'-bis(2-diphenylphosphino-1-
naphthoyl) 
 F 1 (4R)-(+)-4,5-DIHYDRO-2-[2'-(DIPHENYLPHOSPHINO)PHENYL]-4-
ISOPROPYLOXAZOLE 
 F 2 (R)-(-)-2-[2-(Diphenylphosphino)phenyl]-4-phenyl-2-oxazoline 
 F 3 SL-N003-2 ((S)-4-Isopropyl-2-[(S)-2-(diphenylphosphino)ferrocen-1-
yl]oxazoline) 
 F 4 SL-N008-2 ((S)-4-Isopropyl-2-[(S)-2-(bis(3,5.dimethyl-4-
methoxyphenyl)phosphino)ferrocen-1-yl]oxazoline) 
 F 5 SL-N011-2 ((S)-4-Isopropyl-2-[(S)-2-(bis(1-naphtyl)phosphino)ferrocen-1-
yl]oxazoline) 
 F 6 SL-N012-2 ((S)-4-Isopropyl-2-[(S)-2-(bis(2-
methoxyphenyl)phosphino)ferrocen-1-yl]oxazoline) 
 F 7 SL-N004-2 
 F 8 SL-N007-2 
 F 9 SL-N013-1 
 F 10 (S)-Xyl-SDP 
 F 11 (S)-Tol-SDP 
 F 12 (S)-SDP 
 G 1 (R)-MonoPhos 
 G 2 (S)-N-Me-N-Bn-MonoPhos 
 G 3 (S)-PipPhos 
 G 4 (S)-2,6-Me-MonoPhos 
 G 5 (S,R)-(a-MeBn)-MonoPhos 
 G 6 (S,R,R)-(a-MeBn)2-MonoPhos 
 G 7 (S,S,S)-(a-MeBn)2-MonoPhos 
 G 8 (S)-H8-MonoPhos 
 G 9 (S)-H8-PipPhos 
 G 10 (R)-BINOL-P-OiPr 
 G 11 (R)-BINOL-P-OiBu 
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 G 12 (R,R)-TADDOL-P-NMe2 
 H 1 (R)-SIPHOS 
 H 2 (R)-SIPHOS-PE 
 H 3 (R)-ShiP 
 H 4 (S,S)-Mikami Ligand 
 H 5 (S,S)-tBu-Mikami Ligand 
 H 6 (R)-Quinap 
 H 7 (R)-N-PINAP 
 H 8 (R)-MOP 
 H 9 (R,R)-Me-DuPhos Monoxide 
 H 10 (S,S)-Me-RajPhos 
 H 11 (S,S)-Et-RajPhos 
 H 12 (S,S,S)-DiazaPhos-PPE 
 
Table V-3: Upenn Chiral Phosphines Plate 
 A 1 (S)-Binap 
 A 2 (R)-segphos 
 A 3 (S)-SDP 
 A 4 (R)-3,5-xylyl-PHANEPHOS 
 A 5 (R)-Cl,MeO-BIPHEP 
 A 6 (R,R)-Trost Ligand 
 B 1 (R)-BINAPHANE 
 B 2 (R)-CTH-JAFAPHOS 
 B 3 SL-M001-1 
 B 4 SL-J005-1: Ph2P-Fc-Pxyl2 
 B 5 (R,R)-SL-W002-1 
 B 6 (S,S)-SL-T001-1 
 C 1 (+)-Cy-SEGPHOS 
 C 2 SL-J008-1  
 C 3 SL-M002-2 
 C 4 SL-J002-1 
 C 5 SL-W003-1 
 C 6 SL-T002-1 
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 D 1 (S,S)-Ph-BPE 
 D 2 (1S,1'S,2R,2'R)-DuanPhos 
 D 3 (R,R)-QuinoxP* 
 D 4 (R,R)-Me-DuPhos 
 D 5 (R)-Pfaltz (Ph 
 D 6 (S)-PipPhos 
 
Table V-4: Mandyphos and Taniaphos Plate 
 A 1 SL-M001 (Ph mandyphos) 
 A 2 SL-M002 (Cy Mandyphos) 
 A 3 SL-M003 (CF3 Mandyphos) 
 A 4 SL-M004 (Me MeO mandyphos) 
 A 5 SL-M009 (xyl mandyphos) 
 A 6 SL-M012 (otol mandyphos) 
 B 1 SL-T001 (ph taniaphos) 
 B 2 SL-T002 (cy taniaphos) 
 B 3 SL-T021 
 B 4 SL-T025 
 B 5 SL-T026 
 B 6 SL-T027 
 C 1 SL-M001 (Ph mandyphos) 
 C 2 SL-M002 (Cy Mandyphos) 
 C 3 SL-M003 (CF3 Mandyphos) 
 C 4 SL-M004 (Me MeO mandyphos) 
 C 5 SL-M009 (xyl mandyphos) 
 C 6 SL-M012 (otol mandyphos) 
 D 1 SL-T001 (ph taniaphos) 
 D 2 SL-T002 (cy taniaphos) 
 D 3 SL-T021 
 D 4 SL-T025 
 D 5 SL-T026 
 D 6 SL-T027
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Appendix VI  
Terms and Acronyms 
The following are terms, abbreviations, and acronyms used within this thesis, as well as informally 
within my lab notebooks and excel sheet list of reactions. 
η  Hapticity (contiguous donor atoms of ligand) 
κ  Hapticity (non-contiguous donor atoms of ligand) 
ArOTf  Aryl Triflate, Aryl Trifluoromethanesulfonate, ArOSO2CF3 
Bn  Benzyl (PhCH2- or C6H5CH2) 
COD  1,5-Cyclooctadiene ligand 
CrBnA  η6-Tricarbonylchromium N,N-dimethylbenzylamine (27) 
CrBnMorph η6-Tricarbonylchromium N-benzylmorpholine (54) 
CrBOM  η6-Tricarbonylchromium benzylmethyl ether 
CrBOP  η6-Tricarbonylchromium benzylpropyl ether (23) 
CrDHI  η6-Tricarbonylchromium dihidroindane, η6-Tricarbonylchromium Indan (39) 
CrDPM  η6-Tricarbonylchromium diphenylmethane (4a) 
CrEtPh  η6-Tricarbonylchromium ethylbenzene (30) 
CrMes  η6-Tricarbonylchromium mesitylene (9) 
CrOxyl  η6-Tricarbonylchromium o-xylene (18) 
CrBnPip  η6-Tricarbonylchromium N-benzylpiperidine (53) 
CrBnPpz  η6-Tricarbonylchromium N,N′-benzylmethylpiperazine (56) 
CrPth  η6-Tricarbonylchromium phthalan (46) 
CrPxyl  η6-Tricarbonylchromium p-xylene (8) 
CrTAM  η6-Tricarbonylchromium triarylmethane family (5a, etc) 
CrTHN  η6-Tricarbonylchromium tetrahydronaphthalene (40) 
CrTol  η6-Tricarbonylchromium toluene (3) 
Cy  Cyclohexyl group, C6H11 
CyH  1-Cyclohexenyl, C6H9 
D–A  Diels-Alder 
DCM  Dichloromethane, Methylene chloride 
Diox  1,4-dioxane 
DMSO  Dimethyl sulfoxide 
DOM  Directed ortho metalation, selective metalation (of arenes) using a directing group. 
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EAS  Electrophilic Aromatic Substitution 
ee  = 100 × (major enantiomer−minor),      enantiomeric excess 
      (sum of enantiomers) 
F–C  Friedel-Crafts 
H–B  Hüenig’s Base, diisopropylethylamine 
Hex  Hexanes 
HMDS-H  HN(SiMe3)2, Hexamethyldisilazane. 
HRMS  High-resolution mass spectrometry 
HTE  Low-barrier high-throughput experimentation, a parallel microscale reaction 
screening method for the rapid identification of reagents and reaction conditions. 
KHMDS  KN(Si(CH3)3)2, Potassium hexamethylsilazide  
LDA  Lithium Diisopropylamide, LiN(i-Pr)2 
LiCKOR  Schlosser’s base; superbase made of equimolar amounts of Butyllithium and KOtBu 
LiHMDS  or LHMDS: LiN(Si(CH3)3)2, Lithium hexamethyldisilazide 
Mandy  Mandyphos, usually cyclohexyl Mandyphos 
NaHMDS  NaN(Si(CH3)3)2, Sodium hexamethylsilazide 
Norb  Norbornadiene 
OTf  Triflate, trifluoromethanesulfonate, -OSO2CF3 group 
Pent  n-Pentane 
PMDETA  or PMDTA, PMETA: N,N,N′,N″,N″-Pentamethyldiethylenetriamine 
PTFE  teflon [poly(tetrafluoroethylene)]  
s&n base  superbase made of equimolar amounts of sec-butyllithium and n-butyllihtium 
Tania  Taniaphos, usually cyclohexyl Taniaphos 
TEA  Triethylamine, NEt3 
TEEDA  N,N,N′,N′-Tetraethylethylenediamine 
THF  Tetrahydrofuran 
TLC  Thin-Layer Chromatography 
TMEDA  N,N,N′,N′-Tetramethylethylenediamine 
Tol  Toluene; 4-Tolyl- group 
X  Halide (F, Br, Cl, I) or other anionic ligand (OTf) 
Z  Shorthand for any covalently bonded group on the benzylic position of η6-
tricarbonylchromium-coordinated starting materials. 
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